11.02.2014 Views

Trust Board papers November 2012 - Barking Havering and ...

Trust Board papers November 2012 - Barking Havering and ...

Trust Board papers November 2012 - Barking Havering and ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

TRUST BOARD MEETING<br />

Wednesday, 7 <strong>November</strong> <strong>2012</strong> at 1.00 pm<br />

<strong>Board</strong> Room, <strong>Trust</strong> Headquarters<br />

Queen’s Hospital<br />

A G E N D A<br />

1. Apologies for Absence<br />

2. Minutes of the meeting held on 5 September <strong>2012</strong> (Attachment A)<br />

3. Matters Arising <strong>and</strong> Actions<br />

4. GOVERNANCE:<br />

4.1 Update on <strong>Trust</strong>-wide CQC action plan (MG) (Attachment B)<br />

4.2 Information Governance (IG) Strategy <strong>2012</strong>/13 (NM) (Attachment C)<br />

4.3 <strong>Board</strong> Assurance Framework <strong>2012</strong> – Quarter 2 (MG) (Attachment D)<br />

4.4 Risk Management Strategy <strong>and</strong> Policy (MG) (Attachment E)<br />

5. QUALITY AND PATIENT STANDARDS<br />

5.1 Quality & Patient St<strong>and</strong>ards Performance Report – (Attachment F)<br />

September <strong>2012</strong><br />

5.2 Emergency Care Report (DH) (Attachment G)<br />

5.3 Maternity Services Update (DH) (Attachment H)<br />

5.4 Complaints Annual Report 2011/12 (FP-C) (Attachment I)<br />

6. FINANCE, WORKFORCE AND ACTIVITY<br />

6.1 Single Operating Model - Self certification template (NM) (Attachment J)<br />

6.2 Finance Report – Month 6 (September) <strong>2012</strong>/13 (DG) (To Follow - Attachment K)<br />

6.3 Workforce Key Performance Indicators (DH) (Attachment L)<br />

6.4 Cost Improvement Update (DH) (Attachment M)<br />

7. INFORMATION<br />

Matters for Noting:<br />

7.1 Chairman <strong>and</strong> Chief Executive’s Report (Attachment N)<br />

7.2 Minutes of the Quality & Safety Committee meeting held on (Attachment O)<br />

14 August <strong>2012</strong><br />

8. Any Other Business<br />

Date of Next Meeting: The next public meeting will be held on Wednesday,<br />

9 January 2013 at 1.00 p.m. in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

9. Questions from the Public<br />

10. Exclusion of the Public <strong>and</strong> Press In accordance with the Public Bodies Admission to Meetings<br />

Act), to resolve to exclude members of the public <strong>and</strong> press from the remainder of the meeting.<br />

<strong>Trust</strong> <strong>Board</strong> Agenda – 7 <strong>November</strong> <strong>2012</strong> 1


1<br />

BARKING, HAVERING AND REDBRIDGE UNIVERSITY<br />

HOSPITALS NHS TRUST<br />

Minutes of the Part I <strong>Trust</strong> <strong>Board</strong> Meeting held on the 5 September <strong>2012</strong><br />

in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

Present: Mr George Wood Interim Chairman<br />

Mrs Averil Dongworth Chief Executive<br />

Mr Stephen Burgess Director of Clinical Strategy & Deputy Medical Director<br />

Dr Maureen Dalziel Associate Non-Executive Director<br />

Mr William Langley Non-Executive Director<br />

Mr Keith Mahoney Non-Executive Director<br />

Mr Neill Moloney<br />

Director of Planning & Performance<br />

Prof Anthony Warrens Non-Executive Director<br />

Ms Judith Douglas Acting Director of Nursing<br />

Mr David Gilburt<br />

Interim Director of Finance<br />

Mrs Dorothy Hosein Director of Transformation<br />

Ms Caroline Wright Non-Executive Director<br />

Mr Michael White<br />

Non-Executive Director<br />

In Attendance: Mr Nick Hulme Project Director, Integration<br />

Ms Imogen Shillito<br />

Director of Communications<br />

Mrs Sue Williams<br />

Executive Assistant/<strong>Trust</strong> <strong>Board</strong> Secretary<br />

Ms Heather Wright Team Leader for Palliative Care<br />

Dr Andrew Gage<br />

Palliative Care Consultant<br />

Dr Derek Hicks<br />

Clinical Director, Emergency Care<br />

<strong>2012</strong>/042 APOLOGIES FOR ABSENCE<br />

Mrs Cathy Geddes, Chief Operating Officer, Dr Mike Gill, Medical Director <strong>and</strong> Mrs Marie Gabriel, Chair of<br />

NELC.<br />

<strong>2012</strong>/043 MINUTES OF THE PART I MEETING HELD ON 4 JULY <strong>2012</strong><br />

The minutes of the Part I meeting held on the 4 July <strong>2012</strong> were noted as a true record <strong>and</strong> signed by the<br />

Interim Chairman.<br />

<strong>2012</strong>/044 MATTERS ARISING<br />

<strong>2012</strong>/011: Quality & Safety Committee continuing to review the Patient Stories paper <strong>and</strong> would make their<br />

recommendations to the <strong>Trust</strong> <strong>Board</strong> at a future meeting.<br />

<strong>2012</strong>/045 BOARD ASSURANCE FRAMEWORK<br />

Mr Burgess presented the <strong>Board</strong> Assurance Framework (BAF) for the first quarter of <strong>2012</strong>. He confirmed<br />

that following discussions at previous <strong>Trust</strong> <strong>Board</strong> meetings <strong>and</strong> at the <strong>Trust</strong> Executive Committee, there<br />

had been a progressive journey of improvement to the BAF <strong>and</strong> the comments at these meetings had been<br />

incorporated into the latest version.<br />

Mr Wood questioned when there would be a coordinated output from the Learning Lessons Group<br />

identified against Risk No 339. The <strong>Board</strong> was informed that this Group had been established by the<br />

previous Director of Nursing <strong>and</strong> responsibility for this area had now been moved to one of the Deputy<br />

Directors of Nursing, Gary Etheridge. Ms Douglas confirmed that one meeting had taken place to date <strong>and</strong><br />

another was scheduled for mid-September. The Group were amalgamating information/intelligence from<br />

different sources in the organisation, including clinical <strong>and</strong> non-clinical, complaints, compliments, claims<br />

<strong>and</strong> safeguarding <strong>and</strong> would be preparing an action plan to go out to the Directorates <strong>and</strong> the Corporate<br />

areas for them to prioritise the main areas for resolution <strong>and</strong> to learn from the issues identified. It was<br />

agreed that the action plan would feed into the Quality & Safety Committee.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


2<br />

Following Mr White’s concerns raised around the ownership of risk management <strong>and</strong> the sequence of<br />

presenting <strong>papers</strong> to different <strong>Trust</strong> Committees, the Chief Executive confirmed that this was an area that<br />

would be picked up by the new appointment of a Director of Governance <strong>and</strong> Special Projects who would<br />

be starting with the <strong>Trust</strong> on the 10 September. The <strong>Board</strong> noted that the overall <strong>Board</strong> Assurance would<br />

report through the <strong>Trust</strong> Executive Committee <strong>and</strong> on to the <strong>Trust</strong> <strong>Board</strong>. The Clinical Governance Team<br />

was meeting with each Directorate <strong>and</strong> going through a rigorous training programme, in order to ensure<br />

that everyone understood the process. The <strong>Trust</strong>, through this new appointment, would be working<br />

towards Integrated Governance throughout the organisation.<br />

Dr Dalziel was concerned that the ‘Corporate Risks by Year’ chart did not provide a good comparison<br />

between 2011 <strong>and</strong> <strong>2012</strong> <strong>and</strong> she could not get a sense of whether the <strong>Trust</strong> had made improvements in<br />

going from quite a few risks, to less risks. The performance in 2011 looked to have doubled from the<br />

analysis in 2009 <strong>and</strong> 2010. It was agreed by the <strong>Board</strong> that when presenting this type of information, the<br />

report should include some narrative, in order to explain the trends. It was agreed that Mr Moloney,<br />

through the Performance/Information Department, would look at the quality control of information being<br />

presented to the <strong>Board</strong> to ensure it was meaningful for the members <strong>and</strong> complied with Information<br />

Governance. Dr Dalziel also felt that it was important to link these analyses to staffing <strong>and</strong> vacancy levels,<br />

as this information could not sit outside of this <strong>and</strong> needed to be linked to it in some way to ensure<br />

correlation of data.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the changes to the <strong>Board</strong> Assurance Framework.<br />

Action: Neill Moloney 7.11.12<br />

<strong>2012</strong>/046 QUALITY & PATIENT STANDARDS PERFORMANCE REPORT – JULY <strong>2012</strong><br />

Mr Moloney informed the <strong>Board</strong> that there had been three MRSA bacteraemias reported during the month,<br />

bringing the <strong>Trust</strong>’s total up to five. Unfortunately since the report had been finalised, another case had<br />

been reported, bringing the total to six, against a yearly target of seven. It was felt that the target would be<br />

breached by the end of the year.<br />

He also reported that the complaints performance had returned to ‘green’ <strong>and</strong> the <strong>Trust</strong> had achieved 87%<br />

for its response times during the month of July. Another area to note was that length of stay had improved<br />

on non-elective, but worryingly DTOCs had not reduced; increased from 4.39% in June to 4.69% in July.<br />

Mr Mahoney raised the performance for MRSA Screening <strong>and</strong> the <strong>Trust</strong>’s position compared with other<br />

<strong>Trust</strong>s. The <strong>Board</strong> noted that this area had been discussed in detail with the Directorates, both for elective<br />

<strong>and</strong> non-elective <strong>and</strong> there had been a considerable amount of work ongoing since August to ensure an<br />

improvement in performance over the next two to three months. The Emergency Department was also<br />

looking at the Emergency Medicine Decision Unit (EMDU) to capture all the patients going through there as<br />

well, so this would contribute to the improvement in performance. Mr Moloney informed the <strong>Board</strong> that it<br />

had been made very clear at the Directorate Performance Review meetings recently that the performance<br />

against this target had to improve. The Interim Deputy Director of Nursing, Gary Etheridge had taken on<br />

responsibility for patient experience <strong>and</strong> he was currently taking a different approach to the implementation<br />

of the h<strong>and</strong> held devices, in order to encourage both patients <strong>and</strong> their relatives to complete the<br />

questionnaires. The <strong>Board</strong> agreed that this had to be part of the discharge process, so the <strong>Trust</strong> had some<br />

good quality data to refer to.<br />

The Interim Chairman raised his concerns regarding the drop in performance for appraisals (72.69%, a<br />

drop of 3.71% on last month’s position) <strong>and</strong> whether this meant that the <strong>Trust</strong> had a large number of staff in<br />

the organisation who did not have their objectives set for the next year. The <strong>Board</strong> agreed that it was very<br />

important for staff to have their objectives set, in order to performance manage people appropriately. It had<br />

been agreed at a previous <strong>Board</strong> meeting that Clinical Directors would ensure appraisals <strong>and</strong> objectives<br />

were aligned <strong>and</strong> cascaded down through their Directorates. The Chief Executive would take this up with<br />

the two Executive Directors currently covering the Chief Operating Officer’s responsibilities, namely Mrs<br />

Hosein <strong>and</strong> Mr Hulme, to ensure that the Associate Directors <strong>and</strong> other senior management had their<br />

objectives. The Chief Executive would provide the appropriate evidence for the <strong>Board</strong>.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


3<br />

Following Dr Dalziel’s comments regarding staff turnover <strong>and</strong> sickness absence, Mr Moloney confirmed<br />

that the <strong>Trust</strong>’s position was lower than the National average <strong>and</strong> it was the organisation’s ambition to<br />

reduce sickness absence down to the London average of 3.6%. The <strong>Trust</strong> had looked at other <strong>Trust</strong>s<br />

where they had been successful in addressing sickness absence <strong>and</strong> a Sickness Absence Plan paper had<br />

been prepared for the private <strong>Trust</strong> <strong>Board</strong> meeting later in the day. It was also agreed that Mrs Hosein<br />

<strong>and</strong> Mr Moloney would arrange for the staff turnover figure to be validated, as the trend indicated that this<br />

was going up.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the content of the report <strong>and</strong> supported the actions to bring the performance back in<br />

line with trajectory/target.<br />

Action: Averil Dongworth 7.11.12<br />

Dorothy Hosein/Neill Moloney 7.11.12<br />

<strong>2012</strong>/047 EMERGENCY CARE/RESET PROGRAMME UPDATE<br />

Dr Derek Hicks, Clinical Director for Emergency Care, attended the meeting to answer questions on the<br />

update report. He confirmed that the recent changes in the Department should allow the <strong>Trust</strong> to sustain<br />

<strong>and</strong> remain on the current trajectory. The Interim Chairman raised his concerns regarding patients being<br />

left to the last five minutes of the 4 hours, even when beds were available, leaving little room for<br />

unexpected events. It was agreed a cultural change was required by everyone, as there had in the past<br />

been no pressure to move patients as soon as a decision was made. This was happening in some areas<br />

more than others <strong>and</strong> the <strong>Trust</strong> was looking at Consultants <strong>and</strong> Senior Nurses performances to see if there<br />

were any patterns of behaviour that could be addressed, in order to make people accountable for these<br />

delays. Following a point raised by the Interim Chairman, it was noted that although it was not within the<br />

<strong>Trust</strong>’s remit to amend Health Needs Assessment Forms, it was pushing to have them changed/modified to<br />

reduce the time it took to complete them. The <strong>Trust</strong> was also undertaking a lot of work with the Wards, in<br />

order to alleviate what was an onerous task with the double entry of data. This was an area that would be<br />

rectified with the implementation of the new PAS, but in the meantime the <strong>Board</strong> asked the IT Department<br />

to look into a short term solution that would minimise the time involved.<br />

Mr Langley raised the issue of inappropriate admissions <strong>and</strong> if there was a periodic Audit to check these.<br />

Dr Hicks confirmed that there was an increase in senior presence in the Department now <strong>and</strong> patients<br />

would be filtered more effectively. He also informed the <strong>Board</strong> that there were better controls for<br />

managing patients in the Emergency Department <strong>and</strong> the Medical Assessment Unit <strong>and</strong> the recruitment<br />

programme was quite well advanced, which would enable the organisation to take out more bank <strong>and</strong><br />

agency staff. Mr White commented on the low number of discharges pre-11.00 a.m. <strong>and</strong> was concerned<br />

that the <strong>Trust</strong> had the right processes in place to deal with these. As the discharges remained low, Mr<br />

White questioned whether the Discharge Lounge was working as well as the <strong>Trust</strong> expected it to. Dr Hicks<br />

informed the <strong>Board</strong> that the organisation was trying to get flow throughout the day <strong>and</strong> there were a lot of<br />

initiatives around discharging patients pre-11.00 a.m. <strong>and</strong> for using the Discharge Lounge. Discharges<br />

were coming up late in the day, so the <strong>Trust</strong> would be looking at how many discharges were required by<br />

11.00 a.m. <strong>and</strong> would be holding people to account for this. The <strong>Board</strong> noted that the new Medical<br />

Director, Dr Mike Gill, would be undertaking two sessions in the Emergency Department around Care of<br />

the Elderly, in order to assist in turning these patients around much quicker <strong>and</strong> ensuring appropriate<br />

admissions were being made. From next week there would be a Care of the Elderly Consultant in the<br />

Emergency Department everyday. The <strong>Trust</strong> had undertaken an Audit last year, in conjunction with the<br />

local GPs, to look at the quality of admissions <strong>and</strong> this exercise was going to be repeated again this year.<br />

This would provide a healthy clinical challenge with GPs <strong>and</strong> the <strong>Trust</strong>’s clinicians looking at BHRUT’s<br />

practice <strong>and</strong> would provide the evidence that the <strong>Trust</strong> was not inappropriately admitting patients.<br />

Mr White referred to the next steps for the improvement in the emergency pathway; ‘create joint team with<br />

community <strong>and</strong> social care to completely redesign <strong>and</strong> manage complex frail patients’ <strong>and</strong> questioned the<br />

<strong>Trust</strong>’s confidence in having this process in place to prevent some of the problems experienced last Winter.<br />

It was confirmed that this was an ongoing process <strong>and</strong> there were daily Jonah meetings, monthly Cross<br />

Buffer Group meetings <strong>and</strong> the <strong>Trust</strong> was just about to commence weekly meetings with the Cluster to<br />

strengthen processes, in order to get the patients discharged as soon as possible. The <strong>Board</strong> noted that<br />

last week the <strong>Trust</strong> had eleven/twelve patients waiting for community beds <strong>and</strong> the problem was going to<br />

get significantly worse. The <strong>Board</strong> therefore asked for a document to be prepared that showed the <strong>Trust</strong>’s<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


4<br />

forecast in terms of community bed requirements, including the plans the Cluster was going to put in place<br />

to bridge the gap in available community beds. It was noted that the <strong>Trust</strong> was developing its own Winter<br />

Plan <strong>and</strong> it was agreed that the Director of Transformation would bring back the composite plan, based on<br />

credible data, to the next meeting, in order to provide the <strong>Board</strong> with the evidence it required. Executive<br />

Directors of BHRUT would be meeting with the Cluster for a Clinical Strategy Day on the 21 September, in<br />

order to share the work on their different Workstreams <strong>and</strong> use it as a good opportunity to highlight the<br />

issues; admission criteria into nursing homes <strong>and</strong> lack of community beds. This engagement would assist<br />

in bringing all of this to a conclusion before Winter arrived.<br />

Dr Dalziel raised the issue of how the organisation presented performance information <strong>and</strong> whether targets<br />

were right, as with the <strong>Trust</strong>’s previous experience, it should have more of a feel around realistic targets<br />

<strong>and</strong> should not be over estimating what is considered to be an achievable target/performance level. She<br />

felt that the <strong>Trust</strong> should be transparent about what was reasonable <strong>and</strong> how it presented this externally,<br />

otherwise it would always look like it had failed.<br />

The Chief Executive informed the <strong>Board</strong> that she would be attending a meeting tomorrow with the<br />

Consultant Physicians regarding seven day working. There was also a Surgery ‘Awayday’ planned for<br />

tomorrow where they would be looking at how the Surgeons would provide 7/7 working. The <strong>Board</strong> noted<br />

that by the end of the financial year, the Consultants should be working twelve hour shifts <strong>and</strong> have 7/7<br />

working in place.<br />

The Outline Business Case (OBC), which included the closure of the Emergency Department at King<br />

George Hospital, had not yet been completed, but Ernst & Young was working with the <strong>Trust</strong> to put<br />

together a plan for Queen’s <strong>and</strong> King George Hospitals, which would include the cost of moving A&E<br />

across from KGH to Queen’s. The OBC should be completed by the end of October/beginning of<br />

<strong>November</strong> <strong>and</strong> would be made available for the public to review.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the update.<br />

Action: Averil Dongworth 7.11.12<br />

Dorothy Hosein 7.11.12<br />

<strong>2012</strong>/048 MATERNITY SERVICES UPDATE<br />

The <strong>Trust</strong> <strong>Board</strong> noted the content of the Maternity Services Monthly Performance Report covering the<br />

period 1 July to 31 July <strong>2012</strong>. At previous <strong>Board</strong> meetings Ms Wright had raised the issue of data<br />

recorded for the ‘Out of Hours’ Obstetric Assessment Unit (OAU) not being robust <strong>and</strong> wanted to know<br />

when this would be addressed, as there did not appear to be any explanation for her to know that this was<br />

being h<strong>and</strong>led appropriately <strong>and</strong> the <strong>Board</strong> had reliable information to monitor performance against. In the<br />

current format it was difficult to assess whether there had been any improvement, or not.<br />

The timing of Caesarean Section (C/S) Deliveries according to acuity were discussed <strong>and</strong> it was noted by<br />

the <strong>Board</strong> that delays attributed to clinicians/anaesthetists required elsewhere, due to a busy Labour Ward<br />

<strong>and</strong> Theatres, was stated as being in the top three reasons for delays. The <strong>Board</strong> agreed that it would be<br />

helpful for them to underst<strong>and</strong> the proportion of these delays by Grade 1, Grade 2 <strong>and</strong> Grades 3 & 4 <strong>and</strong><br />

what took precedence over these C/S’s. The Chief Executive agreed to look into this <strong>and</strong> to report back to<br />

the <strong>Trust</strong> <strong>Board</strong>. Mrs Dongworth would also seek assurance from the Directorate that the clinical fellow<br />

pathway had been implemented on the 30 July <strong>2012</strong>.<br />

The transfer of some of the <strong>Trust</strong>’s midwives, due to the changes in boundaries, was discussed <strong>and</strong> the<br />

Chief Executive informed the <strong>Board</strong> that there would be further discussions regarding this later this week.<br />

Mr Mahoney highlighted to the <strong>Board</strong> that he had concerns around the TUPE across of midwives to other<br />

<strong>Trust</strong>s in the Cluster, when the births at BHRUT had increased for the second month <strong>and</strong> the organisation<br />

was still delivering over 9k, although the <strong>Trust</strong> had been assured by the Commissioners that this would not<br />

be the case by the end of the financial year.<br />

The <strong>Board</strong> agreed that it was important to have agreement on the Workforce Plan for the future, in order to<br />

ensure a safe service was operating, but the Directorate was not over resourced <strong>and</strong> left with str<strong>and</strong>ed<br />

costs. The <strong>Board</strong> noted that the Clinical Director for Maternity <strong>and</strong> the Director of Midwifery had been<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


5<br />

working with the Cluster over the last few months to ensure the <strong>Trust</strong> was confident that it would be<br />

operating a safe service by the time it opened the Midwifery Led Unit <strong>and</strong> closed Maternity Services on the<br />

King George Hospital site. A shift in the practice of women being referred from GPs to the different<br />

catchment areas was already evident, but it was agreed that it would be useful for members of the <strong>Board</strong> to<br />

receive a much more detailed briefing paper/visual schematic outlining all of this, in order that it could be<br />

explicitly understood <strong>and</strong> risk managed, as it was a very complex plan.<br />

The Commissioners had been informed that BHRUT felt that it was really important to get everything right<br />

before signing up to any plan that would put its patients at risk.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the content of the report.<br />

Action: Averil Dongworth 7.11.12<br />

<strong>2012</strong>/049 BARKING & DAGENHAM SAFEGUARDING CHILDREN BOARD (BDSCB) ANNUAL<br />

REPORT 2011/12<br />

Ms Douglas presented the <strong>Barking</strong> & Dagenham Safeguarding Children <strong>Board</strong> Annual Report for 2011/12.<br />

Several questions from the report were raised by members of the <strong>Board</strong>, including the Interim Chairman’s<br />

reference to the Child Death Overview Panel looking at trends <strong>and</strong> patterns <strong>and</strong> making recommendations,<br />

but it was not evident from the report what these recommendations, or trends, actually were. The <strong>Board</strong><br />

agreed it was important for the <strong>Trust</strong> to follow through on any actions required <strong>and</strong> to support the Local<br />

Authority in the identification of any trends.<br />

Mr White commented that this report only referred to one Safeguarding <strong>Board</strong> <strong>and</strong> he wanted assurance<br />

that the <strong>Trust</strong> was represented on the <strong>Board</strong>s of other Boroughs. He also referred to the <strong>Trust</strong>’s<br />

attendance on the Training Programme, as the report was indicating zero for BHRUT. Ms Douglas<br />

confirmed that the <strong>Trust</strong> had a very robust in-house Training Programme for Safeguarding Children <strong>and</strong><br />

Safeguarding Adults <strong>and</strong> reassured the <strong>Board</strong> members that BHRUT did have representation at each<br />

Borough’s Safeguarding <strong>Board</strong> meetings. The Director of Nursing was a member of each <strong>Board</strong> <strong>and</strong> Ms<br />

Douglas would ensure, when the new Director of Nursing arrived, that appropriate representation was<br />

timetabled for Executive Director attendance across all Boroughs. The <strong>Trust</strong> was committed to delivering<br />

its role in the Safeguarding agenda <strong>and</strong> apart from one meeting when Ms Wheeler was not available, the<br />

<strong>Trust</strong> now had much better representation at these meetings, <strong>and</strong> would be more of an active partner in the<br />

future.<br />

The <strong>Board</strong> agreed that once all the Local Borough reports had been received the Nursing Directorate<br />

would identify someone to sit down <strong>and</strong> cross reference them all to make sure the <strong>Trust</strong> was meeting its<br />

commitments in a timely way. It was also agreed that there would be a more comprehensive discussion<br />

around this subject at a future <strong>Board</strong> meeting, in order to pro-actively comment on these reports. The<br />

<strong>Board</strong> asked for a list of forthcoming reports to be prepared, so the <strong>Board</strong> was aware of the publication<br />

dates, prior to them being issued.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Annual Report.<br />

Action: Judith Douglas 7.11.12<br />

<strong>2012</strong>/050 BHRUT TFA COMPOSITE PLAN<br />

Mr Moloney presented the revised TFA Composite Plan, which had now been signed off by the Cluster <strong>and</strong><br />

NHS London. The content was similar to what had been included in the Performance Report <strong>and</strong> what had<br />

been presented previously to the <strong>Board</strong>, although there were a number of key milestones that required a<br />

due date for delivery to be inserted in the plan. The <strong>Trust</strong> would now be reporting to NHS London on a<br />

monthly basis.<br />

Some milestones had been removed, as they had already been delivered <strong>and</strong> to a large extent the <strong>Trust</strong><br />

was now rated ‘amber’ or ‘green’. The <strong>Trust</strong> would be closely monitoring the timeframes for delivery<br />

through to the end of the financial year. Following a comment from Dr Dalziel, Mr Moloney would arrange<br />

for the TFA to indicate the trends on the key milestones, in order to make the current position much clearer.<br />

Mr Gilburt would ensure that the summary progress in the Financial Viability section was aligned to the<br />

Finance Report, as there was a discrepancy on the figure relating to the Cost Improvement Programme.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


6<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Plan for the period ending August <strong>2012</strong>.<br />

Action: Neill Moloney 30.9.12<br />

David Gilburt 30.9.12<br />

<strong>2012</strong>/051 FINANCE REPORT – MONTH 4 (JULY) <strong>2012</strong>/13<br />

Mr Gilburt highlighted the key points in the Finance Report for Month 4. The <strong>Trust</strong> was reporting a year to<br />

date deficit of £16.9m, excluding impairments <strong>and</strong> IFRS adjustment, against the year end control total of<br />

£40m. The deficit in month was £3.9m, which was ahead of where the <strong>Trust</strong> wanted to be <strong>and</strong> it was<br />

therefore taking measures to bring the in month expenditure down. Further short term actions were also<br />

being implemented to put a ‘cap’ on discretionary spending within the organisation, in order to get back on<br />

track. The <strong>Board</strong> noted that the agreed income re-profiling had been fully reflected in the position.<br />

Mr Gilburt reported that there was a credible plan for delivery of £17m CIPs <strong>and</strong> the <strong>Trust</strong> had identified<br />

other schemes to address the £6m gap. At present it was not clear that these schemes would deliver this<br />

year <strong>and</strong> it was therefore undertaking some further work on this with Ernst & Young. He also informed the<br />

<strong>Board</strong> that the <strong>Trust</strong> was doing a lot of work with the Commissioners around payment for the over<br />

performance in activity going through the <strong>Trust</strong>. Mr Gilburt confirmed that the Commissioners were being<br />

very cooperative in these discussions regarding the funding of the over performance <strong>and</strong> this would play a<br />

key part in the <strong>Trust</strong> delivering its financial target. The <strong>Trust</strong> was also talking to NHS London regarding PFI<br />

funding, which had been previously indicated <strong>and</strong> the <strong>Trust</strong> was doing everything they were being asked to<br />

do to get NHS London to release this funding, which could result in a lower control total at the end of the<br />

year.<br />

Following an issue raised by Mr Langley regarding procurement, Mr Gilburt confirmed that all purchases<br />

had to go through the central procurement route <strong>and</strong> had to have a purchase order. Suppliers had been<br />

informed that unless they had an official purchase order they would not be paid <strong>and</strong> there were<br />

arrangements in place to follow this process. As previously advised, the Capital Programme had been<br />

frozen, but there were ongoing schemes that the <strong>Trust</strong> had contractually signed up to, or were clinically<br />

essential, that were going ahead. Mr Gilburt <strong>and</strong> Mr Moloney were taking a rigorous look at the<br />

Programme <strong>and</strong> had arranged for a review meeting to take place next week to look at priority schemes, as<br />

the organisation was reluctant to sign-off any additional schemes until this review had taken place.<br />

Mr Gilburt highlighted that the <strong>Trust</strong> had recently received an injection of cash from the Commissioners <strong>and</strong><br />

would be monitoring cash flow carefully up to the end of the financial year.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the report.<br />

Action: David Gilburt/Neill Moloney 7.11.12<br />

<strong>2012</strong>/052 WORKFORCE KEY PERFORMANCE INDICATORS – JULY <strong>2012</strong><br />

Mrs Hosein informed the <strong>Board</strong> that the <strong>Trust</strong>’s sickness absence rate for the month of July had increased<br />

by 0.59% on the June position, increasing from 4% to 4.59%, but had decreased by 0.46% when compared<br />

to the same period last year. She reported that there was a lot of work ongoing with the Wards regarding<br />

short term sickness <strong>and</strong> the <strong>Trust</strong> was also strengthening the governance around vacancies <strong>and</strong><br />

scrutinising the recruitment of new staff. The <strong>Board</strong> acknowledged that there would continue to be a level<br />

of recruitment, in order to bring down the bank/agency staff numbers.<br />

In terms of workforce, Mrs Hosein reported that the <strong>Trust</strong> would be reviewing a lot of its policies, in<br />

conjunction with the Joint Staff Committee, now the new Head of Workforce Transformation was in post.<br />

The <strong>Board</strong> noted that the difference in the workforce numbers reported in this report <strong>and</strong> the Finance<br />

Report was due to the <strong>Trust</strong> having to report staff that had transferred to Sodexo under ROE, as these<br />

members of staff maintained their terms <strong>and</strong> conditions of employment with BHRUT.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the report.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


7<br />

<strong>2012</strong>/053 TRANSFORMATION BOARD UPDATE<br />

Mrs Hosein informed the <strong>Board</strong> that against the CIP target of £23.1m, the <strong>Trust</strong> had identified £17.6m,<br />

following a review carried out by Ernst & Young. Further schemes were being worked on to address the<br />

gap <strong>and</strong> the Project Management Office/Service Transformation Team was working with the Workstream<br />

Leads to strengthen the existing schemes, in order to ensure delivery.<br />

The Programme had delivered the target for last month <strong>and</strong> would be working towards achieving a £2m run<br />

rate by the end of March. One Ward had been closed <strong>and</strong> the Team was currently working up a further<br />

proposal to close another Ward. Accountability meetings with the SRO’s were continuing to ensure the<br />

Programme was kept on track. The <strong>Board</strong> was asked to refer to a table within the Finance Report, which<br />

set out the workstreams <strong>and</strong> the deliverables for the CIP.<br />

Mr Langley raised the issue of improving <strong>and</strong> embedding controls in relation to bank <strong>and</strong> agency staff <strong>and</strong><br />

Mrs Hosein confirmed that a lot of work had been put into this with the Wards <strong>and</strong> they would now be<br />

concentrating <strong>and</strong> drilling down on the medical spend. Each Directorate had been asked to identify their<br />

medical staff expenditure <strong>and</strong> to come back with their short, medium <strong>and</strong> long term actions on how they<br />

would reduce their bank <strong>and</strong> agency spend in this area, albeit there were obviously still recruitment issues<br />

in some areas, e.g. Emergency Department.<br />

The <strong>Trust</strong> <strong>Board</strong> noted the update report.<br />

<strong>2012</strong>/054 ANNUAL AUDIT LETTER 2011/12<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Annual Audit Letter 2011/12 submitted to the <strong>Trust</strong> from the Audit Commission.<br />

<strong>2012</strong>/055 END OF LIFE CARE ADVISORY BOARD – BRIEFING PAPER<br />

Ms Heather Wright, Team Leader for Palliative Care <strong>and</strong> Dr Andrew Gage, Palliative Care Consultant<br />

presented their end of life video. Dr Gage informed the <strong>Board</strong> that along with Dr Claire Bates, they had<br />

developed the End of Life Care (EOLC) Advisory <strong>Board</strong> (ELCAB), which aimed to facilitate the<br />

implementation of the EOLC Strategy (2008) <strong>and</strong> NICE End of Life Quality St<strong>and</strong>ards (2011) within the<br />

<strong>Trust</strong>. The Strategy was comprehensive <strong>and</strong> would assist the <strong>Trust</strong> in improving practices in the short term<br />

<strong>and</strong> for the longer term change the culture of End of Life Care. Dr Gage highlighted that there were a high<br />

number of deaths in Outer North East London (ONEL), compared with the rest of the Country <strong>and</strong> the<br />

ONEL community palliative care services were poorly resourced, with inequity across the Boroughs. The<br />

<strong>Board</strong> noted that there was a CQUIN for EOLC, which commenced in April this year following negotiation<br />

with the Commissioners to ensure there was a realistic, but challenging goal agreed (c.£478k to the <strong>Trust</strong>).<br />

It was acknowledged that the education of Doctors was important <strong>and</strong> they had developed a bespoke DVD<br />

for the ‘Dying Matters Week’ in order to empower <strong>and</strong> support <strong>Trust</strong> clinicians to take on the responsibility<br />

themselves. Ms Wright informed the <strong>Board</strong> that the Dying Matters Coalition wanted to put the <strong>Trust</strong>’s DVD<br />

on their website, after addressing any copyright issues.<br />

The <strong>Board</strong> was advised that there were Borough Facilitators who trained staff in the nursing <strong>and</strong> residential<br />

homes, but access to specialist palliative care seven days a week, or ’out of hours’, was difficult, as the<br />

community <strong>and</strong> the acute sector were not joined up at the moment.<br />

The Directorate had been highlighting since 2004 the requirement for an additional nurse at the <strong>Trust</strong>. The<br />

organisation also needed to address the under resourcing of specialist beds. The number of in hospital<br />

deaths occurring on the Liverpool Care Pathway was raised by the Interim Chairman, as well as the<br />

available bed base. Dr Gage confirmed that the current figure for these beds in this locality was three per<br />

100k population, against seven in Tower Hamlets <strong>and</strong> 4.55 for the <strong>Trust</strong>, which was below the National<br />

average. Dr Gage also informed the <strong>Board</strong> that Redbridge <strong>and</strong> Waltham Forest were under resourced for<br />

24 hour cover. Mr Wood would take this up outside of the meeting, in order to assist in moving things<br />

forward in this area.<br />

It was noted that this paper had not been through the normal channels <strong>and</strong> discussions had not taken<br />

place at Executive Director level. The Quality & Safety Committee would therefore review the issues<br />

raised <strong>and</strong> recommend the appropriate actions to be taken.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


8<br />

The Co-Chair of the Improving Patient Experience Group (IPEG) Mrs Elaine Clarke raised the point that<br />

there was no provision for End of Life Care for patients with long term conditions, as with these patients it<br />

was difficult to assess when they would die. The Quality & Safety Committee would also consider this<br />

cohort of patients <strong>and</strong> provide the <strong>Board</strong> with their recommendations.<br />

The <strong>Board</strong> noted the key achievements during 2011/12 <strong>and</strong> the work now in progress.<br />

The <strong>Trust</strong> <strong>Board</strong> agreed that the Quality & Safety Committee should discuss <strong>and</strong> agree the named<br />

Executive <strong>Trust</strong> Lead for End of Life Care <strong>and</strong> this individual would chair the End of Life Care Advisory<br />

<strong>Board</strong> (previously chaired by the Director of Nursing).<br />

Action: Caroline Wright/Anthony Warrens 7.11.12<br />

<strong>2012</strong>/056 DEMENTIA STRATEGY – PHASE 2<br />

Ms Douglas presented the Dementia Strategy – Phase 2, which included meeting the National CQUIN <strong>and</strong><br />

the roll out of the Butterfly Scheme. All the work in the Dementia Strategy would be undertaken in<br />

conjunction with the Elderly Care Strategy.<br />

The Dementia Strategy was launched in 2010 <strong>and</strong> following a gap analysis against the National Dementia<br />

Strategy, 17 key objectives were agreed. Ms Douglas informed the <strong>Board</strong> that a Dementia Steering Group<br />

had been established <strong>and</strong> an Action Plan agreed. She also confirmed that the <strong>Trust</strong>’s overall<br />

responsibilities would be monitored through the Action Plan, in order to ensure a smooth pathway from the<br />

community into hospital. BHRUT had worked with North East London Foundation <strong>Trust</strong> (NELFT), as they<br />

were the leading partner for this Strategy. This Strategy was part of the operational plan requirements<br />

from the Department of Health to improve Dementia Services for all. The <strong>Board</strong> agreed it would be useful<br />

to see the framework of the organisations involved, in order to underst<strong>and</strong> the structure.<br />

It was noted by the <strong>Board</strong> that the Borough of <strong>Havering</strong> had the highest population numbers in this<br />

category <strong>and</strong> this was going to increase by at least 15% over the next ten to fifteen years. The <strong>Trust</strong><br />

therefore needed to prepare for this <strong>and</strong> be assured that someone would be taking this on, as the <strong>Board</strong><br />

did not currently have confidence that the organisation was in a position to meet the challenges that would<br />

present themselves over the coming years. The Chief Executive advised the <strong>Board</strong> that she would be<br />

attending an Integrated Care Coalition meeting with members of the Cluster tomorrow <strong>and</strong> she would<br />

ensure that the <strong>Board</strong>’s concerns were raised there.<br />

Dr Dalziel referred to the earlier End of Life presentation <strong>and</strong> the requirement for both of these to be linked<br />

in a different cultural approach towards people dying, whether they had dementia or not. A lot of patients<br />

were at home, rather than in hospital, <strong>and</strong> it should be acknowledged that this was quite complicated <strong>and</strong><br />

needed to be brought together in some way.<br />

The Interim Chairman raised the point relating to Discharge Coordination rated ‘red’ in the Action Plan <strong>and</strong><br />

the requirement for a <strong>Trust</strong> Lead to be agreed as part of the restructure. Ms Douglas confirmed to the<br />

<strong>Board</strong> that there was a lot of work ongoing on the Wards regarding the discharge coordination of patients<br />

with dementia, in order to ensure patients were being discharged appropriately. The identification of a<br />

<strong>Trust</strong> Lead was obviously a priority, as the Action Plan stated the timescale as January <strong>2012</strong>. Questions<br />

were raised as to why this timescale had slipped <strong>and</strong> how this fitted into the whole Governance<br />

Framework. The <strong>Board</strong> agreed that Ms Douglas would go back <strong>and</strong> review with the relevant clinicians if<br />

there was a case to recruit someone for this post, or for Dr Mike Gill, the Medical Director, to be the Lead.<br />

Mr Langley referred to a further ‘red’ rated theme on the Expected Outcome Measures in relation to<br />

Improved patient <strong>and</strong> carer experience <strong>and</strong> the outcome noted as ‘data non specific for dementia’. He had<br />

concerns that there was insufficient measurement criteria to provide comfort to the <strong>Board</strong>. Ms Douglas<br />

agreed that there was some work to do on this linking to the patient pathway <strong>and</strong> the Butterfly Scheme <strong>and</strong><br />

she informed the <strong>Board</strong> that this would all be tied together.<br />

The <strong>Board</strong> noted the impact of dementia <strong>and</strong> the staggering numbers involved with 700k people living with<br />

dementia in Engl<strong>and</strong>, with this number likely to double over the next thirty years, costing the UK economy<br />

£17bn per year. With the expected increase in patients, the costs in the next thirty years would rise to<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


9<br />

£50bn a year. It was also noted by the <strong>Board</strong> that the number of people over the age of 65 would increase<br />

by 15% <strong>and</strong> over age 85 would increase by 27%. With the number of older people in the population<br />

continuing to rise, it was likely the future cost of dementia care would increase considerably.<br />

The <strong>Board</strong> agreed that all reports of this nature should be presented to the Quality & Safety Committee,<br />

prior to coming to the <strong>Trust</strong> <strong>Board</strong>.<br />

The <strong>Trust</strong> <strong>Board</strong> supported the ongoing development of the work <strong>and</strong> agreed that Ms Douglas would look<br />

into who would be the Executive Champion/Lead for Dementia/Elderly Care.<br />

<strong>2012</strong>/057 MATTERS FOR NOTING:<br />

INTERIM CHAIR AND CHIEF EXECUTIVE’S REPORT<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Interim Chair <strong>and</strong> Chief Executive’s Report.<br />

<strong>2012</strong>/058 DECLARATION OF MEMBERS’ INTERESTS <strong>2012</strong>/13 UPDATE<br />

The <strong>Trust</strong> <strong>Board</strong> noted the Declaration of Members’ Interests <strong>2012</strong>/13 Update.<br />

Action: Averil Dongworth 6.9.12<br />

Judith Douglas 7.11.12<br />

<strong>2012</strong>/059 MINUTES OF THE QUALITY & SAFETY COMMITTEE MEETING HELD ON THE<br />

12 JUNE <strong>2012</strong><br />

The <strong>Trust</strong> <strong>Board</strong> noted the minutes of the Quality & Safety Committee meeting held on the 12 June <strong>2012</strong>.<br />

<strong>2012</strong>/060 MINUTES OF THE CHARITABLE FUNDS COMMITTEE MEETING HELD ON THE<br />

29 MAY <strong>2012</strong><br />

The <strong>Trust</strong> <strong>Board</strong> noted the minutes of the Charitable Funds Committee meeting held on the 29 May <strong>2012</strong>.<br />

<strong>2012</strong>/061 ANY OTHER BUSINESS<br />

No further business.<br />

Meeting closed at 3.30 p.m.<br />

The next meeting of the <strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong> Redbridge University Hospitals NHS <strong>Trust</strong> <strong>Board</strong> will take<br />

place on Wednesday, 7 <strong>November</strong> <strong>2012</strong> in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital.<br />

<strong>Trust</strong> <strong>Board</strong> Minutes Part I – 5 September <strong>2012</strong>


TRUST BOARD MEETING<br />

Actions from Minutes of Part I meeting held on 5 September <strong>2012</strong><br />

in the <strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

Agenda Item Action Deadline<br />

Date<br />

Date<br />

Completed/Upd<br />

ate/<br />

Agenda Item<br />

<strong>2012</strong>/011<br />

(Issues for<br />

Escalation from<br />

Quality & Safety<br />

Committee)<br />

<strong>2012</strong>/031<br />

(Learning Disability<br />

Progress Report)<br />

<strong>2012</strong>/032<br />

(Milestone<br />

Tracker/Composite<br />

Plan)<br />

<strong>2012</strong>/045<br />

(<strong>Board</strong> Assurance<br />

Framework)<br />

Review Patient Stories paper at<br />

Quality & Safety Committee <strong>and</strong><br />

prepare proposal for <strong>Trust</strong> <strong>Board</strong><br />

members to review at<br />

September <strong>Trust</strong> <strong>Board</strong> meeting.<br />

Check mechanisms in place in<br />

each Borough regarding health<br />

checks for people with learning<br />

disabilities.<br />

Draft OBC to be presented at<br />

August <strong>Trust</strong> <strong>Board</strong> meeting.<br />

Review quality control of<br />

information being presented to<br />

the <strong>Board</strong> <strong>and</strong> ensure it<br />

complies with Information<br />

Governance.<br />

CW/AW 5.9.12 Deferred<br />

PW 5.9.12<br />

(advise SW when<br />

proposal ready to<br />

present)<br />

NH 1.8.12 Deferred to<br />

<strong>November</strong><br />

NM 7.11.12 7.11.12<br />

<strong>2012</strong>/046<br />

(Quality & Patient<br />

St<strong>and</strong>ards<br />

Performance<br />

Report – July <strong>2012</strong>)<br />

Ensure Clinical Directors<br />

objectives are set <strong>and</strong> they are<br />

cascading down through their<br />

Directorates.<br />

Review staff turnover figure, as<br />

trend indicated this was going<br />

up.<br />

AD<br />

DH/NM<br />

7.11.12<br />

7.11.12<br />

7.11.12<br />

7.11.12<br />

<strong>2012</strong>/047<br />

(Emergency<br />

Care/RESET<br />

Programme Update<br />

Arrange for the IT Department to<br />

review the double entry of data<br />

for Health Needs Assessment<br />

Forms <strong>and</strong> look at a short term<br />

solution that could minimise the<br />

time involved in completing<br />

these.<br />

Composite Plan around <strong>Trust</strong>’s<br />

forecast for community beds, in<br />

AD<br />

DH<br />

7.11.12<br />

7.11.12<br />

7.11.12<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


Agenda Item Action Deadline<br />

Date<br />

Date<br />

Completed/Upd<br />

ate/<br />

Agenda Item<br />

<strong>2012</strong>/048<br />

(Maternity Services<br />

Update)<br />

<strong>2012</strong>/049<br />

(<strong>Barking</strong> &<br />

Dagenham<br />

Safeguarding<br />

Children <strong>Board</strong><br />

(BDSCB) Annual<br />

Report 2011/12)<br />

<strong>2012</strong>/050<br />

(BHRUT TFA<br />

Composite Plan)<br />

<strong>2012</strong>/051<br />

(Finance Report –<br />

Month 4 (July)<br />

<strong>2012</strong>/13)<br />

<strong>2012</strong>/055<br />

(End of Life Care<br />

Advisory <strong>Board</strong> –<br />

Briefing Paper)<br />

<strong>2012</strong>/056<br />

(Dementia Strategy<br />

– Phase 2)<br />

relation to Winter Plan, including<br />

plans the Cluster is putting in<br />

place to bridge the gap in<br />

available community beds, to be<br />

presented at the <strong>November</strong><br />

<strong>Board</strong> meeting.<br />

Review reasons for delays for<br />

C/S deliveries, by Grade, <strong>and</strong><br />

report back to the <strong>Board</strong> at the<br />

next meeting in <strong>November</strong>.<br />

Ensure there is a timetable for<br />

appropriate Executive Director<br />

representation at Safeguarding<br />

<strong>Board</strong> meetings, across all<br />

Boroughs.<br />

Prepare a list of forthcoming<br />

reports, so the <strong>Board</strong> is aware of<br />

the publication dates for these,<br />

prior to them being issued.<br />

Arrange for the TFA to indicate<br />

the trends on the key<br />

milestones.<br />

Ensure the summary progress in<br />

the Financial Viability section is<br />

aligned to the Finance Report.<br />

Review Capital Programme to<br />

identify priority schemes.<br />

Quality & Safety Committee to<br />

consider the cohort of patients<br />

with long term conditions in<br />

relation to their End of Life Care<br />

<strong>and</strong> provide the <strong>Board</strong> with their<br />

recommendations for addressing<br />

this.<br />

Agree Executive <strong>Trust</strong> Lead for<br />

End of Life Care at the next<br />

Quality & Safety Committee<br />

meeting <strong>and</strong> advise <strong>Board</strong><br />

members.<br />

Attend Integrated Care Coalition<br />

meeting <strong>and</strong> raise <strong>Board</strong>’s<br />

concerns in relation to the<br />

challenge ahead for patients<br />

with Dementia, considering the<br />

AD 7.11.12 7.11.12<br />

JD<br />

JD<br />

NM<br />

DG<br />

7.11.12<br />

7.11.12<br />

30.9.12<br />

30.9.12<br />

7.11.12<br />

7.11.12<br />

Format of plan<br />

has now<br />

changed.<br />

30.9.12<br />

DG/NM 7.11.12 Review has<br />

taken place <strong>and</strong><br />

has been<br />

presented to<br />

the Finance<br />

Committee<br />

CW/AW<br />

CW/AW<br />

7.11.12<br />

7.11.12 7.11.12<br />

AD 6.9.12 6.9.12<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


Agenda Item Action Deadline<br />

Date<br />

Date<br />

Completed/Upd<br />

ate/<br />

Agenda Item<br />

increasing population numbers.<br />

Agree an Executive<br />

Champion/Lead for<br />

Dementia/Elderly Care <strong>and</strong><br />

advise <strong>Board</strong> members (as<br />

above).<br />

JD 7.11.12 7.11.12<br />

Chairman …………………<br />

Date …………………..<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


TRUST BOARD MEETING<br />

5 September <strong>2012</strong><br />

<strong>Board</strong> Room, <strong>Trust</strong> Headquarters, Queen’s Hospital<br />

Points <strong>and</strong> Questions raised by members of the Public<br />

at the above <strong>Trust</strong> <strong>Board</strong> meeting<br />

Question:<br />

In reference to the Maternity Services<br />

Update report <strong>and</strong> the transfer of<br />

women to other <strong>Trust</strong>s with the change<br />

in boundaries, Mr Skillman asked if<br />

patient choice was taken into account<br />

when transferring women, as this had<br />

been highlighted when the Survey was<br />

undertaken regarding the closure of<br />

Maternity Services at King George<br />

Hospital (the vast majority of women<br />

had confirmed in the Survey that they<br />

wanted to give birth at KGH). He was<br />

concerned that there would not be any<br />

patient choice whatsoever if the<br />

proposals came to fruition.<br />

Response/Action:<br />

The Chief Executive confirmed that<br />

there would be a choice for women <strong>and</strong><br />

this would be managed by the GPs.<br />

The <strong>Trust</strong> would want women to be<br />

delivering their babies as close to home<br />

as possible, but it needed to be open<br />

<strong>and</strong> honest about its capacity issues, to<br />

ensure it was running a safe service. It<br />

was acknowledged that the proposal did<br />

take away some choice for women.<br />

Mr Skillman raised the point that the<br />

number of deliveries at the <strong>Trust</strong> had<br />

been discussed at the recent Overview<br />

& Scrutiny Committee meeting with<br />

Heather Mullin, as they differed from<br />

the number the <strong>Trust</strong> was reporting<br />

between Queen’s <strong>and</strong> the Midwifery<br />

Led Unit (MLU). Mr Skillman noted that<br />

an escalation plan was in place, but he<br />

wanted confirmation that the <strong>Trust</strong> was<br />

not going backwards, that it had<br />

everything under control, it was not<br />

going to have problems again with the<br />

service <strong>and</strong> that the figures were not<br />

going to change.<br />

Mr Moloney confirmed that for this year<br />

the <strong>Trust</strong> was expecting to deliver just<br />

over 9k <strong>and</strong> the plan for the next<br />

financial year was approximately 8k,<br />

when taking into account activity from<br />

Outer North East London PCTs <strong>and</strong><br />

some women from Essex.<br />

Mr Moloney also confirmed that the<br />

figures were not changing, as Heather<br />

Mullin would have been referring to<br />

KGH not running a maternity service at<br />

all (the <strong>Trust</strong> could deliver 2,500 at<br />

KGH).<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


Question:<br />

Mr Skillman was pleased to read in the<br />

Telegraph that the Department of<br />

Health was looking to assist some<br />

financially challenged <strong>Trust</strong>s with their<br />

Private Finance Initiatives (PFI’s) <strong>and</strong><br />

wanted to know if anything had been<br />

agreed with BHRUT for this financial<br />

year, or would it be next year.<br />

Mr Skillman mentioned that when<br />

attending outpatients to see a<br />

Consultant, if a follow-up appointment<br />

was required, the patient had to go<br />

back to book this at the desk <strong>and</strong> was<br />

then informed that an appointment<br />

letter would be sent in the post. He<br />

questioned whether appointment cards<br />

could not be re-introduced, which<br />

would not only save posting costs, but<br />

would also be more efficient for the<br />

patient.<br />

Response/Action:<br />

Mr Wood confirmed that BHRUT was<br />

one of the <strong>Trust</strong>s involved <strong>and</strong> the<br />

Department of Health had used<br />

BHRUT’s practices with its PFI partners<br />

to share with other <strong>Trust</strong>s. Most of the<br />

Soft FM contracts were non negotiable,<br />

but some savings had been made on<br />

initiatives led by the <strong>Trust</strong>.<br />

The initial Bond for the PFI could not be<br />

renegotiated, but the <strong>Trust</strong> was working<br />

to achieve as many efficiencies as<br />

possible outside the terms of the<br />

contract.<br />

Mr Wood informed Mr Skillman that it<br />

was worth noting that the PFI had not<br />

just been signed by BHRUT, it had<br />

been agreed by the Strategic Health<br />

Authority, the Department of Health <strong>and</strong><br />

the Treasury.<br />

Mrs Hosein acknowledged that Mr<br />

Skillman was absolutely right <strong>and</strong> this<br />

was part of the outpatient improvement<br />

project that was currently being<br />

undertaken, but due to the <strong>Trust</strong>’s<br />

Patient Administration System (PAS)<br />

<strong>and</strong> how patients were booked, it was<br />

not possible to do this. The <strong>Trust</strong> was<br />

currently installing a new Savience<br />

system (kiosks) for patients to book<br />

themselves in for appointments. It was<br />

acknowledged that the <strong>Trust</strong> currently<br />

generated a lot of unnecessary letters<br />

<strong>and</strong> the new Savience system would<br />

improve this area in the future. Mrs<br />

Hosein asked the public to bear with the<br />

<strong>Trust</strong> in the meantime, as these<br />

improvements involved a great deal of<br />

process change, which would take time<br />

to implement.<br />

Mr Skillman noted that he was pleased<br />

to see in the Finance Report that there<br />

were now vacancy controls in place<br />

<strong>and</strong> recruitment/new posts could only<br />

be approved by the Chief Executive, or<br />

the Director of Transformation.<br />

<strong>Trust</strong> <strong>Board</strong> Meeting (Part I) 5 September <strong>2012</strong>


EXECUTIVE SUMMARY<br />

TITLE:<br />

Update on <strong>Trust</strong> wide CQC action plan<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

This report outlines the progress to date with the<br />

completion of the <strong>Trust</strong> wide action plan following a<br />

series of unannounced CQC inspections in 2010 <strong>and</strong><br />

2011.<br />

Transformation <strong>Board</strong> ( 17/10/12)<br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Board</strong> is asked to:-<br />

• Agree the formal closure report of the <strong>Trust</strong><br />

wide CQC action plan.<br />

• Recognise the progress since June <strong>2012</strong><br />

• Formally agree the ongoing work required for<br />

the ‘part met’ recommendations with key<br />

performance indicators.<br />

• Agree the transition into business as usual<br />

<strong>and</strong> monitoring process.<br />

N.B.<br />

Please note that live access to the<br />

evidence files will be in place<br />

during the <strong>Board</strong> meeting<br />

CQC registration<br />

Health & safety<br />

Assurance framework<br />

Corporate objectives<br />

AUTHOR/PRESENTER:<br />

Dr M. Gill - Medical Director BHRUT<br />

Donna Kinnair- Director Governance<br />

DATE:<br />

25 October <strong>2012</strong><br />

The PMO/STT office will have 6 PC<br />

terminals available on the morning<br />

of the 7 <strong>November</strong> if <strong>Board</strong><br />

members would like to review any<br />

evidence with colleagues on h<strong>and</strong><br />

to provide navigation <strong>and</strong><br />

assistance.<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

5. KEY PERFORMANCE INDICATORS<br />

AGREED AT : CQC <strong>Trust</strong> project board. DATE: 29 October <strong>2012</strong><br />

REVIEW DATE (if applicable) ___________________________


CQC <strong>Trust</strong>-wide Action Plan<br />

Review <strong>and</strong> Closure Report<br />

OCTOBER <strong>2012</strong><br />

Version: <strong>2012</strong>1028.2<br />

Page 1 |<br />

26-Oct-12


EXECUTIVE SUMMARY<br />

This paper has been developed to reassure the <strong>Trust</strong> <strong>Board</strong> of the progress made in respect<br />

of the <strong>Trust</strong> response to the CQC Investigation report <strong>and</strong> subsequent action plan originally<br />

produced in October <strong>and</strong> <strong>November</strong> 2011.<br />

The paper seeks to reassure the <strong>Board</strong> of the current status of the Action Plan, <strong>and</strong> the<br />

transition to routine business as usual, monitored via normal service reviews.<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to :<br />

• To agree the formal closure of the <strong>Trust</strong>-wide CQC Action Plan,<br />

• To recognise the progress made since <strong>November</strong> 2011.<br />

• To recognise the progress made since June <strong>2012</strong>.<br />

• To formally recognise the need for monitoring <strong>and</strong> implementation of the plan <strong>and</strong> its<br />

recommendations, whilst in transition to ‘Business as Usual’<br />

Page 2 |<br />

26-Oct-12


1.0 PURPOSE<br />

1.1 Background<br />

This report has been produced predominantly for information regarding progress against<br />

agreed actions originally identified by the CQC following their formal investigation report in<br />

October <strong>and</strong> <strong>November</strong> 2011.<br />

The initial CQC assessment indicated that <strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong> Redbridge University<br />

Hospitals NHS <strong>Trust</strong> had a history of poor performance under the previous regulatory<br />

framework. At the time of CQC registration, the <strong>Trust</strong> had a high number of ‘conditions’<br />

placed on it to require improvements in care. A series of unannounced inspections in 2010/11<br />

resulted in some of these being lifted, but also resulted in warning notices being issued to the<br />

trust (in March, June <strong>and</strong> July 2011) on staffing levels <strong>and</strong> maternity care.<br />

The CQC saw some evidence of improvements being made in response to these notices, but<br />

the <strong>Trust</strong>’s overall capacity to respond to the extent <strong>and</strong> level of CQC’s concerns was in<br />

question. Throughout this period, the CQC continued to receive information about poor quality<br />

care from patients <strong>and</strong> the public.<br />

This report will confirm the ‘journey’ the <strong>Trust</strong> has taken; the progress made; the current<br />

status of the report <strong>and</strong> its associated action plans <strong>and</strong> the recommendations requiring further<br />

work. It will also seek to outline the key ‘milestones’ which have been reached, which will<br />

demonstrate the continuous improvement of the organisation in addressing the CQC<br />

recommendations.<br />

1.2 Project Closure Status<br />

The CQC have advised the <strong>Trust</strong> that having reviewed the formal Action Plan, its evidence<br />

<strong>and</strong> supporting documentation, <strong>and</strong> given that the formal investigation has been completed,<br />

future monitoring of compliance would be undertaken as part of the normal routine service<br />

reviews. Hence the formal update report published by the CQC in June <strong>2012</strong>, the monitoring<br />

phase has developed into continued improvement being ‘Business as Usual’.<br />

This report is a project review <strong>and</strong> closure report. The original recommendations have either<br />

been met, or embedded into normal business, or have been superseded by other projects<br />

<strong>and</strong> initiatives which will deliver compliance against the CQC’s essential st<strong>and</strong>ards.<br />

1.3 Summary of Actions required by the <strong>Trust</strong> <strong>Board</strong><br />

The <strong>Board</strong> is asked:<br />

• To agree the formal closure of the <strong>Trust</strong>-wide CQC Action Plan,<br />

• To recognise the progress made since <strong>November</strong> 2011.<br />

• To recognise the progress made since June <strong>2012</strong>.<br />

• To formally recognise the need for monitoring <strong>and</strong> implementation of the plan <strong>and</strong> its<br />

recommendations, whilst in transition to ‘Business as Usual’<br />

2.0 CONTEXT AND BACKGROUND<br />

Following the imposition of registration conditions on the <strong>Trust</strong> in 2010, the CQC’s judgement<br />

was that continuing to tackle poor performance at the trust on a case-by-case basis was not<br />

going to address deep-seated issues around the quality of care at the <strong>Trust</strong>. As a result, the<br />

CQC took the decision to launch a full investigation into the quality of care provided by the<br />

trust at Queen’s Hospital <strong>and</strong> King George Hospital.<br />

Page 3 |<br />

26-Oct-12


On 29 June 2011, a team of CQC inspectors <strong>and</strong> external expert advisors, including experts<br />

in maternity, accident <strong>and</strong> emergency, <strong>and</strong> nursing care, began the investigation on 4 July<br />

2011.<br />

The investigation assessed the systems <strong>and</strong> procedures the <strong>Trust</strong> had in place to ensure that<br />

people are protected against the risk of inappropriate care <strong>and</strong> treatment. The team focused<br />

on three care pathways – maternity, elective vascular surgery, <strong>and</strong> emergency care, <strong>and</strong><br />

examined the trust’s governance <strong>and</strong> management systems.<br />

http://www.cqc.org.uk/sites/default/files/media/reports/RF4_<strong>Barking</strong>_<strong>Havering</strong>_<strong>and</strong>_Redbridge_Universit<br />

y_Hospitals_NHS_<strong>Trust</strong>_RF4QH_Queens_Hospital_20110729.pdf<br />

At the end of October 2011, the CQC published its Investigation Report, containing a total of<br />

75 recommendations, with which BHRUT were required to comply; a further 6<br />

recommendations were added in late <strong>November</strong> 2011. These 81 recommendations are<br />

spread across a number of general categories; strategy, capacity, leadership, <strong>and</strong> some more<br />

specific outcomes, including those in relation to maternity services.<br />

14 themes were identified against which the 81 actions were identified:<br />

1) Respecting <strong>and</strong> involving people<br />

2) Care <strong>and</strong> welfare of people<br />

3) Cooperating with other providers<br />

4) Safeguarding people from abuse<br />

5) Cleanliness <strong>and</strong> infection control<br />

6) Management of Medicines<br />

7) Safety <strong>and</strong> suitability of premises<br />

8) Safety, availability <strong>and</strong> suitability of equipment<br />

9) Staffing <strong>and</strong> supporting workers<br />

10) Assessing <strong>and</strong> monitoring the quality of service provision<br />

11) Complaints<br />

12) Records<br />

13) Leadership<br />

14) Capacity<br />

Upon receipt of the full Investigation Report, the <strong>Trust</strong> developed a <strong>Trust</strong>-wide Action Plan,<br />

detailing all 81 recommendations, <strong>and</strong> began implementing the necessary actions required to<br />

achieve compliance with the CQC essential st<strong>and</strong>ards; along with an identification of officers<br />

<strong>and</strong> clinicians responsible for delivery, <strong>and</strong> the target dates for delivery.<br />

http://aglovale/assets/pdfs/comms/cqcactionplan11.xls<br />

As previously reported to the <strong>Board</strong>, significant progress has been made to the point where in<br />

June <strong>2012</strong>, the CQC revisited the <strong>Trust</strong> <strong>and</strong> further assessed progress made against the<br />

original action plan. Report available at http://aglovale/assets/pdfs/comms/cqcupdatereportjun12.pdf<br />

The <strong>Trust</strong> was encouraged that the CQC had confirmed that of the original 81<br />

recommendations identified:<br />

27 were assessed as MET<br />

48 were assessed as PART MET<br />

6 were assessed as NOT MET<br />

In August <strong>2012</strong>, the newly appointed Medical Director commissioned the Service<br />

Transformation Team to review, re-engage <strong>and</strong> re-evaluate progress against implementation<br />

of the required actions allowing the <strong>Trust</strong> to update the current status of each of the ‘PART<br />

MET’ <strong>and</strong> ‘NOT MET’ recommendations from the CQC Update of July <strong>2012</strong>.<br />

http://aglovale/assets/pdfs/comms/cqcstakeholderupdate250612.pdf<br />

In addition to the review of completeness the Team was asked to:<br />

Page 4 |<br />

26-Oct-12


• Review the Senior Responsible Officers (SROs) to align with the new management<br />

<strong>and</strong> executive structures.<br />

• Ensure the Operational leads are appropriate <strong>and</strong> aligned with the organisational<br />

structures.<br />

• Where appropriate, to develop measurable objectives <strong>and</strong> incorporate into a revised<br />

Action Plan<br />

• Reformat the Action Plan to facilitate improved navigation for users <strong>and</strong> external<br />

stakeholders<br />

• Integrate the evidence inventory to the action plan, improving access to users <strong>and</strong><br />

stakeholders.<br />

• Drafting of a formal response to the internal draft Audit Report.<br />

• This assessment was presented to the Quality <strong>and</strong> Safety Committee on the 16 th October.<br />

• This revised Action Plan was presented to the Transformation <strong>Board</strong> on the 17 th October.<br />

This work has been undertaken in conjunction with the Internal Audit report conducted by<br />

Park Hill in August <strong>2012</strong>. A formal response to this report is due to be presented at the next<br />

Audit Committee.<br />

3.0 EXCEPTION REPORT<br />

The Exception report below highlights that 6 of the original 81 recommendations are<br />

assessed as PART MET. This recognises the timescales involved in completion, or the<br />

strategic context by which it is influenced.<br />

The current <strong>Trust</strong> assessment finds that none of the original 81 recommendations remains<br />

‘NOT MET’<br />

The action plan <strong>and</strong> evidence log for this are attached at Appendix 2. Where sufficient<br />

evidence of progress has been made, continued progress continues via ‘Business as Usual’<br />

with Clinical Directors being accountable for delivery <strong>and</strong> achievement on a routine basis.<br />

Where appropriate this is monitored via the <strong>Trust</strong> Audit Programme, <strong>and</strong> clinical governance<br />

structures.<br />

4.0 THE WAY FORWARD<br />

As a result of the work to meet the recommendations of the original action plan, there have<br />

been significant moves to establish good practice <strong>and</strong> embed this in the routine workings of<br />

the <strong>Trust</strong>.<br />

The evidence <strong>and</strong> supporting documentation will be migrated as appropriate to a web based<br />

page. Evidence is currently restricted to those individuals who can access shared secured<br />

drives on the <strong>Trust</strong> system.<br />

These include :<br />

• New Senior Management Team<br />

• New Clinical Leadership structures in place<br />

• Revised Clinical Governance Structure<br />

• Robust Audit Programme<br />

• Improved Communications (Internal <strong>and</strong> External)<br />

• Revised Performance Management arrangements.<br />

• Use of shared drives for the archiving <strong>and</strong> sharing of evidence.<br />

Other helpful documents can be found at :<br />

Page 5 |<br />

26-Oct-12


http://aglovale/assets/pdfs/comms/cqcrecommendationactionplansept12.pdf (Draft)<br />

http://aglovale/assets/pdfs/comms/cqccomp5.pdf (Radiology)<br />

http://aglovale/assets/pdfs/comms/cqccomp4.pdf (Maternity)<br />

http://aglovale/assets/pdfs/comms/cqccomp2.pdf (EU)<br />

http://aglovale/assets/pdfs/comms/cqccomp1.pdf (KGH)<br />

http://www.cqc.org.uk/directory/rf4qh<br />

Page 6 |<br />

26-Oct-12


APPENDIX 1 ‐ CQC ACTION PLAN – EXCEPTION REPORT<br />

(OCTOBER <strong>2012</strong>)<br />

Theme/Outcome CQC Recommendation CQC Observation (June <strong>2012</strong>) Progress Executive Lead Current Status<br />

LEADERSHIP 21. Put a cultural change Building blocks are in place – ‘Big Conversation’ The <strong>Trust</strong> has submitted a bid to NHS Director of Nursing PART MET<br />

programme in place across the underway with staff engagement group set up <strong>and</strong> London for some Organisational<br />

organisation. The programme<br />

of change needs to engage all<br />

staff so that the trust can<br />

clearly articulate what the<br />

expectations are of individual<br />

staff, what a high performing<br />

several staff engagement meetings held.<br />

Executive team now dedicate one day a month to<br />

take on a front line role in order to increase<br />

underst<strong>and</strong>ing of care challenges <strong>and</strong> improve<br />

management visibility <strong>and</strong> accessibility.<br />

Conflict resolution training is being delivered for<br />

Development funding.<br />

Funding has been allocated <strong>and</strong> the<br />

<strong>Trust</strong> is currently identifying suitable<br />

development support to take this<br />

work forward.<br />

The <strong>Trust</strong> is currently working with a<br />

organisation feels like to work managers; BHRUT Code being reviewed with range of external consultants<br />

in <strong>and</strong> be clear of the penalties significant staff input, including seeking clear including:<br />

for staff they should not examples of acceptable <strong>and</strong> unacceptable practice. QFI who run a leadership programme<br />

behave appropriately.<br />

Consultants are carrying out an analysis of team<br />

working <strong>and</strong> practice in women’s services<br />

for CD’s, Clinical Fellows <strong>and</strong> senior<br />

leads, supported <strong>and</strong> funded by NHS<br />

London.<br />

Management Information <strong>and</strong><br />

Development (MIAD) for Consultants<br />

Tavistock Consulting working with<br />

maternity<br />

McKinsey to embed sustainable<br />

patient flow through the <strong>Trust</strong><br />

Ernst <strong>and</strong> Young to support financial<br />

sustainability <strong>and</strong> governance<br />

Transformation Team has been<br />

established <strong>and</strong> is working across the<br />

<strong>Trust</strong> to develop <strong>and</strong> implement<br />

leadership skills locally in multiprofessional<br />

groups.<br />

ASSESSING &<br />

MONITORING<br />

75. Ensure that it has<br />

appropriate levels of staff in<br />

place to allow its governance<br />

systems to function effectively<br />

<strong>and</strong> that these staff are<br />

embedding appropriate<br />

systems in clinical services.<br />

Following the review of governance, suitable staff<br />

have been identified to ensure its recommendations<br />

are properly implemented. As above, proof of<br />

success will be seen through delivery.<br />

Associate Medical Director for Clinical<br />

Governance now in post (3 P.A.)<br />

Business case for Patient Safety<br />

Managers covering Clinical<br />

Directorates in progress following<br />

approval by the Q&S Committee.<br />

Medical Director<br />

PART MET<br />

CARE & WELFARE 29. Develop a culture where The appraisal process for emergency department An additional patient information Medical Director PART MET<br />

Page 7 |<br />

26-Oct-12


‐ EMERGENCY<br />

CARE<br />

SAFETY &<br />

SUITABILITY OF<br />

PREMISES<br />

everyone feels empowered to<br />

challenge episodes of variable<br />

or poor practice, including<br />

regular monitoring of practice<br />

<strong>and</strong> feedback <strong>and</strong> learning<br />

opportunities for staff.<br />

53. Ensure that appropriate<br />

waiting facilities are available<br />

for patients <strong>and</strong> relatives in<br />

the urgent care centre.<br />

staff has been reviewed; all staff in this area have<br />

personal development plans. Hourly vital signs<br />

checks are underway <strong>and</strong> monthly spot audits are<br />

being carried out to ensure staff feel empowered to<br />

challenge poor performance. Patient satisfaction<br />

surveys are in place <strong>and</strong> staff are reminded of the<br />

importance of challenging poor practice as a<br />

st<strong>and</strong>ing item on A&E team meetings. Audit results<br />

do not yet support the processes that have been put<br />

in place.<br />

As above, these waiting facilities are being reviewed<br />

as part of the Health for NEL programme.<br />

leaflet explaining the process of the<br />

ED is being drafted which will have a<br />

section to write who the patients<br />

named nurse <strong>and</strong> doctor are. There<br />

will be a feedback area on this leaflet<br />

to enable patients to anonymously<br />

write any feedback both positive <strong>and</strong><br />

negative. This will enable direct<br />

feedback to the staff that cared for<br />

the patient. It is hoped that this will<br />

provide more audit results as the<br />

feedback mechanism will be directly<br />

accessible for patients.<br />

Trend information on complaints is<br />

being collated to further support<br />

feedback to all staff.<br />

Customer service competency<br />

checklist is being developed to<br />

provide staff with additional training<br />

to support improvements in<br />

communication skills.<br />

Peer challenge on poor practice<br />

remains in place.<br />

The current waiting facilities are<br />

deemed sufficient for the needs of<br />

patients currently.<br />

Investment is currently underway to<br />

extend the Rapid Assessment &<br />

Treatment areas within the<br />

department. This initiative will deliver<br />

shorter waiting times <strong>and</strong> improve<br />

the patient experience. Work is due<br />

to be completed before Christmas.<br />

Patient experience will be measured<br />

via the annual patient surveys, <strong>and</strong> in<br />

house paper <strong>and</strong> electronic solutions.<br />

Director of Nursing<br />

Divisional Manager<br />

(Estates, Facilities &<br />

Capital)<br />

PART MET<br />

RECORDS 80. Improve its systems for The <strong>Trust</strong>’s Medical Records Committee has been re‐ The development of the eH<strong>and</strong>over Chief Operating PART MET<br />

Page 8 |<br />

26-Oct-12


RECORDS<br />

records management to<br />

ensure that notes can be<br />

retrieved effectively <strong>and</strong><br />

expediently, <strong>and</strong> reduce the<br />

risks associated with multiple<br />

sets of temporary notes <strong>and</strong><br />

poor data h<strong>and</strong>ling.<br />

81. Develop integrated patient<br />

administration<br />

<strong>and</strong><br />

information systems to ensure<br />

that, where ever a patient is<br />

being treated within the trust,<br />

their full healthcare history<br />

can be accessed by all staff.<br />

established with new Terms of Reference; training<br />

levels for healthcare professionals are discussed at<br />

this Committee on a regular basis. Weekend<br />

transport for transfer of notes has been<br />

reintroduced <strong>and</strong> a nursing documentation booklet<br />

has been piloted across several wards <strong>and</strong> will be<br />

fully implemented by the autumn.<br />

A procurement process is underway to introduce an<br />

effective system to enable access to patient<br />

histories. Funding challenges have slowed<br />

introducing of a full electronic patient record.<br />

system will provide a <strong>Trust</strong>wide<br />

joined up reference database for the<br />

use in patient care.<br />

A new PAS is being commissioned in<br />

2013 for implementation which will<br />

improve the availability of Patient<br />

records <strong>and</strong> reduce the incidence of<br />

Temporary folders.<br />

It is anticipated that patients will be<br />

migrated onto one hospital number<br />

covered by barcode scanning options<br />

as part of the roll‐out <strong>and</strong><br />

implementation.<br />

Decision on Strategic Capital Funding<br />

for PAS Replacement by NHS London<br />

immanent<br />

A new PAS is being commissioned in<br />

2013 for implementation which will<br />

improve the availability of Patient<br />

records <strong>and</strong> reduce the incidence of<br />

Temporary folders.<br />

It is anticipated that patients will be<br />

migrated onto one hospital number<br />

covered by barcode scanning options<br />

as part of the roll‐out <strong>and</strong><br />

implementation.<br />

Decision on Strategic Capital Funding<br />

by NHS London immanent.<br />

Officer<br />

<strong>and</strong><br />

Director of<br />

Performance &<br />

Planning<br />

Director of<br />

Performance &<br />

Planning<br />

PART MET<br />

Page 9 |<br />

26-Oct-12


APPENDIX 2 ‐ CQC ACTION PLAN – OCTOBER ACTION PLAN FOR<br />

PART MET AND NOT MET RECOMMENDATIONS.<br />

Page 10 |<br />

26-Oct-12


CQC Update Report<br />

<strong>2012</strong><br />

Theme CQC Recommendation CQC Observation (June <strong>2012</strong>) Further Organisational Progress Operational<br />

Lead<br />

LEADERSHIP 20. Ensure its board assures<br />

Averil<br />

itself that it has the right<br />

Dongworth<br />

leaders <strong>and</strong> managers in place<br />

to develop the trust <strong>and</strong><br />

improve the quality of services.<br />

LEADERSHIP 21. Put a cultural change<br />

programme in place across the<br />

organisation. The programme of<br />

change needs to engage all staff<br />

so that the trust can clearly<br />

articulate what the expectations<br />

are of individual staff, what a<br />

high performing organisation<br />

feels like to work in <strong>and</strong> be clear<br />

of the penalties for staff they<br />

should not behave<br />

appropriately.<br />

The <strong>Trust</strong> <strong>Board</strong> has completed its<br />

review of the Executive Team,<br />

leading to appointments of chief<br />

operating officer <strong>and</strong> director of<br />

transformation.<br />

A new management structure is in<br />

place based around clinical<br />

directorates, led by clinical<br />

directors <strong>and</strong> associate directors.<br />

Recent information indicates that<br />

there are several changes being<br />

made to senior management at<br />

the <strong>Trust</strong> <strong>and</strong> the impact of this<br />

will need to be assessed.<br />

Significant staff engagement<br />

process is underway to consult on<br />

wider implementation of the new<br />

structure.<br />

Building blocks are in place – ‘Big<br />

Conversation’ underway with staff<br />

engagement group set up <strong>and</strong><br />

several staff engagement meetings<br />

held.<br />

Executive team now dedicate one<br />

day a month to take on a front line<br />

role in order to increase<br />

underst<strong>and</strong>ing of care challenges<br />

<strong>and</strong> improve management visibility<br />

<strong>and</strong> accessibility.<br />

Conflict resolution training is being<br />

delivered for managers; BHRUT<br />

Code being reviewed with<br />

significant staff input, including<br />

seeking clear examples of<br />

The following appointments have been made to the <strong>Board</strong>:<br />

1. Director of Operations<br />

2. Director of Transformation<br />

3. Director of Governance<br />

4. New Medical Director appointed<br />

5. Director of Nursing appointed<br />

6. New Director of Finance<br />

Clinical Directors <strong>and</strong> Associate Directors now in post.<br />

Consultation on going relating to the final supporting<br />

management structure.<br />

Management structure corporately is now in place with Associate<br />

Medical Directors <strong>and</strong> Deputy Nurse Directors Appointed.<br />

Consultation now ended <strong>and</strong> appointments <strong>and</strong> structure will be<br />

put in place during June '12.<br />

Changes at senior level in June <strong>2012</strong> have now posed questions<br />

about the possibility of delivering as anticipated.<br />

The <strong>Trust</strong> has submitted a bid to NHS London for some<br />

Organisational Development funding.<br />

(JM to share copy of bid)<br />

Donna Kinnear<br />

Julie Meddings<br />

<strong>Trust</strong> RAG<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

PART MET<br />

BUSINESS<br />

AS USUAL<br />

Page 1 of 22


CQC Update Report<br />

<strong>2012</strong><br />

acceptable <strong>and</strong> unacceptable<br />

practice.<br />

Consultants are carrying out an<br />

analysis of team working <strong>and</strong><br />

practice in women’s services<br />

LEADERSHIP<br />

LEADERSHIP<br />

22. Develop a culture of whole<br />

systems working across all<br />

divisions to reduce ‘silo’<br />

working <strong>and</strong> the combative<br />

nature of bed management.<br />

24. Explore how to improve its<br />

communications both internally<br />

<strong>and</strong> externally so that<br />

perceptions of poor<br />

communication can be reduced.<br />

Weekly operations meeting, with<br />

directorate managers, is now in<br />

place; multidisciplinary working<br />

being pursued as part of RESET<br />

project. New bed management<br />

structures is in place, with all<br />

divisions <strong>and</strong> specialities<br />

attending; Matrons working<br />

together to ensure effective<br />

discharge process.<br />

Internally, significant staff<br />

engagement is underway;<br />

externally, meetings have taken<br />

place with LINks <strong>and</strong> Improving<br />

Patient Experience Group (IPEG);<br />

stakeholder briefings being<br />

disseminated; stakeholder event<br />

with commissioners, CQC, LINks,<br />

IPEG <strong>and</strong> local authorities took<br />

place in May.<br />

Some feedback to CQC suggests<br />

there are further improvements<br />

that could be made, particularly in<br />

terms of engagement with MPs.<br />

There has been significant progress in a <strong>Trust</strong>‐wide response to<br />

patient pathways. Initially focussing on Emergency admissions<br />

<strong>and</strong> pathways<br />

Daily Bed <strong>and</strong> Site team meetings held (0830;1200;1500) to<br />

ensure patient flow <strong>and</strong> effective discharge management, Issue<br />

Log kept daily <strong>and</strong> updated at each meeting. Performance tracker<br />

updated daily for the current week. Senior representatives<br />

available from all divisions, escalation protocols allow for this to<br />

be supplemented by executive input, community <strong>and</strong> LAS<br />

representatives<br />

Ward sponsor programme in place to support escalation <strong>and</strong><br />

discharge management. Intensive support is provided by the<br />

Service Transformation Team, <strong>and</strong> QFI.<br />

Performance Meetings weekly with CDs <strong>and</strong> CEO, Dir. of<br />

Transformation.<br />

Daily multidisciplinary JONAH meetings, complex discharge<br />

meetings, cross buffer meeting <strong>and</strong> Top 25 delays all support this.<br />

Dorothy Hosein<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

This is now monitored via normal <strong>Trust</strong> Operations. Imogen Shilito MET<br />

BUSINESS<br />

AS USUAL<br />

Page 2 of 22


CQC Update Report<br />

<strong>2012</strong><br />

ASSESSING &<br />

MONITORING<br />

70. Ensure that it has adequate<br />

systems of governance to<br />

promote high quality care for<br />

patients <strong>and</strong> to deal with<br />

concerns about performance in<br />

an effective <strong>and</strong> timely manner.<br />

Clinical <strong>and</strong> committee structures<br />

have been reviewed <strong>and</strong> a new<br />

Clinical Governance Structure has<br />

recently been considered by the<br />

<strong>Trust</strong>’s <strong>Board</strong>.<br />

Exp<strong>and</strong>ed central data collection<br />

for the Quality <strong>and</strong> Safety<br />

Committee has been proposed. A<br />

central monitoring <strong>and</strong> evidence<br />

database has been introduced for<br />

Serious Incidents, with <strong>Trust</strong>‐wide<br />

audits being introduced <strong>and</strong> KPIs<br />

introduced for reporting <strong>and</strong><br />

completion of investigations. A<br />

web‐based incident reporting<br />

system is being introduced across<br />

the <strong>Trust</strong> after a pilot in maternity.<br />

• All Clinical Directorates have clinical governance<br />

meetings which feed into the Quality <strong>and</strong> Safety<br />

Committee structure.<br />

• Dashboards developed for Quality KPI reports.<br />

• Rolling risk reviews in place for Q&S Committee<br />

• Action Plan monitoring in place.<br />

• Snapshot Audits underway<br />

• Web‐based tracking system in place with on going<br />

training at Induction.<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

ASSESSING &<br />

MONITORING<br />

72. Carry out a comprehensive<br />

review of all corporate <strong>and</strong><br />

clinical governance systems<br />

across the organisation to<br />

ensure that effective <strong>and</strong><br />

streamlined systems <strong>and</strong><br />

reporting structures are in place<br />

to provide robust assurance to<br />

the board.<br />

Clinical <strong>and</strong> committee structures<br />

have been reviewed <strong>and</strong> a new<br />

Clinical Governance Structure has<br />

recently been considered by the<br />

<strong>Trust</strong>’s <strong>Board</strong>.<br />

A complete review of <strong>Trust</strong><br />

corporate committees has been<br />

completed <strong>and</strong> was recently put to<br />

the <strong>Trust</strong> <strong>Board</strong>. A complete<br />

review of maternity clinical<br />

governance was completed by<br />

October 2011 to ensure full<br />

integration with the <strong>Trust</strong>’s main<br />

governance structures. The review<br />

also led to Divisional managers<br />

taking on responsibility for alerting<br />

clinical governance teams to all<br />

external quality <strong>and</strong> safety<br />

recommendations (reinforced<br />

through stringent audit <strong>and</strong><br />

• New Director of Governance <strong>and</strong> Special Projects in<br />

post (September <strong>2012</strong>)<br />

• CDs Governance meetings supported by Facilitators.<br />

• SI reviews embedded in performance structures<br />

• QIPP programme supported by QIAs (Quality Impact<br />

Assessments) within a formalised governance structure.<br />

Averil<br />

Dongworth<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 3 of 22


CQC Update Report<br />

<strong>2012</strong><br />

reporting), with regular reporting<br />

between HR <strong>and</strong> Clinical<br />

Governance to ensure joint<br />

management of patient safety<br />

issues.<br />

ASSESSING &<br />

MONITORING<br />

73. Ensure that it has systems in<br />

place that allow effective<br />

sharing <strong>and</strong> learning across the<br />

whole organisation.<br />

Existing guidance on learning from<br />

serious incidents has been<br />

reviewed <strong>and</strong> KPIs for<br />

implementation have been<br />

introduced. A bi‐monthly ‘Lessons<br />

Learned’ group meets to generate<br />

shared learning. This includes<br />

using the content of Ombudsman<br />

action plans to ensure learning<br />

points are appropriately extracted<br />

<strong>and</strong> shared. A rolling programme<br />

of articles in the Link is supporting<br />

learning. Directorate <strong>Board</strong>s now<br />

review Serious Incident reports<br />

<strong>and</strong> action plans to ensure timely<br />

implementation.<br />

Clinical Directors are sent details<br />

of each relevant Serious Incident<br />

<strong>and</strong> these are agenda items for<br />

directorate clinical governance<br />

meetings until they are responded<br />

to in a suitable way.<br />

This recommendation will only be<br />

fully met when success can be<br />

demonstrated over time. CQC <strong>and</strong><br />

other stakeholders not only expect<br />

to see evidence that Serious<br />

Incidents are being dealt with<br />

internally, but also to see<br />

commissioners <strong>and</strong> other external<br />

organisations being informed<br />

when relevant.<br />

• All closed SIs are available on the <strong>Trust</strong> intranet.<br />

• Clinical Directorate Governance leads review Sis <strong>and</strong><br />

other incidents for learning.<br />

• Clinical Governance is a core topic on all monthly<br />

meeting agendas.<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 4 of 22


CQC Update Report<br />

<strong>2012</strong><br />

ASSESSING &<br />

MONITORING<br />

74. Ensure that the incident<br />

reporting system for the whole<br />

trust is operating effectively <strong>and</strong><br />

all staff are learning from<br />

incidents rather than simply<br />

reporting incidents.<br />

As noted above, a web‐based<br />

incident reporting system is being<br />

introduced across the <strong>Trust</strong> after a<br />

pilot in maternity. If the proposed<br />

clinical governance structure is<br />

introduced as planned, directorate<br />

boards will take on responsibility<br />

for regular reviews of learning<br />

from incidents. Learning from<br />

incidents is now integrated into<br />

the ward staff meeting structure,<br />

<strong>and</strong> better structures have been<br />

introduced to ensure learning is<br />

shared between staff across<br />

divisions. Again, this will need to<br />

be demonstrated over time.<br />

• All closed SIs are available on the <strong>Trust</strong> intranet.<br />

• Clinical Directorate Governance leads review Sis <strong>and</strong><br />

other incidents for learning.<br />

• Clinical Governance is a core topic on all monthly<br />

meeting agendas.<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

ASSESSING &<br />

MONITORING<br />

75. Ensure that it has<br />

appropriate levels of staff in<br />

place to allow its governance<br />

systems to function effectively<br />

<strong>and</strong> that these staff are<br />

embedding appropriate systems<br />

in clinical services.<br />

Following the review of<br />

governance, suitable staff have<br />

been identified to ensure its<br />

recommendations are properly<br />

implemented. As above, proof of<br />

success will be seen through<br />

delivery.<br />

• Associate Medical Director for Clinical Governance now<br />

in post (3 P.A.)<br />

• Business case for Patient Safety Managers covering<br />

Clinical Directorates in progress following approval by<br />

the Q&S Committee.<br />

Pam Strange<br />

PART MET<br />

STRATEGY<br />

1. The <strong>Trust</strong>, in conjunction with<br />

NHS London, should seek<br />

appropriate external expertise<br />

to support a programme of<br />

organisational change <strong>and</strong><br />

service improvement.<br />

The <strong>Trust</strong> has introduced 10<br />

clinical fellows <strong>and</strong> four midwifery<br />

clinical fellows as part of a clinical<br />

leadership <strong>and</strong> engagement<br />

programme, supported by NHS<br />

London. Commissioners are<br />

offering support at executive level<br />

in the development of the <strong>Trust</strong>’s<br />

programme management board to<br />

coordinate the transformation<br />

programme. Health for NEL, Skills<br />

for Health, <strong>and</strong> the RESET<br />

McKinsey Consultancy (RESET);<br />

Ernst & Young (QIPP/CIP);<br />

Averil<br />

Dongworth<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 5 of 22


CQC Update Report<br />

<strong>2012</strong><br />

programme in A&E are evidence of<br />

the <strong>Trust</strong>’s willingness to engage<br />

external support.<br />

STRATEGY<br />

2. The <strong>Trust</strong>, in conjunction with<br />

its commissioners <strong>and</strong> other<br />

partners, should identify <strong>and</strong><br />

implement plans to secure a<br />

long term solution to reduce<br />

over capacity at Queen’s<br />

Hospital.<br />

The Health for NEL proposals <strong>and</strong><br />

estates reconfiguration plan for<br />

the <strong>Trust</strong> should see dem<strong>and</strong><br />

reduce significantly over the next<br />

two years to address capacity<br />

issues. This includes seeing<br />

dem<strong>and</strong> on maternity fall by 15‐<br />

20% (between 1,500 <strong>and</strong> 2,000<br />

births a year) by April 2013<br />

through effective use of<br />

alternative maternity resources in<br />

North East London. Success<br />

depends on partnership working<br />

<strong>and</strong> on going commissioner<br />

engagement, including the role of<br />

primary care in making sure that<br />

people are aware of the treatment<br />

choices open to them.<br />

Project Teams now in place to formulate project briefs <strong>and</strong><br />

manage process to formal Business Case submission.<br />

Some schemes more advanced <strong>and</strong> ready for start on site of<br />

works ie MLU.<br />

April '12 meetings with Estates to discuss extent of plan <strong>and</strong><br />

proposals, which will help inform business case.<br />

Outline Business Case (OBC) being prepared for submission to<br />

<strong>Trust</strong> <strong>Board</strong> beginning of August <strong>and</strong> SHA CIC Sept.<br />

As part of the Health4Nel programme, quarterly meetings have<br />

been held with local authority CX's for some time.<br />

During transition to CCG's these will be wound down, <strong>and</strong> initial<br />

forums have been held with CCG's; these may become timetabled<br />

more regularly in due course.<br />

Options Appraisal recommendations ‐ relating to configuration of<br />

ED ‐ due to be submitted as part of OBC to <strong>Trust</strong> <strong>Board</strong> in Jul '12;<br />

which will be referred to commissioners before month end.<br />

This will be accompanied by discussions with planning providers<br />

<strong>and</strong> PFI, due to potential impact of proposals.<br />

Averil<br />

Dongworth<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

STRATEGY<br />

3. Improve the flow of patients<br />

not only in the emergency<br />

department, but across the<br />

whole hospital to ensure that<br />

processes that do not add value<br />

are removed <strong>and</strong> patients are<br />

seen <strong>and</strong> treated in a timely<br />

fashion.<br />

A range of work is underway to<br />

address this – bed mapping,<br />

revised length of stay, reviews of<br />

decisions to admit, care pathways<br />

in place for emergency <strong>and</strong><br />

gynaecology care.<br />

The RESET programme in A&E is<br />

designed to ensure stronger<br />

visibility <strong>and</strong> accountability of care<br />

Build could take up to 18 months from decision made. This is only<br />

an indicative timescale, which will be confirmed once option<br />

agreed.<br />

Length of S Work stream formed. Terms of reference agreed. 2<br />

bed modelling <strong>papers</strong> presented <strong>and</strong> discussed at Transformation<br />

<strong>Board</strong>.<br />

• A&E Escalation process being developed. This will support<br />

the timeliness of review <strong>and</strong> decision making by specialist<br />

team, <strong>and</strong> improve patients flow.<br />

• Further work has commenced via the Theatres work stream<br />

to improve utilisation of Theatre capacity, which include<br />

Gynaecology.<br />

Dorothy Hosein<br />

Shelagh Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 6 of 22


CQC Update Report<br />

<strong>2012</strong><br />

pathways throughout the hospital,<br />

from admission to discharge.<br />

Progress in this will be carefully<br />

monitored both within the <strong>Trust</strong><br />

(including at Executive <strong>and</strong> <strong>Board</strong><br />

level) <strong>and</strong> by external partners.<br />

• Patient Improvement Programme (PIP)<br />

• Discharge Jonah rolled out in all wards.<br />

• Top delays meetings every Tuesday <strong>and</strong> Thursday at 11h30<br />

reviewing reasons for patient delays.<br />

• Daily Operational Jonah meetings occurring with matrons<br />

<strong>and</strong> senior nursing staff to review bed position <strong>and</strong> delays.<br />

• Now linked with RESET project work stream 3: Improving<br />

continuity of care <strong>and</strong> discharge rate in MAU.<br />

• Now linked with RESET project work stream 5: Pre‐11am<br />

Discharges<br />

• Now linked with RESET project work stream 7: Effective Care<br />

for Elderly Patients.<br />

EQUIPMENT<br />

CLEANLINESS<br />

CLEANLINESS<br />

59. Develop as part of its<br />

cultural change programme<br />

people’s sense of responsibility<br />

to take positive action to ensure<br />

that clinical areas are suitably<br />

equipped to provide safe<br />

patient care.<br />

45. Ensure that all equipment<br />

<strong>and</strong> disposable products are<br />

stored appropriately.<br />

47. Ensure that staff are not<br />

posing an increased risk to<br />

patients from cross infection.<br />

The trust should take any<br />

necessary steps to ensure that<br />

staff can store personal<br />

This will be audited by monitoring<br />

complaints on availability of<br />

equipment <strong>and</strong> regular equipment<br />

audits; a business case may be<br />

considered for a dedicated medical<br />

devices coordinator / trainer if the<br />

need is firmly identified. CQC’s<br />

inspections suggest this remains a<br />

serious issue that needs to be<br />

addressed.<br />

Ward managers have completed<br />

risk assessments of equipment<br />

management <strong>and</strong> storage facilities.<br />

A new <strong>Trust</strong> environment /<br />

equipment disposal policy is in<br />

place. Weekly walkabouts with<br />

facilities <strong>and</strong> estates have been<br />

implemented <strong>and</strong> an action log is<br />

in place.<br />

The staff uniform <strong>and</strong> dress code<br />

policy is being reviewed to ensure<br />

st<strong>and</strong>ards are understood <strong>and</strong><br />

remedial actions are available. An<br />

infection control annual plan is in<br />

place <strong>and</strong> is reported against to<br />

• Equipment deficits are monitored via the Environmental<br />

audits utilised throughout the organisation. There has been<br />

a re‐launch of the Medical equipment policy (hyperlink).<br />

http://aglovale/assets/pdfs/governance/policymedicaldevices.pdf<br />

• Equipment issues are now reported thematically via the<br />

Complaints process. This is reported <strong>and</strong> monitored via the<br />

Patient Experience structures.<br />

• Environmental audits utilised throughout the organisation.<br />

Additional near ward storage is being utilised where<br />

appropriate. Ward stock levels are being reviewed as part of<br />

the CIP <strong>and</strong> procurement work streams, <strong>and</strong> consideration is<br />

being given to a ‘neutral warehouse’ solution<br />

• The Staff Uniform <strong>and</strong> dress policy has been revised <strong>and</strong><br />

ratified.<br />

Judith Douglas<br />

Gary Etheridge<br />

Judith Douglas<br />

Pam Strange<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 7 of 22


CQC Update Report<br />

<strong>2012</strong><br />

COMPLAINTS<br />

property as necessary.<br />

76. Continue to develop <strong>and</strong><br />

improve its complaints h<strong>and</strong>ling<br />

systems to ensure that<br />

complaints are responded to<br />

fully <strong>and</strong> in a timely manner.<br />

Infection Control Committee every<br />

other month.<br />

A review of outst<strong>and</strong>ing<br />

Ombudsman complaints has taken<br />

place; a dedicated manager has<br />

been appointed to follow up<br />

compliance with action plans or to<br />

report non‐compliance to the<br />

Director of Nursing. Complaint<br />

numbers <strong>and</strong> trends are reported<br />

to the Quality <strong>and</strong> Safety<br />

Committee. PALS processes have<br />

been reviewed to try to address<br />

patient concerns at an earlier<br />

stage. CQC is aware that the <strong>Trust</strong><br />

has seen a significant increase in<br />

complaint numbers since the<br />

investigation was published last<br />

year; as a result, while the<br />

underpinning systems have been<br />

improved, they are struggling to<br />

cope with an unprecedented surge<br />

in numbers.<br />

Sept <strong>2012</strong> – Interim Complaints <strong>and</strong> PALS manager appointed.<br />

Key priorities identified:<br />

• Weekly review of open complaints <strong>and</strong> associated<br />

timescales<br />

• Weekly look ahead trends <strong>and</strong> priorities<br />

• Working on resolving <strong>and</strong> clearing reactivated<br />

complaints<br />

• Written investigations of all complaints produced <strong>and</strong><br />

ratified in new complaints policy (can we attached the<br />

policy please)<br />

• Produced <strong>and</strong> ratified new complaints policy<br />

• Clarified <strong>and</strong> ratified the complaint h<strong>and</strong>ling procedures<br />

• Core complaint team <strong>and</strong> divisions working jointly<br />

• Monthly briefing paper sent to commissioners<br />

Gary Etheridge<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

COMPLAINTS<br />

77. Develop <strong>and</strong> support staff to<br />

ensure that open<br />

Transparent investigations take<br />

place, that complainants are<br />

involved as necessary <strong>and</strong> that<br />

culturally complaints are seen<br />

as opportunities to learn <strong>and</strong><br />

improve the quality<br />

of care.<br />

NHS London has supported the<br />

<strong>Trust</strong> to undertake a root cause<br />

analysis training campaign for<br />

senior management to ensure the<br />

importance of timely investigation<br />

of complaints is fully understood.<br />

A report of trends <strong>and</strong> themes<br />

aggregated across the <strong>Trust</strong> is<br />

reported every other month,<br />

including identification of trends<br />

<strong>and</strong> hotspots.<br />

• Quarterly patient experience report, which triangulates<br />

all patient experience issues reviewed by <strong>Trust</strong> <strong>Board</strong><br />

• More robust action planning process is under<br />

development. This will enable review <strong>and</strong> trend<br />

identification to implement changes in systems <strong>and</strong><br />

practice<br />

• ‘Learning lessons’ group chaired by Asst Dir. Of Nursing<br />

• Work in progress to review the support material that<br />

Divisions use to investigate complains this will ensure<br />

that we are following best practice.<br />

• Occupational Health support available to staff in the<br />

investigation process<br />

Gary Etheridge<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

COMPLAINTS 78. Ensure that any staff A revised policy has been drafted • The revised policy has been ratified <strong>and</strong> is now in place, Any Gary Etheridge MET<br />

Page 8 of 22


CQC Update Report<br />

<strong>2012</strong><br />

identified in a complaint are<br />

involved in resolving the<br />

complaint <strong>and</strong> the resulting<br />

learning, but where there is a<br />

complaint about an individual<br />

there is appropriate separation<br />

of the investigation from the<br />

individual.<br />

<strong>and</strong> is awaiting senior<br />

management approval; it is<br />

currently available to staff but will<br />

only be considered on its way to<br />

being met when it is implemented<br />

<strong>and</strong> progress audited.<br />

member of staff who is named in a complaint will be given<br />

access to the complaint. The <strong>Trust</strong> is also developing support<br />

mechanisms to support members of staff who have been<br />

sighted in a complaint. This work is being implemented by<br />

the core complaints team in collaboration with the Divisional<br />

teams.<br />

BUSINESS<br />

AS USUAL<br />

COMPLAINTS 79. Develop its reporting<br />

mechanisms to ensure that the<br />

board are fully informed of all<br />

complaints, that detailed<br />

trend analysis takes place <strong>and</strong><br />

that the board can assure itself<br />

that learning is taking place, <strong>and</strong><br />

repetition of themes is reduced.<br />

The <strong>Trust</strong> Executive Committee<br />

<strong>and</strong> <strong>Board</strong> now receive a monthly<br />

complaints<br />

analysis; reporting is discussed at<br />

the bimonthly Quality <strong>and</strong> Safety<br />

Committee. The Patient<br />

Experience report to the Quality<br />

<strong>and</strong> Safety Committee includes a<br />

full analysis by directorate <strong>and</strong><br />

highlights key issues.<br />

Reporting began in April <strong>2012</strong><br />

• Briefing report sent to commissioners <strong>and</strong> Quality Safety<br />

committee.<br />

• Key Non executives board members identified as Patient<br />

champions who sit on the Quality <strong>and</strong> safety committee <strong>and</strong><br />

IPEG<br />

• Monthly Complaints <strong>and</strong> patient experience to <strong>Trust</strong> <strong>Board</strong><br />

monthly<br />

Gary Etheridge<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

CO‐OPERATION<br />

39. Continue to engage, <strong>and</strong><br />

develop effective working<br />

relations, with external<br />

providers <strong>and</strong> partners.<br />

Regular stakeholder briefings have<br />

been introduced <strong>and</strong> the <strong>Trust</strong> has<br />

set up a regular programme of<br />

meetings at patient representative<br />

groups, OSCs, <strong>and</strong> briefing to<br />

media. CQC recently attended a<br />

stakeholder meeting at the <strong>Trust</strong><br />

<strong>and</strong> feedback from local authority<br />

partners <strong>and</strong> the Improving Patient<br />

Experience Group was that<br />

communications with stakeholders<br />

had significantly improved.<br />

• Active dialogue with Local Authority; Borough Councils, MPs,<br />

London Ambulance Service; PCTs, NHS London etc<br />

Neill Moloney<br />

Clare Burns<br />

Imogen Shilito<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

CO‐OPERATION 41. Work with social care<br />

partners to develop robust<br />

working practices to ensure<br />

appropriate admission <strong>and</strong><br />

A programme director is working<br />

at the <strong>Trust</strong> with funding from the<br />

Cluster to liaise between the acute<br />

<strong>Trust</strong> <strong>and</strong> borough <strong>and</strong> community<br />

Cross Buffer meeting held weekly with Social Service partners to<br />

facilitate timely discharge.<br />

Discharge Partnership <strong>Board</strong>s, Cross Buffer meetings, local<br />

escalations.<br />

Shelagh Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 9 of 22


CQC Update Report<br />

<strong>2012</strong><br />

discharge practices<br />

services. This post will currently<br />

run until October <strong>2012</strong>. There is<br />

now a central point for escalation<br />

<strong>and</strong> consideration is being given to<br />

allocating a budge to the<br />

programme director to allow them<br />

to make spot purchases to resolve<br />

complex discharge problems.<br />

Work is underway to streamline<br />

processes across all boroughs to<br />

access community services. Gaps<br />

in acute <strong>Trust</strong> resources are being<br />

identified to improve discharge to<br />

community services; early data<br />

indicates reduced length of stay.<br />

Development of a patient‐centred management approach,<br />

replacing ward management approach<br />

DISCHARGE<br />

34. Develop its discharge <strong>and</strong><br />

bed management teams <strong>and</strong><br />

processes to ensure that they<br />

are interlinked <strong>and</strong> that patient<br />

flow is managed effectively<br />

from the point of entry to the<br />

point of discharge.<br />

A single discharge policy is now in<br />

place with clear roles <strong>and</strong><br />

responsibilities established <strong>and</strong> six<br />

discharge specialists employed to<br />

help with complex discharges. The<br />

RESET project is playing a crucial<br />

role in ensuring that discharge is<br />

managed across all relevant<br />

pathways <strong>and</strong> wards. The<br />

Discharge JONAH project <strong>and</strong><br />

accompanying audits are in place.<br />

Daily meetings with matrons <strong>and</strong><br />

senior nursing staff review the bed<br />

position <strong>and</strong> delays. The<br />

underpinning processes <strong>and</strong><br />

policies are in place here, but<br />

CQC’s inspections <strong>and</strong> other<br />

performance measures make clear<br />

that delivery needs to improve to<br />

match the <strong>Trust</strong>’s aspirations.<br />

There is a rotational programme of ward staff onto the complex<br />

discharge planning team. This will produce ‘skilled’ nurses back<br />

onto the wards to enable cascade of experience <strong>and</strong> training.<br />

Allocation of deputy nurse director for ops to oversee patient<br />

flow within the organisation including management of both bed<br />

<strong>and</strong> site teams <strong>and</strong> the discharge planning team.<br />

Daily operation JONAH meetings which include ward sisters,<br />

discharge planning team, therapies, <strong>and</strong> radiology These<br />

meetings discuss constraints <strong>and</strong> their resolution in order to aim<br />

for seamless patient pathways.<br />

Twice weekly JONAH meetings to discuss <strong>and</strong> resolve delayed<br />

transfers of care with key stakeholders i.e. <strong>Trust</strong> staff, Social<br />

Services, Discharge planning team, ward staff, management.<br />

Ward Sponsors programme in place throughout hospital<br />

supported by Ward Sponsor Guidelines <strong>and</strong> Service<br />

Transformation<br />

Caroline Moore<br />

Elaine Wynter<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

DISCHARGE 35. Ensure that clear guidance The <strong>Trust</strong> has suitably robust Ward based documentation has been revised <strong>and</strong> relaunched. Porti Omo‐Bare MET<br />

Page 10 of 22


CQC Update Report<br />

<strong>2012</strong><br />

outlining the expectations of all<br />

staff is produced <strong>and</strong> enforced<br />

so that the prescribing <strong>and</strong><br />

dispensing of ‘to take away’<br />

medication is managed<br />

effectively <strong>and</strong> patient<br />

discharges are not delayed. The<br />

trust needs to ensure that it<br />

monitors adherence with policy,<br />

guidance <strong>and</strong> audit <strong>and</strong> takes<br />

any appropriate action to<br />

support staff to deliver a high<br />

quality service.<br />

guidance <strong>and</strong> policies, which is<br />

reaffirmed at induction. Pharmacy<br />

is meeting dispensing targets, but<br />

better monitoring <strong>and</strong> audit needs<br />

to be introduced to ensure that<br />

treatment is appropriate <strong>and</strong><br />

supported by suitable information.<br />

This has also been linked into the<br />

RESET project. The <strong>Trust</strong>’s Visible<br />

Leadership programme has<br />

included a focus on this area of<br />

care, with reports to the Nursing<br />

<strong>and</strong> Midwifery <strong>Board</strong> <strong>and</strong> Quality<br />

<strong>and</strong> Safety Committee.<br />

Ward based Pharmacists in place to facilitate speedy discharge. Magda Smith BUSINESS<br />

AS USUAL<br />

DISCHARGE<br />

EMERGENCY<br />

UNIT<br />

36. Review <strong>and</strong> rationalise the<br />

discharge <strong>and</strong> bed management<br />

information systems to ensure<br />

that the most effective <strong>and</strong><br />

accurate system is fully utilised.<br />

28. Develop its strategy <strong>and</strong><br />

work for improving flow of<br />

emergency/urgent patients.<br />

This strategy needs to have the<br />

engagement of all clinicians <strong>and</strong><br />

managers as a key component.<br />

The Discharge JONAH tool has<br />

been rolled out as per above; this<br />

is linked in with the RESET project.<br />

As mentioned, the underpinning<br />

measures are in place but<br />

performance is yet to meet<br />

expectations.<br />

The ‘Discharge JONAH’ tool is<br />

being implemented to focus on<br />

discharge <strong>and</strong> length of stay. Daily<br />

meetings, weekly performance<br />

reviews, <strong>and</strong> the RESET project<br />

mean there is frequent <strong>and</strong> indepth<br />

scrutiny; this will be met<br />

when outputs match the<br />

aspirations in a sustainable way.<br />

• Discharge Jonah continues to be operational across both<br />

hospital sites. Daily operation meetings in place in addition<br />

to twice weekly top delays <strong>and</strong> monthly cross buffer<br />

meetings.<br />

• Ward sponsors in place <strong>and</strong> supporting Jonah application<br />

<strong>and</strong> timely escalation.<br />

• Intensive support in place <strong>and</strong> key performance indicators<br />

developed for on going monitoring.<br />

• Continue to work on predicted discharges <strong>and</strong> information<br />

flows into operational meetings <strong>and</strong> bed management.<br />

• BedWeb in use at Ward level also<br />

• Discharge Jonah rounds for all wards is completed daily<br />

• RESET project continues focusing on expediting discharges<br />

safely using various methods to ensure the whole MDT is<br />

supported in progressing the patients care plan, e.g. orange<br />

discharge forms at the weekend.<br />

• Daily analysis of 4hour <strong>and</strong> black breaches when they occur<br />

Julie Meddings<br />

Caroline Moore<br />

Claire Dixon<br />

Sam Elden‐Lee<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

EMERGENCY<br />

UNIT<br />

29. Develop a culture where<br />

everyone feels empowered to<br />

The appraisal process for<br />

emergency department staff has<br />

• An additional patient information leaflet explaining the<br />

process of the ED is being drafted which will have a section<br />

Derek Hicks<br />

Claire Dixon<br />

PART MET<br />

Page 11 of 22


CQC Update Report<br />

<strong>2012</strong><br />

challenge episodes of variable<br />

or poor practice, including<br />

regular monitoring of practice<br />

<strong>and</strong> feedback <strong>and</strong> learning<br />

opportunities for staff.<br />

been reviewed; all staff in this area<br />

have personal development plans.<br />

Hourly vital signs checks are<br />

underway <strong>and</strong> monthly spot audits<br />

are being carried out to ensure<br />

staff feel empowered to challenge<br />

poor performance. Patient<br />

satisfaction surveys are in place<br />

<strong>and</strong> staff are reminded of the<br />

importance of challenging poor<br />

practice as a st<strong>and</strong>ing item on A&E<br />

team meetings. Audit results do<br />

not yet support the processes that<br />

have been put in place.<br />

to write who the patients named nurse <strong>and</strong> doctor are.<br />

There will be a feedback area on this leaflet to enable<br />

patients to anonymously write any feedback both positive<br />

<strong>and</strong> negative. This will enable direct feedback to the staff<br />

that cared for the patient. It is hoped that this will provide<br />

more audit results as the feedback mechanism will be<br />

directly accessible for patients.<br />

• Trend information on complaints is being collated to further<br />

support feedback to all staff<br />

• Customer service competency checklist is being developed<br />

to provide staff with additional training to support<br />

improvements in communication skills<br />

• Peer challenge on poor practice remains in place.<br />

EMERGENCY<br />

UNIT<br />

30. Ensure that all staff, both<br />

permanent <strong>and</strong> temporary,<br />

follow hospital policy <strong>and</strong><br />

procedures.<br />

MATERNITY 4. In conjunction with its<br />

commissioners <strong>and</strong> other<br />

partners, identify <strong>and</strong><br />

implement immediate solutions<br />

to deliver safe maternity<br />

services at the <strong>Trust</strong>, especially<br />

at Queen’s Hospital, while<br />

developing plans to secure a<br />

long‐term solution.<br />

As noted, the appraisal process for<br />

emergency department staff has<br />

been reviewed; spot audits of<br />

elective surgical consent have<br />

indicated some issues with<br />

consistency; not all emergency<br />

patients receive all the information<br />

they need about procedures; <strong>and</strong> a<br />

new information leaflet on<br />

anaesthesia risks is being<br />

developed. Performance indicators<br />

are still negative.<br />

Work with NHS London in the<br />

short‐term <strong>and</strong> in the longer term<br />

via Health for NEL, has so far <strong>and</strong><br />

should address the highest risks to<br />

safety for mothers. Improved audit<br />

<strong>and</strong> reporting on c‐sections is in<br />

place. An audit of 1:1 care in<br />

established labour saw the <strong>Trust</strong><br />

achieve 100%. CQC’s inspections<br />

have confirmed that<br />

Some specialities consent elective patients within the outpatients<br />

some on the day of surgery on the ward.<br />

Emergency procedures are generally consented on the ward but<br />

dependant on type of case <strong>and</strong> urgency can be consented in the<br />

ED <strong>and</strong> very rarely in theatre holding bay.<br />

All patients receive an anaesthetic review but again this can vary<br />

due to urgency <strong>and</strong> unconscious patients receive a review but<br />

cannot have a conversation with the anaesthetists <strong>and</strong> are<br />

subject to a ‘Consent Form 4’ being unable to consent.<br />

A consultant Anaesthetist will be preparing a leaflet concerning<br />

Anaesthetic risks.<br />

Pre Admission services are currently under review <strong>and</strong><br />

development.<br />

Work continues in respect of the Health 4 NEL project.<br />

There are regular audits to ensure 1:1 care is maintained <strong>and</strong><br />

these are reported monthly via the performance dashboards.<br />

Geoff<br />

Middleditch<br />

Gill Perry<br />

Wendy<br />

Matthews<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 12 of 22


CQC Update Report<br />

<strong>2012</strong><br />

improvements have been made<br />

<strong>and</strong> are so far being sustained<br />

MATERNITY 9. Further improve the<br />

maternity triage process with<br />

the introduction of regular<br />

monitoring <strong>and</strong> learning to<br />

ensure that services improve for<br />

all mothers.<br />

MATERNITY<br />

10. Take appropriate action to<br />

ensure that babies are not<br />

transferred to the neonatal care<br />

unit unnecessarily.<br />

New pathway implemented with<br />

monitoring in place; performance<br />

reported weekly to NHS London;<br />

triage working group in place.<br />

Performance levels need to<br />

improve.<br />

Policy <strong>and</strong> guidelines in place but<br />

being reviewed; <strong>Trust</strong> audit has<br />

recently taken place. Performance<br />

outputs not meeting required<br />

levels.<br />

New pathway implemented 30th July <strong>2012</strong>. However still issues<br />

with middle grade doctor cover, this will be resolved when KGH<br />

closes. Performance continues to be monitored on a monthly<br />

basis<br />

OAU now has appointment system <strong>and</strong> achieves the st<strong>and</strong>ard.<br />

See performance report above<br />

Target moving towards women seen by a doctor within 30<br />

minutes.<br />

Work has been undertaken in HDU to minimalize hypothermic<br />

babies, e.g. skin to skin, bear‐hugger equipment, thermometers<br />

in each bay in HDU however there are some safeguard reports of<br />

environmental issues (cold rooms / non‐functioning thermostats)<br />

which are impacting the temperatures of babies on postnatal<br />

wards. Discussions underway with estates department The latest<br />

audit of all neonatal admissions was undertaken on the 8 th<br />

September <strong>and</strong> revealed no admission due to environmental<br />

conditions or hypothermic neonates.<br />

Averil Archibald<br />

Wendy<br />

Matthews<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MATERNITY 13. Continue with its<br />

recruitment plans in maternity<br />

services to ensure that it has<br />

suitable numbers of qualified<br />

staff across all service delivery<br />

departments.<br />

Recruitment is on target to deliver<br />

a 1:29 ratio, with higher numbers<br />

of substantive staff in post. CQC<br />

inspections have identified some<br />

concerns around midwifery care<br />

assistant staffing levels. <strong>Trust</strong> has<br />

faced challenges in recruitment<br />

<strong>and</strong> retention, although these are<br />

not particular to this <strong>Trust</strong> alone.<br />

Midwife to birth ratio 1:29 achieve with bank usage, however 26<br />

student midwives qualifying in September to <strong>November</strong> at which<br />

time bank will only be used for maternity leave <strong>and</strong> sickness<br />

HDU nurses available at all times in HDU. Midwives now<br />

undergoing training for management of critical obstetrically ill<br />

women<br />

all vacant MCA posts recruited. Study days for MCA's<br />

implemented as annual m<strong>and</strong>atory training. Competency training<br />

being rolled out.<br />

Proposed boundary changes will ensure that this ratio is<br />

maintained, <strong>and</strong> there are clear plans for the recruitment of<br />

midwives on an on going basis to ensure st<strong>and</strong>ards are<br />

maintained.<br />

Richard Howard<br />

Dele<br />

Olorunshola<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MATERNITY<br />

Increase the level of training on<br />

the interpretation of CTGs, so<br />

that all staff have undertaken<br />

All midwives were due to have<br />

completed training by end of<br />

March <strong>2012</strong>, although the<br />

JP comments ‐ M12.1 number of SIs coming through with CTG<br />

interpretation issues still. Discussion re management framework<br />

for response discussed with SOM <strong>and</strong> DOM with Risk Manager ‐<br />

Jude Piper<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 13 of 22


CQC Update Report<br />

<strong>2012</strong><br />

MATERNITY<br />

MATERNITY<br />

this. maternity dashboard showed 84%<br />

complete. Regular audits of<br />

attendance are in place.<br />

17. Improve the quality of<br />

record keeping <strong>and</strong> records<br />

management in maternity<br />

services.<br />

19. Ensure that maternity audit<br />

processes are integrated with<br />

the rest of the <strong>Trust</strong>.<br />

Training for staff <strong>and</strong> a maternity<br />

records tracker <strong>and</strong> audit process<br />

are in place, but some problems<br />

with implementation <strong>and</strong> targets<br />

not being met to date. More that<br />

50% of staff have now been<br />

trained in appropriate governance.<br />

While a clinical audit plan is in<br />

place <strong>and</strong> infection control is being<br />

audited, an audit midwife has only<br />

recently been recruited. The full<br />

set of policy <strong>and</strong> process measures<br />

are in place but performance is not<br />

meeting expected levels as of the<br />

time of writing.<br />

st<strong>and</strong>ard approach to be taken 1. SOM review <strong>and</strong> education is<br />

required / template to be developed <strong>and</strong> used to show audit trail<br />

2. second offence ‐ disciplinary process + SOM input.<br />

For obstetric team need to liaise with tutors to determine correct<br />

process in line with deanery programme<br />

90% for June <strong>2012</strong>, however due to a number of SI's with CTG<br />

misinterpretation please see new process <strong>and</strong> comments above.<br />

Training in place highlights ‘barn door’ competence. The revised<br />

training package which has just been implemented will ensure<br />

that there is a test <strong>and</strong> assess element to the training. Specific<br />

support is available to those midwives who require additional<br />

support.<br />

There have been no SUI reports which have involved CTG<br />

interpretation in September.<br />

Tracker implemented. Audit of compliance commencing Sept<br />

<strong>2012</strong>.<br />

Retrospective tracking has been completed <strong>and</strong> all women are<br />

now covered.<br />

Old Maternity notes are subject to tracking as women attend the<br />

unit.<br />

Training in this is now included in M<strong>and</strong>atory Training for all staff<br />

<strong>and</strong> as part of Induction for all new staff.<br />

Maternity Department has in place an annual audit plan for<br />

<strong>2012</strong>/13 compiled by the Audit Lead Consultant <strong>and</strong> the Audit<br />

Midwife. Audit findings are presented at monthly Audit meetings<br />

attended by multidisciplinary representation. The action plans are<br />

discussed at the meeting <strong>and</strong> uploaded onto the intranet by the<br />

Clinical Audit Team .<br />

FU comment: The crib sheet has not been shared with the Audit<br />

midwife therefore cannot provide an update.<br />

Wendy<br />

Matthews<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MEDICINES<br />

MANAGEMENT<br />

48. Reinforce its policy on<br />

medication prescribing,<br />

dispensing <strong>and</strong> administration,<br />

ensuring that all staff are<br />

A briefing for clinical staff<br />

explaining the importance of this<br />

policy <strong>and</strong> setting out<br />

accountabilities for prescribing <strong>and</strong><br />

FU comment: The audit team adheres to the <strong>Trust</strong> procedures,<br />

uses approved tools <strong>and</strong> ensures that the audits are centrally<br />

recorded by the <strong>Trust</strong> Clinical Audit Team.<br />

The BHRuT Medicines Care, Custody, prescribing <strong>and</strong><br />

Administration Policy has been finalised <strong>and</strong> ratified by the Drugs<br />

<strong>and</strong> Therapeutics Committee, Nursing <strong>and</strong> Midwifery <strong>Board</strong> <strong>and</strong><br />

the Policy ratification Committee. It is available on the intranet<br />

Ian Grant<br />

Jane Stevens<br />

Pam Strange<br />

Portia Omo‐Bare<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 14 of 22


CQC Update Report<br />

<strong>2012</strong><br />

aware of their roles <strong>and</strong><br />

responsibilities.<br />

administration has been prepared;<br />

this is due to be rolled out shortly.<br />

A Policy Ratification Group has<br />

been set up to ensure policies are<br />

corporately signed off, published<br />

on the<br />

intranet, with summaries added to<br />

the Link to raise awareness of<br />

changes <strong>and</strong> expectations around<br />

compliance. Trends <strong>and</strong> issues<br />

relating to prescribing <strong>and</strong><br />

medicines are reported in the Link,<br />

with a bimonthly prescribing<br />

newsletter in place to ensure a<br />

strong focus on medicines safety.<br />

An ongoing audit programme has<br />

looked at omitted drugs in the<br />

MAU, pharmacist errors, <strong>and</strong> is<br />

looking at a range of other<br />

relevant issues.<br />

<strong>and</strong> has been publicised for all staff in the Link <strong>and</strong> via the<br />

Medicine Matters Bulletin. Copies have been distributed to all<br />

wards <strong>and</strong> clinical areas in the <strong>Trust</strong> <strong>and</strong> ward matrons have been<br />

tasked with providing a list to pharmacy of all staff who have read<br />

the policy. A summary quick reference guide has also been<br />

prepared <strong>and</strong> distributed for nursing <strong>and</strong> medical staff which<br />

contains key responsibilities in the policy as applicable to these<br />

staff groups. This is reinforced in nurse induction <strong>and</strong> m<strong>and</strong>atory<br />

training.<br />

MEDICINES<br />

MANAGEMENT<br />

49. Ensure that the results of<br />

learning from medication errors<br />

are widely publicised across all<br />

services in the organisation.<br />

PREMISES 50. Review the directional<br />

signage at Queen’s Hospital.<br />

The trust should ensure that it<br />

seeks the input of patients,<br />

relatives, visitors <strong>and</strong> staff, to<br />

ensure that any new signage<br />

Safe Medicines Practice Group in<br />

place <strong>and</strong> produces a summary of<br />

incident themes <strong>and</strong> serious<br />

incidents to be used in directorate<br />

meetings. Pharmacists <strong>and</strong> wards<br />

receive monthly reports on<br />

medicines <strong>and</strong> prescribing. Error<br />

trends are fed back to relevant<br />

directorates <strong>and</strong> are published on<br />

the intranet.<br />

Working group involving patients,<br />

non‐execs <strong>and</strong> staff set up in<br />

December<br />

2011 to set signage st<strong>and</strong>ards;<br />

main signage reviewed with<br />

specialist input <strong>and</strong> new signs<br />

Monthly meetings are taking place to review all medicines related<br />

clinical incidents in which action plans are made to address<br />

serious incidents <strong>and</strong> also key trends are identified <strong>and</strong> reported<br />

back monthly to wards/directorates. Learning from these is also<br />

shared more widely across the <strong>Trust</strong> via a range of media<br />

including the intranet, The LINK <strong>and</strong> the pharmacy bulletin. All<br />

medicine incidents are reported to the <strong>Trust</strong> Quality <strong>and</strong> Safety<br />

Committee on the dashboard. The trust has recently introduced<br />

electronic incident reporting which will improve incident<br />

investigation timeframes <strong>and</strong> provide better data on key trends<br />

than the previous paper reporting system.<br />

This work has been completed. The new maps <strong>and</strong> directions are<br />

available to visitors via the <strong>Trust</strong> website. Sodexho are currently<br />

reviewing the signage throughout the hospital as part of the<br />

routine maintenance arrangements of the site.<br />

Portia Omo‐Bare<br />

Jackie Doyle<br />

Imogen Shilito<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 15 of 22


CQC Update Report<br />

<strong>2012</strong><br />

meets the needs of its<br />

populations.<br />

commissioned to arrive in June<br />

<strong>2012</strong>. Leaflet <strong>and</strong> map under<br />

review to ensure signage is in<br />

context of better overall patient<br />

information.<br />

Hyperlinks to the maps are given below:<br />

http://www.bhrhospitals.nhs.uk/for‐patients‐<strong>and</strong>‐visitors/mapof‐queens.htm<br />

http://www.bhrhospitals.nhs.uk/for‐patients‐<strong>and</strong>‐visitors/mapof‐king‐george.htm<br />

PREMISES 51. Review the emergency<br />

department paediatric facilities<br />

at Queen’s Hospital in line with<br />

the st<strong>and</strong>ards outlined in<br />

Services for children in<br />

Emergency<br />

Department’s document <strong>and</strong><br />

then develop an appropriate<br />

strategy involving both the<br />

emergency <strong>and</strong> paediatric<br />

departments.<br />

PREMISES 52. Finalise <strong>and</strong> implement<br />

plans to improve x‐ray facilities<br />

<strong>and</strong> ensure that patients<br />

waiting for x‐rays in the<br />

emergency department are<br />

appropriately cared for.<br />

Paediatric waiting areas reviewed<br />

<strong>and</strong> funding agreed to improve<br />

observation of sick children;<br />

project group set up to implement<br />

Health for NEL redesign of<br />

paediatric services.<br />

Review of x‐ray services including<br />

department layout linked to<br />

Health for NEL programme; project<br />

group set up with dedicated<br />

project management support.<br />

Current process of caring for<br />

patients in waiting area addressed<br />

via a short‐term solution using a<br />

mobile x‐ray device to limit patient<br />

waiting times.<br />

The Paediatrics A&E is a 24 hour unit.<br />

The Paediatric A&E is a st<strong>and</strong> alone area of the main department,<br />

with a dedicated entrance <strong>and</strong> waiting area.<br />

The Paediatric assessment Unit is currently part of the Paediatric<br />

ward Tropical Lagoon.<br />

There are currently plans being developed to extend A&E which<br />

will include Paediatrics, PAU <strong>and</strong> the HDU being housed alongside<br />

A&E.<br />

No child under the age of 16 is admitted onto an adult ward. Sick<br />

children are resuscitated in a Paediatric cubicle within the main<br />

adult resuscitation area.<br />

Seriously ill children are transferred via CATS to appropriate High<br />

Level units across London.<br />

The Paediatrics Early warning skills are currently being developed<br />

for A&E in collaboration with the Paediatric department.<br />

Work is planned to align facilities with health 4 NEL agenda.<br />

The current waiting facilities are deemed sufficient for the needs<br />

of patients currently. A programme of continuous review is on<br />

going <strong>and</strong> will form part of a focus visit for the new Director of<br />

Nursing.<br />

The redevelopment of the A&E <strong>and</strong> local waiting areas is under<br />

review. Schemes are under development <strong>and</strong> will be deployed<br />

when capital funding <strong>and</strong> complimentary schemes are realised.<br />

In the short term, two HCAs have been appointed to chaperone<br />

patients between A&E <strong>and</strong> A&E Radiology. This means that<br />

although the patients are still waiting on the hospital street, they<br />

Jackie Doyle<br />

Carol<br />

Drummond<br />

Stephen<br />

Griffiths<br />

Judith Douglas<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 16 of 22


CQC Update Report<br />

<strong>2012</strong><br />

are now supervised during part of the working day. This is an<br />

improvement because prior to this, patients were left unescorted<br />

outside of the A&E Radiology department. We also now have<br />

dedicated changing room facilities so that patients are afforded<br />

greater dignity <strong>and</strong> privacy. The <strong>Trust</strong> has also purchased a Digital<br />

Radiography Mobile X ray unit. This unit is based in Resus but has<br />

the potential to be used to support the service if the A&E<br />

Radiology room breaks down <strong>and</strong> services have to be diverted to<br />

the main X Ray Department.<br />

PREMISES<br />

53. Ensure that appropriate<br />

waiting facilities are available<br />

for patients <strong>and</strong> relatives in the<br />

urgent care centre.<br />

As above, these waiting facilities<br />

are being reviewed as part of the<br />

Health for NEL programme.<br />

The current waiting facilities are deemed sufficient for the needs<br />

of patients currently. A programme of continuous review is on<br />

going <strong>and</strong> will form part of a focus visit for the new Director of<br />

Nursing.<br />

Jackie Doyle<br />

PART MET<br />

BUSINESS<br />

AS USUAL<br />

PREMISES 55. Review <strong>and</strong> take any<br />

necessary action in all inpatient<br />

areas to ensure that there are<br />

clear lines of sight so that<br />

patients can be observed at all<br />

times.<br />

The ‘hourly staffing of wards’<br />

element of the Safer Nursing Care<br />

Tool <strong>and</strong> other tools are being<br />

used to try to ensure there is<br />

suitable observation of patients,<br />

although concerns about staffing<br />

levels suggest there is room for<br />

improvement.<br />

The <strong>Trust</strong> has decided against a ‘line of sight’ audit <strong>and</strong> opted to<br />

focus efforts on Ward Establishments, Patient Acuity scoring,<br />

Professional Judgement module; Dependency scoring; Patient<br />

safety tool<br />

These elements are also considerate of Hourly rounding <strong>and</strong><br />

single sex accommodation in assessing patient safety issues<br />

• Reflect <strong>and</strong> mitigate results from the National Patient<br />

Survey.<br />

Julie Meddings<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

PREMISES 56. Develop appropriate<br />

facilities to ensure the day case<br />

surgical patients are cared for in<br />

appropriate environments at<br />

Queen’s Hospital.<br />

The use of overnight recovery has<br />

been reviewed <strong>and</strong> works are<br />

underway to Improve facilities<br />

subject to funding. There is a plan<br />

in place to develop a 23‐hour<br />

facility in the day surgery unit <strong>and</strong><br />

allow space in Recovery to be used<br />

as a ‘day of surgery’ admissions<br />

area, but these are pending the<br />

outcomes of the bed‐modelling<br />

work stream.<br />

Appropriate use of Day Case <strong>and</strong> O/N recover is a st<strong>and</strong>ing<br />

agenda item on the Daily Bed Meetings.<br />

Any single‐sex or ‘step down’ breach is treated seriously <strong>and</strong><br />

investigated via RCA methodology<br />

Eileen Moore<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 17 of 22


CQC Update Report<br />

<strong>2012</strong><br />

RADIOLOGY<br />

31. Develop its planning <strong>and</strong><br />

bed management processes to<br />

ensure all patients are cared for<br />

in appropriate facilities.<br />

Matrons <strong>and</strong> ward sisters are<br />

monitoring this but the <strong>Trust</strong> has<br />

not yet established how best to<br />

measure success in this area. The<br />

X‐Ray department has introduced<br />

appropriate checklists for ensuring<br />

patients are properly prepared.<br />

The Department has developed St<strong>and</strong>ard Operating Procedures<br />

attached below which are evidence based <strong>and</strong> serve as the<br />

baseline expectation for all staff. These have been ratified<br />

internally, <strong>and</strong> are based on good practice examples.<br />

These are well publicised throughout the department, <strong>and</strong><br />

subject to internal review.<br />

• A Plan is in place to ensure publicity <strong>and</strong> accessibility at<br />

ward level<br />

• The impact of these documents is subject to audit in 6<br />

months time.<br />

Stephen<br />

Griffiths<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

RADIOLOGY<br />

32. Put in place clear protocols<br />

for the management of<br />

interventional rradiology<br />

patients with audit <strong>and</strong><br />

improvement cycles to ensure<br />

st<strong>and</strong>ards are attained <strong>and</strong><br />

maintained.<br />

Audit processes are in place <strong>and</strong><br />

are monitored at interventional<br />

radiology meetings <strong>and</strong> at the<br />

Divisional <strong>Board</strong>. SOPs are in place<br />

<strong>and</strong> are being implemented for<br />

each procedure in interventional<br />

radiology.<br />

CQC’s compliance activity supports<br />

the <strong>Trust</strong>’s assessment of<br />

significant progress in this area,<br />

although more audit activity needs<br />

to be delivered for this to be<br />

considered fully met.<br />

The Department has developed St<strong>and</strong>ard Operating Procedures<br />

attached below which are evidence based <strong>and</strong> serve as the<br />

baseline expectation for all staff. These have been ratified<br />

internally, <strong>and</strong> are based on good practice examples.<br />

These are well publicised throughout the department, <strong>and</strong><br />

subject to internal review.<br />

Stephen<br />

Griffiths<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

RECORDS<br />

80. Improve its systems for<br />

records management to ensure<br />

that notes can be retrieved<br />

effectively <strong>and</strong> expediently, <strong>and</strong><br />

reduce the risks associated with<br />

multiple sets of temporary<br />

notes <strong>and</strong> poor data h<strong>and</strong>ling.<br />

The <strong>Trust</strong>’s Medical Records<br />

Committee has been reestablished<br />

with new Terms of<br />

Reference; training levels for<br />

healthcare professionals are<br />

discussed at this Committee on a<br />

regular basis. Weekend transport<br />

for transfer of notes has been<br />

reintroduced <strong>and</strong> a nursing<br />

documentation booklet has been<br />

piloted across several wards <strong>and</strong><br />

will be fully implemented by the<br />

The development of the eH<strong>and</strong>over system will provide a<br />

<strong>Trust</strong>wide joined up reference database for the use in patient<br />

care.<br />

A new PAS is being commissioned in 2013 for implementation<br />

which will improve the availability of Patient records <strong>and</strong> reduce<br />

the incidence of Temporary folders.<br />

It is anticipated that patients will be migrated onto one hospital<br />

number covered by barcode scanning options as part of the rollout<br />

<strong>and</strong> implementation.<br />

Ian Grant<br />

Alex<br />

Hammerton<br />

PART MET<br />

BUSINESS<br />

AS USUAL<br />

Page 18 of 22


CQC Update Report<br />

<strong>2012</strong><br />

autumn.<br />

RECORDS<br />

81. Develop integrated patient<br />

administration <strong>and</strong> information<br />

systems to ensure that, where<br />

ever a patient is being treated<br />

within the trust, their full<br />

healthcare history can be<br />

accessed by all staff.<br />

A procurement process is<br />

underway to introduce an<br />

effective system to enable access<br />

to patient histories. Funding<br />

challenges have slowed<br />

introducing of a full electronic<br />

patient record.<br />

A new PAS is being commissioned in 2013 for implementation<br />

which will improve the availability of Patient records <strong>and</strong> reduce<br />

the incidence of Temporary folders.<br />

It is anticipated that patients will be migrated onto one hospital<br />

number covered by barcode scanning options as part of the rollout<br />

<strong>and</strong> implementation.<br />

Paul Richards<br />

RESPECT &<br />

INVOLVEMENT<br />

27. Make sure that proactive<br />

<strong>and</strong> m<strong>and</strong>atory training <strong>and</strong><br />

education regarding dignity,<br />

respect <strong>and</strong> tolerance is<br />

delivered to all staff.<br />

Dignity <strong>and</strong> respect benchmarking<br />

has been done; compliance<br />

reports on non‐attendance are<br />

being reviewed <strong>and</strong> a m<strong>and</strong>atory<br />

training programme is being<br />

developed. A leaflet for new staff<br />

about the <strong>Trust</strong>’s expectations of<br />

behaviour has been drafted <strong>and</strong> is<br />

due to be reviewed with the staff<br />

engagement group before roll out.<br />

The BHRUT Code is being reviewed<br />

<strong>and</strong> will be issued to all new<br />

starters with contract. Quality of<br />

Care audits of dignity <strong>and</strong> respect<br />

have been carried out in<br />

December <strong>and</strong> March so far <strong>and</strong><br />

will continue in order to audit<br />

feedback from the real time<br />

patient survey.<br />

Bank managers to ensure that<br />

competence of all temporary<br />

clinical staff in this respect is<br />

monitored; if concerns are raised<br />

about temporary staff they should<br />

either not be booked again or only<br />

done so with documented<br />

supervision.<br />

M<strong>and</strong>atory training development, reports on non‐attendance,<br />

leaflet re Behaviour <strong>and</strong> expectations; reviewed BHRUT Code;<br />

Survey Feedback, Update from Gill Perry re Bank competency<br />

framework monitoring.<br />

Gill Perry<br />

Claire O’Toole<br />

Alison Crombie<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 19 of 22


CQC Update Report<br />

<strong>2012</strong><br />

STAFFING 60. Continue to review its<br />

human resource information<br />

systems <strong>and</strong> ensure that<br />

accurate data is available for<br />

the entire organisation, so that<br />

a clear <strong>and</strong> comprehensive<br />

underst<strong>and</strong>ing of vacancies can<br />

be established.<br />

The <strong>Trust</strong> has introduced a phased<br />

programme to consolidate<br />

establishment data against the<br />

electronic staff record, including<br />

cleansing the record of posts that<br />

are no longer in use, <strong>and</strong> with<br />

finance support. There have been<br />

challenges in aligning the HR<br />

ledger data with the electronic<br />

record. Further work is needed<br />

<strong>and</strong> there is, as yet, no formal<br />

process in place or agreed for<br />

managing establishment control.<br />

The move to electronic staff<br />

change / termination forms has<br />

been difficult to implement, <strong>and</strong><br />

there has been a delay in getting<br />

fully accurate reporting on<br />

vacancies <strong>and</strong> establishment.<br />

The <strong>Trust</strong> systems to reconcile ledger <strong>and</strong> ESR will ‘go live’ on<br />

07/11/12 <strong>and</strong> will be evaluated for compliance on 30/11/12.<br />

The work is led by Gill Perry; Leigh Malyon supported by Mark<br />

Greene (Finance)<br />

Sept 12 update: A great deal of work has taken place to align the<br />

financial ledger with ESR. This work is now complete except for<br />

the updating of the old subjective codes for medical staff within<br />

the finance ledger. Updating these codes by finance will<br />

completely align the ledger to ESR. Finance are in the process of<br />

cleansing the old subjective codes ,<br />

it is envisaged that this work will be complete in the next few<br />

weeks. A process & procedure for establishment control has been<br />

developed <strong>and</strong> agreed. Next step is the development of the<br />

electronic change form <strong>and</strong> testing of the system – it is<br />

anticipated this will be complete by beginning <strong>November</strong>.<br />

Mark Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

STAFFING 61. Continue to review its<br />

workforce strategy to ensure<br />

that it meets the needs of the<br />

organisation <strong>and</strong> reflects the<br />

reality of service delivery.<br />

A review of the Workforce<br />

Strategy has been completed <strong>and</strong><br />

is now being tested via the staff<br />

engagement group.<br />

A Number of work streams are currently active which affect the<br />

current workforce strategy. These schemes are led by senior<br />

managers <strong>and</strong> report to the Director of Transformation <strong>and</strong> the<br />

Transformation <strong>Board</strong> initially.<br />

• Length of Stay Work stream (Julie Meddings & Ernst<br />

<strong>and</strong> Young)<br />

• AHP Review (Nick Hume, Director of Strategy)<br />

• Workforce Transformation (Mark Smith, Head of<br />

Workforce Transformation)<br />

Mark Smith<br />

BUSINESS<br />

AS USUAL<br />

STAFFING<br />

62. Undertake systematic skill<br />

mix <strong>and</strong> staffing needs analysis<br />

to ensure that they have the<br />

right staff with the right skills at<br />

the right locations <strong>and</strong> that<br />

trust is receiving value for<br />

money.<br />

Skills for Health are supporting the<br />

<strong>Trust</strong> in this, funded via NHS<br />

London Financial Support. Pilot<br />

work in the Emergency <strong>and</strong><br />

Maternity Departments is<br />

underway. Future phases are<br />

heavily dependent on the success<br />

Sept 12 update: Paediatric skill mix project has now commenced<br />

Plan now in place to link overall SfH project with Clinical<br />

transformation lead’s work in relating to review of the ward<br />

nursing establishments. Meeting scheduled for Wed 3rd October<br />

to include discussions on implementing A&E recommendations<br />

provided by SfH in their review.<br />

Linda Baker<br />

PART MET<br />

Page 20 of 22


CQC Update Report<br />

<strong>2012</strong><br />

of the pilot analysis <strong>and</strong> capacity to<br />

roll its findings out across the <strong>Trust</strong><br />

<strong>and</strong> this will only be able to be<br />

assessed in the longer term. CQC<br />

compliance activity continues to<br />

suggest that the <strong>Trust</strong> faces<br />

challenges in terms of building a<br />

sustainable workforce with the<br />

right skills mix.<br />

STAFFING 63. Continue to recruit<br />

appropriate permanent staff to<br />

ensure that it reduces its<br />

reliance on agency <strong>and</strong> locum<br />

staff improving the quality of<br />

care, <strong>and</strong> have in place effective<br />

retention strategies.<br />

An accelerated recruitment project<br />

<strong>and</strong> reduced use of agency staff<br />

have been put in place, with<br />

recruitment needs assessed on a<br />

monthly basis. Exit interviews are<br />

now in place as part of KPIs <strong>and</strong><br />

are reviewed by Directors.<br />

The <strong>Trust</strong> has introduced suitable<br />

procedures here, but CQC<br />

compliance activity has identified<br />

on‐going challenges around locum<br />

use, particularly in A&E.<br />

Sept 12 update: Improved bank & agency controls have been<br />

introduced which are linked to more proactive booking of bank<br />

staff. E‐rostering KPI’s are measured at the same time as bank<br />

usage is requested in order to ensure every possible use of<br />

permanent staff has been explored first.<br />

Gill Perry<br />

Mark Smith<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

STAFFING<br />

66. Support a skills escalation<br />

programme in the emergency<br />

department that seeks to<br />

develop nurses who have<br />

already successfully completed<br />

an emergency nurse<br />

practitioner or advanced clinical<br />

practitioner course <strong>and</strong> reduce<br />

reliance on them undertaking<br />

traditional nursing duties due to<br />

shortages of staff.<br />

A review of the A&E workforce has<br />

been completed <strong>and</strong> the unit has<br />

been benchmarked against other<br />

comparable trusts. A review of the<br />

skills mix, current roles, <strong>and</strong><br />

supporting roles has been<br />

undertaken <strong>and</strong> budgets reviewed<br />

in light of this. Current staff are<br />

taking part in an on‐going training<br />

programme to ensure staff update<br />

<strong>and</strong> refresh their skills. CQC’s<br />

compliance activity has identified<br />

on‐going staffing challenges in A&E<br />

<strong>and</strong> the longer term impact of this<br />

review work will need to be<br />

Head of Nursing for A&E appointed <strong>and</strong> in Post September <strong>2012</strong>.<br />

Lead for ANP<br />

•Review of KGH ED nursing workforce has commenced <strong>and</strong> is<br />

being led by the Clinical Nurse Director for Emergency Care. A<br />

review of the paediatric nursing workforce on both sites <strong>and</strong> the<br />

RAT (rapid, assessment <strong>and</strong> treatment) area nursing workforce at<br />

QH will also be undertaken in October.<br />

•Training competencies are being reviewed for all roles in the<br />

department to ensure that all staff have clear responsibilities <strong>and</strong><br />

competencies to undertake that role. This work is being led by<br />

the Clinical Nurse Director with support from the Matrons.<br />

•Advanced nurse practitioners have started in the ED.<br />

•Established weekly middle grade <strong>and</strong> SHO teaching is in place<br />

with a clear <strong>and</strong> structured training curriculum<br />

Derek Hicks<br />

Clare Dixon<br />

Samantha<br />

Elden‐Lee<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 21 of 22


CQC Update Report<br />

<strong>2012</strong><br />

assessed at some point in<br />

the future<br />

STAFFING 67. Ensure that its<br />

whistleblowing systems <strong>and</strong><br />

processes allow staff a route to<br />

raise concerns early so that<br />

quick action can be taken <strong>and</strong><br />

staff feel empowered to raise<br />

concerns.<br />

The <strong>Trust</strong>’s whistleblowing policy<br />

has been revised <strong>and</strong><br />

communicated to staff through<br />

Team Brief, the Link <strong>and</strong> the<br />

intranet. Staff feedback on the<br />

effectiveness of the policy is now<br />

part of the staff engagement<br />

strategy <strong>and</strong> new starters will be<br />

audited after six months to see if<br />

they are aware of it. Delivery of<br />

this recommendation is contingent<br />

on cultural change embedding<br />

itself across the <strong>Trust</strong> (although it<br />

should be noted that CQC has<br />

usually found staff open <strong>and</strong><br />

willing to talk frankly about<br />

challenges during inspections,<br />

whether in confidence or openly).<br />

We are now launching a further communications exercise to raise<br />

the profile of the new policy <strong>and</strong> offer training to staff. In<br />

October <strong>2012</strong> this will include a payslip message <strong>and</strong> wide<br />

circulation of the attached letter signed by the Chief Executive<br />

<strong>and</strong> Staff side lead.<br />

Training sessions have now also been arranged on both sites <strong>and</strong><br />

will initially run from the end of October to beginning of<br />

December <strong>2012</strong> when they will be reviewed<br />

Claire O’Toole<br />

MET<br />

BUSINESS<br />

AS USUAL<br />

Page 22 of 22


EXECUTIVE SUMMARY<br />

TITLE:<br />

Information Governance (IG) Strategy <strong>2012</strong>/13<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

7 th <strong>November</strong> <strong>2012</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

Information Governance (IG) is a framework □ PEQ ……………..….. □ STRATEGY……….….…….<br />

that brings together best practice, st<strong>and</strong>ards<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

<strong>and</strong> requirements that apply to the h<strong>and</strong>ling of<br />

information. This includes sensitive <strong>and</strong> □ CLINICAL GOVERNANCE …………..………….....……<br />

personal information, of patients <strong>and</strong> employees □ CHARITABLE FUNDS ………………………………...…<br />

as well as commercially sensitive information.<br />

√ TRUST BOARD …05/09/12…..………<br />

This strategy sets out <strong>Barking</strong> <strong>Havering</strong> <strong>and</strong> □ REMUNERATION ………………………………….…...<br />

Redbridge University Hospitals NHS <strong>Trust</strong>’s □ OTHER … ……………………..……. (please specify)<br />

(BHRUT’s) approach to providing a robust<br />

Information Governance framework. It is<br />

essential that appropriate management<br />

structures, leadership <strong>and</strong> organisational<br />

processes are in place to deliver successful<br />

information governance, <strong>and</strong> important the<br />

Information Governance agenda is adequately<br />

resourced.<br />

Purpose:<br />

• To ensure that patient <strong>and</strong> corporate data<br />

collected or created is of the best possible<br />

quality.<br />

• To ensure that data is held in such a<br />

manner as to prevent unauthorised access<br />

to loss, but to available to those authorised<br />

when required for the provision of patient<br />

care or for commissioning purposes.<br />

• To ensure that its policies <strong>and</strong> procedures<br />

reflect the requirements of the Information<br />

Governance agenda, in clearly outlining to<br />

staff their responsibilities.<br />

• To ensure there is a management structure<br />

to reflect IG requirements<br />

2. DECISION REQUIRED: CATEGORY:<br />

To approve the Information Governance<br />

Strategy.<br />

√ NATIONAL TARGET □ CNST<br />

√ CQC REGISTRATION □ HEALTH & SAFETY<br />

√ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER … …………………….. (please specify)<br />

AUTHOR/PRESENTER: Neill Moloney<br />

Director of Planning <strong>and</strong> Performance<br />

DATE: 29 October <strong>2012</strong>


3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

Level 2 or above in all 45 IG Toolkit st<strong>and</strong>ards to achieve satisfactory IG compliance<br />

5. KEY PERFORMANCE INDICATORS<br />

Compliance with the IG toolkit<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2


INFORMATION GOVERNANCE<br />

STRATEGY<br />

<strong>2012</strong>/2013<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 1 of 9<br />

Information Governance Strategy Version 1.4 Issued October <strong>2012</strong>


BACKGROUND<br />

Information Governance (IG) is a framework that brings together best practice, st<strong>and</strong>ards<br />

<strong>and</strong> requirements that apply to the h<strong>and</strong>ling of information. This includes sensitive <strong>and</strong><br />

personal information, of patients <strong>and</strong> employees as well as commercially sensitive<br />

information.<br />

Information Governance provides a way for employees to deal consistently with the many<br />

different rules about how information is h<strong>and</strong>led, including those set out in:<br />

• The Data Protection Act 1998<br />

• The common law duty of confidentiality<br />

• The Confidentiality NHS Code of Practice<br />

• The NHS Care Record Guarantee for Engl<strong>and</strong><br />

• The Social Care Record Guarantee for Engl<strong>and</strong><br />

• The international information security st<strong>and</strong>ard: ISO/IEC 27002: 2005<br />

• The Information Security NHS Code of Practice<br />

• The Records Management NHS Code of Practice<br />

• The Freedom of Information Act 2000<br />

• The Caldicott Report<br />

This strategy sets out <strong>Barking</strong> <strong>Havering</strong> <strong>and</strong> Redbridge University Hospitals NHS <strong>Trust</strong>’s<br />

(BHRUT’s) approach to providing a robust Information Governance framework. It is essential<br />

that appropriate management structures, leadership <strong>and</strong> organisational processes are in<br />

place to deliver successful information governance, <strong>and</strong> important the Information<br />

Governance agenda is adequately resourced.<br />

Information Governance sits alongside clinical <strong>and</strong> corporate governance in providing the<br />

service users <strong>and</strong> other organisations with the assurance that personal <strong>and</strong> commercially<br />

sensitive information is h<strong>and</strong>led in a confidential <strong>and</strong> secure manner to appropriate legal,<br />

ethical <strong>and</strong> quality st<strong>and</strong>ards.<br />

The Information Governance strategy is monitored by the Connecting for Health (CfH)<br />

Information Governance Toolkit. This is a performance tool produced by the Department of<br />

Health (DH) which draws together the legal rules <strong>and</strong> central guidance set out above <strong>and</strong><br />

presents them in one place as a set of Information Governance requirements.<br />

This document should be read in conjunction with the Information Governance Policy. The<br />

Action Plan sets out a delivery of actions to satisfy the requirements.<br />

PURPOSE<br />

1. To ensure that patient <strong>and</strong> corporate data collected or created is of the best possible<br />

quality.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 2 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


Information is a vital asset in terms of the clinical management of individual patients <strong>and</strong><br />

the efficient management of services <strong>and</strong> resources. It plays a key part in clinical<br />

governance, service planning <strong>and</strong> performance management. It is therefore important<br />

that information is efficiently managed within the <strong>Trust</strong> through a robust Information<br />

Governance Framework to assure <strong>and</strong> demonstrate that all information is dealt with<br />

legally, securely, effectively <strong>and</strong> efficiently in order to deliver the best possible care to<br />

patients, staff <strong>and</strong> other service users.<br />

As accurate, timely <strong>and</strong> relevant information is essential to deliver the highest quality<br />

health care, it is the responsibility of all clinicians <strong>and</strong> managers to ensure <strong>and</strong> promote<br />

the quality of information <strong>and</strong> to actively use information in decision making processes.<br />

2. To ensure that data is held in such a manner as to prevent unauthorised access to loss,<br />

but to available to those authorised when required for the provision of patient care or for<br />

commissioning purposes.<br />

As there is a need for an appropriate balance between openness <strong>and</strong> confidentiality in<br />

the management <strong>and</strong> use of information, the <strong>Trust</strong> fully supports the principles of<br />

corporate governance <strong>and</strong> recognises its public accountability. However it equally<br />

places importance on the confidentiality of <strong>and</strong> the security arrangements to safeguard<br />

personal information about patients <strong>and</strong> staff <strong>and</strong> commercially sensitive information.<br />

The <strong>Trust</strong> also recognises the need to share patient information with other health<br />

organisations <strong>and</strong> other agencies in a controlled manner.<br />

To achieve this aim BHRUT will:<br />

• Require the ongoing support of the <strong>Trust</strong> <strong>Board</strong> in placing IG as a high<br />

organisational priority, which promotes the importance to all staff of maintaining<br />

confidentiality <strong>and</strong> following policies/procedures outlined<br />

• Establish <strong>and</strong> maintain policies to ensure the secure management of its<br />

information assets <strong>and</strong> systems<br />

• Comply with legal <strong>and</strong> regulatory requirements, introducing best practice guidance<br />

relating to Information where appropriate<br />

• Ensure patient, staff <strong>and</strong> commercial information is treated as confidential<br />

• Ensure records are stored <strong>and</strong> transported securely<br />

• Ensure that Directorate <strong>and</strong> Service procedures <strong>and</strong> processes relating to<br />

information <strong>and</strong> data flows are fully mapped<br />

• Provide Information Governance training to staff at induction, <strong>and</strong> through<br />

m<strong>and</strong>atory training sessions/via e-training<br />

• Monitor information security alerts through the <strong>Trust</strong> incident reporting process<br />

• Ensure contracts with companies processing data on behalf of the <strong>Trust</strong> include<br />

clauses with reference to Information Governance, the expectations to follow this<br />

requirement <strong>and</strong> the consequences of non-compliance<br />

3. To ensure that its policies <strong>and</strong> procedures reflect the requirements of the Information<br />

Governance agenda, in clearly outlining to staff their responsibilities.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 3 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


There are three key components underpinning this strategy:<br />

• The <strong>Trust</strong> Information Governance Framework, which provides a<br />

summary/overview of how the <strong>Trust</strong> is addressing the IG agenda<br />

• The <strong>Trust</strong> Information Governance Policy, which outlines the objectives for<br />

Information Governance; <strong>and</strong><br />

• The annual action plan arising from a baseline assessment against the st<strong>and</strong>ards<br />

set out in the NHS Connecting for Health Information Governance Toolkit<br />

4. To ensure there is a management structure to reflect IG requirements<br />

Within the <strong>Trust</strong>, the Chief Executive Officer (CEO) has overall responsibility for<br />

Information Governance (IG), this responsibility is discharged through the Executive<br />

Chief Information Officer (from 3 rd December <strong>2012</strong>). This individual is responsible for all<br />

aspects of IG including the submission of the Connecting for Health’s Information<br />

Governance Toolkit, is the chair of the Information Governance Steering Group (IGSG),<br />

as well as being the <strong>Trust</strong>’s Senior Information Risk Officer (SIRO).<br />

The SIRO is responsible for underst<strong>and</strong>ing how the strategic business goals of the<br />

<strong>Trust</strong> may be impacted by information risks <strong>and</strong> for the ongoing development <strong>and</strong> dayto-day<br />

management of the <strong>Trust</strong>’s Risk Management Programme for information privacy<br />

<strong>and</strong> security. The SIRO will review <strong>and</strong> agree action in respect of identified information<br />

risks, ensure that the <strong>Trust</strong>’s approach to information risk is effective in terms of<br />

resource, commitment <strong>and</strong> execution <strong>and</strong> that this is communicated to all staff. In<br />

addition they will provide a focal point of resolution <strong>and</strong>/or discussion of information risk<br />

issues, <strong>and</strong> ensure the <strong>Board</strong> is adequately briefed on information risks.<br />

The IGSG comprises of senior representatives from across the <strong>Trust</strong> <strong>and</strong> its<br />

professional disciplines, to promote a holistic approach to IG. It has overall<br />

responsibility for overseeing the implementation of the Information Governance<br />

Strategy, Framework, IG Policy <strong>and</strong> any IG actions plans, by embedding IG within the<br />

organisational structure, <strong>and</strong> sharing the responsibility for completion of the annual IG<br />

Toolkit assessments. It is therefore vital to the development of best practices which are<br />

acceptable, practicable, ‘owned’ <strong>and</strong> therefore better supported across the whole <strong>Trust</strong>,<br />

<strong>and</strong> influences the integration <strong>and</strong> inclusion of IG st<strong>and</strong>ards with other governance,<br />

strategies, work programmes <strong>and</strong> projects, e.g. IT programmes.<br />

The IGSG is accountable to the <strong>Trust</strong> <strong>Board</strong> through the Executive Chief Information<br />

Officer, the named Director on the <strong>Board</strong> with responsibility for Information Governance<br />

(IG). This post is supported by the Director of Clinical Strategy who is the <strong>Trust</strong>’s<br />

Caldicott Guardian, the Head of Commissioning, Information <strong>and</strong> Planning, the IG Lead<br />

<strong>and</strong> members of the IGSG. The IGSG is a sub-group of the Quality <strong>and</strong> Safety<br />

Committee. Terms of Reference <strong>and</strong> membership of the IGSG are defined in the <strong>Trust</strong><br />

document, ‘Information Governance Steering Group Terms of Reference’.<br />

Developing an IG culture within the <strong>Trust</strong> will be achieved through IG training being<br />

provided as part of the <strong>Trust</strong>’s m<strong>and</strong>atory corporate induction programme for new<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 4 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


starters as well as being m<strong>and</strong>atory for all <strong>Trust</strong> staff as part of the <strong>Trust</strong>’s IG training<br />

program, requiring all staff to undertake IG training annually, either at face to face<br />

presentations or by e-learning.<br />

The Director of Clinical Governance <strong>and</strong> the Executive Chief Information Officer will<br />

ensure that IG requirements are reflected in the annual Clinical Governance<br />

Development plan <strong>and</strong> ICT strategy.<br />

IG PROCESS<br />

The wide range of processes covered by the IG Toolkit <strong>and</strong> the diversity of specialisation<br />

resulted in the IGSG taking the decision that responsibility for IG within the <strong>Trust</strong> should not<br />

be allocated to one individual or department. The <strong>Trust</strong> approach is to identify senior<br />

managers who will have responsibility for the management <strong>and</strong> co-ordination of IG<br />

Requirements. These senior staff will be Executive Directors, Directorate Managers or, in<br />

some cases, General Managers. They will be referred to in IG documentation as<br />

Requirement Owners. All Requirement Owners will be full members of the Information<br />

Governance Steering Group. Other staff with specific areas of expertise will be co-opted onto<br />

the Group when required.<br />

As there is often an overlap between IG Requirements, by agreement; one Requirement<br />

Owner may provide evidence for another IG Requirement. However, the identified<br />

Requirement Owner has ultimate responsibility for ensuring that the Requirement is complete<br />

<strong>and</strong> with evidence uploaded to support the compliance level.<br />

The IG Lead will be supporting the st<strong>and</strong>ard owners in developing their action plans, <strong>and</strong> is<br />

responsible for submitting the baseline, performance <strong>and</strong> final assessment to CfH. The<br />

Director of Planning <strong>and</strong> Performance will sign off a report from the IG Toolkit, to confirm he<br />

has authorised the final submission for 31st March 2013.<br />

The <strong>Trust</strong>’s IG performance will be monitored by the IGSG throughout the year with reports<br />

that monitor achievements against requirements. These regularly presented reports <strong>and</strong><br />

minutes of the IGSG meetings where they were approved, will provide the evidence to be<br />

uploaded into the IG Toolkit.<br />

In February 2013 an independent audit will be undertaken of a selection of IG st<strong>and</strong>ards, to<br />

highlight to st<strong>and</strong>ard owners changes <strong>and</strong> improvements required before the final<br />

submission.<br />

PAST PERFORMANCE<br />

Although in 2010/11 64% IG compliance was reported to CfH, following further review the<br />

IGSG considered that evidence submitted needed strengthening, policies <strong>and</strong> procedures<br />

needed to be improved <strong>and</strong> updated, <strong>and</strong> the IGSG governance strengthened to reflect a<br />

more structured approach to completing the requirements. With a baseline return of only 9%<br />

in July 2011, reliance was being placed on old evidence submitted, which was now either not<br />

fit for purpose or required updating.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 5 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


The IGSG was changed to ensure that attendance at meetings was improved with deputies<br />

attending in place of absentees. In addition minutes were more structured to accurately<br />

reflect the subjects discussed, outst<strong>and</strong>ing <strong>and</strong> completed action logs were developed to<br />

ensure action points were resolved, <strong>and</strong> an overall IG action plan was added as a regular<br />

agenda item. To support the evidence required for the st<strong>and</strong>ards <strong>and</strong> ensure IG key subjects<br />

are regularly discussed, monthly, quarterly <strong>and</strong> yearly reports were introduced with a<br />

st<strong>and</strong>ard format for presentation.<br />

It was also identified that IG awareness needed improving across the organisation. To<br />

support this the intranet pages were rebr<strong>and</strong>ed <strong>and</strong> improved to provide a good source of<br />

information for staff, including grouping all IG policies in one place for ease of reference. An<br />

IG local brochure was also developed to be given to staff at training sessions.<br />

In light of the Department of Health (DH) requirement to train staff annually in Information<br />

Governance, the current training presentation was rebr<strong>and</strong>ed to incorporate all aspects of<br />

Information Governance, <strong>and</strong> added to the Central Induction to capture all new starters. An<br />

e-learning system was also procured which reflected the IG content of face to face training<br />

sessions, to improve the choice to staff for completing their training <strong>and</strong> the potential to<br />

achieve the requirements of CfH for 95% of staff to be trained annually.<br />

Improvements were also made to the information given to patients <strong>and</strong> service users, by<br />

rebr<strong>and</strong>ing the <strong>Trust</strong> website pages <strong>and</strong> updating the patient information leaflet.<br />

An audit was undertaken of the IG policies <strong>and</strong> procedures, <strong>and</strong> any gaps where these were<br />

missing or out of date, allocated to areas to resolve.<br />

These improvements enabled us to submit a final assessment of 62%.<br />

<strong>2012</strong>/13 PERFORMANCE<br />

With a strengthened IGSG the overall managerial commitment has improved, including joint<br />

working between st<strong>and</strong>ards owners where the st<strong>and</strong>ard covers several areas.<br />

Several st<strong>and</strong>ard owners have also developed action plans for their st<strong>and</strong>ards <strong>and</strong> uploaded<br />

evidence currently available, rather than waiting until the final submission date. As such the<br />

baseline return submitted 31 st July <strong>2012</strong> was 28%. However, it was noted that further<br />

improvements are required in:<br />

• All members of the IGSG regularly attending the IGSG<br />

• The presentation of all reports required to the IGSG<br />

• All polices <strong>and</strong> procedures identified as requiring updating/creation completed in<br />

<strong>2012</strong>/2013<br />

• All st<strong>and</strong>ard owners reviewing the IG Toolkit st<strong>and</strong>ards <strong>and</strong> removing out of date<br />

information<br />

• All st<strong>and</strong>ard owners developing action plans for each of their st<strong>and</strong>ards to chart their<br />

progress<br />

There is a commitment by the IGSG to achieve at least a level 2 in all 45 st<strong>and</strong>ards, which as<br />

required by the CfH will provide satisfactory assurance of the <strong>Trust</strong>’s IG compliance.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 6 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


The st<strong>and</strong>ards are split into the areas of information governance management, confidentiality<br />

& data protection assurance, information security assurance, clinical information assurance,<br />

secondary use assurance <strong>and</strong> corporate information assurance. As such the st<strong>and</strong>ard<br />

owners have been allocated reflecting their knowledge <strong>and</strong> skill set in the subjects, to ensure<br />

both an underst<strong>and</strong>ing of the requirements <strong>and</strong> an ability to achieve these.<br />

To make sure adequate progress is being made with all st<strong>and</strong>ards, all st<strong>and</strong>ard owners will<br />

be presenting their individual action plans at the September <strong>2012</strong> IGSG. This will highlight<br />

any potential barriers to achieving the level 2 required, which as appropriate will be fed<br />

through to the <strong>Trust</strong> <strong>Board</strong>.<br />

In addition, recommendations from the 2011/12 internal audit of 20 IG Toolkit st<strong>and</strong>ards<br />

received in August <strong>2012</strong> will be developed into an action plan agreed with the Executive<br />

Director of Planning <strong>and</strong> Performance. Where appropriate, these will then be incorporated<br />

into the individual st<strong>and</strong>ard action plans to ensure compliance.<br />

The over-arching IG action plan (see below) continues to be reviewed at the IGSG, <strong>and</strong> in<br />

co-ordination with the individual st<strong>and</strong>ard action plans there is the potential to achieve at<br />

least 73% compliance rate by the final return on 31 st July 2013.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 7 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


Over-arching IG action plan<br />

Action Plan for improvements to IG compliance<br />

Task Programme of work Task owner Current<br />

status<br />

Status<br />

date<br />

1 Consistent attendance from all<br />

st<strong>and</strong>ard owners in IGSG <strong>and</strong><br />

support for IG Toolkit compliance<br />

2 Submission of monthly, quarterly<br />

<strong>and</strong> yearly reports to IGSG<br />

3 Review latest version of IG toolkit<br />

to identify any changes to<br />

requirements<br />

3a Advise all st<strong>and</strong>ard owners of<br />

requirements/function changes<br />

<strong>and</strong> need to start work on version<br />

10<br />

3b<br />

Remove out of date information<br />

on Version 10 of IG toolkit <strong>and</strong><br />

upload current information where<br />

available<br />

4 Development of st<strong>and</strong>ard owner<br />

action plans<br />

4a Presentation of st<strong>and</strong>ard owner<br />

action plans at September IGSG<br />

4b Further discussion concerning<br />

st<strong>and</strong>ard owner action plans<br />

5 Submission of baseline return by<br />

31/07/12<br />

6 Updating of IG policies required<br />

out of date to IGSG for approval<br />

7 Review of IG toolkit report from<br />

auditors<br />

7a Formulate <strong>Trust</strong> response to<br />

audit report<br />

7b Incorporation of auditor<br />

comments into st<strong>and</strong>ard owner<br />

action plans<br />

8 Conclude distribution of IG local<br />

Guide<br />

9 Update e-learning instructions for<br />

IG module <strong>and</strong> include on the<br />

Intranet<br />

10 Promote annual training<br />

requirement via the Link,<br />

updating Learning &<br />

Development prospectus<br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

Completion<br />

due date<br />

In progress 02/10/<strong>2012</strong> On going<br />

through the<br />

year<br />

In progress 02/10/<strong>2012</strong> On going<br />

through the<br />

year<br />

SB Completed 01/06/<strong>2012</strong> 01/06/<strong>2012</strong><br />

SB Completed 01/06/<strong>2012</strong> 01/06/<strong>2012</strong><br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

St<strong>and</strong>ard<br />

owners<br />

In progress 02/10/<strong>2012</strong> Imminent<br />

for<br />

remaining<br />

st<strong>and</strong>ard<br />

owners<br />

In progress 02/10/<strong>2012</strong> Imminent<br />

for<br />

remaining<br />

st<strong>and</strong>ard<br />

owners<br />

Completed 02/10/<strong>2012</strong> 26/09/<strong>2012</strong><br />

To start 02/10/<strong>2012</strong> 22/10/<strong>2012</strong><br />

SB Completed 31/07/<strong>2012</strong> 31/07/<strong>2012</strong><br />

St<strong>and</strong>ard On going 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

owners<br />

NM/SB/NMk Completed 22/08/<strong>2012</strong> 24/08/<strong>2012</strong><br />

NM/SB/NMk To start 22/08/<strong>2012</strong> 30/09/<strong>2012</strong><br />

St<strong>and</strong>ard<br />

owners<br />

To start 02/10/<strong>2012</strong> 31/10/<strong>2012</strong><br />

SB Started 02/10/<strong>2012</strong> on-going via<br />

training<br />

courses<br />

SB Completed 17/05/<strong>2012</strong> 17/05/<strong>2012</strong><br />

SB Completed 17/05/<strong>2012</strong> 17/05/<strong>2012</strong><br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 8 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


10a Reapproval of IG training<br />

programme with DOH<br />

11 Sub group to review risk<br />

assessments/information flows<br />

from Parkhill project<br />

11a Ensure current risk register<br />

captures all systems <strong>and</strong><br />

appropriate risk owners<br />

11b<br />

11c<br />

Proposal from Auditors of IG<br />

work programme for <strong>2012</strong>/13 for<br />

improving risk assessment <strong>and</strong><br />

information flow st<strong>and</strong>ards<br />

Auditor IG work programme roll<br />

out<br />

12 Submit IG Toolkit performance<br />

return by 31/10/12 deadline<br />

13 Fax directory - work to identify all<br />

fax numbers, ensure<br />

confidentiality posters displayed,<br />

update fax directory on the<br />

intranet<br />

14 Distribute Patient Information<br />

Leaflets<br />

15 Review Data Quality processes -<br />

linked with Data Quality Group<br />

16 Review Business Continuity<br />

Management plans<br />

SB To start 02/10/<strong>2012</strong> Imminent<br />

Sub-group Completed 30/05/<strong>2012</strong> 30/05/<strong>2012</strong><br />

SB/Subgroup<br />

NMk/agreed<br />

with NM<br />

NMk in coordination<br />

with SB<br />

To start 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

Completed 31/07/<strong>2012</strong> 31/07/<strong>2012</strong><br />

Started 02/10/<strong>2012</strong> 30/10/<strong>2012</strong><br />

SB To start 02/10/<strong>2012</strong> 31/10/<strong>2012</strong><br />

SB/Telecoms To start 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

GE In progress 02/10/<strong>2012</strong> on-going<br />

CB To start 02/10/<strong>2012</strong> on-going<br />

DB/JH In progress 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

17<br />

Development of survey monkey<br />

training evaluation forms SB In progress 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

17a Sending of evaluation forms SB To start 02/10/<strong>2012</strong> 31/01/2013<br />

17b<br />

Evaluation of training evaluation<br />

forms SB To start 02/10/<strong>2012</strong> 28/02/2013<br />

18<br />

Review <strong>and</strong> update Information<br />

Governance Information on the<br />

<strong>Trust</strong> website SB Completed 22/08/<strong>2012</strong> 22/08/<strong>2012</strong><br />

18a<br />

Update FOI Publication Scheme,<br />

update on website SB To start 02/10/<strong>2012</strong> 28/02/2013<br />

19<br />

Arrange audit date for <strong>2012</strong>/13<br />

Toolkit return NM/SB To start 02/10/<strong>2012</strong> 31/12/<strong>2012</strong><br />

20<br />

All evidence uploaded to IG<br />

toolkit<br />

St<strong>and</strong>ard<br />

owners To start 02/10/<strong>2012</strong> 15/03/2013<br />

20a<br />

Final review of evidence,<br />

marking all st<strong>and</strong>ards as<br />

complete SB To start 02/10/<strong>2012</strong> 25/03/2013<br />

20b Sign off of final IG toolkit return NM To start 02/10/<strong>2012</strong> 28/03/2013<br />

20c<br />

Submission of final IG toolkit<br />

return by 31/03/13 deadline SB To start 02/10/<strong>2012</strong> 29/03/2013<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 9 of 9<br />

Information Governance Strategy Version 1.3 Issued August <strong>2012</strong>


EXECUTIVE SUMMARY<br />

TITLE:<br />

<strong>Board</strong> Assurance Framework – <strong>2012</strong> Quarter 2<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong><br />

DATE:<br />

Attached is the <strong>Board</strong> Assurance Framework for the second quarter of<br />

<strong>2012</strong>.<br />

The purpose of the BAF is for the risks which impact on the <strong>Trust</strong>’s strategic<br />

& principal objectives to be assessed <strong>and</strong> current controls reviewed to<br />

provide assurance to the <strong>Board</strong> that mitigating actions are undertaken to<br />

reduce the impact <strong>and</strong> risk level.<br />

Progress<br />

Following detailed review at the October <strong>Trust</strong> Executive Committee,<br />

elements of the BAF have been amended to reflect a more detailed risk<br />

profile. This continues to be work in progress.<br />

The following improvements have been made:<br />

1. The recommendations from the recent TEC meeting have been<br />

implemented.<br />

2. Risk Review forms were introduced to ensure efficiency of risk<br />

reporting.<br />

3. Closure Forms were introduced to ensure that Clinical Directors<br />

<strong>and</strong> General Managers gave approval for risk closure<br />

4. Corporate Risk Register training including the use of controlling<br />

documents is ongoing<br />

5. Evidence of updated Action plans for each Extreme <strong>and</strong> High Risk will<br />

streamline management of the BAF <strong>and</strong> is ongoing.<br />

□ TEC ……….. □ STRATEGY……….…..…<br />

□ FINANCE ……..……… □ AUDIT ………….<br />

□ QUALITY & SAFETY<br />

…………..………….....……….…<br />

□ WORKFORCE<br />

………………………………………….…<br />

□ CHARITABLE FUNDS<br />

………………………………...…<br />

□ TRUST BOARD<br />

……………………………….……….….<br />

□ REMUNERATION<br />

………………………………….….....<br />

□ OTHER …………………………..……. (please<br />

specify)<br />

6. Continued review has resulted in the following changes to the BAF this<br />

month: Risks Removed or Added to the BAF:<br />

<strong>Trust</strong> Information<br />

Status<br />

Ref:<br />

339 Complaints has been removed from the BAF Removed<br />

the controls have reduced the residual risk<br />

impact on the <strong>Trust</strong>s but it would remain on<br />

the corporate risk register <strong>and</strong> monitored via<br />

action plans<br />

311 Potential severe disruption to services arising Removed<br />

from the removal of London Deanery posts pose<br />

major difficulties in the delivery of quality care at<br />

KGH obstetric services. This risk was removed<br />

following TEC review, this was approved by<br />

the Clinical Director<br />

323 Risk of adverse impact on profitability due to Removed<br />

introduction of new London wide GU <strong>and</strong> FP<br />

Tariff in April <strong>2012</strong>, this risk would be<br />

managed within the Women Directorate<br />

342 Risks: Executive leadership changes would Removed<br />

compromise the strategic agenda This risk<br />

was closed by the CEO because of<br />

successful recruitment of suitable strategic<br />

directors to progress BHRUT's plans / goals.<br />

341 End of life Strategy because the internal<br />

control <strong>and</strong> action plan was instrumental in<br />

reducing the risk scoring <strong>and</strong> there is<br />

reasonable assurance that it is managed<br />

adequately with the aid of the Life <strong>Board</strong>s<br />

Removed<br />

1


343 Directorate Anaesthetic:<br />

Risk: Failure to comply with NSPA directive<br />

(see BAF P.7 for more details)<br />

Added /<br />

New<br />

7. Action Plans<br />

Monthly review <strong>and</strong> management of the action plans in place to mitigate all<br />

of the extreme <strong>and</strong> high risks is in place.<br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to note the changes to the BAF.<br />

□ NATIONAL TARGET<br />

□ CQC REGISTRATION<br />

□ RMS<br />

□ HEALTH & SAFETY<br />

X ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE<br />

……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER Pam Strange Clinical<br />

Governance Director/ Donna Kinnair, Director of<br />

Governance<br />

DATE: 26th October <strong>2012</strong><br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

<strong>Trust</strong> key objectives.<br />

5. KEY PERFORMANCE INDICATORS<br />

As detailed in the BAF.<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2<br />

EXECUTIVE SUMMARY/ Clinical Governance Pam Strange


BOARD ASSURANCE FRAMEWORK <strong>2012</strong><br />

2nd Quarter: July to September <strong>2012</strong><br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

1


Table of Contents<br />

TRUST PRINCIPAL OBJECTIVES ........................................................................................................................................................... 3<br />

BHRUT STRATEGIC OBJECTIVES WITH EACH PRINCIPAL OBJECTIVE ............................................................................................ 4<br />

BHRUT RISK TREND ANALYSIS FOR 2007- <strong>2012</strong> .................................................................................................................................. 5<br />

RISKS DETAILS ........................................................................................................................................................................................ 8<br />

Strategic Objective 1 – Deliver Safe, Quality Effective Care ............................................................................................................................... 8<br />

Strategic Objective 4: Services Are Rated Positively By Patients. Families & All Stakeholders ................................................................... 13<br />

Strategic Objective 5 – To Ensure BHRUT is Financially Secure...................................................................................................................... 14<br />

RISK DESCRIPTORS.............................................................................................................................................................................. 16<br />

TABLE: RISK SCORING = SEVERITY X LIKELIHOOD (S X L) .......................................................................................................................... 17<br />

BOARD ASSURANCE FRAMEWORK ELEMENTS .............................................................................................................................................. 18<br />

CARE QUALITY COMMISSION: Regulations <strong>and</strong> Outcome Guide ................................................................................................................... 19<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

2


TRUST PRINCIPAL OBJECTIVES<br />

BHRUT Strategic Objectives are: To Deliver Safe, Quality <strong>and</strong> Effective Care, To Deliver Operational Excellence ensuring that all st<strong>and</strong>ards are met, To<br />

Provide a First -Class Educational Experience, Services are Rated Positively by Patients, Families <strong>and</strong> all Stakeholders, Ensure that BHRUT’s <strong>Trust</strong> is<br />

Financially Secure <strong>and</strong> Staff Actively engaged in the Success of the <strong>Trust</strong>.<br />

Introduction: The <strong>Board</strong> Assurance Framework (BAF) evidences the <strong>Board</strong> control over delivery of its principle objectives. The BAF directly underpins the<br />

annual statement on Internal Control (SIC) <strong>and</strong> is the subject of annual enquiry by its host commissioning body <strong>and</strong> Internal <strong>and</strong> External Audit.<br />

Function of the BAF<br />

The BAF is a tool for the <strong>Board</strong> corporately to assure itself (be assured based on evidence) about successful delivery of the organisation’s principle objectives.<br />

The framework is designed to focus the <strong>Board</strong> on controlling principle risks threatening the delivery of those objectives. The BAF aligns principle risks, key<br />

controls <strong>and</strong> assurances on controls alongside each objective. Gaps are identified where key controls <strong>and</strong> assurances are insufficient to reduce the risk of<br />

non-delivery of objectives. This enables the <strong>Board</strong> to develop <strong>and</strong> subsequently monitor a <strong>Board</strong> Assurance Action Plan for closing gaps. The Direction of the<br />

<strong>Board</strong> in these matters ensures appropriate allocation of resources to improve the effectiveness of management.<br />

The process <strong>and</strong> purpose of the BAF may be summarised as:<br />

• Description of the risks which present a major threat to achievement of any of the objectives <strong>and</strong> are not well controlled.<br />

• Identify <strong>and</strong> evaluate the design of key controls intended to manage these principle risks, underpinned by self assessment against the Care Quality<br />

Commission regulated st<strong>and</strong>ards.<br />

• BHRUT CQC development action plan is referenced to each risk on the BAF<br />

• All significant risks whether to the objectives or otherwise are also described on the <strong>Trust</strong> Risk Register. Those risks are identified initially through<br />

review of the objectives themselves. Alternatively they may initially be identified by Directorates as operational risks.<br />

• The BAF <strong>and</strong> the Risk Register will provide confirmation that there are action plans to put in place controls for the risks they contain <strong>and</strong> that there is<br />

assurance that plans <strong>and</strong> controls are robust.<br />

• Those risks which present a major threat to any of the objectives <strong>and</strong> are not well controlled are defined <strong>and</strong> graded as Extreme (red). By definition all<br />

the <strong>Trust</strong>’s residual Extreme risks appear on the BAF. Q1 BAF: An action plan would be attached Extreme risks.<br />

• Significant risks which require high level attention but do not present a major threat to any of the objectives are defined <strong>and</strong> graded as residual High<br />

(orange) <strong>and</strong> are described on the Risk Register but not on the BAF unless a potential for major threat.. Oversight of their control <strong>and</strong> assurance is<br />

allocated to the responsible Directorate. This is monitored <strong>and</strong> tracked by the Compliance Team at the Directorate level.<br />

• Extreme risks that threaten any of the objectives but which then become better controlled will be downgraded to a less threatening High or Moderate<br />

risks will be relegated from the BAF to the Risk Register alone <strong>and</strong> oversight of their control will be allocated to the responsible Directorate.<br />

• The Framework will be reviewed by the Audit Committee at each meeting <strong>and</strong> by the <strong>Board</strong> quarterly.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

3


BHRUT STRATEGIC OBJECTIVES WITH EACH PRINCIPAL OBJECTIVE<br />

VISION: BHRUT is a flourishing Foundation <strong>Trust</strong> providing first class services to patients <strong>and</strong> families,<br />

in which the public <strong>and</strong> commissioner’s have full confidence<br />

MISSION: To become a Foundation <strong>Trust</strong><br />

THERE ARE 6 STRATEGIC OBJECTIVES<br />

1. DELIVER SAFE,<br />

QUALITY, EFFECTIVE<br />

CARE<br />

2. DELIVER OPERATIONAL<br />

EXCELLENCE ENSURING<br />

THAT ALL STANDARDS ARE<br />

MET<br />

3. TO PROVIDE A FIRST<br />

CLASS EDUCATIONAL<br />

EXPERIENCE<br />

4. SERVICES ARE RATED<br />

POSITIVELY BY PATIENTS,<br />

FAMILIES & ALL<br />

STAKEHOLDERS<br />

5. TO ENSURE BHRUT<br />

TRUST IS FINANCIALLY<br />

SECURE<br />

6. STAFF ACTIVELY<br />

ENGAGED IN SUCCESS OF<br />

TRUST<br />

THERE ARE 4 PRINCIPAL OBJECTIVES FOR EACH STRATEGIC OBJECTIVE<br />

Ensure that robust plans<br />

are in place to produce <strong>and</strong><br />

deliver the Schedule of<br />

Information (Quality<br />

Accounts)<br />

Achieving excellence in<br />

patient safety <strong>and</strong> clinical<br />

effectiveness including:<br />

Developing <strong>and</strong> using<br />

technology <strong>and</strong> information<br />

systems to improve quality<br />

Deliver all local / national<br />

st<strong>and</strong>ards <strong>and</strong> targets<br />

including comply with CQC,<br />

RMS & HSE regulations.<br />

To ensure service line<br />

reporting is fully established<br />

<strong>and</strong> working effectively<br />

To increase service quality,<br />

delivery <strong>and</strong> choice<br />

Ensuring learners <strong>and</strong> new staff<br />

have an excellent experience<br />

<strong>and</strong> that all elements of<br />

education <strong>and</strong> training are<br />

delivered in a safe environment<br />

for patients, staff <strong>and</strong> learners.<br />

All staff to undergo a high<br />

quality Personal Development<br />

Plan, identifying opportunities<br />

for staff development<br />

To embed a reputation of being<br />

a high performing <strong>Trust</strong> with the<br />

best outcomes for patients<br />

,families, visitors, all<br />

stakeholders & the media<br />

Continuous improvements to<br />

be demonstrated in staff &<br />

patient surveys (locally &<br />

nationally)<br />

Maintain efficient economic<br />

use of resources : costs<br />

reduced productivity improved<br />

income collected<br />

Ensure capital programme is<br />

effectively prioritised.<br />

Staff have the necessary<br />

values <strong>and</strong> behaviors to<br />

enhance the quality of the<br />

patient experience through<br />

education, training <strong>and</strong><br />

Personal <strong>and</strong> Professional<br />

development<br />

To establish the correct<br />

governance arrangements<br />

<strong>and</strong> ensuring we recruit <strong>and</strong><br />

retain staff to deliver our<br />

objectives<br />

Maintain patient flow at all<br />

times through the<br />

organisation<br />

- 4 Hour<br />

- Cancer<br />

- 18 Weeks<br />

-<br />

To ensure the patient<br />

safety agenda is fully<br />

established in all areas of<br />

the <strong>Trust</strong>.<br />

A system to ensure that<br />

infection, prevention <strong>and</strong><br />

control is in place<br />

Full achievement of all<br />

contract KPIs & CQUIN<br />

indicators resulting in<br />

maximum contract<br />

income<br />

Achievement of all m<strong>and</strong>atory<br />

training targets<br />

Robust & successful systems<br />

in place for succession<br />

planning & talent<br />

management<br />

To fully embed the patient<br />

experience framework &<br />

demonstrate improvements<br />

made to patient experience<br />

Improve stakeholders<br />

relationship to deliver a<br />

seamless service that improves<br />

health outcomes for patients /<br />

service users<br />

The CIP be delivered fully to<br />

the agreed timescales without<br />

affecting the quality of care<br />

adversely<br />

Meet our in-year<br />

financial targets<br />

(including net<br />

I&E surplus, liquidity,<br />

Productivity)<br />

Ensure that capacity <strong>and</strong><br />

dem<strong>and</strong> planning is based on<br />

robust health <strong>and</strong> workforce<br />

demographic information<br />

To manage a positive,<br />

inclusive <strong>and</strong> engaging<br />

culture within the <strong>Trust</strong><br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

4


BHRUT RISK TREND ANALYSIS FOR 2007- <strong>2012</strong><br />

CORPORATE RISKS ON BAF<br />

6<br />

High<br />

Extreme<br />

45<br />

40<br />

CURRENT RISKS ON CORPORATE RISK REGISTER<br />

43<br />

34<br />

Low<br />

Moderate<br />

High<br />

Extreme<br />

6<br />

4<br />

2<br />

1<br />

35<br />

30<br />

25<br />

20<br />

15<br />

10<br />

7<br />

12<br />

0<br />

High<br />

Extreme<br />

5<br />

0<br />

Low Moderate High Extreme<br />

CORPORATE RISKS BY TYPE<br />

4 2 6<br />

Risks on the BAF: The BAF only reflects residual risks after controls / assurance have been<br />

agreed. Currently there are 2 High <strong>and</strong> 7 Extreme risks.<br />

Risks Removed:<br />

17<br />

Risk 339: Complaints has been removed from the BAF, the controls have reduced the<br />

residual risk but it would remain on the corporate risk register <strong>and</strong> monitored via action plans.<br />

30<br />

Risk 323: Risk of adverse impact on profitability due to introduction of new London wide GU<br />

<strong>and</strong> FP Tariff in April <strong>2012</strong>, this risk would be managed within the directorate<br />

18<br />

19<br />

Accreditation<br />

Clinical<br />

Health & Safety<br />

Finance<br />

Service Delivery<br />

Security<br />

Reputation<br />

Risk 341: End of life Strategy. The internal control <strong>and</strong> action plan was instrumental in<br />

reducing the risk scoring <strong>and</strong> there is reasonable assurance that it is managed adequately<br />

with the aid of the Life <strong>Board</strong>s<br />

Risk 311: Potential severe disruption to services arising from the removal of London Deanery<br />

posts pose major difficulties in the delivery of quality care at KGH obstetric services. The<br />

London Deanery agreed plans have removed the risks.<br />

It is evident that the Internal risk management processes have successfully reduced the<br />

number of corporate of risk by mitigating the risk either with local resources or closure<br />

because the risk no longer impacts the Department or the <strong>Trust</strong> objectives. This is widely<br />

contributed by the willingness of management <strong>and</strong> employees to embrace the BHRUT risk<br />

management framework of action plan, risk validation forms, closure forms <strong>and</strong> exception<br />

reporting.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

5


DIRECTORATES RISKS REVIEW<br />

12<br />

10<br />

8<br />

6<br />

4<br />

2<br />

0<br />

3<br />

2<br />

Acute Med<br />

Anaest.<br />

Child ren<br />

3<br />

NO. OF RISKS BY DIRECTORATES<br />

11<br />

0<br />

6<br />

4<br />

0<br />

Emerg.Care<br />

Neuro Scie<br />

Pathology<br />

Radiology<br />

Surgery<br />

9<br />

6 6<br />

10<br />

Spec. Surg<br />

Spec.M ed<br />

Supp. Serv<br />

Women<br />

Estates<br />

1<br />

1<br />

0.9<br />

0.8<br />

0.7<br />

0.6<br />

0.5<br />

0.4<br />

0.3<br />

0.2<br />

0.1<br />

0<br />

ANAESTHETIC RISKS<br />

1<br />

1<br />

0<br />

0<br />

Low Moderate High Extreme<br />

EM ERGENCY CARE RISKS<br />

WOMEN RISKS<br />

7<br />

6<br />

7<br />

6<br />

6<br />

5<br />

4<br />

3<br />

2<br />

1<br />

1<br />

2<br />

1<br />

5<br />

4<br />

3<br />

2<br />

1<br />

1<br />

3<br />

0<br />

0<br />

Low Moderate High Extreme<br />

0<br />

Low Moderate High Extreme<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

6


SPECIALISTS MEDICINE RISKS<br />

SUPPORT SERVICES RISKS<br />

4<br />

6<br />

4<br />

3.5<br />

6<br />

5<br />

3<br />

2.5<br />

2<br />

1.5<br />

1<br />

0.5<br />

0<br />

0<br />

1 1<br />

Low Moderate High Extreme<br />

4<br />

3<br />

2<br />

1<br />

0<br />

0 0<br />

Low Moderate High Extreme<br />

0<br />

New Risk on the Corporate Risk Register<br />

<strong>Trust</strong> Reference: 343<br />

Area: Directorate Anaesthetic:<br />

Risk: Failure to comply with NSPA Alert to change over to a non-Luer connection on needles used for Neuroaxial procedures can potentially cause serious harm to patients<br />

Controls: All current safety measures are in keeping with recommendations made by the Royal Colleges of Anaesthesia <strong>and</strong> Pharmacology. NPSA has recommended the use<br />

of one system but this is at present untested <strong>and</strong> potentially unsafe. All Anaesthetic <strong>and</strong> Pharmacology Professional Agencies <strong>and</strong> the Medical Director for NHSL have voiced<br />

concern in proceeding to the change without assurance of safety. Paper presented to Quality <strong>and</strong> Safety for decision on way forward where it was agreed that it would be unwise<br />

to invest in an untested <strong>and</strong> potentially unsafe system <strong>and</strong> this would be raised with the Commissioners.<br />

Directorates<br />

The Directorates that are not reflected currently on the BAF have risks that are controlled within their own Directorate <strong>and</strong> mirrored on their locals risk registers. All risks are<br />

renewed regularly.<br />

The Directorates are increasingly building their local risk management systems by a continuous process which is dem<strong>and</strong>ing awareness <strong>and</strong> proactive action. The drivers are to<br />

base each risk on reducing the likelihood <strong>and</strong> consequences of adverse impacts on agreed objectives <strong>and</strong> on increasing the opportunities for improvement.<br />

This requires infusing risk management into organisational culture <strong>and</strong> everyday business operations including planning, reporting <strong>and</strong> governance. This is monitored by the<br />

Clinical Governance team.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

7


RISKS DETAILS<br />

PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Strategic Objective 1 – Deliver Safe, Quality Effective Care<br />

Principal Objective: Achieving excellence in patient safety <strong>and</strong> clinical effectiveness – Corporate Clinical<br />

Risk No 87: The inability<br />

to manage patient flow<br />

through the <strong>Trust</strong> could<br />

result in patients<br />

attending the ED<br />

experiencing delays in<br />

care <strong>and</strong> treatment which<br />

would be detrimental to<br />

patient safety <strong>and</strong><br />

experience.<br />

Date on Register: 01.04.2009<br />

Rating Scoring: Impact:4 x<br />

Likelihood:4 = 16<br />

Area: Emergency Care<br />

<strong>Trust</strong> Objective: To deliver 95%<br />

of patients seen in 4 hours<br />

Impact on:<br />

Patient: Patient safety<br />

Staff: increase stress levels,<br />

workforce development <strong>and</strong><br />

recruitment<br />

Stakeholder: Confidence is<br />

compromised<br />

<strong>Trust</strong>: Viability of the <strong>Trust</strong><br />

Constantly monitored by TEC<br />

Paper presented to <strong>Trust</strong><br />

<strong>Board</strong> which addresses<br />

processes in place to reduce<br />

length of stay – Jonah<br />

programme will assist in this<br />

issue.<br />

Emergency Care Programme<br />

superseded by RESET<br />

programme approved by <strong>Trust</strong><br />

<strong>Board</strong><br />

4 9 6 16<br />

Extreme Risk<br />

(RESET) Rapid End to<br />

End Sustainable<br />

Emergency<br />

Transformation Steering<br />

Group <strong>and</strong> Programme<br />

<strong>Board</strong> in place.<br />

Transformation<br />

Reports to TEC <strong>and</strong> <strong>Trust</strong><br />

<strong>Board</strong><br />

This risk is cross<br />

referenced to the BHRUT<br />

CQC related<br />

development plan <strong>and</strong><br />

the references are G4 5<br />

6. 7 10 11 12 18 53 54<br />

Maintain improved resilience<br />

within the A&E systems <strong>and</strong><br />

throughput to the MAU<br />

There are 4 work -streams:<br />

• Emergency care<br />

• EMAU<br />

• Medicine<br />

• Care of the Elderly<br />

Work-streams plans are led by<br />

Consultants<br />

Emergency Care action plan<br />

is currently being audited for<br />

effectiveness.<br />

The focus is on<br />

Emergency Care <strong>and</strong><br />

Medicine <strong>and</strong> doesn’t<br />

include other speciality -<br />

these can impact on<br />

Emergency Departments<br />

waiting times <strong>and</strong> bed<br />

occupancy<br />

Failure to improve<br />

against the 95%<br />

compliance within<br />

the four hour<br />

st<strong>and</strong>ard<br />

Manpower<br />

resources to<br />

maintain systems<br />

Whilst<br />

improvement in<br />

trajectory is<br />

moving upward<br />

the day to day<br />

stability is<br />

variable resulting<br />

in increased<br />

number of<br />

breaches often<br />

during or<br />

immediately after<br />

the weekend<br />

Financial<br />

implication for the<br />

Directorate in<br />

delivering the<br />

programme.<br />

Claire Dixon (GM) / Dr Derek Hicks Clinical Director<br />

Details updated: 15.10.12<br />

There has been no major change<br />

Educating<br />

Directorates<br />

ensuring support<br />

for: Consultant<br />

leadership <strong>and</strong><br />

prompt discharge<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

8


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

Principal Objective: To ensure the patient safety agenda is fully established in all areas of the <strong>Trust</strong> – Nursing<br />

Risks No 251: Failure to Admission screening for all<br />

protect our patients<br />

elective <strong>and</strong> emergency<br />

against Health Care<br />

admissions.<br />

Associated Infections Decolonisation therapy for<br />

(HCAI’s)<br />

known positive patients.<br />

Limit set at 7 for MRSA Patients known to be<br />

Bacteraemia <strong>and</strong> 59 for previously positive are flagged<br />

on PAS.<br />

C.difficile<br />

Date on Register: 25.01.2010<br />

Rating Scoring: Impact:4 x<br />

Likelihood:4 = 16<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Poor patient outcomes<br />

Staff: Risk to <strong>Trust</strong> reputation<br />

affecting staff morale<br />

<strong>Trust</strong>: In year financial risk of<br />

every C.difficile cases over the<br />

limit <strong>and</strong> on ability for <strong>Trust</strong> to<br />

reach FT status<br />

Details updated: 24.10.<strong>2012</strong><br />

Detailed RCA of all<br />

bacteraemia led by DIPC.<br />

Daily reporting on MRSA<br />

bacteraemia numbers <strong>and</strong><br />

C.difficile<br />

CQC supporting actions have<br />

been completed<br />

Re-launching h<strong>and</strong> hygiene<br />

awareness training in<br />

September<br />

All clinical staff are being<br />

taught <strong>and</strong> assessed on<br />

aseptic non-touch technique<br />

started in July 3 sessions<br />

occurred – ( FY1 51junior<br />

doctors trained)<br />

8 16<br />

Extreme Risk<br />

RCA summary action<br />

sheets highlights key non<br />

compliances, screening<br />

of patients, appropriate<br />

decontamination of<br />

positive patients,<br />

documentation of such<br />

<strong>and</strong> the practice of blood<br />

culture taking. Training<br />

implementation of<br />

policies is actively<br />

reviewed.<br />

Internal –Internal Audit,<br />

Infection Prevention<br />

Control Committee<br />

External – CQC<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

A <strong>Trust</strong> wide RCA action plan<br />

has been developed.<br />

Learning from previous RCA’s<br />

– this is included in the annual<br />

infection prevention control<br />

plan for <strong>2012</strong>/ 2013<br />

Monthly action plan is being<br />

developed<br />

Plans to be developed for<br />

rapid reduction in rate of<br />

progress in C.difficile curve<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

MRSA trajectory target<br />

breached for <strong>2012</strong>, ( 8<br />

incidents)<br />

C.difficile 59 or<br />

exceeding this target<br />

with 38 cases mid year<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

Targets set but<br />

not achieved<br />

consistently<br />

because of lack<br />

of underst<strong>and</strong>ing<br />

<strong>and</strong> also<br />

insufficient<br />

implementation of<br />

the controls.<br />

Requires<br />

constant<br />

monitoring <strong>and</strong><br />

evaluation.<br />

LEAD<br />

Ian Hosein, Director of Infection Control<br />

Full review of all C difficile<br />

case to date to be undertaken<br />

to determine key themes on<br />

causation. Action to be<br />

completed by mid Nov. for<br />

review by DIPC<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

9


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Principal Objective: Deliver all local / national st<strong>and</strong>ards <strong>and</strong> targets including comply with CQC, RMS & HSE regulations - NHSLA<br />

Risks 298: Failure to achieve<br />

Level 2 Accreditation of Risk<br />

Management St<strong>and</strong>ards<br />

(RMS) which will achieve<br />

increased patient safety<br />

systems recognised by NHS<br />

Litigation Authority <strong>and</strong><br />

reduction in annual premium,<br />

causing increased scrutiny<br />

from external regulators.<br />

Date on Register: 17.08.2011<br />

Rating Scoring: Impact :4 x<br />

Likelihood:4 = 20<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Increased patient safety<br />

Staff: Morale <strong>and</strong> pride in care<br />

provided.<br />

<strong>Trust</strong>: The <strong>Trust</strong> sustaining<br />

progressive quality improvement<br />

measures<br />

Up-to-date gap analysis,<br />

Medical Devices Committee,<br />

Medical Records keeping<br />

committee, RMS co-ordinating<br />

committee.<br />

16<br />

High Risk<br />

Frequent meeting with<br />

Risk Management<br />

Criterion Leads the<br />

feedback is filtered in the<br />

gap analysis report<br />

Risk Management<br />

Steering Group monitors<br />

the status<br />

This risk is cross<br />

referenced to the BHRUT<br />

CQC related<br />

development plan <strong>and</strong><br />

the references are G 40 -<br />

45<br />

Proposal to provide a<br />

businesses case for staff to<br />

support the RMS process, job<br />

descriptions are currently<br />

reviewed in light of potential<br />

posts<br />

Review in resourcing as part<br />

of the clinical governance<br />

overview was presented to<br />

TEC <strong>and</strong> <strong>Trust</strong> <strong>Board</strong>.<br />

Quality <strong>and</strong> Safety Committee<br />

approved resource plan in<br />

principle. An “ invest to save”<br />

business case being<br />

developed against the<br />

achievement of level 2 <strong>and</strong> 3<br />

RMS st<strong>and</strong>ards.<br />

Financial resourcing<br />

required<br />

Areas of high risk:<br />

Medical Devices<br />

Lead Trainer,<br />

Centralised<br />

training records,<br />

Release of staff<br />

for training,<br />

Medical record<br />

keeping<br />

(documentation)<br />

Collecting<br />

evidence of Risk<br />

Management<br />

St<strong>and</strong>ards<br />

Storage of data<br />

(electronic)<br />

Lyn Wilson/ Pam Strange Clinical Governance Director<br />

Details updated: 15.10.12<br />

No change<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

10


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Principal Objective: To ensure a robust IM&T infrastructure to an improve our care <strong>and</strong> service delivery<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

11


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Risk No 340: The contract<br />

for the current PAS<br />

system provided by<br />

McKesson terminates on<br />

1 st April 2014. This is a<br />

national contract awarded<br />

via CFH. Following this<br />

date PAS will become<br />

“read only” <strong>and</strong> not<br />

available as a “live”<br />

system. Failure to<br />

procure another system in<br />

time will seriously<br />

compromise service<br />

delivery.<br />

Business case is going to the<br />

<strong>Trust</strong> <strong>Board</strong> for sign off <strong>and</strong><br />

NHS London for approval <strong>and</strong><br />

funding<br />

Received <strong>Trust</strong> board<br />

approval for replacement of<br />

PAS with the additional<br />

functionality of order<br />

communications.<br />

The recently appointed<br />

Chief Information Officer<br />

will review this risk as a<br />

priority on joining the<br />

<strong>Trust</strong>.<br />

The <strong>Trust</strong> must plan to<br />

procure <strong>and</strong> deploy a new<br />

PAS. This procurement<br />

process is at an advanced<br />

stage<br />

Awaiting on NHS London for<br />

ratification <strong>and</strong> financial<br />

approval<br />

None identified during<br />

review<br />

Reliant upon the<br />

timeliness of the<br />

approval process.<br />

The timeline is<br />

very tight, a<br />

typical PAS<br />

implementation is<br />

12 - 18 months<br />

19.6.<strong>2012</strong>: none<br />

identified to date<br />

Simon Adams IMT Manager<br />

Date on Register:13.04.<strong>2012</strong><br />

Rating Scoring:Impact:4 x<br />

Likelihood: 4 = 16<br />

11 21<br />

Extreme Risk<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Poor patient outcome<br />

Staff: Inability to access key<br />

information.<br />

<strong>Trust</strong>: major impact on service<br />

delivery including disruption to<br />

service<br />

Details updated: 25.09.<strong>2012</strong><br />

No change<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

12


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Strategic Objective 4: Services Are Rated Positively By Patients. Families & All Stakeholders<br />

Principal Objective: To embed a reputation of being a high performing <strong>Trust</strong> with the best outcomes for patients with all external stakeholder & the media<br />

Risk No: 258 Failure to<br />

provide timely quality of<br />

care will compromise the<br />

<strong>Trust</strong>s reputation which<br />

will impact on future<br />

service business,<br />

development & recruitment<br />

opportunities.<br />

Date on Register: 23.02.2011<br />

Rating Scoring: Impact: 3 x<br />

Likelihood:5 = 15<br />

Area: <strong>Trust</strong>-wide<br />

Impact on:<br />

Patient: Outcomes/ service/<br />

developments/achievements<br />

Staff: ~ Staff morale <strong>and</strong> staff<br />

engagement<br />

<strong>Trust</strong>: Media interest which<br />

compromised the <strong>Trust</strong> Reputation<br />

Quality <strong>and</strong> Safety Committee<br />

to identify root causes <strong>and</strong> to<br />

disseminate learning <strong>and</strong><br />

monitor improvements in care.<br />

Quality <strong>and</strong> Improvement plan<br />

focus <strong>and</strong> resource for<br />

improvement.<br />

Clinical Governance Team<br />

monitor Directorate<br />

implementation.<br />

16<br />

Extreme Red<br />

Quality & Safety<br />

Committee bi-monthly<br />

reviewed the risks<br />

Learning Lessons Group<br />

meeting identify trends<br />

from PALS, Complaints,<br />

Incidents <strong>and</strong> other<br />

feedback.<br />

Audit quarterly patient<br />

experience reports<br />

Reputational risks are<br />

escalated to the<br />

Executive <strong>and</strong> impending<br />

media coverage alerted<br />

to the <strong>Trust</strong> <strong>Board</strong>. <strong>Trust</strong><br />

<strong>Board</strong> is also made<br />

aware by satisfaction<br />

surveys<br />

CQC Action plan provides the<br />

knowledge of key issues <strong>and</strong><br />

concerns liable to affect<br />

reputation.<br />

Whistle blowing policy is being<br />

widely promoted<br />

There is a drive to strengthen<br />

the relationship between all<br />

stakeholders <strong>and</strong> the <strong>Trust</strong>.<br />

CQC Report on Maternity<br />

Directorate reflected that out<br />

of the 16 recommendations 9<br />

were fully met <strong>and</strong> 6 were<br />

partly met <strong>and</strong> only 1 was not<br />

met, this was added to the<br />

BHRUT development plan for<br />

review on the 1/11/12.<br />

Evidence for reputation<br />

rebuilding, particularly<br />

focusing on Emergency<br />

department performance,<br />

improved patient<br />

experience, complaints<br />

h<strong>and</strong>ling, finance.<br />

Resourcing of exp<strong>and</strong>ed<br />

programmes of staff <strong>and</strong><br />

community engagement.<br />

None identified<br />

following review<br />

Imogen Shillito, Director of Comms<br />

Details updated: 19.10.<strong>2012</strong><br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

13


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Strategic Objective 5 – To Ensure BHRUT is Financially Secure<br />

Principal Objective: The CIP be delivered fully to the agreed timescales without affecting the quality of care adversely<br />

Risk No: 292 Clinical<br />

Directorates will not<br />

achieve financial target<br />

<strong>and</strong> CIP deliveries<br />

Previous descriptor: <strong>Trust</strong><br />

would not achieve financial<br />

balance<br />

Date on Register: 15.06.2011<br />

Rating Scoring:<br />

Severity:5 x Likelihood:5 = 25<br />

Area: All Clinical<br />

Impact on:<br />

Patient: Poor patient outcome<br />

Staff: none<br />

<strong>Trust</strong>: The <strong>Trust</strong> sustaining<br />

progressive measures<br />

Details updated 24.10.12<br />

**All financial risks will be<br />

reviewed by the newly<br />

appointed Finance Director<br />

8.10.12<br />

- <strong>Trust</strong> has prepared Clinical<br />

Strategy <strong>and</strong> Long-Term<br />

Financial Model (with support<br />

from EY) - reviewed at<br />

October <strong>Trust</strong> <strong>Board</strong>. Model<br />

shows <strong>Trust</strong> reducing but not<br />

eliminating deficit by 2017/18,<br />

although further options are<br />

now being reviewed.<br />

- PMO with support from EY is<br />

developing CIP plans for<br />

2013/14 <strong>and</strong> ensuring full year<br />

benefit from existing schemes<br />

meets <strong>2012</strong>/13 target<br />

4 16<br />

Extreme Red<br />

8.10.12<br />

- Review of Clinical<br />

Strategy, LTFM,<br />

CIP/Transformation<br />

programme by<br />

Transformation <strong>Board</strong>,<br />

Finance Committee,<br />

<strong>Trust</strong> <strong>Board</strong>, NHS<br />

London <strong>and</strong><br />

Commissioners.<br />

Executive sponsorship of<br />

all programmes.<br />

8.10.12<br />

Ongoing work to finalise<br />

clinical strategy <strong>and</strong> LTFM<br />

<strong>and</strong> CIP plan for 2013 /14<br />

8.10.12<br />

- Further options to be<br />

fully developed to<br />

demonstrate financial<br />

viability in the longer<br />

term<br />

- Full year CIP<br />

programme yet to be fully<br />

developed<br />

None identified<br />

following review<br />

David Gilburt Finance Director / Alan Davies Deputy Director of Finance<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

14


PRINCIPAL RISK<br />

What could prevent the objective being<br />

achieved<br />

Risk no, Date on Risk Register<br />

& Risk Scoring:<br />

KEY EXISTING CONTROLS<br />

What controls/systems are in<br />

place to assist in securing delivery<br />

of objective <strong>and</strong> managing<br />

principle risks?<br />

CQC REF:<br />

RESIDUAL RISK<br />

ASSURANCES ON<br />

CONTROLS & IMPACT<br />

Where we gain evidence<br />

that our controls/systems, on<br />

which we are placing<br />

reliance, are effective? The<br />

impact following assurances.<br />

PROGRESS AGAINST<br />

RISKS/ ACTION<br />

PLAN UPDATE<br />

What Actions are undertaken to<br />

mitigate the actual risks?<br />

GAPS IN ASSURANCE<br />

Where we are failing to gain<br />

evidence that our controls /<br />

systems, on which we place<br />

reliance, are effective<br />

GAPS IN<br />

CONTROL<br />

Where are we<br />

failing to put<br />

controls / systems<br />

in place? Where are<br />

we failing in making<br />

them effective?<br />

LEAD<br />

Principal Objective: Meet our in-year financial targets (including net I&E surplus, liquidity, productivity)<br />

Risk no: 104 Failure in<br />

financial management <strong>and</strong><br />

budgetary control including<br />

expenditure restrictions,<br />

leading to reputational<br />

damage.<br />

Date on Register: 18.01.2008<br />

Rating Scoring: Impact 4 x<br />

Likelihood:5 = 20<br />

Area: <strong>Trust</strong><br />

Impact on:<br />

Patient: Cash shortfalls may lead<br />

to suppliers suspending deliveries<br />

Staff: Cash shortfalls may lead to<br />

delays in payroll<br />

<strong>Trust</strong>: Financial Risks<br />

Details updated 24.10.12<br />

8.10.12<br />

- Monthly budget statements,<br />

Business Unit financial reports,<br />

<strong>Trust</strong> financial reports<br />

- Monthly Business Unit<br />

performance review meetings<br />

(including CIP) to review key<br />

financial risks & agree<br />

mitigating actions.<br />

- Budget training provided to<br />

budget holders (April-June)<br />

- CIP governance<br />

arrangements – Work-stream<br />

Accountability review<br />

meetings; weekly pay controls;<br />

weekly vacancy controls;<br />

Transformation <strong>Board</strong>.<br />

- Non-pay expenditure <strong>and</strong><br />

capital expenditure restrictions<br />

in place<br />

4 6 16<br />

Extreme Red<br />

8.10.12<br />

- Internal Audit of<br />

Financial Management<br />

arrangements - limited<br />

assurance given<br />

8.10.12<br />

- Actions have been agreed<br />

through monthly Business Unit<br />

performance review meetings<br />

to address adverse variances,<br />

including CIP<br />

- Actions being progressed<br />

via CIP Accountability<br />

meetings with work-stream<br />

leads to implement further<br />

savings<br />

- Further discussions with<br />

budget holders to resolve<br />

outst<strong>and</strong>ing budget ownership<br />

issues<br />

- Ongoing discussions with<br />

commissioners regarding<br />

transitional funding<br />

24.10.12: This risk is<br />

currently being reviewed<br />

<strong>and</strong> will be updated as soon<br />

as we have concluded our<br />

conversations with<br />

commissioners.<br />

8.10.12<br />

- Ownership of budgets<br />

by budget holders<br />

remains a key issue, as<br />

identified by the Internal<br />

Audit report.<br />

- Significant risk of c.<br />

£13m in achieving I&E<br />

control total of £40m,<br />

primarily related to high<br />

risk CIPs £6.3m,<br />

unidentified CIP £5.4m<br />

<strong>and</strong> transitional funding<br />

risk of £4.3m<br />

Mitigation plan<br />

being drawn up<br />

but at significant<br />

risk<br />

CIP non-delivery<br />

by issue<br />

David Gilburt Finance Director / Alan Davies Deputy Director of Finance<br />

No significant change except risk<br />

descriptor has been changed.<br />

*All financial risks will be reviewed<br />

by the newly appointed Finance<br />

Director<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

15


RISK DESCRIPTORS<br />

OBJECTIVE<br />

SAFE, HIGH<br />

QUALITY<br />

EFFECTIVE<br />

CARE:<br />

EFFICIENT<br />

ECONOMIC USE<br />

OF<br />

RESOURCES:<br />

PROVIDE A<br />

FIRST CLASS<br />

EDUCATIONAL<br />

EXPERIENCE<br />

AND A<br />

EFFECTIVE AND<br />

VALUED<br />

WORKFORCE<br />

MAJOR<br />

High Orange = 9-12 score<br />

Major injury leading to long-term<br />

incapacity/disability<br />

Requiring time off work for >14<br />

days<br />

Increase in length of hospital stay<br />

by >15 days<br />

Mismanagement of patient care<br />

with long-term effects<br />

Uncertain delivery of key objective<br />

/Loss of 0.5–1.0 per cent of budget<br />

Claim(s) between £100,000 <strong>and</strong> £1<br />

million<br />

Purchasers failing to pay on time<br />

Non-compliance with national 10–<br />

25 per cent over project budget<br />

Schedule slippage / Key objectives<br />

not met<br />

Uncertain delivery of key<br />

objective/service due to lack of staff<br />

Unsafe staffing level or competence<br />

(>5 days)<br />

Loss of key staff or Very low staff<br />

morale<br />

No staff attending m<strong>and</strong>atory/ key<br />

training<br />

CATASTROPHIC<br />

Extreme Reds = 15-25 score<br />

Incident leading to death<br />

Multiple permanent injuries or<br />

irreversible health effects<br />

An event which impacts on a large<br />

number of patients<br />

Non-delivery of key objective/ Loss of<br />

>1 per cent of budget<br />

Claim(s) >£1 million<br />

Failure to meet specification/ slippage<br />

Loss of contract / payment by results<br />

Incident leading >25 per cent over<br />

project budget<br />

Schedule slippage /Key objectives not<br />

met<br />

Non-delivery of key objective/service<br />

due to lack of staff<br />

Ongoing unsafe staffing levels or<br />

competence<br />

Loss of several key staff<br />

No staff attending m<strong>and</strong>atory training<br />

/key training on an ongoing basis<br />

OBJECTIVE<br />

CREATING AND<br />

SUSTAINING<br />

PURPOSEFUL<br />

PARTNERSHIPS<br />

DELIVERY<br />

AGAINST BHRUT<br />

PRIORITIES AND<br />

OBJECTIVES:<br />

STRONG<br />

RESPECTED AND<br />

CREDIBLE<br />

LEADERSHIP<br />

MAJOR<br />

High Orange = 9-12 score<br />

Loss/interruption of >1 week<br />

Major impact on environment<br />

Enforcement action<br />

Multiple breeches in statutory duty<br />

Improvement notices<br />

Low performance rating<br />

Critical report<br />

National media coverage with 3 days service well below<br />

reasonable public<br />

expectation. MP concerned<br />

(questions in the House)<br />

Total loss of public<br />

confidence<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

16


TABLE: RISK SCORING = SEVERITY X LIKELIHOOD (S X L)<br />

SEVERITY SCORE<br />

5 CATASTROPHIC - Death or major disaster / loss; loss of<br />

>£1million including litigation settlement. Loss of ability to<br />

achieve/maintain financial stability of BHRUT<br />

4 MAJOR - Significant / permanent harm Major financial loss<br />

(£100K - £1 million) Including litigation settlement.<br />

3 MODERATE - Hospitalised or medium term injury Major<br />

financial loss (£20K to £100K) including litigation settlement.<br />

2 MINOR - More than 3 days off sick due to injury moderate<br />

financial loss (£1K to 20K);<br />

1 NEGLIGIBLE - No obvious injury or harm Minimal financial<br />

loss (


BOARD ASSURANCE FRAMEWORK ELEMENTS<br />

STEP1<br />

KEY PILLARS OF THE BAF<br />

Principal Objectives<br />

Principal Risks<br />

Key Controls<br />

Assurances on Controls<br />

STEP2<br />

APPLICATION TO THE BAF<br />

Those strategic <strong>and</strong> directorate level principal objectives crucial to the <strong>Board</strong>'s overall goals<br />

Risks threatening the achievement of principal objectives<br />

Control (s) to manage one or more principal risks<br />

Confidence, based on sufficient evidence, that internal controls are in place, operating<br />

effectively <strong>and</strong> objectives are being achieved<br />

.<br />

Regular <strong>Board</strong> reports, Directorates escalation <strong>and</strong> recognition of Principal<br />

Risks as well as summary reports from the Audit Committee identify:<br />

Gaps in Assurance<br />

Failure to gain sufficient evidence that policies/ procedures, practices or organisational<br />

resources / structures on which reliance is placed are operating effectively <strong>Trust</strong>-wide.<br />

Failure to put controls / systems in place to mitigate the risks adequately <strong>and</strong> effectively.<br />

STEP 3<br />

Gaps in Control<br />

Action plan generated from the Gaps<br />

<strong>Board</strong> Assurance Action Plan<br />

An action plan approved by the board to improve its key controls to manage its principal<br />

risks, <strong>and</strong> gain assurances where required <strong>and</strong> mitigate the gaps in assurance.<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

18


CARE QUALITY COMMISSION: Regulations <strong>and</strong> Outcome Guide<br />

Regulation 17 Outcome 1: Respecting <strong>and</strong> involving people who use services<br />

Regulation 18 Outcome 2: Consent to care <strong>and</strong> treatment<br />

Regulation 9 Outcome 4: Care <strong>and</strong> welfare of people who use services<br />

Regulation 14 Outcome 5: Meeting nutritional needs<br />

Regulation 24 Outcome 6: Co-operating with other providers<br />

Regulation 11 Outcome 7: Safeguarding people who use services from abuse<br />

Regulation 12 Outcome 8: Cleanliness <strong>and</strong> infection control<br />

Regulation 13 Outcome 9: Management of medicines<br />

Regulation 15 Outcome 10: Safety <strong>and</strong> suitability of premises<br />

Regulation 16 Outcome 11: Safety, availability <strong>and</strong> suitability of equipment<br />

Regulation 21 Outcome 12: Requirements relating to workers<br />

Regulation 22 Outcome 13: Staffing<br />

Regulation 23 Outcome 14: Supporting workers<br />

Regulation 10 Outcome 16: Assessing <strong>and</strong> monitoring the quality of services<br />

Regulation 19 Outcome 17: Complaints<br />

Regulation 20 Outcome 21: Records<br />

BHRUT BAF 2nd Quarter <strong>2012</strong>: SB/PS<br />

19


EXECUTIVE SUMMARY<br />

TITLE:<br />

Risk Management Strategy <strong>and</strong> Policy<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

The attached Risk Management Strategy <strong>and</strong> Policy<br />

describes the <strong>Trust</strong>s expectations of how the management<br />

of risk at different levels within the organisation must be<br />

managed. This has been updated in line with national<br />

guidance <strong>and</strong> local developments <strong>and</strong> changes to systems<br />

<strong>and</strong> processes.<br />

The key changes to this document over the previous one<br />

include:<br />

Update to comply with the revised NHS Litigation Authority<br />

Risk Management St<strong>and</strong>ards issued this year.<br />

The Roles <strong>and</strong> Responsibilities have been revised in line<br />

with leadership <strong>and</strong> responsibility changes. (P.6)<br />

Introduction of the NPSA recently revised risk grading<br />

matrix. (Appendix 1 P.33)<br />

Framework for Risk Management self assessment tool to<br />

support staff in the development <strong>and</strong> monitoring of risk<br />

management systems. (Appendix 3 P. 38)<br />

The routine systems for all staff remain essentially the<br />

same.<br />

□ TEC ……………... □ STRATEGY……….….…….<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

x QUALITY & SAFETY …………..………….....……<br />

□ WORKFORCE<br />

□ CHARITABLE FUNDS ………………………………...…<br />

□ TRUST BOARD ……………………………….………….<br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

Training on the document is provided at every Induction,<br />

M<strong>and</strong>atory Training <strong>and</strong> Junior Doctor training.<br />

.<br />

2. DECISION REQUIRED: CATEGORY:<br />

It is a requirement of the NHSLA Risk Management<br />

St<strong>and</strong>ards that the <strong>Trust</strong> <strong>Board</strong> approve the attached<br />

Strategy <strong>and</strong> Policy<br />

NATIONAL TARGET x RMS<br />

x CQC REGISTRATION x HEALTH & SAFETY<br />

x ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER: Dr Mike Gill<br />

DATE: 26.10.12<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

4. DELIVERABLES<br />

5. KEY PERFORMANCE INDICATORS<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


RISK MANAGEMENT STRATEGY AND POLICY<br />

This policy can be made available in other formats <strong>and</strong> languages<br />

upon request to the PALS office on 01708 435454<br />

Contents Include: Purpose, Definitions, Risk Management Approach, Tools, Risk Register<br />

Policy Number:<br />

Ratified by:<br />

Approved by:<br />

Name & Title of originator/author:<br />

Responsible committee/individual:<br />

Responsible Division:<br />

Date issued:<br />

Target audience:<br />

Policy Template Issued 2nd <strong>November</strong> 2011<br />

Version:<br />

Date:<br />

Date:<br />

Review Date<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 1 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Contents<br />

Section<br />

Page<br />

1 Introduction 3<br />

2 Purpose 3<br />

3 Definitions 4<br />

4 Roles <strong>and</strong> Responsibilities 6<br />

4.1 <strong>Trust</strong> Committees with responsibility for Risk Management 9<br />

4.2 Strategic Objectives 11<br />

4.3 <strong>Trust</strong> Risk Management Approach 11<br />

4.4 The Risk Management Process 12<br />

4.5 Risk Identification tools 13<br />

4.6 Risk Grading <strong>and</strong> acceptable/unacceptable risk 16<br />

4.7 Assessments, control <strong>and</strong> acceptance of risk 16<br />

4.8 Risk Register 19<br />

4.9 <strong>Board</strong> Assurance Framework 19<br />

5 Development of the Policy 20<br />

5.2 Equality Impact Assessment 21<br />

5.3 Approval <strong>and</strong> Ratification 21<br />

6 Review <strong>and</strong> Revision Processes 21<br />

7 Dissemination <strong>and</strong> Implementation 22<br />

7.1 Implementation 22<br />

8 Monitoring 22<br />

9 References 25<br />

10 Associated Documents 26<br />

11. Amendments 26<br />

Appendices<br />

1 Risk Grading Matrix 32<br />

2 Reporting Structure for Risk 36<br />

3 Framework for Risk Management 37<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 2 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


1. INTRODUCTION<br />

"<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals <strong>Trust</strong> is committed to the<br />

control of risks in a strategic <strong>and</strong> organised fashion, to ensure that risks can be<br />

eliminated or reduced to an acceptable level thereby improving the experience <strong>and</strong><br />

safety of patients, staff, visitors <strong>and</strong> the public. This commitment is commensurate<br />

with the <strong>Trust</strong>'s aim to provide Excellence in Healthcare. Managing business risk<br />

is fundamental to achieving this aim.”<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> (the <strong>Trust</strong>) is aware that, as a<br />

large organisation, it is exposed to a very wide range of risks <strong>and</strong> threats to the delivery of key<br />

services <strong>and</strong> it has a responsibility to identify, evaluate <strong>and</strong> manage those risks. There is a<br />

structured approach to risk management through its systematic identification, assessment,<br />

evaluation <strong>and</strong> treatment of risk. It is a continuous process aimed at reducing <strong>and</strong> monitoring<br />

risks to the organisation <strong>and</strong> individuals alike. The <strong>Trust</strong> <strong>Board</strong> expects staff to adhere to the risk<br />

management processes outlined in this document.<br />

The increasing numbers of recommendations from the National Patient Safety Agency (NPSA)<br />

<strong>and</strong> National Institute of Health <strong>and</strong> Clinical Excellence (NICE), developments in Information<br />

Governance, Care Quality Commission (CQC) Quality St<strong>and</strong>ards <strong>and</strong> the NHSLA Risk<br />

Management St<strong>and</strong>ards for CNST are all factors which require the <strong>Trust</strong> <strong>Board</strong> to consider <strong>and</strong><br />

regularly review the organisational arrangements for integrated governance <strong>and</strong> risk<br />

management.<br />

To support this it is essential that the appropriate policy is in place to minimise risk.<br />

The <strong>Trust</strong> adopts an inclusive approach to risk management:<br />

• The <strong>Trust</strong> board sets the strategy for the organisation <strong>and</strong> identifying the risk to that<br />

strategy, determining appropriate mitigating actions <strong>and</strong>/or deciding to ‘carry the risk’<br />

• Each Directorate will identify the operational risk/s that arise within their area which<br />

compromises their delivery of the <strong>Trust</strong> key objectives <strong>and</strong> mitigating it where possible, or<br />

escalating the risk for higher level review <strong>and</strong> decision making.<br />

This Policy sets out the strategy for the continued development of risk management throughout<br />

the <strong>Trust</strong> <strong>and</strong> the processes to implement it. This document applies to all staff working within the<br />

<strong>Trust</strong>, or on behalf of the <strong>Trust</strong> in other environments.<br />

It is imperative that all Directorates ensure that the message “risk management is everybody’s<br />

responsibility” is well understood <strong>and</strong> acted upon throughout the <strong>Trust</strong><br />

2. PURPOSE<br />

This Risk Management Strategy, Policy <strong>and</strong> Guidance sets out the <strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong><br />

Redbridge University Hospitals NHS <strong>Trust</strong> (BHRUT) key aims <strong>and</strong> objectives to ensure there are<br />

strong systems to manage risks <strong>Trust</strong>-wide, with which the staff are familiar.<br />

This document provides advice on implementing effective risk management. It also outlines the<br />

objectives, duties, benefits of managing risk, describes the responsibilities for risk management<br />

<strong>and</strong> provides an overview of the process that we will implement together to manage risk<br />

successfully.<br />

The Policy describes how the <strong>Trust</strong> will record all risks <strong>and</strong> the high <strong>and</strong> extreme risks which are<br />

identified as potential threats to the delivery of its key objectives within Risk Registers <strong>and</strong><br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 3 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


incorporate mitigation controls within action plans, allocating appropriate resources according to<br />

the level of risk exposure <strong>and</strong> will report findings within the reporting <strong>Board</strong> Assurance<br />

Framework.<br />

This Policy requires Clinical Directorates, Executive Leads <strong>and</strong> Employees alike to assist in, <strong>and</strong><br />

take responsibility for, the identification, control <strong>and</strong> reduction of risk <strong>and</strong> containment of cost in all<br />

aspects of their activities <strong>and</strong> areas of responsibility.<br />

It explains how the benefits gained with through Risk Management Framework are improved<br />

strategic, operational <strong>and</strong> financial management, improved decision making, compliance,<br />

improved customer service which result in better outcomes for patients <strong>and</strong> a safe <strong>and</strong> secure<br />

environment for patients, staff <strong>and</strong> visitors.<br />

The document should be read in conjunction with the <strong>Trust</strong>’s:<br />

• Complaints Policy<br />

• Claims Policy<br />

• Incident & Serious Incident Policy<br />

• Investigating <strong>and</strong> Learning from Incidents, Claims <strong>and</strong> Complaints Policy<br />

• Risk Assessment Toolkit<br />

BHRUT requires that the management of risk supports the delivery of the <strong>Trust</strong> objectives to<br />

enable the provision of high quality services for service users, visitors, stakeholders <strong>and</strong> staff;<br />

also minimise loss of resources <strong>and</strong> protect the reputation of the <strong>Trust</strong>.<br />

3. DEFINITIONS<br />

BHRUT<br />

CAS<br />

CNST<br />

COSHH<br />

CPA<br />

Directorates<br />

ESR<br />

HSE<br />

H&S<br />

MHRA<br />

NCEPOD<br />

NHSLA<br />

NICE<br />

NSF<br />

PALS<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong><br />

Central Alerting System<br />

Clinical Negligence Scheme for <strong>Trust</strong>s<br />

Control of Substances Hazardous to Health<br />

Clinical Pathology Accreditation<br />

Electronic Staff Record<br />

Health & Safety Executive<br />

Health <strong>and</strong> Safety<br />

Medicines Practice & Healthcare products Regulatory Agency<br />

National Confidential Enquiry into Patient Outcome <strong>and</strong> Death<br />

National Health Services Litigation Authority - responsible for the Clinical<br />

Negligence Scheme for <strong>Trust</strong>s<br />

National Institute of Health & Clinical Excellence<br />

National Service Framework<br />

Patient Advice & Liaison Service<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 4 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


PARTENRSHIP<br />

PFI<br />

SIC<br />

SI<br />

TNA<br />

Partners who provide to the <strong>Trust</strong> e.g. Sodexo, Siemens<br />

Partners for whom the <strong>Trust</strong> provide services, e.g. Barts Renal Services, HCA<br />

Harley Street at Queen’s<br />

Commissioning partnerships, e.g. Commissioning Cluster, SLAs with other<br />

commissioners<br />

Private Finance Initiative<br />

Statement of Internal Control<br />

Serious Incident<br />

Training Needs Analysis<br />

Any expression, to which a meaning is given in the Health Service Act, or in the Financial<br />

Directions made under the Act, shall have the same meaning in this Policy:<br />

“Action Owner”<br />

“Serious Incident”<br />

“Clinical Risk”<br />

“<strong>Board</strong> Assurance<br />

Framework”<br />

“Corporate Risk”<br />

“Information Risk”<br />

“Initial Risk Score”<br />

“Risk List”<br />

“Risk Management<br />

System”<br />

“Risk Mitigation”<br />

Assurance on<br />

effectiveness of<br />

identified controls<br />

“Risk Owner”<br />

The individual responsible for completing the actions to mitigate the<br />

risk.<br />

Any event or circumstance that could or did lead to unintended or<br />

unexpected harm, loss or damage to persons, property or the<br />

organisation.<br />

An uncertain event or set of events which, should it occur, will have<br />

an effect upon patient care<br />

Comprehensive method for the effective <strong>and</strong> focused management<br />

of the principal risks to meeting the BHRUT objectives.<br />

An uncertain event or set of events which, should it occur, will have<br />

an effect upon the achievement of objectives.<br />

An uncertain event or set of events which, should it occur, will have<br />

an effect on persons, property or the organisation.<br />

The calculation of risk consequence <strong>and</strong> probability excluding<br />

control mechanisms.<br />

The simple list of areas of risk, derived from relevant objectives<br />

The detailed explanation of how things work in practice. It includes<br />

this procedural guidance, the reporting processes that secure<br />

implementation of the procedural guidance, the st<strong>and</strong>ard forms, IT<br />

system <strong>and</strong> processes to support implementation, together with local<br />

application of the procedural guidance<br />

Is the process of selecting <strong>and</strong> implementing appropriate controls to<br />

modify the risk. Control – a process (not a committee or group) in<br />

place that contributes to mitigating / managing risk - The real<br />

challenge is not just to design appropriate processes, but to ensure<br />

they are properly embedded into the operations <strong>and</strong> culture of the<br />

organisation. Integral to this is the quality of the reporting of risk <strong>and</strong><br />

operational performance.<br />

Assurance – evidence that control is real <strong>and</strong> operates effectively in<br />

mitigating / managing risk. (Internal <strong>and</strong> External) These assurances<br />

must be relevant in time <strong>and</strong> support the control in its effectiveness.<br />

The individual responsible for:<br />

Completing the entry on the risk register,<br />

Assigning actions to mitigate the risk <strong>and</strong> completion targets for<br />

these actions (in consultation with action owners)<br />

Reviewing the risk at least every fortnight to ensure that the action<br />

plan is being implemented, the current risk score is calculated <strong>and</strong><br />

that all stakeholders are being updated regarding the management<br />

of this risk.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 5 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


“Risk Register”<br />

“Risk Register<br />

Manager”<br />

“Risk Register<br />

Owner”<br />

“Risk Tolerance”<br />

“Target Risk<br />

Score”<br />

The register is a refined <strong>and</strong> developed version of the Risk List. It is<br />

a table which shows – the risk assessment, risk mitigation actions,<br />

re-assessment <strong>and</strong> action plans. The table thereby shows the risk<br />

portfolio of the whole organisation or a selected part of it.<br />

Is the individual who is responsible for ensuring that the risk register<br />

is kept up to date <strong>and</strong> reviewed at least once a month.<br />

The risk register owners are as follows:<br />

Directorate Risk Register – Clinical Director<br />

Matrix/Commissioning Risk Register – Senior Commissioners<br />

<strong>Board</strong> Assurance Framework – Chief Executive/Medical Director<br />

Information Risk Register – Executive Director / Manager of<br />

Information Management <strong>and</strong> Technology/Information Governance<br />

Lead<br />

Is the level of risk the BHRUT is prepared to tolerate<br />

The calculation of risk consequence <strong>and</strong> probability including control<br />

mechanisms. This score provides a measure of how controllable the<br />

risk is <strong>and</strong> will help management decide which risks they should be<br />

4. ROLES AND RESPONSIBILITIES<br />

The <strong>Trust</strong> <strong>Board</strong> is a statutory body, governed by the Act of Parliament with the function of the<br />

<strong>Trust</strong> conferred by legislation. The Code of Accountability requires clear arrangements to be in<br />

place to demonstrate that responsibilities have been delegated to Executive Directors <strong>and</strong> for<br />

BHRUT this requirement is fulfilled by the <strong>Trust</strong>’s St<strong>and</strong>ing Orders, St<strong>and</strong>ing Financial Instructions<br />

<strong>and</strong> Scheme of Delegation, all of which are available on the Intranet.<br />

The arrangements set out in this document regarding identification, assessment <strong>and</strong> control of<br />

risk, apply to the <strong>Trust</strong>’s corporate risks as they apply to all other risks. At an Executive level<br />

responsibility for their implementation is allocated as follows:<br />

• <strong>Trust</strong> Objectives Chief Executive Officer<br />

• Service objectives Chief Operating Officer<br />

• Staffing objectives Chief Operating Officer<br />

• Financial objectives Director of Finance<br />

• Clinical Governance objectives Medical Director / Director of Nursing<br />

• Corporate <strong>and</strong> Clinical Governance Director of Governance/Clinical Governance Director<br />

• Maternity Services Director of Nursing<br />

Responsibility for the maintenance <strong>and</strong> assessment of effective internal <strong>and</strong> external assurances<br />

for organisational risk <strong>and</strong> patient safety is allocated on the same basis.<br />

The <strong>Trust</strong> <strong>Board</strong><br />

The <strong>Trust</strong> <strong>Board</strong>’s monitoring responsibilities, as defined in the Scheme of Delegation are to<br />

‘receive such reports as the <strong>Board</strong> sees fit from committees in respect of their exercise of<br />

delegated powers’.<br />

The <strong>Trust</strong> <strong>Board</strong> is made up of Executive <strong>and</strong> Non Executive Directors that are required to<br />

implement sound <strong>and</strong> effective systems of internal control; challenging poor performance <strong>and</strong><br />

deciding the priority of risks carried. The <strong>Trust</strong> <strong>Board</strong> reviews all risks rated as 'red'/extreme via<br />

the <strong>Board</strong> Assurance Framework. The <strong>Trust</strong> <strong>Board</strong> will review other risks drawn to their attention<br />

through the Quality <strong>and</strong> Safety Committee <strong>and</strong> Audit Committee.<br />

The <strong>Trust</strong> <strong>Board</strong> will receive regular reports from various <strong>Trust</strong> Committees which ensures<br />

significant risks are escalated, considered <strong>and</strong> actioned accordingly. The <strong>Trust</strong> <strong>Board</strong> members<br />

will receive annual risk assessment training to support them in their assessment of risk<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 6 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Chief Executive<br />

The Chief Executive has overall responsibility for having an effective governance system,<br />

including risk management, in place in the <strong>Trust</strong> <strong>and</strong> for meeting all statutory requirements <strong>and</strong><br />

adhering to guidance issued by the Department of Health in respect of governance <strong>and</strong> risk<br />

management. To fulfil this responsibility the Chief Executive will:<br />

• Ensure that full support <strong>and</strong> commitment is provided <strong>and</strong> maintained in the risk<br />

management activities;<br />

• Ensure an appropriate <strong>Board</strong> Assurance Framework is in place;<br />

• Ensure that the Annual Governance Statement adequately reflects the risk<br />

management issues within the organisation<br />

Executive Directors<br />

All Executive Directors have corporate responsibility for risk management within the activities of<br />

the <strong>Trust</strong>. This is exercised through attendance at <strong>Trust</strong> <strong>Board</strong> meetings <strong>and</strong> through the<br />

reviewing of the <strong>Board</strong> Assurance Framework.<br />

Non-Executive Directors<br />

The Non-Executive Directors are responsible for providing independent assurance to the <strong>Trust</strong><br />

<strong>Board</strong> on the risk management structure <strong>and</strong> processes as described in this policy.<br />

Director of Finance<br />

The Director of Finance, on behalf of the Chief Executive has responsibility for systems of<br />

financial control, implementing the <strong>Trust</strong>’s financial procedures, providing financial advice<br />

to the <strong>Trust</strong> <strong>Board</strong>, preparing <strong>and</strong> maintaining <strong>Trust</strong> accounts <strong>and</strong> all areas of financial<br />

<strong>and</strong> business risk. The Director of Finance is the Accountable Officer who signs the<br />

Annual Governance Statement.<br />

Medical Director<br />

The Medical Director, on behalf of the Chief Executive, is charged with the responsibility for<br />

providing assurance on the outcomes Medical Leadership, Clinical Governance <strong>and</strong> Risk<br />

Management systems throughout the <strong>Trust</strong>, with a special responsibility for clinical risk<br />

management.<br />

Director of Nursing<br />

The Director of Nursing, on behalf of the Chief Executive, is charged with the responsibility for<br />

Professional Leadership of Nurses, Midwives <strong>and</strong> Allied Health Professionals, quality st<strong>and</strong>ards<br />

<strong>and</strong> practice.<br />

Director of Governance <strong>and</strong> Special Projects.<br />

On behalf of the Chief Executive, the Director of Governance is the nominated lead for<br />

compliance to Care Quality Commission St<strong>and</strong>ards, NHSLA Risk Management St<strong>and</strong>ards,<br />

NHSLA Maternity Clinical Negligence Scheme St<strong>and</strong>ards, <strong>and</strong> Clinical Governance systems <strong>and</strong><br />

is managerially responsible for the Clinical Governance Department.<br />

Clinical Governance Director<br />

On behalf of the Executive Directors, the Clinical Governance Director has the day to day<br />

responsibility for all areas of development of clinical governance <strong>and</strong> clinical risk management<br />

Chief Information Officer<br />

The Chief Information Officer, on behalf of the Chief Executive is responsible for Information<br />

Governance <strong>and</strong> is the designated Senior Information Risk Owner (SIRO)<br />

Partnerships<br />

In order to deliver a successful partnership, risk management must form an integral part of the<br />

incident management system <strong>and</strong> evaluation process. Partners need to underst<strong>and</strong> what<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 7 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


potential risks they may face in achieving the planned objectives <strong>and</strong> identify these in a<br />

partnership risk register. Key decision making processes should be the subject of a risk<br />

assessment <strong>and</strong> where necessary risk management plans to identify timelines, responsible<br />

individuals, contingency plans <strong>and</strong> financial monitoring arrangements need to be agreed<br />

confirming what action should be taken should the risks be realised.<br />

All directorates are required to formerly identify <strong>and</strong> record their major partnerships in accordance<br />

with the <strong>Trust</strong> Key Objectives <strong>and</strong> Code of Practice for Partnerships<br />

Clinical Directors<br />

The <strong>Trust</strong> has 11 Clinical Directorates:<br />

1. Emergency care<br />

2. Acute Medicine<br />

3. Neurosciences<br />

4. Surgery<br />

5. Specialist Surgery<br />

6. Anaesthetics<br />

7. Specialist medicine<br />

8. Pathology<br />

9. Women<br />

10. Children<br />

11. Support services<br />

The risk management responsibilities of the <strong>Trust</strong> are shared by the Executive Directors<br />

(corporate risks) <strong>and</strong> the Clinical Directors who are responsible for ensuring Clinical Directorates<br />

operational risks are assessed, mitigated as appropriate <strong>and</strong> reported upon when they cannot be<br />

mitigated locally. Each Clinical Directorate has its own Risk Register.<br />

The Clinical Directors are responsible for the implementation of risk management in all areas<br />

within their Clinical Directorate <strong>and</strong> the process to be followed is described in Section 7.1,<br />

Assessment Process.<br />

Clinical Directors are responsible for implementing <strong>and</strong> monitoring any identified risk management<br />

control or assurance measures within their designated area/s <strong>and</strong> scope of responsibility. Any<br />

serious risks to Corporate <strong>and</strong> Directorate objectives must be brought to the immediate attention<br />

of the Clinical Governance Director.<br />

In situations where significant risks have been identified <strong>and</strong> where local control measures are<br />

considered to be potentially inadequate <strong>and</strong> local resolution has not been satisfactorily achieved,<br />

Clinical Directors are responsible for <strong>and</strong> have the authority to;<br />

• Add risks to the local <strong>and</strong> Directorate risk register<br />

• Monitor <strong>and</strong> review the risks<br />

• Bring these risks to the attention of the Clinical Governance Director<br />

General Managers/Line Managers<br />

General Managers/Line Managers must ensure that all staff are aware of the risk management<br />

processes <strong>and</strong> report risks for consideration. There is a requirement, where significant risks have<br />

been identified <strong>and</strong> where local resources/control measures are considered inadequate, that<br />

Managers report such risks to their Clinical Director<br />

They are required to:<br />

• underst<strong>and</strong> <strong>and</strong> implement the <strong>Trust</strong>’s Risk Training Policy, Risk Management<br />

Strategy/Policy <strong>and</strong> other <strong>Trust</strong> policies <strong>and</strong> procedures, all relevant legislation <strong>and</strong> ensure<br />

that they <strong>and</strong> all staff can access appropriate expert advice where required<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 8 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


• ensure that they keep up to date records of staff attendance at all m<strong>and</strong>atory <strong>and</strong> best<br />

practice training as per the <strong>Trust</strong>’s TNA<br />

• ensure that all staff are given the necessary information <strong>and</strong> training together with the<br />

appropriate resources <strong>and</strong> that these are monitored, to enable them to;<br />

o work safely<br />

o raise concerns<br />

o make risk assessments<br />

o take appropriate risk reduction measures<br />

o report risk to their line managers <strong>and</strong> /or Directorate Leads when applicable.<br />

All managers have a key responsibility to ensure that risk assessment is undertaken to minimise:<br />

• Potential harm to patients, staff <strong>and</strong> visitors<br />

• Risks to the achievement of Directorates business plans <strong>and</strong> service<br />

Clinical Governance Team<br />

The Clinical Governance Team will provide leadership, advice <strong>and</strong> support in the implementation<br />

of this policy.<br />

The Clinical Governance Team will ensure that all reporting to <strong>Trust</strong> Committees is co-ordinated<br />

<strong>and</strong> provide reports, training <strong>and</strong> on-going support in relation to Ulysses database <strong>and</strong> risk<br />

registers.<br />

All Staff<br />

All staff have a key role in identifying <strong>and</strong> reporting risks <strong>and</strong> incidents promptly thereby allowing<br />

risks to be managed <strong>and</strong> added to the local risk register if appropriate. In addition, staff have the<br />

responsibility for taking steps to avoid injuries <strong>and</strong> risks to patients, staff, visitors. If in fulfilling this<br />

role, it involves staff in raising concerns about st<strong>and</strong>ards, staff must report this following the<br />

<strong>Trust</strong>’s Speaking Up for a Healthy <strong>Trust</strong> (Whistleblowing) Policy.<br />

It is the responsibility of All Staff (including agency, locums, volunteers <strong>and</strong> contractors) to be<br />

alert to, identify <strong>and</strong> report risks including those relating to patient care, health <strong>and</strong> safety or the<br />

hospital environment. It is also their responsibility to be aware of <strong>and</strong> comply with all risk<br />

management requirements including <strong>Trust</strong> policies. Information <strong>and</strong> training will be provided as<br />

necessary to enable contractors <strong>and</strong> agency/bank staff to fulfil this responsibility.<br />

All <strong>Trust</strong> employees are accountable, through the terms <strong>and</strong> conditions of their employment,<br />

professional regulations, clinical governance <strong>and</strong> statutory health <strong>and</strong> safety regulations.<br />

This responsibility also includes reporting incidents, being aware of any emergency procedures<br />

relevant to their role <strong>and</strong> place of work, e.g. resuscitation, evacuation <strong>and</strong> fire precaution<br />

procedures; being aware of the risk management strategy/policy <strong>and</strong> attendance at training as<br />

specified in the <strong>Trust</strong>’s Risk Management Training Needs Analysis.<br />

All staff have a responsibility to manage risk within their sphere of responsibility. It is a statutory<br />

duty to take reasonable care of their own safety <strong>and</strong> the safety of others who may be affected by<br />

acts or omissions of <strong>Trust</strong> employees.<br />

4.1 TRUST COMMITTEES WITH RESPONSIBILITY FOR RISK MANAGEMENT<br />

There are two committees with delegated responsibility from the <strong>Trust</strong> <strong>Board</strong> for<br />

overseeing the management of risk in the <strong>Trust</strong>, the Quality <strong>and</strong> Safety Committee <strong>and</strong><br />

the Audit Committee. A chart showing the relationship to the <strong>Board</strong> of its delegated Sub<br />

Committees is shown in Appendix 2.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 9 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


4.1.1 Quality <strong>and</strong> Safety Committee<br />

The Committee meets six times per year <strong>and</strong> the core membership comprises two Non<br />

Executives, of whom one acts as Chairman, the Director of Nursing, the Medical Director <strong>and</strong> the<br />

Clinical Governance Director. The purpose of the Committee is to provide assurance to the <strong>Trust</strong><br />

<strong>Board</strong> on all aspects of patient safety, patient outcomes <strong>and</strong> patient experience. Attendance from<br />

finance <strong>and</strong> human resources will be dependent on agenda topics for discussion.<br />

The key risk management responsibilities of the Quality & Safety Committee are as follows:<br />

• To make recommendation on the quality aspects of implementing the <strong>Board</strong>’s objectives<br />

based on consideration of the adequacy of controls, action plans <strong>and</strong> sources of<br />

assurance relating to major risks escalated from the <strong>Trust</strong>’s Risk Register to the <strong>Board</strong><br />

Assurance Framework.<br />

• To review <strong>and</strong> make recommendations relation to the <strong>Trust</strong>’s performance with particular<br />

focus on proposed changes to its strategic directions, i.e. re-structuring of organisational<br />

service <strong>and</strong> care delivery framework. Ensuring that the impact of any organisational<br />

change is risk assessed to ensure delivery of safe, quality patient care <strong>and</strong> effective levels<br />

of performance <strong>and</strong> outcome.<br />

• To develop <strong>and</strong> monitor a Dashboard of key performance indicators that incorporate topics<br />

such as mortality data, incidents/near misses, claims, complaints <strong>and</strong> findings of<br />

investigations into serious incidents/events. Ensuring the monitoring data is measurable<br />

<strong>and</strong> incorporates maternity <strong>and</strong> general acute services <strong>and</strong> enables the Committee to<br />

define priorities <strong>and</strong> make recommendations.<br />

• To provide strategic leadership for ensuring systems <strong>and</strong> processes are in place<br />

throughout the organisation to support risk management, quality assurance <strong>and</strong><br />

governance.<br />

The Committee’s full terms of reference are available on the <strong>Trust</strong> Intranet. The Quality <strong>and</strong><br />

Safety Committee reports to the <strong>Trust</strong> <strong>Board</strong>.<br />

4.1.2 Audit Committee<br />

The Audit Committee has responsibility for assuring that appropriate financial <strong>and</strong> corporate<br />

governance risk management arrangements are in place. The Committee meets not less than<br />

four times per year <strong>and</strong> the membership comprises not less than three Non Executives, of whom<br />

one acts as Chairman. The Director of Finance, the Financial Controller, the Chief Internal<br />

Auditor, <strong>and</strong> a representative of the External Auditors normally attend meetings.<br />

The key risk management responsibilities of the Audit Committee are to review:<br />

• the establishment <strong>and</strong> maintenance of an effective system of internal control <strong>and</strong> risk<br />

management;<br />

• the adequacy of all risk control related disclosure statements, together with any<br />

accompanying Head of Internal Audit Statement, prior to endorsement by the <strong>Board</strong>;<br />

• the structures, processes <strong>and</strong> responsibilities for identifying <strong>and</strong> managing key risks facing<br />

the organisation;<br />

• Policies for ensuring that there is compliance with relevant regulatory, legal <strong>and</strong> code of<br />

conduct requirements as set out in the Department of Health Directions <strong>and</strong> other relevant<br />

guidance.<br />

The Audit Committee receives information on a number of topics primarily on the <strong>Trust</strong>’s financial<br />

position, assurance framework, local development plans, corporate objectives, counter fraud<br />

issues, charitable funds <strong>and</strong> reports from both the internal <strong>and</strong> external auditors.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 10 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


The Statutory Safety Committee, a feeder committee of the Audit Committee, has specific<br />

responsibility for ensuring risks to patients, staff <strong>and</strong> visitors are managed robustly. The Statutory<br />

Safety Committee takes reports on Health, Safety & Fire, Major Incident & Emergency Planning,<br />

Safety Alerts, health & safety key performance indicators, Manual H<strong>and</strong>ing <strong>and</strong> Radiation issues,<br />

<strong>and</strong> approval of risk policies.<br />

Any risks identified by the Audit Committee are reported to the <strong>Trust</strong> <strong>Board</strong> for information /<br />

action. The Committee’s full terms of reference are available on the <strong>Trust</strong> Intranet.<br />

4.2 STRATEGIC OBJECTIVES<br />

BHRUT has St<strong>and</strong>ing Orders, St<strong>and</strong>ing Financial Instructions <strong>and</strong> a Scheme of Delegation, which<br />

include the roles <strong>and</strong> responsibility of its sub-committees. BHRUT’s risk management processes<br />

aim to ensure:<br />

• There is a common framework within which risks are identified <strong>and</strong> assessed via the Risk<br />

Assessment Tool Kit for inclusion in the <strong>Trust</strong> Risk Register.<br />

• Risks to the effective functioning of the <strong>Trust</strong> in its principal objectives are systematically<br />

<strong>and</strong> consistently identified.<br />

• Action plans are in place to prevent or mitigate the adverse effects of identified risks.<br />

• Obstetric risks are managed through the Maternity Risk Management Strategy<br />

• All other risks, including financial risks, are identified, managed <strong>and</strong> audited through the<br />

<strong>Trust</strong>'s risk management procedures<br />

• Action is taken to manage identified risks so that they are kept to an acceptable level.<br />

• There is recognition that innovation <strong>and</strong> improvement within the wider NHS has to include<br />

an element of risk.<br />

• The Risk Management Strategy/Policy is communicated to all staff <strong>and</strong> is embedded in<br />

everyday practice.<br />

• The Risk Management Strategy <strong>and</strong> policy is available to the public <strong>and</strong> other<br />

stakeholders.<br />

4.3 TRUST RISK MANAGEMENT APPROACH<br />

This <strong>Trust</strong> will approach the management of risk from two aspects:<br />

• Strategic Risks<br />

• Operational Risks<br />

Strategic risks are considered as:<br />

Those business risks that if realised, could fundamentally affect the way in which the organisation<br />

conducts its business financially <strong>and</strong> complies with the Health <strong>and</strong> Social Care Act 2008<br />

st<strong>and</strong>ards. Strategic risks will have a detrimental effect on the achievement of the key business<br />

objectives. Strategic risks are detailed in the <strong>Trust</strong> <strong>Board</strong> Assurance Framework <strong>and</strong> are mapped<br />

against the <strong>Trust</strong>s strategic objectives.<br />

Operational risks are considered as:<br />

Those risks associated with the delivery of the key business processes <strong>and</strong> the delivery of patient<br />

care in a safe environment. Issues arising from operational risk assessments will be considered at<br />

Directorate level <strong>and</strong> escalated through the directorate structure before these are reported on the<br />

<strong>Trust</strong> Corporate Risk Register. Operational risks can include:<br />

• Clinical risks: risks associated with the inpatient, day case, outpatient <strong>and</strong> diagnostic<br />

activities of the <strong>Trust</strong>.<br />

• Non-clinical risks: risks associated with the environment of care e.g. use of the building<br />

<strong>and</strong> facilities by staff, patients, contractors <strong>and</strong> other visitors; health <strong>and</strong> safety risks; staff<br />

management; availability <strong>and</strong> use of information.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 11 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


• Financial risks: risks associated with income, expenditure, fulfilment of contracts <strong>and</strong> the<br />

correct application of St<strong>and</strong>ing Orders, St<strong>and</strong>ing Financial Instructions, Scheme of<br />

Delegation <strong>and</strong> other financial obligations.<br />

• Reputational risks: risks associated with public opinion <strong>and</strong> risks which may damage the<br />

credibility or good name of the <strong>Trust</strong>.<br />

It is recognised that the boundaries between these categories are not always clear, <strong>and</strong> that some<br />

risks may fall into more than one category.<br />

Business Planning & Risk Management<br />

Operational risks should link to each Directorate’s Business Plan. The Business Plan is a<br />

document that brings key information together in one place <strong>and</strong> demonstrates the service’s focus<br />

on service <strong>and</strong> <strong>Trust</strong>’s priorities. All major risks impacting the provision of service <strong>and</strong> to other<br />

services <strong>and</strong> partners resulting from the consequences, then a risk assessment <strong>and</strong> action plan<br />

should be recorded with brief mitigation.<br />

4.4 THE RISK MANAGEMENT PROCESS<br />

The <strong>Trust</strong>’s strategy is to apply the following principles to the management of risk:<br />

Establish the context<br />

A strategic, organisational, operational <strong>and</strong> risk management context will be established in<br />

which the process will take place. A criteria against which risk will be evaluated should be<br />

established <strong>and</strong> the structure of the analysis defined.<br />

Identify Risks<br />

Identify what, why, when <strong>and</strong> how risks can arise as the basis for further analysis.<br />

Risk Assessment<br />

Decide who might be harmed <strong>and</strong> how. Using the <strong>Trust</strong>’s generic risk assessment template<br />

<strong>and</strong> transferring the results to a comprehensive risk register. Escalating the findings to line<br />

management <strong>and</strong> all staff.<br />

Analyse risks<br />

Determine the existing controls <strong>and</strong> analyse risks in terms of consequence <strong>and</strong> likelihood in<br />

the context of those controls. The analysis should consider the range of potential<br />

consequences <strong>and</strong> how likely those consequences are to occur. Consequence <strong>and</strong> likelihood<br />

will be combined to produce an estimated level of risk.<br />

Evaluate risks<br />

Evaluate the risks <strong>and</strong> decide on precautions. Compare estimated levels of risk against the<br />

pre-established criteria. This enables risks to be ranked so as to identify management <strong>and</strong><br />

<strong>Board</strong> priorities. It is essential that the evidence used to compare the risk to these criteria is of<br />

known st<strong>and</strong>ards of quality <strong>and</strong> reliability, otherwise the risk may be over or under rated or not<br />

identified at all.<br />

Treat risks<br />

Accept <strong>and</strong> monitor low-priority risks. For other risks, develop <strong>and</strong> implement a specific<br />

Management action plan that includes consideration of the resources required to address the<br />

risk, the impact that treating the risk as well as not treating the risk will have in other service<br />

areas, whether the risk, if realised would be reversible <strong>and</strong> in what context, if any, realising the<br />

risk would be defensible. Record your findings.<br />

Service development planning process<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 12 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Where there are actual or potential risks with high or extreme consequences <strong>and</strong>/or likelihood<br />

that require additional resources, the relevant Directorate will submit Risk assessment <strong>and</strong><br />

action plans for consideration by <strong>Trust</strong> Executive Leads <strong>and</strong> <strong>Trust</strong> <strong>Board</strong>.<br />

Monitor <strong>and</strong> Review<br />

Monitor <strong>and</strong> review the performance of the risk action plan, undertake assessment to identify<br />

gaps <strong>and</strong> improvement. Review your risk assessment <strong>and</strong> update if necessary<br />

Communicate <strong>and</strong> consult<br />

Communicate <strong>and</strong> consult any difficulties with the Clinical Governance Director as appropriate<br />

at each stage of the risk management process <strong>and</strong> concerning the process as a whole.<br />

Shared Learning<br />

Share knowledge <strong>and</strong> learning across other directorates. It is essential to safeguard against<br />

incidents that could have been prevented had lessons learned elsewhere been passed on <strong>and</strong><br />

adopted across the organisation.<br />

4.5 RISK IDENTIFICATION TOOLS<br />

It is the policy of the <strong>Trust</strong> to make systematic use of the risk management tools which are<br />

available for the identification of all risks affecting its activities.<br />

4.5.1 What is a Risk?<br />

Risks will <strong>and</strong> can be identified using the following approaches:<br />

• Risk Assessments using st<strong>and</strong>ard tools e.g. COSHH,<br />

• Legal Risk (mainly risks arising through non-compliance with existing legislation,<br />

national guidance e.g. occupational health & safety legislation)<br />

• Clinical risks (mainly associated with the diagnosis <strong>and</strong> treatment of patients)<br />

• Incidents Management (Near misses, Serious Incidents)<br />

• Complaints/PALS<br />

• CQC<br />

• Expressed concerns by service users ,visitors or stakeholders<br />

• External reviews/ Services user satisfaction surveys<br />

• Audits<br />

• Organisational Risk (mainly risks arising from ineffective implementation of policies<br />

<strong>and</strong> procedures, poor communication, poor staffing <strong>and</strong> management structures).<br />

• Staff survey<br />

• Sickness/Absence information<br />

• Mortality & Morbidity review<br />

• NICE<br />

• NCEPOD<br />

• NHSLA RMS<br />

• Central Alerting system<br />

• Information Risk (mainly risks arising from ineffective management <strong>and</strong> security of<br />

information, including decisions on when <strong>and</strong> when not to share personally<br />

identifiable information)<br />

• Business <strong>and</strong> Financial Risk (mainly concerned with Contracts, revenue, capital<br />

fund)<br />

Proactive Risk Identification<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 13 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Proactive risk assessment enables the <strong>Trust</strong> to identify actual or potential hazards or<br />

threats that may or may not have resulted in actual incidents <strong>and</strong> ensure adequate control<br />

measures are in place to eliminate or reduce the risk of harm occurring. From this<br />

information, the <strong>Trust</strong> can assess whether or not there are sufficient precautions in place<br />

or if more needs to be done to mitigate the risk in order to prevent a particular harm or<br />

threat materialising. Proactive risk assessment also fulfils the <strong>Trust</strong>’s statutory obligations<br />

in terms of Health <strong>and</strong> Safety risk assessments.<br />

Under the management of Health <strong>and</strong> Safety at Work Regulations 1992, employers are<br />

required to make a “suitable <strong>and</strong> sufficient” assessment of the risks to the health <strong>and</strong><br />

safety of employees whilst at work as well as the risks to non employees as a<br />

consequence of work activities.<br />

Ongoing proactive risk assessment will minimise the likelihood of both patient safety <strong>and</strong><br />

non-clinical incidents occurring <strong>and</strong> supports safety improvements across the<br />

organisation.<br />

Range of Internal Inspections<br />

There are a number of internal inspection processes carried out by specialists such as<br />

Infection Control or Fire Safety Officer <strong>and</strong> where risks are pro-actively identified. There is<br />

a requirement for all services to carry out a quarterly Health <strong>and</strong> Safety Inspection <strong>and</strong><br />

ensure improvements are made if indicated.<br />

Nursing <strong>and</strong> Midwifery Audit<br />

There are monthly visible leadership audits undertaken in patient areas. The audits are a<br />

proactive way of measuring compliance with High Impact Actions for Nursing <strong>and</strong><br />

Midwifery <strong>and</strong> Essence of Care. Action plans are developed <strong>and</strong> implementation<br />

monitored by the Nursing <strong>and</strong> Midwifery <strong>Board</strong><br />

Self Assessment of Risk<br />

Upon identification of an individual risk at any time a staff member can complete a generic<br />

risk assessment proforma or one of the specific non clinical assessment proforma’s which<br />

are available on the <strong>Trust</strong>’s intranet site. The risk will be reported to <strong>and</strong> discussed with a<br />

line manager <strong>and</strong> scored using the <strong>Trust</strong> risk scoring matrix. Action plans will be<br />

developed <strong>and</strong> the risk will populate the Risk Register <strong>and</strong> be escalated in line with the<br />

<strong>Trust</strong> risk escalation process. If immediate action is required steps must be taken to<br />

mitigate the risk in the short term whilst longer term plans are implemented. If a staff<br />

member has concerns regarding the practice of another employee of the <strong>Trust</strong>, they<br />

should raise their concerns using the <strong>Trust</strong> Raising Concerns Policy available on intranet<br />

Evaluation of National Reports<br />

As key reports are published appointed members of staff will be directed to review the<br />

content to evaluate the relevance of the report <strong>and</strong> st<strong>and</strong>ards that will be required of the<br />

<strong>Trust</strong>. This includes deficits in compliance with a range of st<strong>and</strong>ards<br />

such as Maternity or any of the National Inquiry reports such as those into Peri-Operative<br />

Care or Maternal <strong>and</strong> Child Deaths. It also includes Independent Inquiries where risks are<br />

identified that apply to services within this <strong>Trust</strong> including those that relate to<br />

Safeguarding Children <strong>and</strong> Vulnerable Adults, clinical services <strong>and</strong> health <strong>and</strong> safety.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 14 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Central Alert System (CAS)<br />

Review <strong>and</strong> response to CAS which is an electronic system developed by the Department<br />

of Health, the National Patient Safety Agency (NPSA), NHS Estates <strong>and</strong> the Medicines<br />

<strong>and</strong> Healthcare products Regulatory Agency (MHRA) that includes medicines, healthcare<br />

products, medical device, National Patient Safety Agency alerts <strong>and</strong> NHS Estate warning<br />

notices. Where alerts are issued <strong>and</strong> the <strong>Trust</strong> is not compliant a risk will be registered<br />

<strong>and</strong> an action plan implemented<br />

Reactive Risk Identification<br />

Incident Reporting / Near Miss Reporting<br />

Incident <strong>and</strong> near miss reporting by staff is an efficient <strong>and</strong> effective system for identifying<br />

risk. Rapid action in resolving how <strong>and</strong> why an incident may have occurred can facilitate<br />

the organisation in learning how to avoid repeat occurrences of similar incidents. The<br />

<strong>Trust</strong> operates within a just <strong>and</strong> fair blame culture, to ensure that staff feel safe in being<br />

open to report events. Incidents <strong>and</strong> near misses are scored using the <strong>Trust</strong>’s risk matrix<br />

Complaint Reporting<br />

Complaint reporting is a very effective way through which an organisation can learn to<br />

manage its services <strong>and</strong> risks. Complaints are responded to by the Clinical Directorates /<br />

Corporate Departments <strong>and</strong> the <strong>Trust</strong> has a systematic approach which attempts a<br />

frontline instant response where possible, followed up <strong>and</strong> escalated through the line<br />

management structure in the Division if necessary. Formal complaint responses are coordinated<br />

in accordance with the <strong>Trust</strong>'s Complaints Policy <strong>and</strong> Procedure<br />

Informal concerns also provide useful information to support the <strong>Trust</strong> to enhance the<br />

patient experience. Concerns are assigned a risk score by the Patient Advice <strong>and</strong> Liaison<br />

Service (PALS)<br />

Claims<br />

The review of claims is also an effective way through which the organisation can learn to<br />

prevent the reoccurrence of incidents, manage its risks <strong>and</strong> improve the quality of care<br />

delivered. The <strong>Trust</strong> response to claims is managed on behalf of the <strong>Trust</strong> by the Legal<br />

Services Team in accordance with the <strong>Trust</strong>’s Claims H<strong>and</strong>ling Policy, Clinical<br />

Directorates are involved in reviews to support the management of risk locally <strong>and</strong> review<br />

closed claims as they arise.<br />

External Assessments <strong>and</strong> Reviews<br />

Care Quality Commission (CQC)<br />

A review is undertaken of st<strong>and</strong>ards across the <strong>Trust</strong> that identify lapses, lapses identified<br />

result in action plans developed which are monitored for implementation via the<br />

Transformation <strong>Board</strong><br />

Risks highlighted during service reviews <strong>and</strong> the audit work that is undertaken by the<br />

<strong>Trust</strong>’s auditors are sources of risk identification. Risks identified are scored using the<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 15 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


<strong>Trust</strong>’s risk matrix <strong>and</strong> will populate the <strong>Trust</strong>’s Risk Register <strong>and</strong> be escalated in line with<br />

the <strong>Trust</strong>’s escalation process.<br />

4.6 RISK GRADING AND ACCEPTABLE / UNACCEPTABLE RISK<br />

4.6.1 Grading<br />

Once risks are identified, it is the policy of the <strong>Trust</strong> that they must be prioritised for full<br />

assessment <strong>and</strong> management by initially grading them, according to their impact <strong>and</strong> the<br />

likelihood that they will occur again in the future.<br />

The <strong>Trust</strong> has adopted a risk assessment matrix for grading all non-financial risks whether<br />

clinical, non-clinical or organisational. The matrix is set out in the <strong>Trust</strong>’s Risk Assessment Tool<br />

Kit, which can be found on the <strong>Trust</strong>’s Intranet. The grading matrix is attached in Appendix 1. It<br />

has four grades of risk - low, moderate, high <strong>and</strong> extreme, which are identified respectively by the<br />

four colours: green, yellow, orange <strong>and</strong> red.<br />

Incidents are also graded using the same matrix in accordance with the <strong>Trust</strong>’s Incident Reporting<br />

& SI Policy which can be accessed on the <strong>Trust</strong>’s intranet.<br />

4.6.2 Acceptable / Unacceptable Risk<br />

It is the policy of the <strong>Trust</strong> that control action is:<br />

• considered for all risks where the initial grading is more than green / low<br />

• implemented to reduce the residual risk after the action to green / low, unless the impact<br />

<strong>and</strong> likelihood of the risk is such that the burden of the available action is disproportionate<br />

to the reduction of risk to be achieved.<br />

Thus, risks graded low / green need to be revisited annually unless further concerns arise.<br />

Yellow <strong>and</strong> low orange (under a risk score of 9) represent increasing levels of risk <strong>and</strong> therefore<br />

require control action <strong>and</strong> review at intervals depending on the impact of the risk <strong>and</strong> the<br />

likelihood of recurrence as identified through risk assessment processes.<br />

Red represents extreme levels of risk which are by definition unacceptable <strong>and</strong> require control<br />

action <strong>and</strong> review at intervals to reduce them as far as reasonably practicable.<br />

4.7 ASSESSMENTS, CONTROL AND ACCEPTANCE OF RISK<br />

4.7.1. Assessment Process<br />

It is the responsibility of each Clinical Directorate Directors, Senior Nurses, Directorates General<br />

Managers/Managers, Clinical Leads, Nurse Consultants <strong>and</strong> Ward / Service Managers to ensure<br />

that the <strong>Trust</strong>’s risk assessment programme is implemented within their areas in accordance with<br />

this policy.<br />

Each Directorate must undertake risk assessments locally in accordance with the <strong>Trust</strong> Risk<br />

Assessment Tool Kit. Directorates have the responsibility to assess their clinical, environmental,<br />

health, safety, financial <strong>and</strong> performance related risks.<br />

The local management of risk will be carried out by various different groups of senior staff<br />

according to the grading of the risk identified but would have an overview in regards to mitigation<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 16 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


y the Directorate Lead <strong>and</strong> or General Manager. The following table describes the type of<br />

evidence that will be used to demonstrate compliance with the aims of this policy.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 17 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Risk Grading Staff Group Evidence<br />

Red/Extreme<br />

Orange/High<br />

Yellow/Moderate<br />

Green/Low<br />

Executive Directors<br />

Clinical Directors<br />

Directorates Manager<br />

Matron<br />

Other relevant senior staff<br />

Clinical Directors<br />

Directorates Managers<br />

Matron<br />

Other relevant senior staff<br />

Matrons<br />

Service Leads<br />

Ward/Departmental Manager<br />

Directorates Risk Registers<br />

Investigation report<br />

Risk Assessment <strong>and</strong> action plan<br />

Committee minutes<br />

External reporting - STEIS, HSE<br />

MHRA etc<br />

IR1 Form<br />

Investigation report<br />

Risk Assessment <strong>and</strong> action plan<br />

Minutes of Directorates directorate<br />

meetings<br />

IR1 Form<br />

Local investigation<br />

IR1 Form<br />

Local investigation<br />

Where risks cannot be effectively managed or responded to locally that is where they require<br />

resources <strong>and</strong>/or authority beyond the remit of the local area, or where the risk is common to<br />

more than one area the risk assessment should be forwarded to:<br />

#riskregister@bhrhospitals.nhs.uk for inclusion in the <strong>Trust</strong> Risk Register<br />

Newly identified risks that are rated high/extreme will be added to the <strong>Trust</strong> corporate risk register<br />

<strong>and</strong> for risks that require immediate action these will be reported via the <strong>Trust</strong> SI process (see SI<br />

policy)<br />

Review of Assessments<br />

A quarterly review will be undertaken by the directorates on their risks to ensure that the<br />

information recorded on their Local risk register is reflective of the <strong>Trust</strong> Corporate Risk Register<br />

(high orange <strong>and</strong> extreme risks). Failure to receive review from Directorates will be noted on the<br />

register <strong>and</strong> this information is cascaded to the Audit Committee <strong>and</strong> <strong>Trust</strong> <strong>Board</strong> via the <strong>Board</strong><br />

Assurance Framework.<br />

Risk Closure Form<br />

This ensures that risks are considered <strong>and</strong> agreed prior to closure. It also prevents unauthorised<br />

closure of Corporate risks by any staff<br />

Risk Review Form<br />

Risk assessments must be reviewed regularly <strong>and</strong> immediately if there is any reason to suspect<br />

the assessment is no longer valid such as there has been significant change to the work of to the<br />

risks of the work<br />

Exception Report<br />

To identity the material deviation between actual risk occurrence <strong>and</strong> controls in a report, which<br />

warrants management investigation<br />

Risk Validation Report<br />

The risk validation report is a very effective way to define <strong>and</strong> determine efficient methods to<br />

reduce emotional risk scoring. It reduces the unnecessary cost <strong>and</strong> where appropriate promotes<br />

a robust process.<br />

Archiving of risk assessments<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 18 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


All risk assessments must be archived by the local area in accordance with the records<br />

management policy. The length of time individual risk assessments will be dependent on the<br />

particular subject of the assessment for instance clinical assessments form part of the patients<br />

medical records <strong>and</strong> therefore should be retained as such. Assessments made in relation to<br />

human resource issues such as workplace assessments should be kept in accordance with the<br />

personnel file. Generic risk assessments or environmental risk assessments should be kept as a<br />

minimum for five years following the last review date.<br />

4.7.4 Other Escalation Processes<br />

Other mechanisms are open to Executive Directors <strong>and</strong>/or Directorates to escalate risks for wider<br />

discussion before they become high level risks; this may be as exception reports to the Quality &<br />

Strategy Committee or presentations/reports as part of the rolling assessment programme of the<br />

Audit Committee. Lower level risks should be discussed <strong>and</strong> risks fully considered at feeder<br />

committees throughout the organisation that are specific to particular topics ie the Drugs <strong>and</strong><br />

Therapeutic Committee or the Clinical Risk Committee. An overview of this process is described<br />

in section 13, Key Performance Indicators.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 19 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


4.8 RISK REGISTER<br />

The Risk Registers set out the existing controls that relate to the risk as most are already subject<br />

to some degree of management. This helps BHRUT to set a more realistic or “real” prioritisation<br />

of the issues by assignment of a residual risk score. This means effort <strong>and</strong> resource can be<br />

targeted to mitigate or manage the risk <strong>and</strong> actions with responsibilities <strong>and</strong> target dates being set<br />

out in the Risk Register. Through this reassessment of priority scores (using the “Residual Risk<br />

Score) further work or “solutions” can be planned to address the risk until it reaches an<br />

acceptable level (i.e. within the risk appetite set).<br />

Managing risk is part of everyday management in the NHS, however due to the time that is<br />

required to implement solutions to risks <strong>and</strong> financial constraints; the concept of Risk Registers<br />

has been developed to provide an on-going log of these risks. Risk Registers are primarily an<br />

internal management tool to support Directorates/corporate departments in managing their risks<br />

whilst there is an opportunity to raise/escalate particular risks for inclusion on to the <strong>Trust</strong>’s<br />

Corporate Risk Register <strong>and</strong> the <strong>Board</strong> Assurance framework for input on mitigation of the risk.<br />

It is the policy of the <strong>Trust</strong> to maintain a Risk Register recording financial <strong>and</strong> non-financial risks<br />

as identified by its processes for continuous risk identification <strong>and</strong> risk assessment. For the<br />

avoidance of doubt, non-financial risks include clinical, non-clinical <strong>and</strong> organisational risks.<br />

The Risk Register is maintained <strong>and</strong> updated by the Risk Management Team <strong>and</strong> provides<br />

quarterly reports to the directorates via the Safeguard Risk Management system to enable them<br />

to scrutinise their risk to ensure that they are adequately described <strong>and</strong> graded <strong>and</strong> that action<br />

plans are formulated the Risk register.<br />

4.8.1 Clinical Directorate risk registers<br />

All risks must be submitted with a risk assessment <strong>and</strong> an action plan which would be updated to<br />

reflect the current Directorate risk profile, Risk action plan with details of key dates <strong>and</strong><br />

individual responsibility for action should be integrated into service plans <strong>and</strong> project<br />

plans. Appropriate review is needed to keep the risk register current. Each risk owner will<br />

need to have a securely retained copy of the register <strong>and</strong> a clear<br />

history of changes made as risk registers may be requested at any time by<br />

decision makers, project boards, the Risk Manager, Internal or External Auditors<br />

or any interested parties in the interest of openness & accountability<br />

Local Monitoring of incidents, complaints <strong>and</strong> claims including serious incidents<br />

Make reference to policies<br />

4.9 BOARD ASSURANCE FRAMEWORK<br />

The <strong>Board</strong> Assurance Framework (BAF) will identify which of BHRUT’s principal objectives are at<br />

risk because of inadequacies in the operation of the organisational controls or areas where the<br />

organisation has insufficient assurance about the effectiveness of the controls in place. At the<br />

same time the <strong>Board</strong> Assurance Framework will provide structured assurances where key risks<br />

are being managed effectively <strong>and</strong> which principal objectives are being delivered.<br />

The <strong>Board</strong> Assurance Framework will form the key document for the <strong>Trust</strong> <strong>Board</strong> in ensuring all<br />

principal risks are controlled, that the effectiveness of these key controls has been assured, <strong>and</strong><br />

that there is sufficient evidence to support the Annual Governance Statement<br />

Review by the <strong>Trust</strong> <strong>Board</strong> of the BAF provides the opportunity for risk to prioritisation <strong>and</strong> ensure<br />

effective performance management. The structure of the BAF allows for the identification of where<br />

the <strong>Trust</strong>’s objectives may not be met because of inadequacies in the operation of controls or<br />

where the organisation has insufficient assurances.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 20 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


The <strong>Trust</strong>’s BAF is audited by the <strong>Trust</strong>’s internal auditors <strong>and</strong> will be the basis for reports to the<br />

Audit Committee. It is the policy of the <strong>Trust</strong> to maintain effective assurance of the risk<br />

management arrangements for its organisational risks, through:<br />

• identification, assessment, review <strong>and</strong> control of the risks associated with its principal<br />

service, staffing, financial <strong>and</strong> governance objectives, at both the corporate <strong>and</strong><br />

departmental / directorate level;<br />

• assessment of both the internal <strong>and</strong> external assurances available of the effectiveness of<br />

the control of those risks;<br />

• action to put in place effective assurance where assessment indicates that to be<br />

necessary;<br />

• recognising gaps in the controls <strong>and</strong><br />

• regular review of organisational risk management <strong>and</strong> its associated assurance<br />

arrangements by the <strong>Trust</strong> <strong>Board</strong>.<br />

The BAF demonstrates the sequential actions taken quarter by quarter to reduce <strong>and</strong> remove<br />

risks facing the organisation.<br />

4.10 EXTERNAL RISK MANAGEMENT STANDARDS<br />

The <strong>Trust</strong> is committed to pursue best practice in its risk control measures by continuously<br />

applying external risk management st<strong>and</strong>ards, advice <strong>and</strong> recommendations relevant to its<br />

activities.<br />

To that end it will maintain continuous comprehensive compliance programmes with relevant<br />

st<strong>and</strong>ards, including the following:<br />

• The Care Quality Commission’s (CQC)<br />

• The NHS Litigation Authority’s (NHSLA) risk management st<strong>and</strong>ards - Clinical Negligence<br />

Scheme for <strong>Trust</strong>s (CNST)<br />

• The st<strong>and</strong>ards of Clinical Pathology Accreditation Ltd (CPA)<br />

• The advice of the National Confidential Enquiries into patient mortality<br />

• The guidance of the National Institute for Health & Clinical Excellence (NICE).<br />

• The guidance within National Service Frameworks <strong>and</strong> High Level Enquiries<br />

• The Health & Safety at Work Act <strong>and</strong> subordinate legislation.<br />

• Patient Environment Action Team<br />

5. THE DEVELOPMENT OF THIS POLICY<br />

This policy was written using the <strong>Trust</strong> Policy Template <strong>and</strong> giving consideration to all the<br />

elements required within the <strong>Trust</strong> Policy for the Development <strong>and</strong> Management of <strong>Trust</strong>-<br />

Wide Procedural Documents.<br />

The individual/group nominated as responsible for this Policy is the <strong>Trust</strong> <strong>Board</strong>.<br />

This Policy was developed through an update to the existing policy, consultation with<br />

stakeholders <strong>and</strong> discussion/agreement at the Quality & Safety Committee, the Audit<br />

Committee <strong>and</strong> the <strong>Trust</strong> <strong>Board</strong>.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 21 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


5.1 Consultation <strong>and</strong> Communication with Stakeholders<br />

Stakeholders identified for this process are<br />

• Clinical Governance Director<br />

• <strong>Trust</strong> <strong>Board</strong><br />

• Clinical Directors<br />

• Managers<br />

• Clinical Governance Staff<br />

• All Staff<br />

They were included in the development of the updated Policy by consultation, either<br />

individual or as part of the approving Committees.<br />

They were included in the approval of the Policy by representation at the Audit Committee<br />

or the Quality & Safety Committee.<br />

All involved stakeholders received a copy of the final approved policy or were notified that<br />

it is available on the Intranet.<br />

5.2 Equality Impact Assessment<br />

This policy has been equality impact assessed to ensure that the guidance provided does<br />

not place at a disadvantage any service, population or workforce over another. A<br />

completed Equality Impact Assessment is shown page 30<br />

5.3 Approval <strong>and</strong> Ratification<br />

A copy of the Checklist for Review <strong>and</strong> Approval of Procedural Documents has been<br />

completed for this Policy <strong>and</strong> submitted with the final draft for approval <strong>and</strong> ratification.<br />

This policy was reviewed <strong>and</strong> approved by the Quality & Safety Committee on<br />

………………….<br />

This policy was reviewed <strong>and</strong> approved by the Audit Committee on ……………………….<br />

This policy was reviewed <strong>and</strong> ratified by the Policy Ratification Committee on<br />

………………………..<br />

6. REVIEW AND REVISION ARRANGEMENTS<br />

6.1 Review<br />

This policy will be reviewed every 2 years or sooner if there are pertinent legislative or<br />

organisational changes.<br />

6.2 Revision<br />

Details of all/any revision to this Policy are documented in Amendments – Section 11.<br />

7. DISSEMINATION AND IMPLEMENTATION<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 22 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


7.1 Dissemination<br />

Once approved, the Strategy will be placed on the <strong>Trust</strong>’s intranet site for ease of access by staff.<br />

Risk <strong>and</strong> patient safety issues will be raised frequently through the weekly electronic newsletter<br />

‘The Link’, ‘MISSES’ maternity newsletter <strong>and</strong> ‘PHAT’ public health midwives newsletter. Key<br />

information from this Strategy will be used to provide guidance <strong>and</strong> advice at the <strong>Trust</strong>’s corporate<br />

<strong>and</strong> specialist induction sessions <strong>and</strong> m<strong>and</strong>atory risk management training to ensure the<br />

maximum coverage of staff at all levels in the organisation.<br />

A Plan for Dissemination of Procedural Documents has been completed <strong>and</strong> submitted<br />

with the final draft for approval <strong>and</strong> ratification.<br />

7.2 Implementation<br />

The <strong>Trust</strong> will ensure that training is provided in order that the objectives of this document are<br />

met.<br />

There is corporate responsibility to ensure a framework of corporate, local <strong>and</strong> specialty<br />

inductions are in place together with m<strong>and</strong>atory <strong>and</strong> risk management training for all permanent<br />

staff at all levels of the organisation. The <strong>Trust</strong> carries out an annual training needs analysis to<br />

assess the training requirements of the organisation to ensure there is sufficient risk management<br />

training provision to enable its workforce to perform their duties safely. Details of the courses<br />

available are contained within the Learning & Development Prospectus.<br />

A copy of the current training needs analysis is incorporated within the Guidance for Accessing<br />

Education & Learning Opportunities.<br />

Examples of training that the <strong>Trust</strong> provides:<br />

Risk management training for <strong>Board</strong> members <strong>and</strong> members of Executive Team by<br />

representative from Clinical Governance Team, Non attendance is followed up by Clinical<br />

Governance Team. Attendance is recorded on a database kept by Clinical Governance centrally<br />

M<strong>and</strong>atory Nurse Training (three day course)<br />

Root cause analysis – (one-day course)<br />

8. MONITORING<br />

It is the policy of the <strong>Trust</strong> to monitor adherence to the relevant st<strong>and</strong>ards by means of<br />

programmes of annual self-assessment <strong>and</strong> audit <strong>and</strong> it is the responsibility of the Clinical<br />

Directors to ensure the <strong>Trust</strong>’s rolling programme of corporate audits is undertaken.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 23 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


The <strong>Trust</strong> recognises the importance of collecting meaningful <strong>and</strong> relevant data in a statistical<br />

format so the analysis <strong>and</strong> trends can be monitored <strong>and</strong> appropriate action taken. Where<br />

possible both qualitative <strong>and</strong> quantitative information is sought to inform decision-making, <strong>and</strong> is<br />

aggregated to provide a holistic interpretation of the risks faced by the organisation via the <strong>Board</strong><br />

Assurance Framework <strong>and</strong> quarterly Aggregated Data reports sent to the Directorates <strong>and</strong><br />

reviewed by the Quality <strong>and</strong> Safety Committee.<br />

Each Directorate has an allocated clinical governance lead that attends the Directorates <strong>Board</strong><br />

meetings <strong>and</strong> can assist with risk issues if required, <strong>and</strong> a named complaints manager that can<br />

offer advice <strong>and</strong> guidance. Audit advice <strong>and</strong> guidance can be provided through the <strong>Trust</strong>’s Audit<br />

Department. Each Directorate also has financial <strong>and</strong> human resource support from named leads.<br />

It is the policy of the <strong>Trust</strong> that the impact of its risk management processes should be monitored<br />

continuously via appropriate, quantified key indicators, capable of indicating progress over time.<br />

The following key performance indicators will be used to monitor implementation at both a<br />

corporate <strong>and</strong> local level.<br />

It is the policy of the <strong>Trust</strong> that comprehensive quarterly monitoring reports on the identified risks<br />

are produced <strong>and</strong> considered at each meeting of the Audit Committee. Copies of the reports are<br />

also made available at the appropriate level of detail to internal stakeholders including all levels of<br />

management with responsibilities for risk management <strong>and</strong> to relevant external stakeholders as<br />

requested.<br />

The matrix below identifies all the monitoring of this policy which will be carried out, how<br />

this will be done (e.g. audit), frequency, who is the lead person responsible for ensuring<br />

that the monitoring is carried out, where reports from monitoring are reported, who<br />

(individual/group/committee) is responsible for ensuring that any gaps or deficiencies are<br />

recorded on an action plan which is followed up <strong>and</strong> who is responsible for ensuring that<br />

implementation of any changes which follow the action plan completion are implemented<br />

<strong>and</strong>, where appropriate, information disseminated within the <strong>Trust</strong> to enable learning from<br />

the experience<br />

What will be<br />

monitored<br />

<strong>and</strong>/or<br />

St<strong>and</strong>ard To Be<br />

Achieved<br />

How/Method Frequency Lead Reported to Deficiencies/gaps<br />

recommendations<br />

<strong>and</strong> action plans<br />

followed up by<br />

Implementation<br />

of any required<br />

change<br />

responsibility<br />

of<br />

In date risk<br />

management<br />

strategy in<br />

place with<br />

risk<br />

management<br />

structures<br />

described<br />

Significant<br />

risk register<br />

reviewed by<br />

Audit<br />

Committee<br />

<strong>Board</strong><br />

Assurance<br />

Framework is<br />

scrutinised<br />

by the Audit<br />

Strategy in place<br />

<strong>and</strong> approved<br />

Assurance that<br />

the <strong>Trust</strong> <strong>Board</strong><br />

are aware of the<br />

organisations<br />

significant risks<br />

Minutes of<br />

meetings<br />

evidence review<br />

Every two<br />

years<br />

Quarterly<br />

Clinical<br />

Governance<br />

Director<br />

Audit<br />

Committee<br />

Audit<br />

Committee<br />

Relevant<br />

Directorates<br />

Quarterly <strong>Trust</strong> <strong>Board</strong> Relevant<br />

Directorates<br />

/ Relevant<br />

Executive<br />

Policy <strong>and</strong><br />

Ratification<br />

Committee<br />

Audit<br />

Committee<br />

Audit<br />

Committee<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 24 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Committee<br />

Review <strong>and</strong><br />

monitoring of<br />

risks<br />

Incident<br />

Reporting<br />

(Patient<br />

Safety)<br />

Reporting to<br />

external<br />

agencies to<br />

support<br />

shared<br />

learning<br />

(NRLS)<br />

Information<br />

on<br />

complaints,<br />

claims <strong>and</strong><br />

incidents is<br />

aggregated,<br />

analysed <strong>and</strong><br />

disseminated<br />

Incidents<br />

graded<br />

according to<br />

severity<br />

Serious<br />

Incident<br />

investigations<br />

compliant<br />

with Incident<br />

<strong>and</strong> SI policy<br />

Safety Alerts<br />

implemented<br />

within<br />

Evidence of<br />

review <strong>and</strong><br />

actions<br />

undertaken -<br />

recorded on<br />

Ulysses database<br />

quarterly reports<br />

Assurance that<br />

delivery <strong>and</strong><br />

performance<br />

against the<br />

<strong>Trust</strong>’s objectives<br />

are being<br />

appropriately<br />

monitored.<br />

Incident reporting<br />

rate > NPSA<br />

average<br />

Evidence of<br />

timely reporting to<br />

NRLS<br />

Aggregated data<br />

reports are<br />

presented to<br />

Committees,<br />

Directorates <strong>and</strong><br />

are published on<br />

the <strong>Trust</strong> Intranet<br />

including<br />

commentary on<br />

organisational<br />

learning<br />

All incidents are<br />

triaged <strong>and</strong> coded<br />

accurately, in line<br />

with severity as<br />

set out in the<br />

Incident <strong>and</strong> SI<br />

policy<br />

Audit of reports<br />

shows<br />

compliance with<br />

Incident <strong>and</strong> SI<br />

policy<br />

CAS alerts are<br />

implemented<br />

within time frames<br />

Quarterly<br />

Risk<br />

Management<br />

Team<br />

Performance<br />

Efficiency<br />

<strong>and</strong> Quality<br />

Committee<br />

Audit<br />

Committee<br />

Quality &<br />

Strategy<br />

Committee<br />

Relevant<br />

Directorates<br />

/ Relevant<br />

Executive<br />

Monthly <strong>Trust</strong> <strong>Board</strong> Relevant<br />

Directorates<br />

On<br />

publication<br />

Quarterly<br />

On-going<br />

On-going<br />

Quarterly<br />

Clinical Risk<br />

Management<br />

Committee<br />

Clinical Risk<br />

management<br />

Committee<br />

Statutory<br />

Safety<br />

Committee<br />

Audit<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Directorates<br />

Patient<br />

Safety<br />

Adviser<br />

Patient<br />

Safety<br />

Adviser<br />

Clinical<br />

Governance<br />

Director<br />

Clinical Risk<br />

Management<br />

Committee<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Relevant<br />

Directorates<br />

Audit<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Clinical Risk<br />

Management<br />

Committee<br />

Clinical Risk<br />

Management<br />

Committee<br />

Clinical Risk<br />

management<br />

Committee<br />

Statutory<br />

Safety<br />

Committee<br />

Audit<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Directorates<br />

Patient Safety<br />

Adviser<br />

Patient Safety<br />

Adviser<br />

Clinical<br />

Governance<br />

Director<br />

Clinical Risk<br />

Management<br />

Committee<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 25 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


timescale<br />

with supporting<br />

evidence<br />

provided<br />

Annual<br />

Health <strong>and</strong><br />

Safety review<br />

Annual report<br />

detailing Health<br />

<strong>and</strong> Safety Issues<br />

within the <strong>Trust</strong><br />

submitted to<br />

Statutory Safety<br />

Committee<br />

Annual<br />

Audit<br />

Committee<br />

Relevant<br />

Directorates<br />

Audit<br />

Committee<br />

Clinical<br />

Governance<br />

Review<br />

Annual report<br />

regarding Clinical<br />

Governance<br />

within the <strong>Trust</strong><br />

submitted to<br />

Quality <strong>and</strong><br />

Strategy<br />

Committee<br />

Annual<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Relevant<br />

Directorates<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Procedural<br />

documents<br />

are reviewed<br />

in line with<br />

review date<br />

Annual report to<br />

Clinical<br />

Governance Risk<br />

Committee<br />

Annual<br />

Relevant<br />

Committees<br />

Quality<br />

Systems<br />

Manager<br />

Quality<br />

Systems<br />

Manager<br />

Service<br />

Users<br />

Annual Patient<br />

Survey<br />

Annual<br />

Clinical Risk<br />

Management<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Relevant<br />

Directorates<br />

Clinical Risk<br />

Management<br />

Committee<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Complaints<br />

compliant<br />

with national<br />

targets for<br />

responses<br />

<strong>Trust</strong><br />

performance with<br />

acknowledgement<br />

within 2 days <strong>and</strong><br />

30 days targets<br />

Monthly<br />

Quarterly<br />

<strong>Trust</strong> <strong>Board</strong><br />

Relevant<br />

Directorates<br />

Quality <strong>and</strong><br />

Safety<br />

Committee<br />

Any deficiencies identified during monitoring will be recorded <strong>and</strong> reported to the Quality<br />

<strong>and</strong> Safety Committee. The nominated persons <strong>and</strong>, ultimately, the Quality <strong>and</strong> Safety<br />

Committee, will be responsible for ensuring that an action plan has been developed, is<br />

followed through, all required actions taken to remedy the deficiency/s identified <strong>and</strong>,<br />

where appropriate, information disseminated within the <strong>Trust</strong> to enable learning from the<br />

experience.<br />

9. REFERENCES<br />

NHSLA Risk Management Strategy Checklist March <strong>2012</strong>/13<br />

The NHS Improvement Plan; 2006: Department of Health www.doh.org<br />

Making it Happen – a Guide for Risk Managers on How to Populate a Risk<br />

Register. Controls Assurance Support<br />

The How to Guide for Leadership for Safety. Patient Safety First Campaign.<br />

2008.www.patientsafetyfirst.nhs.uk<br />

The Healthy NHS <strong>Board</strong> Principles for Good Governance.<br />

The H<strong>and</strong>book to the NHS Constitution. Department of Health<br />

Quality governance in the NHS – a guide for provider boards – National Quality <strong>Board</strong> 2011<br />

Compliance Framework - Monitor<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 26 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


10. ASSOCIATED DOCUMENTATION<br />

Other <strong>Trust</strong> policies <strong>and</strong> procedures with links to this Risk Management Strategy are<br />

listed below:<br />

• Blood Transfusion Policy<br />

• Claims Policy <strong>and</strong> Procedure<br />

• Clinical & Non Clinical Documentation<br />

• Clinical Audit & Effectiveness Strategy<br />

• Clinical Governance Annual report<br />

• Complaints Policy <strong>and</strong> Procedure<br />

• Consent to Examination or Treatment Policy<br />

• Control of Contractors Policy<br />

• Corporate Governance Manual<br />

• COSHH Policy<br />

• Display Screen Equipment (DSE)<br />

• Fire Policy <strong>and</strong> Procedures<br />

• Guidance for Accessing Education & Learning Opportunities<br />

• Incident Reporting & SI Policy<br />

• Induction Policy<br />

• Infection Control Policy<br />

• Latex Policy<br />

• Learning & Development Prospectus<br />

• Lockdown Policy<br />

• Lone Workers Policy<br />

• Major Incident Plan.<br />

• Manual H<strong>and</strong>ling Operations Policy<br />

• Maternity Services Risk Management Strategy 2009-10<br />

• Medical Devices – Policy for the Safe Use of<br />

• Mental Capacity Act 2005 Interim Policy<br />

• NCEPOD at BHR Policy on Compliance<br />

• Evidence Based Practice Policy & Procedure<br />

• PALS Policy<br />

• P<strong>and</strong>emic Flu (H1NI) <strong>and</strong> Winter Resilience Plan<br />

• Patient Identification Policy<br />

• Patient Information Policy<br />

• Policy on Policies<br />

• Radiation Protection Policy<br />

• Risk Assessment Tool Kit<br />

• Aggregated Data reports<br />

• Safety Alert Broadcast System Policy<br />

• Safety Policy<br />

• Service Improvement & Reconfiguration Policy<br />

• Slips Trips <strong>and</strong> Falls Policy<br />

• Transportation of Dangerous Goods Policy<br />

• Violence <strong>and</strong> Aggression Policy<br />

11. AMENDMENTS<br />

To be completed only when the Policy has been reviewed <strong>and</strong> changed.<br />

Page/Section<br />

Strategy <strong>and</strong> Policy<br />

updated to reflect<br />

<strong>2012</strong>/2013 risk<br />

management st<strong>and</strong>ards<br />

Change<br />

Whole document<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 27 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Checklist for the Review <strong>and</strong> Approval of Procedural Documents<br />

To be completed <strong>and</strong> attached to any procedural document when submitted to the appropriate<br />

committee for consideration <strong>and</strong> approval or ratification.<br />

1. Title<br />

Title of document being reviewed:<br />

Is the title clear <strong>and</strong> unambiguous?<br />

Is it clear whether the document is a policy,<br />

protocol or guideline?<br />

2. Rationale<br />

Are reasons for development of the document<br />

stated?<br />

3. Development Process<br />

Is the method described in brief?<br />

Are individuals involved in the development<br />

identified?<br />

Do you feel a reasonable attempt has been made<br />

to ensure relevant expertise has been used?<br />

Is there evidence of consultation with stakeholders<br />

<strong>and</strong> users?<br />

4. Content<br />

Is the objective of the document clear?<br />

Is the target population clear <strong>and</strong> unambiguous?<br />

Are the intended outcomes described?<br />

Are the statements clear <strong>and</strong> unambiguous?<br />

5. Evidence Base<br />

Is the type of evidence to support the document<br />

identified explicitly?<br />

Are key references cited?<br />

Are the references cited in full?<br />

Are local/organisational supporting documents<br />

referenced?<br />

6. Approval<br />

Does the document identify which committee/group<br />

will approve it?<br />

Does the document identify which committee/group<br />

will ratify it?<br />

If appropriate, have the joint staff side committee<br />

(or equivalent) approved the document?<br />

7. Dissemination <strong>and</strong> Implementation<br />

Yes/No/<br />

Unsure<br />

Comments, including where<br />

information is included in the<br />

document<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 28 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Title of document being reviewed:<br />

Is there a completed Plan for Dissemination of<br />

Procedural Documents which identifies how this will<br />

be done?<br />

Does the plan include the necessary<br />

training/support to ensure compliance?<br />

8. Document Control<br />

Does the document identify where it will be held?<br />

Have archiving arrangements for superseded<br />

documents been addressed?<br />

9. Process for Monitoring Compliance<br />

Are there measurable st<strong>and</strong>ards or KPIs to support<br />

monitoring compliance of the document?<br />

Is there a plan to review or audit compliance with<br />

the document?<br />

10. Review Date<br />

Is the review date identified?<br />

Is the frequency of review identified? If so, is it<br />

acceptable?<br />

11. Overall Responsibility for the Document<br />

Is it clear who will be responsible for coordinating<br />

the dissemination, implementation <strong>and</strong> review of<br />

the documentation?<br />

Yes/No/<br />

Unsure<br />

Comments, including where<br />

information is included in the<br />

document<br />

Individual/Group/Committee Approval<br />

If you are happy to approve this document, please sign <strong>and</strong> date below <strong>and</strong> forward to the chair of the<br />

committee where it will receive ratification.<br />

Name<br />

Signature<br />

Date<br />

On behalf of<br />

Committee Ratification<br />

If the committee is happy to ratify this document, please sign <strong>and</strong> date below <strong>and</strong> forward copies to the person<br />

with responsibility for disseminating <strong>and</strong> implementing the document <strong>and</strong> the Quality Systems Manager.<br />

Name<br />

Date<br />

Signature<br />

On behalf of<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 29 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Equality Impact Assessment Tool<br />

To be completed <strong>and</strong> attached to any policy when submitted to the appropriate committee/group for<br />

consideration <strong>and</strong> approval or ratification.<br />

Policy Title<br />

Policy Number<br />

Responsible Individual/Committee<br />

Approving Committee<br />

Ratifying Committee<br />

1. Does the policy affect one group less or more<br />

favourably than another on the basis of:<br />

Age<br />

Disability – learning disabilities, physical disability,<br />

sensory impairment <strong>and</strong> mental health problems.<br />

Race<br />

Nationality<br />

Ethnic origin – including gypsies <strong>and</strong> travellers<br />

Gender / Gender reassignment<br />

Religion<br />

Beliefs<br />

Sexual orientation – including lesbian, gay <strong>and</strong><br />

bisexual people<br />

Domestic circumstances<br />

Social <strong>and</strong> employment status<br />

Marital/partnership status<br />

HIV status<br />

Political affiliation<br />

Trade Union membership<br />

2. What is the overall purpose of this policy area,<br />

function or activity?<br />

3. What approaches are currently used to measure<br />

progress <strong>and</strong> performance in this area?<br />

4. What counts as success in this area?<br />

5. Are there opportunities within this policy to:<br />

Eliminate illegal discrimination<br />

Promote equality of opportunity<br />

Promote good relations between people of different<br />

groups?<br />

Yes/No<br />

Comments<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 30 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


6. Is the impact of the policy likely to be negative<br />

e.g. is their risk of:<br />

Illegal discrimination<br />

Reducing equality of opportunity for some groups?<br />

Harming relations between different people of<br />

different groups?<br />

7. If you have identified potential discrimination,<br />

are any exceptions valid, legal <strong>and</strong>/or<br />

justifiable?<br />

8. If so, what action could be taken to reduce<br />

adverse effects <strong>and</strong> promote or enhance<br />

positive effects?<br />

9. Please describe the options available for<br />

incorporating equality monitoring into routine<br />

arrangements?<br />

Yes/No<br />

Comments<br />

If you have identified a potential discriminatory impact of this policy document, please refer the issue<br />

to the Workforce Equality Lead, together with any suggestions as to the action required to<br />

avoid/reduce this impact.<br />

For advice in respect of answering the above questions, please contact the Workforce Equality Lead,<br />

HR Department, Queen’s Hospital on extension 3294.<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 31 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Plan for Dissemination of Procedural Documents<br />

To be completed <strong>and</strong> attached to any procedural document when submitted to the appropriate<br />

committee for consideration <strong>and</strong> approval or ratification.<br />

Title of document:<br />

Dissemination lead (name <strong>and</strong> contact details):<br />

Date finalised:<br />

Previous document<br />

already being used?<br />

Yes / No<br />

(Please delete as<br />

appropriate)<br />

Date due to be reviewed:<br />

If yes, in what format <strong>and</strong> where?<br />

Proposed action to retrieve out of date copies of the document:<br />

Have any training needs been identified <strong>and</strong> addressed (give details):<br />

To be disseminated to:<br />

How will it be disseminated,<br />

who will do it <strong>and</strong> when?<br />

Format (i.e.<br />

paper<br />

or electronic)<br />

Comments:<br />

Quality Systems Manager<br />

Originator to send after<br />

ratification at committee<br />

Electronic<br />

For numbering, logging <strong>and</strong> issue<br />

Web Manager<br />

Sent by Quality Systems<br />

Manager once numbered <strong>and</strong><br />

logged<br />

Electronic<br />

For inclusion on <strong>Trust</strong> Intr@net<br />

<strong>and</strong>, where appropriate, archiving<br />

previous version.<br />

Originator<br />

Sent by Quality Systems<br />

Manager once issued<br />

Electronic<br />

For dissemination<br />

All staff<br />

Placed on Intr@net<br />

(fill in date once issued)<br />

Dissemination Record - to be used once document is approved, ratified <strong>and</strong> issued<br />

Disseminated to: (either<br />

directly or via meetings, etc.)<br />

Format<br />

(i.e. paper or<br />

electronic)<br />

Date<br />

disseminated:<br />

No. of<br />

copies<br />

sent:<br />

Contact details /<br />

comments:<br />

Please add as many extra lines as required to this document to ensure it reflects the dissemination<br />

plan for the Policy.<br />

Issued <strong>November</strong> 2010 Version 1<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 32 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


APPENDIX 1<br />

RISK GRADING MATRIX<br />

Likelihood<br />

Likelihood score 1 2 3 4 5<br />

Rare Unlikely Possible Likely Almost certain<br />

5 Catastrophic 5 10 15 20 25<br />

4 Major 4 8 12 16 20<br />

3 Moderate 3 6 9 12 15<br />

2 Minor 2 4 6 8 10<br />

1 Negligible 1 2 3 4 5<br />

1 - 3 Low risk<br />

4 - 6 Moderate risk<br />

8 - 12 High risk<br />

15-25 Extreme risk<br />

RISK<br />

GRADING<br />

ACTION TO BE TAKEN<br />

EXTREME<br />

Urgent senior management attention needed. For risks graded as extreme the investigation should be led by a Director, General Manager or Matron.<br />

HIGH<br />

Urgent senior management attention needed. A decision about risk acceptability must be made within 4 weeks <strong>and</strong> an action plan for controlling the risk must be devised.<br />

MODERATE<br />

Management responsibility for risk control must be identified (unless a decision is made to accept the risk). Any action requirements must be added to a ward / department action<br />

plan.<br />

LOW<br />

Risks can be / are already being managed by routine procedures – no further action required.<br />

Consequence Scoring table (C)<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 33 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Consequence score (severity levels) <strong>and</strong> examples of descriptors<br />

1 2 3 4 5<br />

Domains Negligible Minor Moderate Major Catastrophic<br />

Impact on the safety of patients, staff<br />

or public (physical/psychological<br />

harm)<br />

Minimal injury requiring<br />

no/minimal intervention or<br />

treatment.<br />

Minor injury or illness,<br />

requiring minor intervention<br />

Moderate injury requiring<br />

professional intervention<br />

Major injury leading to long-term<br />

incapacity/disability<br />

Incident leading to death<br />

No time off work<br />

Requiring time off work for >3<br />

days<br />

Increase in length of hospital<br />

stay by 1-3 days<br />

Requiring time off work for 4-14<br />

days<br />

Increase in length of hospital<br />

stay by 4-15 days<br />

Requiring time off work for >14<br />

days<br />

Increase in length of hospital<br />

stay by >15 days<br />

Multiple permanent injuries or<br />

irreversible health effects<br />

An event which impacts on a<br />

large number of patients<br />

RIDDOR/agency reportable<br />

incident<br />

Mismanagement of patient care<br />

with long-term effects<br />

An event which impacts on a<br />

small number of patients<br />

Quality/complaints/audit<br />

Peripheral element of<br />

treatment or service<br />

suboptimal<br />

Informal complaint/inquiry<br />

Overall treatment or service<br />

suboptimal<br />

Formal complaint (stage 1)<br />

Local resolution<br />

Single failure to meet internal<br />

st<strong>and</strong>ards<br />

Minor implications for patient<br />

safety if unresolved<br />

Treatment or service has<br />

significantly reduced<br />

effectiveness<br />

Formal complaint (stage 2)<br />

complaint<br />

Local resolution (with potential<br />

to go to independent review)<br />

Repeated failure to meet<br />

internal st<strong>and</strong>ards<br />

Non-compliance with national<br />

st<strong>and</strong>ards with significant risk to<br />

patients if unresolved<br />

Multiple complaints/<br />

independent review<br />

Low performance rating<br />

Critical report<br />

Totally unacceptable level or<br />

quality of treatment/service<br />

Gross failure of patient safety if<br />

findings not acted on<br />

Inquest/ombudsman inquiry<br />

Gross failure to meet national<br />

st<strong>and</strong>ards<br />

Human resources/ organisational<br />

development/staffing/ competence<br />

Short-term low staffing<br />

level that temporarily<br />

reduces service quality (<<br />

1 day)<br />

Reduced performance rating if<br />

unresolved<br />

Low staffing level that reduces<br />

the service quality<br />

Major patient safety implications<br />

if findings are not acted on<br />

Late delivery of key objective/<br />

service due to lack of staff<br />

Unsafe staffing level or<br />

competence (>1 day)<br />

Low staff morale<br />

Poor staff attendance for<br />

m<strong>and</strong>atory/key training<br />

Uncertain delivery of key<br />

objective/service due to lack of<br />

staff<br />

Unsafe staffing level or<br />

competence (>5 days)<br />

Loss of key staff<br />

Very low staff morale<br />

No staff attending m<strong>and</strong>atory/<br />

key training<br />

Non-delivery of key<br />

objective/service due to lack of<br />

staff<br />

Ongoing unsafe staffing levels or<br />

competence<br />

Loss of several key staff<br />

No staff attending m<strong>and</strong>atory<br />

training /key training on an<br />

ongoing basis<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 34 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Statutory duty/ inspections<br />

Adverse publicity/ reputation<br />

Business objectives/ projects<br />

Finance including claims<br />

No or minimal impact or<br />

breech of guidance/<br />

statutory duty<br />

Rumours<br />

Potential for public concern<br />

Insignificant cost increase/<br />

schedule slippage<br />

Small loss Risk of claim<br />

remote<br />

Breech of statutory legislation<br />

Reduced performance rating if<br />

unresolved<br />

Local media coverage –<br />

short-term reduction in public<br />

confidence<br />

Elements of public expectation<br />

not being met<br />

25 per cent<br />

over project budget<br />

Schedule slippage<br />

Key objectives not met<br />

Non-delivery of key objective/<br />

Loss of >1 per cent of budget<br />

Failure to meet specification/<br />

slippage<br />

Loss of contract / payment by<br />

results<br />

Service/business interruption<br />

Environmental impact<br />

Loss/interruption of >1<br />

hour<br />

Minimal or no impact on<br />

the environment<br />

Loss/interruption of >8 hours<br />

Minor impact on environment<br />

Loss/interruption of >1 day<br />

Moderate impact on<br />

environment<br />

Loss/interruption of >1 week<br />

Major impact on environment<br />

Claim(s) >£1 million<br />

Permanent loss of service or<br />

facility<br />

Catastrophic impact on<br />

environment<br />

Likelihood Scoring table (L)<br />

Likelihood score 1 2 3 4 5<br />

Descriptor Rare Unlikely Possible Likely Almost certain<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 35 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Frequency<br />

How often might it/does it<br />

happen<br />

This will probably never<br />

happen/recur<br />

Do not expect it to happen/recur<br />

but it is possible it may do so<br />

Might happen or recur<br />

occasionally<br />

Will probably happen/recur but it<br />

is not a persisting issue<br />

Will undoubtedly<br />

happen/recur,possibly frequently<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 36 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


APPENDIX 2<br />

REPORTING STRUCTURE<br />

FOR RISK<br />

TRUST BOARD PUBLIC<br />

Quality <strong>and</strong> Strategy<br />

Committee<br />

Audit Committee<br />

Clinical Risk Management Committee<br />

(CRC)<br />

Statutory Safety Committee<br />

Safeguarding Children Committee<br />

(SCC)<br />

Safeguarding Adults Committee<br />

(SAC)<br />

Evidence Based Practice <strong>Board</strong><br />

(EBPC)<br />

Drugs <strong>and</strong> Therapeutic Committee<br />

(D&TC)<br />

Infection Control Committee<br />

(ICC)<br />

Clinical Audit Committee<br />

(CAC)<br />

Research & Development Committee<br />

(R&DC)<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 37 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Appendix 3<br />

Framework for Risk Management<br />

Self Assessment tool for Directorates/Departments<br />

Key Element Required Action Complaint<br />

Yes<br />

No<br />

N/A<br />

Leadership The Directorate/Department has a local clinical governance or risk<br />

management group which evaluates implementation of risk management<br />

systems <strong>and</strong> strategies <strong>and</strong> aggress service changes as necessary<br />

The Directorate group considers matters pertaining to risk management<br />

including incidents, complaints <strong>and</strong> claims<br />

There is an indentified lead for risk management who is part of the local<br />

clinical governance (or similar) group <strong>and</strong> whose remit includes sharing<br />

information <strong>and</strong> learning on incidents, complaints, claims <strong>and</strong> health <strong>and</strong><br />

safety<br />

The Clinical Directorate team provide the medical director with an annual<br />

governance report outlining their progress against directorate <strong>and</strong> corporate<br />

objectives<br />

Culture<br />

Accountability<br />

The Clinical Director receives copies of all relevant guidance including NICE<br />

guidelines <strong>and</strong> Centralised Alerting Systems (CAS) alerts, national<br />

confidential enquiries <strong>and</strong> ensures that appropriate action is instigated<br />

All leaders behave in a way which is consistent with <strong>and</strong> demonstrates<br />

commitment to being open <strong>and</strong> fair<br />

The Directorate identify areas of required improvement through both<br />

corporate <strong>and</strong> local risk management systems <strong>and</strong> implement appropriately<br />

Incidents, near misses <strong>and</strong> risks are regularly reported using the <strong>Trust</strong> Risk<br />

Management reporting system<br />

Incidents <strong>and</strong> near misses are investigated <strong>and</strong> analysed <strong>and</strong> where specific<br />

areas of learning are identified or changes to practice required appropriate<br />

action is taken<br />

Major Incident<br />

Planning<br />

Incident investigation to the level appropriate for severity (as per policy) <strong>and</strong><br />

final approval is undertaken within the agreed timescales<br />

The Directorate/Department managers are aware of the <strong>Trust</strong> Major Incident<br />

Plan<br />

The Directorate/Department managers are aware of their responsibilities in<br />

relation to the Major Incident Plan<br />

Business<br />

Continuity<br />

Management<br />

Strategy<br />

External<br />

Assessments<br />

Where relevant staff have received briefing/training on the Major Incident<br />

Plan <strong>and</strong> associated policies<br />

Directorate/Department Business Continuity plans are maintained<br />

The Directorate/Department teams participate in Business Continuity<br />

planning<br />

The Directorate/Department is aware of the objectives of the <strong>Trust</strong> Risk<br />

Management Policy <strong>and</strong> Strategy <strong>and</strong> has formulated a plane to enable these<br />

to be achieved locally<br />

The Directorate/Department has an action plan to meet local objectives<br />

related to risk management<br />

The Directorate/Department are aware of the safety <strong>and</strong> risk management<br />

st<strong>and</strong>ards as indentified by external agencies such as Care Quality<br />

Commission <strong>and</strong> NHS Litigation Authority<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 38 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


External Reporting<br />

Responsibility<br />

Induction<br />

Training<br />

Requirements <strong>and</strong> achievements against external assessments are<br />

communicated to all relevant staff<br />

Directorate/Department managers are aware of their responsibilities in<br />

relation to reporting incidents <strong>and</strong> near misses to external agencies<br />

All staff are aware of their responsibility in relation to risk management <strong>and</strong><br />

health <strong>and</strong> safety<br />

All permanent staff have attended the <strong>Trust</strong> corporate induction programme<br />

All staff including temporary staff <strong>and</strong> volunteers have completed the local<br />

induction process<br />

A training needs assessment is undertaken within the<br />

Directorate/Department on an annual basis<br />

There is a system for monitoring attendance at m<strong>and</strong>atory training <strong>and</strong> for<br />

following up those that fail to attend<br />

All permanent staff have completed the required m<strong>and</strong>atory training<br />

programme<br />

The Directorate/Department participates in the system for assessment <strong>and</strong><br />

training for medical equipment <strong>and</strong> devices<br />

Relevant staff have received training in risk management techniques such as<br />

risk assessment <strong>and</strong> root cause analysis<br />

Patient <strong>and</strong> Public<br />

Involvement<br />

Risk Assessment<br />

Relevant staff have received training in incident reporting <strong>and</strong> management<br />

of risk register<br />

There is patient information available to support patients to be guardians of<br />

their own safety<br />

Patients <strong>and</strong> where relevant carers are informed of incidents as per Being<br />

Open Policy<br />

The Directorate/Department have undertaken risk assessments <strong>and</strong> reported<br />

compliance with regards to health <strong>and</strong> safety<br />

Risk assessment of patient falls is undertaken buy nursing staff on<br />

admission, if clinical condition changes or at a minimum weekly<br />

Infection Control<br />

Risk assessment of VTE is undertaken by the doctors on each admission<br />

The <strong>Trust</strong> has a designated representative for infection control<br />

Infection control high risk areas have been identified <strong>and</strong> the<br />

Directorate/Department is working with Infection Control to minimise <strong>and</strong><br />

manage risk<br />

All relevant areas have access to infection control policies<br />

There is evidence that staff received appropriate training <strong>and</strong> updates in<br />

infection control issues<br />

There is a system for reporting, analysing <strong>and</strong> learning from serious incidents<br />

associated with infection control<br />

Each clinical team can demonstrate consistently high levels of compliance<br />

with the H<strong>and</strong> Hygiene Policy<br />

Medical Equipment<br />

<strong>and</strong> Devices<br />

The local cleaning arrangements are informed by <strong>Trust</strong> Infection policies<br />

The Directorate/Department is aware of the training in the use of Medical<br />

Devices Policy<br />

• Ensuring that all equipment used <strong>and</strong> is recorded on <strong>Trust</strong> inventory<br />

• Agreeing with individual members of staff which equipment from the<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 39 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


Risk Register<br />

inventory they are expected to use <strong>and</strong> process for training <strong>and</strong><br />

competency assessment, including frequency of updates<br />

• Ensuring that training is made available for all uses of devices where<br />

training is necessary <strong>and</strong> that all equipment users are properly<br />

trained <strong>and</strong> competent<br />

• Ensuring that users complete competency records for appropriate<br />

medical devices<br />

• Reviewing the inventory annually <strong>and</strong>/or when the new<br />

equipment/devices are introduced into their area of responsibility<br />

• Identifying training <strong>and</strong> assessment needs at appointment, local<br />

induction <strong>and</strong> as part of annual reviews<br />

The Directorate/Department has a Risk Register which is compiled <strong>and</strong> kept<br />

up to date by nominated trained staff following risk assessment <strong>and</strong> data<br />

from incidents, complaints <strong>and</strong> claims<br />

The Risk Register is reviewed <strong>and</strong> updated on an ongoing, live basis<br />

Where risks have been indentified, risk reduction measures are developed<br />

<strong>and</strong> included in action plans<br />

Medicines<br />

Management<br />

The Risk Register is linked to local business planning <strong>and</strong> service<br />

development <strong>and</strong> is assessed at each Directorates performance review<br />

All clinical areas are aware of the Procedure for the Prescribing, Recording<br />

<strong>and</strong> Administration of Medicines<br />

All medication errors are reviewed by a senior nurse, pharmacist <strong>and</strong>/or<br />

clinician<br />

All areas of non-compliance should be indentified on the Risk Register with<br />

appropriate controls, risk reduction measures <strong>and</strong> action plan<br />

Completed by …………………………………………<br />

Directorate/Department …………………………….<br />

Date ……………………………………………………<br />

Planned date of next review ……………………<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals NHS <strong>Trust</strong> Page 40 of 40<br />

????????????? ??/??/???? Version ?? Issued ????


EXECUTIVE SUMMARY<br />

TITLE:<br />

BOARD/GROUP/COMMITTEE:<br />

Quality <strong>and</strong> Patient St<strong>and</strong>ards Performance<br />

Report – September <strong>2012</strong><br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

The Quality <strong>and</strong> Patient St<strong>and</strong>ards Performance Report<br />

provides an analysis of performance against trust-wide<br />

<strong>and</strong> national targets for the following domains:<br />

• Patient Safety <strong>and</strong> Quality<br />

• Performance<br />

• Workforce<br />

• Productivity<br />

• Finance<br />

The following areas where monthly performance is of<br />

concern are discussed within the report:<br />

• Clostridium Difficile<br />

• MRSA<br />

• MRSA Screening – Emergency<br />

• MRSA Screening - Elective<br />

• Complaints not Responded To over 3 months old<br />

• Patients Assessed as Risk Free<br />

• Elective <strong>and</strong> Non-elective Re-admissions


2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to note the content of the report<br />

<strong>and</strong> support the actions to bring the performance back in<br />

line with trajectory/target.<br />

NATIONAL TARGET □ CNST<br />

□ CQC REGISTRATION □ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR: Claire Burns, Head of Planning, Commissioning<br />

<strong>and</strong> Information<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Not applicable.<br />

PRESENTER: Neill Moloney, Director of Performance <strong>and</strong><br />

Planning<br />

DATE: Oct <strong>2012</strong><br />

4. DELIVERABLES<br />

The delivery of the <strong>Trust</strong> wide objectives.<br />

5. KEY PERFORMANCE INDICATORS<br />

Please see attached <strong>Trust</strong> Performance Dashboard.<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2


Performance Report<br />

September <strong>2012</strong><br />

Performance Indicators - Exception Report<br />

1. Introduction<br />

This report provides the <strong>Board</strong> with an overview of mitigating actions identified by the Business<br />

Units to improve performance such that it brings it back into line with target. Finance <strong>and</strong> Human<br />

Resources performance are subject to separate reports to the <strong>Trust</strong> <strong>Board</strong>.<br />

2. Patient Safety <strong>and</strong> Quality<br />

MRSA bacteraemia –.2 MRSA bacteraemia were reported this month, both of which were found<br />

to be deep seated infections related to septic arthritis. One patient had this in multiple sites <strong>and</strong><br />

for the other patient only in the shoulder. On investigation some clinical practice issues were<br />

identified which are now being addressed.<br />

The New Director of Infection Prevention <strong>and</strong> Control is now in post. There is a change of focus<br />

to infection prevention <strong>and</strong> the current action plan is being reviewed to identify the high impact<br />

actions, one of which is ANTT.<br />

ANTT has been introduced across the <strong>Trust</strong> <strong>and</strong> to date 60% of Matrons <strong>and</strong> 72% of senior<br />

sisters have achieved Train the Trainer competencies. These staff will now roll out the training<br />

across the wards. New h<strong>and</strong> washing campaigns <strong>and</strong> training programmes introduced. Training<br />

for doctors has commenced for FY1/2s, Consultants <strong>and</strong> is being planned for staff grades.<br />

Clostridium difficile infection – There were 7 cases of infection reported during September,<br />

none of the patients acquiring the infection occurred as a result of cross contamination. No<br />

primary cause was identified for the infection on Heather ward but the ward has been required to<br />

produce an action plan to address the issues highlighted by the Infection Control team<br />

investigation of the infection. The Infection Control Committee will monitor the ward’s progress<br />

against this action plan.<br />

MRSA screening – Elective<br />

A number of actions have been identified to improve performance to ensure delivery of this<br />

st<strong>and</strong>ard. These include:<br />

• A review of the pathway for<br />

patients who go straight to a<br />

procedure without attending a preadmission<br />

clinic to ensure that<br />

these patients are swabbed prior to<br />

admission. This pathway will be<br />

implemented from October <strong>and</strong> so<br />

will improve performance during<br />

December <strong>2012</strong> <strong>and</strong> reported to<br />

the <strong>Board</strong> in January 2013.<br />

Page 1 of 8


• A review of data capture to ensure that all swabs are matched correctly to admissions –<br />

this will be completed in September <strong>and</strong> therefore will be shown in the performance at the<br />

<strong>November</strong> <strong>Board</strong> meeting.<br />

• Training of Admissions Team Leader on data accuracy, which will improve data quality<br />

when patients are added to waiting list <strong>and</strong> thereby improve coverage of data for MRSA<br />

elective screening; this will be completed in September <strong>and</strong> therefore will be shown in the<br />

performance at the <strong>November</strong> <strong>Board</strong> meeting.<br />

MRSA screening – Emergency. A number of actions have been identified to improve<br />

performance to ensure delivery of the st<strong>and</strong>ard for September. These include:<br />

• A change of process in the<br />

Emergency Day Unit (EMDU) to<br />

screen patients who currently do<br />

not qualify for screening was<br />

implemented in September <strong>and</strong><br />

will be demonstrated in the data<br />

received at the <strong>November</strong> <strong>Board</strong><br />

Meeting.<br />

• Using the ward board rounds to<br />

check patents have been<br />

screened. The Ward Sponsors<br />

will work with the wards to<br />

ensure that screening takes place.<br />

• Staff to be reminded to write legibly on test requests to ensure that the Lab is able to<br />

identify which patient the swabs have come from. This error will be addressed by the roll<br />

out of order communications for Pathology in December <strong>2012</strong>, <strong>and</strong> will be reflected in the<br />

performance reported to the <strong>Board</strong> in January 2013.<br />

• Review of the data to ensure patients who do not require screening are excluded from the<br />

data. This will be completed in October <strong>and</strong> therefore will be shown in the performance at<br />

the <strong>November</strong> <strong>Board</strong>.<br />

Number of complaints not yet responded to over 3 months old - The number of complaints<br />

over 3 months old has reduced from 55 last month to 53 this month, this figure includes both new<br />

<strong>and</strong> reactivated complaints. The Complaints Team continue to agree a closure timescale for a<br />

formal response with each complainant. Extending an agreed response date can now only be<br />

agreed either by an Executive Director or an Associate Director. In order to ensure there is a<br />

clear line of responsibility for responding to complaints during October the complaints h<strong>and</strong>ling<br />

process will be re-launched via Associate Directors, who will cascade the procedure down to<br />

General <strong>and</strong> Services Managers. In addition the Medicine Directorate is piloting a new tracking<br />

process to identify earlier issues which may prevent the timely resolution of a complaint. If<br />

successful the process will be rolled out across the <strong>Trust</strong>.<br />

Page 2 of 8


% Patients assessed as risk free - This indicator measure the % of patients free from the four<br />

harms of 1.Venous Thromboembolism (VTE),<br />

2.category 3 <strong>and</strong> 4 pressure ulcers, 3.catheter<br />

associated urinary tract infections (CAUTI) <strong>and</strong><br />

4. falls resulting in harm.<br />

The main areas of concern within the trust remain<br />

pressure ulcers <strong>and</strong> falls. These are being<br />

addressed by the relevant action plans <strong>and</strong><br />

significant progress has been made. More<br />

detailed analysis is now being undertaken as six<br />

months data is now available to identify where the<br />

trends for harm are occurring from both a community <strong>and</strong> hospital perspective.<br />

Re-admissions Elective <strong>and</strong> Emergency


Pilot Wards<br />

Division<br />

Discharges<br />

Per<br />

Ward<br />

Surveys<br />

ompleted<br />

%<br />

ompleted<br />

Surveys<br />

NPS Score<br />

Bluebell B Medicine 62 17 27.4 68<br />

Ocean A Surgery 48 35 72.9 23<br />

Coral Ward Maternity 185 137 74.1 47<br />

Cornflower B Women 109 16 14.7 6<br />

Pilot Ward Totals 404 205 50.7% 31<br />

Following evaluation of the pilot the paper based survey will, during October, be rolled out across<br />

all wards areas <strong>and</strong> A&E<br />

Same sex breaches –.There were 13 single sex breaches for the month of September <strong>2012</strong>.<br />

These occurred within the High Dependency Unit (9), Intensive Therapy Unit (3), <strong>and</strong> Coronary<br />

Care Unit (1) at Queen’s Hospital. This is an improvement from August position when 18 single<br />

sex breaches were reported.<br />

All of the breaches occurred due to delays in the<br />

transfer out of patients who had been ‘stepped<br />

down’ to general care. This was due to<br />

constraints on the availability of suitable beds<br />

for ‘step down’ due to patient flow delays across<br />

the organisation. A root cause analysis on all<br />

patients who breach will commence on the 1 st<br />

October <strong>2012</strong>.<br />

The Deputy Director of Nursing has received<br />

feedback from a number of patients who<br />

breached in September who were interviewed following the breach <strong>and</strong> they confirmed that the<br />

reason for the breach was explained to them <strong>and</strong> that their privacy <strong>and</strong> dignity was maintained<br />

during this period of their care.<br />

Page 4 of 8


3. Performance<br />

Referral to treatment – delivery in all specialties Specialties continue to fail on the<br />

admitted RTT pathway. The <strong>Trust</strong> has not been commissioned to deliver RTT by<br />

specialty in <strong>2012</strong>/13 but is required to meet the target as a cumulative performance.<br />

Discussions have commenced with Commissioners regarding the approach in 2013/14.<br />

The <strong>Trust</strong> requires an early decision as to whether specialty performance will be<br />

purchased as this will require an additional investment in 2013/14 over <strong>and</strong> above that<br />

already agreed as specialty backlog will need to be cleared. A scoping exercise is<br />

currently under way.<br />

Cancer - 62 days urgent RTT from hospital specialist – this is an in-month problem due to<br />

the small number of patients who are affected. The year to date performance is 88.6% for<br />

this measure against an 85% target. Three patients breached the st<strong>and</strong>ard in the month<br />

<strong>and</strong> these were complex clinical cases.<br />

Four hour wait in A&E – in September the <strong>Trust</strong> failed to meet the 95% st<strong>and</strong>ard <strong>and</strong> has<br />

deteriorated from the August performance. The <strong>Trust</strong> achieved <strong>Trust</strong> 89.37% with Queens at<br />

85.14 <strong>and</strong> KGH at 95.79%<br />

% of patients referred to specialist team < 2hours of registration - the percentage of patients<br />

waiting more than 2hrs from registration to referral has remained the same. Daily performance<br />

information is shared with Emergency Department senior staff with peer challenge of decision<br />

making to identify alternatives to referrals by using care pathways such as ambulatory care /<br />

virtual ward.<br />

% Patients seen by speciality team within less than 30 minutes of request – the percentage<br />

of patients seen by specialty teams within 30 minutes has deteriorated in September. Any that<br />

occur are fed back daily to the specialties concerned to discuss with their teams with feedback<br />

requested at the daily bed meetings.<br />

Number of ambulance black breaches - there were 14 black breaches in September all of<br />

which occurred during the week beginning 17th September. Full Serious Incident investigations<br />

were undertaken for each patient <strong>and</strong> in the main these breaches were caused by lack of bed<br />

availability. The extended Rapid Assessment <strong>and</strong> Treatment area will be completed by the end of<br />

<strong>November</strong> <strong>and</strong> will improve offload times <strong>and</strong> support a reduction in the number of black<br />

breaches.<br />

Page 5 of 8


Workforce<br />

Appraisals – the actions included in last month’s report have not improved performance – the<br />

performance has deteriorated from last month. Business Units have been asked to provide plans<br />

showing dates for all outst<strong>and</strong>ing appraisals <strong>and</strong> the forward plan for appraisals that will be due in<br />

the coming months.<br />

Basic life support training (BLS) – Resuscitation training compliance for this month is 75.09%.<br />

This is the same overall compliance rate as last month. Uptake on all advertised resuscitation<br />

training sessions has increased slightly since last month’s report. Monthly compliance reports<br />

continue to be sent to the Business Units to highlight those staff that still need to book onto a<br />

training session. Projected overall compliance for the year end (December 31 st <strong>2012</strong>) is estimated<br />

at 80.17%, based on bookings already made. This would be a slight improvement on the same<br />

time last year when compliance stood at 72.15%.<br />

Page 6 of 8


4. Productivity<br />

Length of stay (LOS) – elective <strong>and</strong> non-elective.<br />

Non elective LoS has increased slightly in September <strong>and</strong> Elective had decreased (including<br />

<strong>and</strong> excluding 0 days). The reason for this is considered to be due to the closure of Foxglove<br />

ward resulting in medical wards keeping their patients on the main wards <strong>and</strong> discharging<br />

straight patients from there (Foxglove was a step-down ward). The LoS work-stream<br />

continues to focus on three main areas of delay:<br />

• Therapy input<br />

• Discharge paperwork<br />

• Family disputes<br />

This work has enabled Foxglove to close <strong>and</strong> also gradually reduce the medical outliers.<br />

Other key actions in month were:<br />

• Care of Elderly in-reach senior consultant cover is provided within the Acute<br />

Medicine Unit to further support the Care of Elderly admissions <strong>and</strong> expedite<br />

discharges.<br />

• 7 day Cardiology rota implemented<br />

• 7 day Consultant model agreed to start beginning <strong>November</strong>.<br />

Page 7 of 8


Delayed transfers of care (DTOC) - The closure of Foxglove ward has necessitated greater<br />

focus on complex discharge support <strong>and</strong> to that<br />

end a rotational training programme has been<br />

implemented to improve the timeliness of this<br />

process. As yet there has not been a matching<br />

decrease in LoS due to DTOC patients remaining<br />

on their base wards but as outliers reduce this is<br />

expected to follow. This work has been<br />

implemented as part of the Ernest & Young Cost<br />

Improvement Plan (CIP) work-streams with the<br />

outcomes now business as usual.<br />

The 7 day Consultant ward cover starts at the beginning of <strong>November</strong> <strong>and</strong> this is expected to<br />

support a reduction in DTOC by more timely completion of the medical reports required for<br />

discharge. In order to improve the discharge interface across the whole health economy the <strong>Trust</strong><br />

is working in partnership with the local Boroughs <strong>and</strong> Community Services, facilitated by<br />

McKinsey, to reduce h<strong>and</strong>over delays.<br />

% Patients discharges between 6am <strong>and</strong> 11am - these have reduced slightly from August.<br />

This measure is to ensure availability of beds <strong>and</strong> there has also been work undertaken to reduce<br />

the discharges between 6am <strong>and</strong> 11am.<br />

Goal directed fluid therapy (GDFT) for planned colorectal <strong>and</strong> emergency abdominal<br />

patients –To increase performance the follow actions are being taken:<br />

When reviewing the notes to identify when the GDFT method has been used the Enhanced<br />

Recovery Program (ERP) Facilitator will escalate to the General Manager <strong>and</strong> Lead Anaesthetist<br />

immediately where this is not the case. Performance in emergency has increased from 33% to<br />

57% but the elective pathway has deteriorated. This was raised at the recent audit meeting where<br />

it was agreed that the profile of GDFT needed to be raised further within the <strong>Trust</strong>.<br />

DNA rates for first <strong>and</strong> follow-up appointments –<br />

The trust is carrying out three key projects to reduce DNA rates. They are:<br />

• The text reminder service<br />

• Phoning patients who have DNA’d to underst<strong>and</strong> why they did not attend the appointment.<br />

• Exploring additional approaches for appointment reminders<br />

Page 8 of 8


Patient Safety <strong>and</strong> Quality<br />

July Aug Sept Target red July Aug Sept Target red July Aug Sept Target Red<br />

Reducing hospital mortality<br />

SHMI ‐ quarterly December 11 95.96<br />

93.92 95.00 % untreated waiting less than 18 weeks 92.70% 92.10% 92.60% 92% 87% LOS (Elective) 3.15 3.31 3.01 3.1 3.48<br />

% emergency admitted patients review by<br />

senior clinician within 12 hours ND ND ND 95% 94% RTT admitted in 18 weeks 91.20% 90.50% 90.40% 90% 85% LOS (Non‐Elective) 5.13 5.02 5.22 4.454 5.05<br />

% emergency admitted patients review by<br />

consultant within 12 hours ND ND ND 95% 94% RTT non‐admitted in 18 weeks 99.50% 98.90% 98.50% 95% 90% LOS (Elective‐ excluding 0 LOS) 3.62 3.78 3.53 3.5 3.92<br />

Maternal Death Rate per 100000 ( rolling 12<br />

m) 32.36 21.66 21.73 TBA TBA RTT not delivered in all specialties 9 6 7 0 >20 LOS (Non‐ Elective‐excluding 0 LOS) 6.36 6.27 6.41 5.8 6.53<br />

% Day case rate ‐ All 88% 90% 88% 80% 75%<br />

Serious Untoward Incidents<br />

Cancer<br />

DTOC 4.69 5.54 4.18 3.50% 5.00%<br />

Number 13 23 18 18 19 2 Wk. % seen all urgent refs & ref for breast* 98.8% 95.3% 94.4% 93% 88% admissions on day of surgery 86.04 94.44 93.83 85% 80%<br />

% reported within 48Hours ‐ quarterly 64%<br />

50% 49% 2 Wk. GP RefTo 1st OP for susp cancer* 99.5% 99.5% 98.4% 93% 88% % patients discharged between 6 am <strong>and</strong> 11 am 11% 13.18% 11.12% 50% 30%<br />

2 Wk GP Ref To 1st OP for breast symptoms* 94.3% 98.9% 97.9% 93% 88%<br />

Infection Control<br />

31 Day 2nd Or Subs Treatment ‐ Surgery* 100.0% 100.0% 100.0% 94% 89%<br />

Enhanced Recovery<br />

MRSA Bacteraemia 6 YTD<br />

6 7 31 Day 2nd Or Subs Treatment ‐ Drug* 100.0% 100.0% 100.0% 98% 93%<br />

% patients with an ERP code entered onto the national<br />

database* 86% 74% 99% 95% 95%<br />

C Diff Infection 37YTD<br />

59 60 31 Day DTT for all cancers* 97.5% 100.0% 99.5% 96% 91% % planned colorectal having GDFT* 57% 78% 37% 80% 80%<br />

MRSA Elective Screening 78% 79% 84% 95% 86% 62 Day RTT From Cancer Screening** 100.0% 90.9% 100.0% 90% 85% % emergency abdominal patients having GDFT* 33% 33% 57% 80% 80%<br />

MRSA Emergency Screening 77% 75% 79% 95% 86% 62 Days ‐ treated from referral ** 88.5% 84.1% 91.4% 86% 80% *one month in arrears * JUNE , JULY <strong>and</strong> AUG data reported<br />

62 Day RTT From Hosp Specialist** 100.0% 100.0% 77.8% 85% 80%<br />

Outpatients<br />

Complaints<br />

62 Days Urgent RTT of all cancers** 88.2% 82.0% 91.5% 85% 80% FFU Ratio 2.13 2.08 2.06 2.16 2.20<br />

% complaints responded to in line with<br />

agreement with patients 87.00% 86.00% 95.00% 80% 79% 31 Day Subs Treatment ‐ Radiotherapy* 100.0% 100.0% 100.0% 94% 89% DNA First 9.83% 9.42% 10.12% 5.00% 5.50%<br />

number of complaints not yet responded to<br />

over 3 months old 18 42 53 TBA TBA * fully validated data provided one month in arrears ** JUNE , JULY <strong>and</strong> AUG data reported DNA Follow‐Up 10.58% 10.58% 10.84% 5.00% 5.50%<br />

Dementia<br />

% patients aged over 75% having a mental<br />

test score 55% 60% 78% 50% 49%<br />

Performance<br />

Referral to Treatment<br />

A&E<br />

Productivity<br />

Four‐Hour Maximum Wait In A&E 92.26% 94.59% 89.37% 95% 94%<br />

Finance<br />

Percentage of patients referred to speciality team<br />


EXECUTIVE SUMMARY<br />

TITLE:<br />

Emergency Care Report<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

• To advise <strong>Trust</strong> <strong>Board</strong> of the<br />

improvements in the Emergency Care<br />

Pathway<br />

• To advise <strong>Trust</strong> <strong>Board</strong> of the Emergency<br />

Access performance<br />

• To advise <strong>Trust</strong> <strong>Board</strong> of the action plan<br />

to sustain improved performance<br />

2. DECISION REQUIRED: CATEGORY:<br />

PEQ……….…...…….<br />

□ STRATEGY……….….…….<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

□ CLINICAL GOVERNANCE …………..………….....……<br />

□ CHARITABLE FUNDS ………………………………...…<br />

□ TRUST BOARD<br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

None<br />

NATIONAL TARGET<br />

□ CQC REGISTRATION<br />

□ CNST<br />

□ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR: Shelagh Smith/Claire Dixon<br />

PRESENTER: Dorothy Hosein<br />

DATE: 16 th October <strong>2012</strong><br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Reduction in temporary staff<br />

4. DELIVERABLES<br />

Improved ED access performance<br />

Improved quality of care<br />

Reduction in the use of temporary staff<br />

5. KEY PERFORMANCE INDICATORS<br />

ED access target<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


Performance for September<br />

Emergency Care Pathway Report<br />

Four Hour Maximum wait in ED<br />

In September the <strong>Trust</strong> failed to meet the 95% st<strong>and</strong>ard <strong>and</strong> has deteriorated from August. The <strong>Trust</strong> achieved <strong>Trust</strong> 89.37% with Queens at 85.14 <strong>and</strong> KGH at<br />

95.79%<br />

Ambulance Offload Times<br />

There were 14 black breaches in September all of which occurred during the week beginning 17 th September. Full SI investigations have been done for each patient<br />

<strong>and</strong> in the main these were caused by lack of bed availability during that week.<br />

Urgent Care Workstream<br />

A significant amount of work has been undertaken within the UCC <strong>and</strong> the number of breaches in the UCC in August was 4 this is a significant improvement form the<br />

July figure of 174.<br />

Additional actions are being taken <strong>and</strong> monitored with the Director of Transformation as part of the ongoing action plan for the RESET sustainability programme.<br />

These are:<br />

1. Implemented ED Actions<br />

1.1 Daily Performance Management<br />

• ED breaches are discussed daily with the ED doctors involved to review if alternative management plans could have been taken <strong>and</strong> provide educational feedback to<br />

prevent reoccurrence.<br />

• Specialty breaches have reduced <strong>and</strong> any that occur are fed back to the specialties concerned to discuss with their teams.<br />

• Daily performance information is shared with ED seniors both nursing <strong>and</strong> consultants to identify trends <strong>and</strong> agree actions to prevent reoccurrence.<br />

• Daily peer challenge of decision making at board rounds <strong>and</strong> identifying alternatives to referrals by using alternative care pathways such as ambulatory care / virtual<br />

ward is completed.<br />

• Daily productivity monitoring is completed by consultants <strong>and</strong> performance issues are fedback to juniors<br />

1.2 ED Workforce Actions<br />

• Recruitment of doctor’s ongoing, SHOs <strong>and</strong> middle grades appointed last week.<br />

• Paediatric ED consultant post advertised <strong>and</strong> General ED consultant in progress for advertising.<br />

• Review of Senior Medical Cover on the Weekends has been undertaken <strong>and</strong> additional middle grade shift has been implemented as a trial for Saturday <strong>and</strong> Sunday<br />

• Clinical Nurse Director in post in Emergency Care<br />

• Review of KGH nursing workforce has been undertaken by the Clinical Nurse Director<br />

• Review of Paediatric workforce to be commenced<br />

• Review of RAT nursing workforce to be undertaken<br />

• Competency skillset has been completed for OIC role, training to be developed with a plan to implement by mid-<strong>November</strong><br />

1


• Training competencies are being reviewed for all roles in the department to ensure that all staff have clear responsibilities <strong>and</strong> competencies to undertake that role.<br />

This work is being led by the Clinical Nurse Director with support from the Matrons.<br />

2. Implemented Acute Medicine Unit Actions<br />

• Additional senior consultant cover is provided to further support the General Medicine junior on call team in ED <strong>and</strong> to support the team to look at alternatives to<br />

admissions.<br />

• Re-launch to the <strong>Trust</strong> of the Ambulatory Care / Virtual Ward referral route is being completed<br />

• Continued focus on Category B discharges<br />

• GP calls diverted to KGH daily<br />

3. Implemented General Medicine Actions<br />

• Care of Elderly in reach senior consultant cover is provided within the Acute Medicine Unit to further support the Care of Elderly admissions <strong>and</strong> expedite discharges.<br />

• 7 day Cardiology rota implemented<br />

4. ED Quality Improvements:<br />

• Patient information leaflet explaining the process of the ED is being drafted which will include a feedback section. This will enable direct feedback to the staff that<br />

cared for the patient.<br />

• Trend information on complaints is being collated to further support feedback to all staff<br />

• Customer service competency checklist is being developed to provide staff with additional training to support improvements in communication skills<br />

5. Enablers to support fundamental changes:<br />

5.1 Estates at QH<br />

• Improvements in the RAT area at QH to be operational by mid-<strong>November</strong> will improve <strong>and</strong> sustain the ambulance h<strong>and</strong>over performance times <strong>and</strong> provide rapid<br />

assessment <strong>and</strong> treatment for all patients including walk in patients.<br />

• Expediting the redesign of the ‘Majors’ area as per the new designs would facilitate further improvements in the flow in majors in conjunction with the new RAT model<br />

<strong>and</strong> ensure an improved patients experience.<br />

• Expediting the expansion of the Resuscitation Room is crucial to ensure that the ED critical care capacity matches the current dem<strong>and</strong>, therefore enabling the staff to<br />

provide improved quality or care <strong>and</strong> ensure patients receive appropriate care in a timely fashion.<br />

• Expediting the redesign of the UCC / minors area would enhance the current service improvements in patient flow.<br />

5.2 Reconfiguration<br />

• Closure of KGH to acute admissions would enable 7 day working for Acute <strong>and</strong> General Medicine<br />

5.3 Organisation Development<br />

• There has been a high turnover of ED nurse staffing over the last 12 months (45%) a clear recruitment <strong>and</strong> retention plan is underway <strong>and</strong> recruitment has improved.<br />

• It is difficult to recruit medical staff to ED therefore in order to avoid agency staff higher salaries should be available to complete with local organisations.<br />

2


3<br />

5.4 Key actions to be delivered<br />

• Implement redesigned medical rotas<br />

• Bed Management review<br />

• Ward reviews to commence<br />

• 7 day working across the <strong>Trust</strong> including support services<br />

• Reducing Length of Stay by working with partner organisations <strong>and</strong> families to reduce length of stay<br />

• Improve communication with partner organisation to expedite discharges <strong>and</strong> forward planning to meet dem<strong>and</strong>


Appendix A: Trajectory for all type performance for <strong>Trust</strong> <strong>and</strong> by site<br />

Monthly plan Monthly actuals Quarterly plan Quarterly actuals<br />

Month QH KGH <strong>Trust</strong> QH KGH <strong>Trust</strong> QH KGH <strong>Trust</strong> QH KGH <strong>Trust</strong><br />

No. of Black<br />

Breaches<br />

April 77.50% 88.39% 79.50% 77.49% 92.92% 83.90% 55<br />

May 84.63% 93.17% 87.49% 85.71% 94.75% 89.49% 3<br />

June 89.26% 89.26% 89.26% 87.99% 95.77% 91.26% 84.44% 90.42% 85.93% 83.82% 94.51% 88.29% 15<br />

July 89.30% 96.50% 92.90% 88.42% 97.36% 92.26% 0<br />

August 92.50% 97.50% 95.00% 92.96% 97.14% 94.51% 0<br />

September 93.00% 97.00% 95.00% 85.14% 95.79% 89.37% 92.20% 96.33% 94.30% 88.97% 96.76% 92.07% 14<br />

October 95.00% 95.00% 95.00%<br />

<strong>November</strong> 95.00% 95.00% 95.00%<br />

December 95.00% 95.00% 95.00% 95.00% 95.00% 95.00%<br />

January 95.00% 95.00% 95.00%<br />

February 95.00% 95.00% 95.00%<br />

March 95.00% 95.00% 95.00% 95.00% 95.00% 95.00%<br />

4


EXECUTIVE SUMMARY<br />

TITLE:<br />

Maternity Update – September <strong>2012</strong><br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong><br />

DATE:<br />

The purpose of this report is to provide the <strong>Trust</strong><br />

<strong>Board</strong> with an update on the monthly performance<br />

for maternity services <strong>and</strong> other key issues.<br />

The key areas to note are:<br />

• Births continue to be high at 781 <strong>and</strong> are<br />

red on the maternity dashboard.<br />

• The escalation policy was implemented<br />

once in September.<br />

• 88% of women were seen in the triage by<br />

a doctor within 30 minutes, in hours.<br />

• Out of hours triage achieved 57% however<br />

the data collection is not robust. A new<br />

Proforma has been devised <strong>and</strong><br />

implemented. Early results are showing<br />

significant improvements.<br />

• The OAU achieved 95%.<br />

• Women continue to be booked for delivery<br />

at Bart’s Health to reduce activity at<br />

BHRUT. The impact of this will commence<br />

in late <strong>November</strong> <strong>2012</strong>.<br />

• A caseload transfer of women is likely to<br />

occur in <strong>November</strong> <strong>2012</strong>, the impact of this<br />

on the deliveries will be in February 2013.<br />

• A formal consultation on TUPE of staff has<br />

commenced <strong>and</strong> will finish on 24 th October<br />

<strong>2012</strong>. It is anticipated that 11 wte staff will<br />

TUPE to Barts Health<br />

• NELC are undertaking an assurance<br />

review on 22 nd October <strong>2012</strong> to assess<br />

readiness for reduction in capacity,<br />

opening of QBC <strong>and</strong> closure of KGH<br />

• Full recruitment of midwives for Queen’s<br />

Birth Centre has taken place. The staff are<br />

competent <strong>and</strong> trained.<br />

• Discussions with Deanery continue with<br />

regard to timing of closure of KGH<br />

• Births are to be reduced to 8000 2013/14<br />

• There were 2 SI’s reported SI’s in<br />

September Full RCA are being<br />

undertaken.<br />

• Discussions have taken place with NELC<br />

as to the future structure of the<br />

performance report. The assurance<br />

framework, maternity dashboard <strong>and</strong><br />

exemption report will now replace the<br />

monthly reporting template The Directorate<br />

□ TEC …….….. □ STRATEGY…….…….<br />

□ FINANCE …… □ AUDIT ………………<br />

□ QUALITY & STRATEGY ………….....……<br />

□ CHARITABLE FUNDS …………………...…<br />

□ TRUST BOARD ………………….………….<br />

□ REMUNERATION …………………….…...<br />

□ OTHER …………………………..…….<br />

(please specify)


would welcome feedback from the <strong>Trust</strong><br />

<strong>Board</strong> as to whether they would want to<br />

adopt a similar approach. Weekly reporting<br />

continues.<br />

• Maternity Modernisation <strong>Board</strong> inaugural<br />

meeting to be held in October <strong>2012</strong><br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Board</strong> are asked to note the content of the<br />

report <strong>and</strong> feedback comments on replacing the<br />

monthly reporting with assurance framework,<br />

maternity dashboard <strong>and</strong> exemption report.<br />

□ NATIONAL TARGET<br />

□ RMS<br />

□ CQC REGISTRATION □ HEALTH &<br />

SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM<br />

COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………....<br />

□ OTHER ……………….. (please specify)<br />

AUTHOR/PRESENTER: W Matthews<br />

Presenter:<br />

DATE: 30 th September <strong>2012</strong><br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

N/A<br />

4. DELIVERABLES<br />

Maternity Dashboard, Monthly meeting with NELC.<br />

5. KEY PERFORMANCE INDICATORS<br />

98% of women seen within 15 minutes of arrival within Triage<br />

98% of women seen within an hour of referral to an obstetrician within the obstetric assessment<br />

unit.<br />

All emergency LSCS performed within the graded time allocated.<br />

AGREED AT ______________________<br />

MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________<br />

2


<strong>Barking</strong>, <strong>Havering</strong> <strong>and</strong> Redbridge University Hospitals NHS <strong>Trust</strong><br />

Source<br />

Responsibility On Target<br />

Target<br />

Of<br />

Concern<br />

Q1 12/13 Q2 12/13<br />

Q3 12/13<br />

Q4 12/13<br />

Action<br />

Required Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13<br />

Maternity Quality <strong>and</strong> Safety Committee attendance<br />

Number of guidelines over due for review<br />

SI's- declared with care service problems <strong>and</strong> contributory factors<br />

S.I panel meeting within 4 days<br />

No of S.I submitted within required time frame<br />

Improved patient satisfaction- 50% of women surveyed<br />

Complaints<br />

CNST JP Quorate<br />

Not<br />

Quorate Quorate Quorate Quorate Quorate Quorate Quorate<br />

CNST CH 5 10 0 25 19 16 10 12<br />

CQUINN JP 0 3 5 5 3 6 2/5 6 / 11 0/2<br />

CQUINN JP 95% 90% 50% 3 7 4/5 11 / 11 2/2<br />

CQUINN JP 75% 60% 55% 0 7 2/5 5 / 13* 9/9<br />

CQUINN WM 50% 40% 30% NA NA NA NA NA 70%<br />

TRUST SL 10 2 5 3 7 8 4<br />

Activity<br />

Workforce<br />

Births Benchmarked to 8,700<br />

KPI SL 710 730 766 667 802 782 823 804 781<br />

Births in acute Queens LW setting<br />

KPI SL 540 560 580 516 605 591 641 636 617<br />

Births taking place at KGH<br />

KPI SL 165 175 185 136 175 166 160 167 147<br />

Midwife led unit (10%) of births<br />

KPI SL 70 75 80 NA NA NA NA NA NA<br />

Homebirths<br />

KPI SL 2% 1% 0.50% 1.00% 1% 1.50% 0.85% 1.30% 1.10%<br />

No of referrals received<br />

KPI SE 741 929(86) 1123(69) 985(66) 1136(59) 869(62) 943(84)<br />

No of referrals received by 10 weeks <strong>and</strong> 6 days<br />

KPI SE 720 769 621 590 726 521<br />

No: of women booked before 12 weeks <strong>and</strong> 6 days<br />

KPI SE 90% 85-90%


Maternity Services Monthly Performance Report<br />

<strong>Trust</strong> Name<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals<br />

NHS <strong>Trust</strong><br />

Reporting month<br />

This report covers the period:<br />

1 st September to 30 th September <strong>2012</strong><br />

Completed by<br />

Mr Dele Olorunshola<br />

Clinical Director of Obstetrics, Gynaecology <strong>and</strong><br />

Sexual Health<br />

Wendy Matthews, Director of Midwifery<br />

Reviewed by<br />

Dorothy Hosein, Director of Transformation<br />

On behalf of<br />

Director of Nursing<br />

Neill Moloney<br />

Director of Planning & Performance<br />

Contact Details<br />

<strong>Barking</strong>, <strong>Havering</strong> & Redbridge University Hospitals<br />

NHS <strong>Trust</strong><br />

1st Floor Green Zone<br />

Maternity Services, Queens Hospital<br />

Rom Valley Way, Romford, RM7 0AG<br />

Tel: 01708 435 000 x 3894<br />

A monthly report will be provided to; monitor the progress made against the maternity services<br />

improvement plan, provide assurance that the safety <strong>and</strong> quality of maternity services are<br />

improving within BHRUT. It will summarise the themes <strong>and</strong> actions that have arisen from the<br />

analysis of activity within the unit.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 1 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

1


1. Introduction<br />

The purpose of this report is to summarise the progress made in September <strong>2012</strong> against the<br />

maternity service improvement plan <strong>and</strong> the KPIs outlined in the maternity service specification as<br />

agreed with NELC.<br />

2. Total Number of Births at BHRUT for September <strong>2012</strong><br />

KGH Queens BHRUT (%)<br />

Elective CS 14 53 67<br />

Emergency CS 26 113 139<br />

Others 107 451 558<br />

Total 147 617 764<br />

9%<br />

18%<br />

73%<br />

* There were 17 births outside of the unit, registered as BBA <strong>and</strong> homebirths. Total birth rate for<br />

the <strong>Trust</strong> including outside deliveries is 781.<br />

3. Monthly Activity (excluding elective LSCS)<br />

Monthly Hospital Delivery Activity<br />

800<br />

700<br />

600<br />

500<br />

400<br />

300<br />

Queens<br />

Optimum QH<br />

KGH<br />

Optimum KGH<br />

200<br />

100<br />

May Jun Jul Aug Sep<br />

Month<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 2 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

2


4. Capping<br />

The maternity service is no longer subject to capping births as BHRUT have moved towards business<br />

as usual. The service continues to use internal escalation <strong>and</strong> conforms to the pan London escalation<br />

policy.<br />

Discussions are underway with the commissioners to cap maternity bookings to ensure that births<br />

reduce to 8000 by 2013/14<br />

5. Diverts<br />

Diverts occur when the number of labouring women accessing the service is greater than the service<br />

can deal with without compromising care. The <strong>Trust</strong> has moved to the pan London escalation policy<br />

since the lifting of restrictions in early June. In these instances, women are diverted to the nearest<br />

accepting unit unless their clinical presentation indicates that transfer to another provider would pose a<br />

greater risk. Since the lift of the cap, diverts are recorded based on a 24 hour clock (i.e. 0000 – 2400)<br />

<strong>and</strong> not between the hours of 18:00 - 18:00 as was the case previously.<br />

The divert policy was activated once across the <strong>Trust</strong> during the month of September. However, no<br />

women were actually diverted. On that occasion there were no other hospitals that could accept<br />

women from BHRUT which increased the risk at Queen’s Hospital.<br />

6. Triage<br />

The st<strong>and</strong>ard is that 98% of women should be seen by a midwife within 30 minutes of arrival at<br />

triage. In September, 1014 women accessed the Triage service at Queen’s. Of these women 88%<br />

were seen within 30 minutes.<br />

The graph below depicts the monthly average percentage of patients seen within 30 minutes of their arrival in triage,<br />

indicated by a single figure for the month<br />

Triage Attendance - % seen ≤ 30 mins <strong>and</strong> No. of Women Attending<br />

% Seen ≤ 30 minutes<br />

100%<br />

90%<br />

80%<br />

70%<br />

60%<br />

50%<br />

40%<br />

30%<br />

20%<br />

10%<br />

0%<br />

STANDARD 1200<br />

STANDARD (98%)<br />

87%<br />

1163<br />

86% 89%<br />

1149 86%<br />

88%<br />

85%<br />

1150<br />

81%<br />

1140 1146<br />

78%<br />

1110 1110<br />

73%<br />

1100<br />

1085<br />

1050<br />

1014<br />

1000<br />

973<br />

950<br />

900<br />

850<br />

Jan Feb Mar Apr May Jun Jul Aug Sep<br />

% SEEN ≤ 30 MINS STANDARD No of women attending<br />

No of Women Attending (Actual)<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 3 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

3


The graph below depicts the daily actual percentages of patients seen within 30 minutes of their arrival in triage,<br />

indicated by a collection of figures for each month 1<br />

100<br />

Triage - % of Patients Seen within 30 Minutes of Arrival<br />

(JANUARY <strong>2012</strong> - AUGUST <strong>2012</strong> Inclusive weekly capture)<br />

90<br />

Number of Patients<br />

80<br />

70<br />

60<br />

50<br />

40<br />

30<br />

20<br />

10<br />

0<br />

January<br />

<strong>2012</strong><br />

February<br />

<strong>2012</strong><br />

March<br />

<strong>2012</strong><br />

April <strong>2012</strong><br />

May <strong>2012</strong><br />

June <strong>2012</strong><br />

July <strong>2012</strong><br />

August<br />

<strong>2012</strong><br />

September<br />

<strong>2012</strong><br />

Day<br />

% of patients Seen within 30 minutes Target<br />

As part of the continuous improvement programme the Triage pathway has gone through several<br />

iterations including most recently in June <strong>2012</strong>. This explains day to day the variances during the<br />

month of June. This process is continuing through the work of Maternity Clinical Fellows. It is<br />

anticipated the service will settle with much higher percentages of women seen in 15 minutes once<br />

this work is completed. Phase one of the new pathway commenced on 30 th July.<br />

1 Triage figures Jan – July inclusive were 98% st<strong>and</strong>ard against 15 minutes. This has changed in September to 98%<br />

st<strong>and</strong>ard against 30 minutes.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 4 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

4


7. Obstetric Assessment Unit (OAU)<br />

It has been agreed that 98% of women should be seen by an obstetrician, where this is deemed<br />

clinically appropriate, within 1 hour of their arrival to the Obstetric Assessment Unit (OAU). The<br />

<strong>Trust</strong> average for September <strong>2012</strong> was 95%.<br />

% of Patients seen within 1 hour on OAU by an Obstetrician<br />

85<br />

St<strong>and</strong>ard<br />

90 94<br />

92 91<br />

99 96<br />

98 99<br />

St<strong>and</strong>ard<br />

95<br />

65<br />

45<br />

25<br />

Jan<br />

Feb<br />

Mar<br />

Apr<br />

% of patients seen<br />

May<br />

Jun<br />

Jul<br />

Aug<br />

Sep<br />

Seen


.<br />

% of Patients seen within 1 Hour of Referral<br />

120<br />

100<br />

St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard St<strong>and</strong>ard<br />

80<br />

60<br />

40<br />

59<br />

70<br />

65<br />

72<br />

60<br />

58<br />

60<br />

65<br />

57<br />

20<br />

0<br />

Jan<br />

Feb<br />

Mar<br />

Apr<br />

May<br />

Jun<br />

Jul<br />

Aug<br />

Sep<br />

Seen


10. Serious Incidents Reported<br />

Incidents which meet the NHS London SI reporting criteria are declared as they occur /<br />

are detected. Because they are reported retrospectively, the information below details<br />

incidents that either occurred within September <strong>2012</strong> or were reported in September<br />

<strong>2012</strong>. There will be overlap <strong>and</strong> repetition between information provided each month<br />

for this report.<br />

Full summaries <strong>and</strong> details are to be found on the STEIS system (references numbers<br />

provided).<br />

Summary:<br />

STEIS<br />

number<br />

Site<br />

22405 QH<br />

23880 QH<br />

Issue<br />

controlled<br />

drugs<br />

potentially<br />

missing<br />

NNU<br />

admission /<br />

transfer to<br />

UCLH<br />

Incident<br />

date<br />

Date of<br />

declaration<br />

MDT /<br />

panel<br />

reviews<br />

10/09/12 10/09/12 10/09/12<br />

23/09/12 25/09/12<br />

27/09/<strong>2012</strong><br />

2/10/12<br />

Comment<br />

At routine controlled drug check on<br />

morning of 10/9/12 it was found<br />

that the controlled drug book had<br />

been altered (pages removed) <strong>and</strong><br />

potentially some controlled drugs<br />

were missing<br />

congenital pneumonia / no<br />

contributory care or service<br />

delivery problems identified at<br />

panel<br />

11. Caesarean Deliveries including Elective Activity<br />

When a decision is made to perform an emergency LSCS, the timing for this is dictated by the<br />

acuity of each case which is graded from 1-4.<br />

Grade 1<br />

Caesarean section is considered as urgent <strong>and</strong> has an immediate threat to the life of the<br />

woman <strong>and</strong> foetus. To be performed within 30 minutes.<br />

At BHRUT hospitals, 54% of the audited grade 1 C/S were performed within 30 minutes.<br />

Delays were due to:<br />

• Increased BMI impacting on the procedure<br />

• Difficulty in sitting the spinal<br />

• Delay due to anaesthetic issues.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 7 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

7


Grade 2<br />

Caesarean section is considered urgent with maternal or foetal compromise which is not<br />

immediately life threatening. To be performed within 60 minutes<br />

At BHRUT hospitals, of 63% the audited grade 2 emergency C/S were performed within 60<br />

minutes.<br />

An audit of the grading of emergency caesarean sections is being carried out to ensure that<br />

emergency caesarean sections are not being misclassified.<br />

Grade 3 & 4<br />

Caesarean section is an emergency with no maternal or foetal compromise, but requires<br />

early delivery. To be performed at a time to suit the mother <strong>and</strong> the department.<br />

At BHRUT, 100% of the audited grade 3/4 emergency C/S were performed within time.<br />

There were no adverse outcomes associated with delayed LSCS.<br />

It should also be noted that the target of 100% achievement is not based on national guidance.<br />

Royal College of Obstetricians <strong>and</strong> Gynaecologists Good Practice No. 11 2 of 4noted that:<br />

To formalise the concept that urgency of caesarean section represents a continuum of risk:<br />

● four broad categories of risk are defined<br />

● all staff should be aware that, within each category, the degree of risk in individual cases can<br />

vary<br />

● a coloured spectrum is used to emphasise that continuum of risk<br />

● this variance in degree of risk requires an individual, case-by-case approach in deciding the<br />

specific<br />

decision-to-delivery interval (DDI).<br />

The ‘Sentinel’ caesarean section audit suggested that in cases such as cord prolapse, a DDI of 15<br />

minutes was feasible. However, in many category-1 cases, delivery within 30 minutes was not<br />

achieved. Delivery within 75 minutes does not appear to increase the risk of compromise, while<br />

delivery within 30 minutes may not<br />

always result in a good neonatal outcome. Once a decision to deliver has been made, therefore,<br />

delivery should be carried out with an urgency appropriate to the risk to the baby <strong>and</strong> the safety<br />

of the mother. Units should strive to design guidelines that result in the shortest safely achievable<br />

DDI. Evidence suggests that any delay is usually associated with the delay in transfer to theatre.<br />

A target DDI for caesarean section for ‘fetal compromise’ of 30 minutes is an audit tool that<br />

allows testing of the efficiency of the whole delivery team <strong>and</strong> has become accepted practice;<br />

however:<br />

• certain clinical situations will require a much quicker DDI than 30 minutes <strong>and</strong> units should<br />

work towards improving their efficiency<br />

• undue haste to achieve a short DDI can introduce its own risk, both surgical <strong>and</strong><br />

anaesthetic, with the potential for maternal <strong>and</strong> neonatal harm.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 8 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

8


12. Maternity Dashboard<br />

The dashboard <strong>and</strong> exception report for September <strong>2012</strong> is attached seperatly.<br />

Discussions have taken place with NEC as to the future structure of the performance report. The<br />

assurance framework, maternity dashboard <strong>and</strong> exemption report will now replace the monthly<br />

reporting template The Directorate would welcome feedback from the <strong>Trust</strong> <strong>Board</strong> as to whether<br />

they would want to adopt a similar approach.<br />

.<br />

Mat 2 October <strong>2012</strong> (2).doc<br />

Page 9 of 9<br />

Compiled by C Frisby 12.07.<strong>2012</strong><br />

9


Women’s Services<br />

Exception Report for the Maternity Performance Dashboard <strong>and</strong><br />

Assurance Framework<br />

September <strong>2012</strong><br />

Red Areas<br />

Guidelines<br />

There are 12 guidelines which have expired; the reasons being:<br />

An Increase has been noted from the previous month due to a large number of<br />

guidelines expiring in September. Most of these have been updated but are waiting<br />

approval or uploading onto the Intr@net.<br />

Deliveries<br />

There were a high number of deliveries at both units during September. This<br />

continues a trend for the first six months of the year. Births are monitored very<br />

carefully <strong>and</strong> escalation occurred as required. It is anticipated that births should start<br />

to decrease in <strong>November</strong> due to an increase in the bookings in <strong>Barking</strong> being<br />

undertaken by Barts Heath for the last five months. The case load transfer has been<br />

delayed by a month to mid <strong>November</strong>. Discussions are ongoing with the<br />

commissioners; the bookings have reduced over the last month.<br />

Triage<br />

The triage area on the Labour Ward at Queen’s Hospital achieved 88% in seeing women<br />

within 30 minutes. As part of the continuous improvement programme the Triage<br />

pathway has gone through several iterations including most recently in July <strong>2012</strong>. This<br />

process is continuing through the work of Maternity Clinical Fellows. It is anticipated the<br />

service will settle with much higher percentages of women seen in 15 minutes once this<br />

work is completed. Phase one of the new pathway commenced on 30 th July.<br />

LSCS Grading.<br />

This continues to be problematic with data recording <strong>and</strong> appropriate grading of<br />

LSCS with only 54% achievement of grade 1 LSCS. It has been agreed that the clinical<br />

director will identify one of the obstetric team to monitor the doctors to ensure that<br />

they have completed the E3 at the time of LSCS, this will ensure that we have<br />

accurate data. It will also ensure that we are able to accurately record the grading of<br />

the LSCS <strong>and</strong> any inappropriateness will be addressed with individuals. We hope to<br />

see an improvement in the next month’s figures. There were no poor outcomes<br />

noted from the notes audited.


It should also be noted that the target of 100% achievement is not based on national<br />

guidance. Royal College of Obstetricians <strong>and</strong> Gynaecologists Good Practice No. 11 2<br />

of 4noted that:<br />

To formalise the concept that urgency of caesarean section represents a continuum<br />

of risk:<br />

● four broad categories of risk are defined<br />

● all staff should be aware that, within each category, the degree of risk in<br />

individual cases can vary<br />

● a coloured spectrum is used to emphasise that continuum of risk<br />

● this variance in degree of risk requires an individual, case‐by‐case approach in<br />

deciding the specific<br />

decision‐to‐delivery interval (DDI).<br />

The ‘Sentinel’ caesarean section audit suggested that in cases such as cord prolapse,<br />

a DDI of 15 minutes was feasible. However, in many category‐1 cases, delivery within<br />

30 minutes was not achieved. Delivery within 75 minutes does not appear to<br />

increase the risk of compromise, while delivery within 30 minutes may not<br />

always result in a good neonatal outcome. Once a decision to deliver has been made,<br />

therefore, delivery should be carried out with an urgency appropriate to the risk to<br />

the baby <strong>and</strong> the safety of the mother. Units should strive to design guidelines that<br />

result in the shortest safely achievable DDI. Evidence suggests that any delay is<br />

usually associated with the delay in transfer to theatre.<br />

A target DDI for caesarean section for ‘fetal compromise’ of 30 minutes is an audit<br />

tool that allows testing of the efficiency of the whole delivery team <strong>and</strong> has become<br />

accepted practice; however:<br />

• certain clinical situations will require a much quicker DDI than 30 minutes<br />

<strong>and</strong> units should work towards improving their efficiency<br />

• undue haste to achieve a short DDI can introduce its own risk, both surgical<br />

<strong>and</strong> anaesthetic, with the potential for maternal <strong>and</strong> neonatal harm.<br />

PPH’s<br />

There were 6 PPH’s the governance department has reviewed the care of all these<br />

deliveries <strong>and</strong> has not noted any specific care issue.


Maternity Services Assurance Framework <strong>2012</strong>-13<br />

September <strong>2012</strong><br />

Introduction<br />

This report sets out an assurance framework for patient safety <strong>and</strong> minimum quality st<strong>and</strong>ards at BHRUT. This framework compliments a range of<br />

other assurances both commissioners <strong>and</strong> the trust boards already have in place.<br />

From 1 st April <strong>2012</strong> Maternity Services is moving back to ward business as normal. However BHRUT will need to continue to provide assurance to<br />

external organisations such as NELC, that the services remain safe.<br />

Following discussions at the monthly NELC Cluster & BHRUT Maternity Sub Group Meeting it was agreed that BHRUT would devise a Maternity<br />

Services Assurance Framework based on several indicators including:<br />

• Key Performance Indicators<br />

• Workforce<br />

• Governance<br />

• Dem<strong>and</strong> <strong>and</strong> Activity<br />

• Patient experience<br />

Governance Arrangements<br />

Both the trust <strong>and</strong> the PCT boards have established committees which focus on safety <strong>and</strong> clinical governance. However, the assurance<br />

framework below outlines how the priority areas will be scrutinised <strong>and</strong> monitored.<br />

Interim Chairman: George Wood<br />

Chief Executive: Averil Dongworth


Priority Action Lead Monitoring Tool Current Risk<br />

Rating<br />

Risk rating<br />

previous<br />

month<br />

Antenatal<br />

Access to maternity<br />

services<br />

Intrapartum<br />

Ensure that Labour Ward<br />

remains safe <strong>and</strong><br />

appropriate escalation<br />

occurs<br />

Women where the referral received by<br />

10+6weeks to be booked by 12+6 weeks for<br />

90% of maternities<br />

90% of women to be triaged within 30<br />

minutes of arrival<br />

Number of bookings must not exceed cap<br />

C:\Data\matthews w\<br />

Bookings\New Templa<br />

Escalation policy in place<br />

NELC informed of diverts as per PAN London<br />

divert policy<br />

W<br />

Matthews<br />

Monthly reporting to <strong>Trust</strong> <strong>Board</strong> <strong>and</strong><br />

on maternity dashboard<br />

92% 92%<br />

A Archibald Monthly performance report 88% 89%<br />

W<br />

Matthews<br />

Avril<br />

Archibald<br />

Weekly teleconference, weekly<br />

submission of booking data<br />

*Evidence of BHRUT escalation<br />

implemented.<br />

NELC informed of escalation in line<br />

with agreed process.<br />

Evidence of LSA database updated<br />

with escalation details.<br />

Awaiting cap<br />

implementation<br />

date<br />

1 3<br />

Ensuring woman receive<br />

1:1 care by a midwife in<br />

established labour<br />

Staffing levels on Labour Ward to allow for<br />

1:1 care in labour.<br />

Clinical pathways facilitator to have an<br />

overview of staffing levels across maternity in<br />

hours, out of hours this is undertaken by<br />

Labour Ward co-ordinator<br />

Avril<br />

Archibald<br />

BHRUT to maintain a minimum<br />

midwife ratio of 1:29.<br />

Weekly audit of one to one care<br />

Review of patient feedback.<br />

Dashboard entry monthly<br />

100% 100%<br />

All women presenting to the<br />

unit are assessed in a<br />

timely way.<br />

High risk women identified<br />

*BHRUT to ensure that 90% of women seen<br />

within 30mins of arrival to triage.<br />

*Daily percentage of high risk women seen<br />

within target time (98% within 1hour).<br />

2<br />

Monthly reporting. 88% 89%


Priority Action Lead Monitoring Tool Current Risk<br />

Rating<br />

<strong>and</strong> treated in a timely way.<br />

Risk rating<br />

previous<br />

month<br />

100%Grade 1 LSCS are<br />

performed within 30<br />

minutes<br />

Maintain high st<strong>and</strong>ard of<br />

care for women. Women<br />

cared for in appropriate<br />

location.<br />

Audit appropriateness of grading LSCS<br />

Identify reasons why grade 1LSCS not<br />

undertaken within 30 minutes<br />

Once Birthing Centre is open ensure that low<br />

risk women are encouraged to birth there.<br />

Agree trajectory with NELC<br />

D<br />

Olorunshola<br />

J<br />

Richardson<br />

Monthly monitoring report 54% 65%<br />

% Births in Birthing Centre<br />

Monthly Dashboard entry<br />

Decision still<br />

awaited on<br />

opening of QBC<br />

To ensure that maternal<br />

<strong>and</strong> neonatal morbidity <strong>and</strong><br />

mortality is in line with<br />

national targets<br />

Revise maternity dashboard to include<br />

national benchmarks.<br />

S Lovell<br />

Monthly Dashboard<br />

Exemption reporting on outliers<br />

3 2<br />

Postnatal<br />

Ensure that neonatal<br />

readmissions is not an<br />

outlyer<br />

Audit pathway for neonatal readmissions<br />

Revise pathway to ensure that neonates are<br />

readmitted in the most appropriate<br />

environment<br />

M O’Leary<br />

D Jones<br />

Dashboard entry monthly.<br />

Exemption reporting if outlying<br />

1 2<br />

To review discharge<br />

pathway <strong>and</strong> reduce LOS<br />

NPAN midwife rota 100% coverage<br />

Pathway review through Clinical fellow<br />

programme<br />

Clinical<br />

Fellows<br />

Helen<br />

Mansfield<br />

Dashboard entry<br />

Monthly performance report<br />

87% coverage 87% coverage<br />

Workforce<br />

Strengthen the levels of<br />

statutory supervision of<br />

midwives within the <strong>Trust</strong><br />

Ratio of SOM to Midwives improves. Current<br />

position 1:20.<br />

D Jones<br />

J Read<br />

Shift in ratio towards 1:15 1:18 1:19<br />

Review midwifery numbers Agree baseline based on Birthrate Plus D Jones 1:29 midwife to birth ratio 1:29 1:29<br />

3


Priority Action Lead Monitoring Tool Current Risk<br />

Rating<br />

as births decrease<br />

findings.<br />

Review WTE on a quarterly basis depending<br />

on birth numbers<br />

W<br />

Matthews<br />

Reduction in bank <strong>and</strong> move towards<br />

removing agency midwives<br />

Risk rating<br />

previous<br />

month<br />

Governance<br />

Information <strong>and</strong><br />

Governance Arrangements<br />

*Ensure that BHRUT are recording <strong>and</strong><br />

reviewing all serious untoward incidents<br />

Compliance with CQUIN requirements.<br />

D Jones<br />

J Piper<br />

Monthly performance report.<br />

SI’s notified to NHS London<br />

CQUIN performance<br />

2 11<br />

Patient Experience<br />

Ensure that women receive<br />

a positive experience<br />

Monitor complaints <strong>and</strong> ensure timely<br />

response.<br />

Appoint patient experience midwife<br />

50% of delivered women to use patient<br />

tracker device<br />

Action Plan developed to improve patient<br />

experience.<br />

Collate positive feedback from women<br />

W<br />

Matthews<br />

D Jones<br />

Monthly reporting of complaints<br />

Milestone of CQUIN<br />

70% compliance<br />

on pilot ward<br />

N/A<br />

C:\Data\matthews w\<br />

Patient experience\03<br />

September <strong>2012</strong><br />

4


Complaints Annual Report<br />

2011 - <strong>2012</strong>


Contents<br />

Section No: Description Page No:<br />

1. Introduction 3<br />

2. Overview of the Service 3<br />

3. Complaints Activity 4<br />

4. Actions taken in Response to Complaints 10<br />

5. Service Developments 11<br />

6. The Year Ahead - Future Plans 12<br />

2


1. Introduction<br />

Under the Local Authority Social Services <strong>and</strong> NHS Complaints (Engl<strong>and</strong>) Regulations<br />

2009, all NHS bodies are required to prepare an annual report on complaints received. The<br />

report should include the number <strong>and</strong> subject matter of all complaints received during the<br />

year, the number upheld, the number known to have been referred to the Parliamentary<br />

<strong>and</strong> Health Service Ombudsman (PHSO) <strong>and</strong> any actions taken to improve services as a<br />

result of complaints.<br />

This report provides a summary of complaints received by <strong>Barking</strong>, <strong>Havering</strong> & Redbridge<br />

University Hospitals NHS <strong>Trust</strong> (BHRUT) in relation to its own services during the period 1 st<br />

April 2011 - 31 st March <strong>2012</strong>.<br />

2. Overview of the Complaints Service<br />

2.1 <strong>Barking</strong> <strong>Havering</strong> & Redbridge University Hospital NHS <strong>Trust</strong> (BHRUT) complaints service<br />

is accessible to all patients who have used the services provided by the <strong>Trust</strong>.<br />

Specifically these services are delivered on the two main hospital sites - King George<br />

Hospital (KGH) <strong>and</strong> Queen’s Hospital, but also include any outreach services provided.<br />

Every effort is made to ensure that complainants are able to access the service in a way<br />

which meets their needs. The service operates Monday to Friday, 9am - 5pm.<br />

The Complaints Team can be contacted in the following ways:<br />

<br />

<br />

<br />

Telephone - there is a dedicated complaints telephone number which is supported by<br />

an answer phone facility at busy times <strong>and</strong> outside of core working hours.<br />

Email - there is one dedicated complaints email address where enquirers can send<br />

their complaint.<br />

Letter - enquirers can write to the Complaints Team at either of the two main hospital<br />

sites.<br />

The complaints process in the <strong>Trust</strong> is for all formal complaints to be received, logged <strong>and</strong><br />

acknowledged by the core Complaints Team. They are then sent to the Directorates who<br />

are responsible for liaising with the complainant, agreeing the complaint plan, agreeing<br />

appropriate response times, undertaking a full investigation <strong>and</strong> providing a draft response.<br />

The core Complaints Team then resume responsibility for the complaint, checking the<br />

investigation <strong>and</strong> response before it is reviewed <strong>and</strong> signed by the Accountable Officer.<br />

During 2011 - <strong>2012</strong>, the core Complaints Team was resourced by:<br />

1 WTE B<strong>and</strong> 7 Complaint Manager<br />

1 WTE B<strong>and</strong> 6 Complaint Manager<br />

2.92 WTE B<strong>and</strong> 4 Complaints Administrators<br />

The service is also supported by four B<strong>and</strong> 3 Directorate Complaint Co-ordinators <strong>and</strong> adhoc<br />

Directorate administrative support as needed.<br />

During 2011 - <strong>2012</strong>, the budget for complaints was £305,131.<br />

3


3. Complaints Activity<br />

3.1 Total Complaints Received<br />

During the year, the <strong>Trust</strong> received 1096 formal complaints. There was a significant rise in<br />

the number of complaints received this year compared with the previous year of 671.<br />

During the year, the <strong>Trust</strong> was the subject of a Care Quality Commission (CQC)<br />

investigation which highlighted a number of areas of concern across the <strong>Trust</strong>, <strong>and</strong> the<br />

increase in the number of complaints received reflects this.<br />

The chart below shows the total activity received on a monthly basis:<br />

140<br />

120<br />

100<br />

80<br />

60<br />

40<br />

20<br />

0<br />

April<br />

May<br />

June<br />

July<br />

August<br />

September<br />

October<br />

<strong>November</strong><br />

December<br />

January<br />

February<br />

March<br />

Each complaint is assigned to the relevant Directorate it is regarding <strong>and</strong> the chart below<br />

demonstrates the percentage of total complaints received for each Directorate.<br />

21%<br />

10%<br />

2%<br />

33%<br />

C.D.T<br />

Corporate Non Clinical<br />

Medical<br />

Surgical<br />

Women And Children<br />

34%<br />

4


3.2 Acknowledgement Time<br />

The Complaints Regulations (2009), state that all complainants should receive an<br />

acknowledgement from the <strong>Trust</strong> within 3 working days.<br />

During the year, 99.6% of complainants received an acknowledgement within 3 working<br />

days.<br />

3.3 Response Time<br />

During the year the <strong>Trust</strong>’s target for percentage of complainants receiving a response<br />

within the agreed timescale was 80%. Unfortunately, the <strong>Trust</strong> did not meet this target.<br />

The chart below outlines the actual monthly percentages achieved:<br />

100%<br />

90%<br />

80%<br />

70%<br />

60%<br />

50%<br />

40%<br />

30%<br />

20%<br />

10%<br />

0%<br />

April<br />

May<br />

June<br />

July<br />

August<br />

September<br />

October<br />

<strong>November</strong><br />

December<br />

January<br />

February<br />

March<br />

3.4 Outcome<br />

Of the 1096 complaints received <strong>and</strong> investigated by the <strong>Trust</strong>, 604 were upheld.<br />

The table below reflects the status of all complaints received during this period. 85% of<br />

complaints received were resolved after a first written response or a first response meeting<br />

with the complainant, even though this may not have been within the agreed timeframe.<br />

Stage<br />

No of Complaints<br />

Open 44<br />

Open - reactivated complaint 32<br />

Closed - no consent 15<br />

Closed after first response/first meeting 930<br />

Closed after additional response/ local resolution<br />

75<br />

meeting<br />

Total 1096<br />

5


3.5 Themes<br />

General care issues <strong>and</strong> communication were the two main themes of complaints received<br />

during the year accounting for 92% of complaints received, <strong>and</strong> as outlined above, this is in<br />

line with the outcome of the CQC investigation. These two main themes are common<br />

across all Directorates.<br />

General Care Issues<br />

General care issues received during the past year related to:<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

Delay in diagnosis<br />

Wrong diagnosis<br />

Failure to respond to patients’ buzzers in a timely manner <strong>and</strong>/or leaving buzzers<br />

out of reach of patient<br />

Failure to respond to a patient needing help with getting to the toilet/personal<br />

hygiene<br />

Failure to provide assistance to patients needing help to eat<br />

Food <strong>and</strong> water being left out of the reach of patients<br />

Failure to supervise the taking of medication<br />

Communication Issues<br />

Communication issues received during this period included:<br />

<br />

<br />

<br />

<br />

<br />

Staff interaction with patients <strong>and</strong> families - a lack of basic courtesy to visitors or<br />

telephone callers<br />

Patients <strong>and</strong> visitors being spoken to in an abrupt manner on the ward or in the<br />

clinic environment<br />

Failure to keep patients <strong>and</strong> visitors informed as to developments whilst they are in<br />

hospital<br />

Failure to document fully in medical <strong>and</strong> nursing records, which then leads to<br />

problems for other staff to determine the up-to-date position.<br />

Difficulties in being able to contact the Appointments Call Centre, particularly as<br />

there was no queuing facility resulting in patients often hearing an engaged tone<br />

Overall, the <strong>Trust</strong> received complaints about the following:<br />

Category<br />

No. of<br />

Complaints<br />

Category<br />

No. of<br />

Complaints<br />

Care general -<br />

316 Wait - in out-patient<br />

4<br />

nurse/midwife<br />

department<br />

Care general - treatment 290 Care process - in<br />

3<br />

department<br />

Communication 160 Safety - other, accident 3<br />

Care general - diagnosis 145 Safety - other, assault etc 3<br />

Communication - staff<br />

54 Security - general 3<br />

attitude<br />

Care process - cross<br />

department<br />

19 Wait - for tests/scans etc<br />

out-patient<br />

2<br />

6


Category<br />

Communication -<br />

privacy/dignity/<br />

discrimination<br />

Care process -<br />

transfer/discharge<br />

Wait - for out-patient<br />

appointment<br />

No. of<br />

Category<br />

Complaints<br />

17 Facilities/equipment - hotel<br />

services<br />

No. of<br />

Complaints<br />

2<br />

13 Care process - attendance 2<br />

etc<br />

13 Care procedure - other 1<br />

Wait- in A&E 12 Communication - patient 1<br />

property/ expenses<br />

Care general - patient<br />

10 Facilities/equipment -<br />

1<br />

event<br />

availability<br />

Care procedure -<br />

7 Facilities/equipment -<br />

1<br />

medication<br />

maintenance<br />

Care procedure -<br />

7 Safety - patient, accident 1<br />

documentation<br />

Wait - for in-patient<br />

5 Safety – patient, accident 1<br />

admission<br />

fall from height<br />

Total 1096<br />

The categories for each Directorate are outlined in the tables below.<br />

Specialist Medicine<br />

Category<br />

Number of Complaints<br />

Communication 46<br />

Care general - treatment 23<br />

Communication - staff attitude 10<br />

Care general - diagnosis 6<br />

Care process - cross department 5<br />

Care general - nurse/midwife 4<br />

Communication - privacy/dignity/discrimination 3<br />

Wait - in out-patient department 3<br />

Care procedure - medication 2<br />

Care process - transfer/discharge 2<br />

Wait - for tests/scans etc (out-patient) 2<br />

Care procedure - documentation 1<br />

Facilities/Equipment - hotel services 1<br />

Wait - for out-patient appointment 1<br />

Total 109<br />

7


Corporate Non Clinical<br />

Category<br />

Number of Complaints<br />

Communication 6<br />

Communication - staff attitude 3<br />

Care process - cross department 1<br />

Care general - nurse/midwife 1<br />

Facilities/equipment - availability 1<br />

Safety - other, accident 1<br />

Safety - other, assault etc 1<br />

Security - general 3<br />

Total 17<br />

Medical<br />

Surgical<br />

Category<br />

Number of Complaints<br />

Communication 58<br />

Care general - treatment 121<br />

Communication - staff attitude 19<br />

Care general - diagnosis 43<br />

Care process - cross department 3<br />

Care general - nurse/midwife 100<br />

Communication - privacy/dignity/discrimination 2<br />

Care procedure - medication 1<br />

Care process - transfer/discharge 6<br />

Care procedure - documentation 2<br />

Wait - for out-patient appointment 1<br />

Communication - patient property/expenses 1<br />

Safety - other, assault etc 2<br />

Safety - patient, accident 1<br />

Safety - patient, accident fall from height 1<br />

Wait - in A&E 12<br />

Total 373<br />

Category<br />

Number of Complaints<br />

Communication 36<br />

Care general - treatment 120<br />

Communication - staff attitude 10<br />

Care general - diagnosis 70<br />

Care process - cross department 9<br />

Care general - nurse/midwife 75<br />

Communication - privacy/dignity/discrimination 7<br />

Wait - in out-patient department 1<br />

Care procedure - medication 3<br />

Care process - transfer/discharge 5<br />

Care procedure - documentation 1<br />

Facilities/equipment - hotel services 1<br />

8


Category<br />

Number of Complaints<br />

Wait - for out-patient appointment 11<br />

Care general - patient event 8<br />

Care procedure - other 1<br />

Care process - attendance etc 2<br />

Care process - in department 2<br />

Facilities/equipment - maintenance 1<br />

Safety - other, accident 1<br />

Wait - for in-patient admission 5<br />

Total 369<br />

Women & Children<br />

Category<br />

Number of Complaints<br />

Communication 14<br />

Care general - treatment 26<br />

Communication - staff attitude 12<br />

Care general - diagnosis 26<br />

Care process - cross department 1<br />

Care general - nurse/midwife 136<br />

Communication - privacy/dignity/discrimination 5<br />

Care procedure - medication 1<br />

Care procedure - documentation 3<br />

Care general - patient event 2<br />

Care process - in department 1<br />

Safety - other, accident 1<br />

Total 228<br />

3.6 Reactivated Complaints<br />

During the year the <strong>Trust</strong> received 75 new requests from complainants to re-open their<br />

complaint.<br />

By Directorates these were:<br />

Directorates<br />

Specialist Medicine 9<br />

Medical 36<br />

Surgical 13<br />

Women <strong>and</strong> Children 15<br />

Corporate non-clinical 2<br />

No of Reactivated<br />

The majority of reactivated complaints related to complex medical cases where the<br />

complainant was seeking further clarification of the response or where they did not agree<br />

with the <strong>Trust</strong>’s response. A number of complaints were reactivated as following a written<br />

response the complainant had requested financial recompense.<br />

Where complaints were reactivated, complainants were offered a further written response<br />

or the opportunity to have a local resolution meeting with relevant <strong>Trust</strong> representatives in<br />

9


order to resolve concerns. Particularly where there are complex medical issues which<br />

require explanation, it is often more helpful for the complainant if this is achieved through a<br />

face-to-face meeting as it allows the complainant to ask questions <strong>and</strong> to raise any<br />

outst<strong>and</strong>ing concerns.<br />

3.7 Parliamentary <strong>and</strong> Health Service Ombudsman (PHSO)<br />

Once the local resolution process has been concluded between the <strong>Trust</strong> <strong>and</strong> the<br />

complainant, if they are dissatisfied with the way in which the complaint has been h<strong>and</strong>led<br />

or if it is not possible to resolve the complaint, they can ask the PHSO to review the case.<br />

Sometimes, complainants do not wait until the local resolution process has concluded<br />

before approaching the PHSO <strong>and</strong> the case is then returned to the <strong>Trust</strong> to continue with<br />

local resolution. Where local resolution has concluded, the PHSO reviews the case <strong>and</strong><br />

either upholds the complaint, often suggesting the resolution that needs to take place, or<br />

rejecting the complaint <strong>and</strong> no further action is required.<br />

During the last year the <strong>Trust</strong> were advised of 38 complaints which were referred by<br />

complainants to the PHSO.<br />

Of this number, the status of the cases were:<br />

Still being considered 5<br />

Local resolution 17<br />

Upheld 3<br />

Rejected 13<br />

Although a number of cases were referred to the PHSO, it is encouraging to note that only<br />

8% of these cases were upheld. The remainder were either rejected, returned to the <strong>Trust</strong><br />

to conclude local resolution or are still awaiting PHSO consideration.<br />

The PHSO are unable to provide the <strong>Trust</strong> with details as to why a complaint has been<br />

referred to them without the consent of the complainant. It is therefore sometimes difficult<br />

to determine the specific reasons why complainants refer their complaint to the PHSO.<br />

However, during this period, delays in the <strong>Trust</strong> complaint h<strong>and</strong>ling process has led to<br />

some referrals being made to the PHSO prior to conclusion of local resolution.<br />

According to the PHSO findings <strong>and</strong> recommendations, the large majority of cases referred<br />

to them during 2011-12 were as a result of failures <strong>and</strong>/or delays in care <strong>and</strong> treatment <strong>and</strong><br />

this is in line with the overall themes from complaints.<br />

Of the 38 cases referred to the PHSO during 2011-12, 3 referred to Specialist Medicine, 1<br />

to Corporate Non-clinical, 20 to Medical, 10 to Surgical, 4 to Women & Children.<br />

Of the cases that the PHSO upheld against the <strong>Trust</strong>, 2 related to Surgical Division <strong>and</strong> 1<br />

related to Medical Division.<br />

4. Actions Taken in Response to Complaints<br />

BHRUT is keen to learn from all patient feedback including complaints. Any complaint<br />

which identifies shortcomings in services provided to patients is supported by an individual<br />

action plan which details learning <strong>and</strong> actions required to prevent a recurrence of the<br />

events which led to the complaint.<br />

10


The following improvements / actions were implemented during the year:<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

<br />

Additional pain management capacity identified to ensure patients are seen as<br />

quickly as possible<br />

Every patient admitted to a ward is seen within 24 hours by a consultant even if their<br />

own consultant is not available<br />

Introduction of 1 - 2 hourly comfort ward rounds ensure patients needs are regularly<br />

identified<br />

A communication book is now available on all wards to assist patients with<br />

communication difficulties. This is a pictorial book <strong>and</strong> allows patients who cannot<br />

verbalise to point out their needs<br />

The <strong>Trust</strong> senior nursing team undertake a rolling programme of weekly audits that<br />

concentrate on a topic of the week. The process of audit allows the senior nursing<br />

team to monitor documentation <strong>and</strong> feedback to staff any issues with inappropriate<br />

or inadequate documentation. This then identifies the gaps <strong>and</strong> support if given to<br />

that ward area. During these audits the senior nursing team speak to patients about<br />

their experience, particularly around issues of privacy <strong>and</strong> dignity, access to nurse<br />

call buzzers, nutrition, quality of food, use of ‘red tray’ <strong>and</strong> water jug system that is<br />

in place for patients who require assistance<br />

Within the Care of the Elderly Unit, the Matrons are introducing a twice weekly<br />

Matron’s surgery. This will be publicised to families <strong>and</strong> patients in the ward areas.<br />

This will allow patients <strong>and</strong> next-of-kin to have direct access to a Matron to discuss<br />

any concerns they may have. This will promote <strong>and</strong> improve communication. It is<br />

anticipated that following a review period, if successful, it will be rolled out across<br />

the <strong>Trust</strong><br />

Introduction of a parents advice leaflet within paediatrics<br />

Redesign of emergency department to include a dedicated room for mothers to use<br />

to breast-feed their babies<br />

Introduction of enhanced telephony system for Appointment Call Centre<br />

Medical Director led communication forums for junior medical staff<br />

Complaints discussed in consultant governance meetings, learning identified <strong>and</strong><br />

shared<br />

5. Service Developments<br />

Review of Complaints H<strong>and</strong>ling<br />

Following the publication of the CQC investigation report into issues at the <strong>Trust</strong>, in January<br />

<strong>2012</strong>, NHS London provided a resource to the <strong>Trust</strong> to undertake a review into the reasons<br />

for the decline in the <strong>Trust</strong> meeting its own targets for providing responses to complainants.<br />

The review took place throughout January <strong>2012</strong> <strong>and</strong> all aspects of the complaints h<strong>and</strong>ling<br />

process were considered.<br />

11


The findings of the review were that there were two main areas of concern relating to<br />

process issues <strong>and</strong> systems issues. Along with the review report, the project lead also<br />

submitted a proposed action plan to address the issues raised.<br />

At the time of this report progress on delivering the actions in the plan are being regularly<br />

reviewed at the <strong>Trust</strong>’s Quality & Safety Committee.<br />

H<strong>and</strong>ling Complaints Policy & Procedure<br />

During the later part of the year, the <strong>Trust</strong>’s H<strong>and</strong>ling Complaints Policy <strong>and</strong> Procedure was<br />

reviewed to bring the <strong>Trust</strong> in line with the Complaint Regulations 2009. The draft policy<br />

includes all aspects of the 2009 regulations <strong>and</strong> places greater emphasis on getting it right<br />

for the complainant. It aims to ensure a flexible, proportionate approach is implemented in<br />

order that the process be as easy to underst<strong>and</strong> <strong>and</strong> as un-bureaucratic as possible.<br />

The draft policy <strong>and</strong> procedure has been widely circulated to internal <strong>and</strong> external<br />

stakeholders for comment, prior to being presented at the <strong>Trust</strong>’s Policy Ratification<br />

Committee.<br />

New Complaints Leaflets<br />

A new <strong>Trust</strong> complaints leaflet has been designed <strong>and</strong> is currently in the process of being<br />

printed. The new leaflet is completely different to the old version <strong>and</strong> provides much more<br />

information for patients <strong>and</strong> relatives on making a complaint <strong>and</strong> other services <strong>and</strong><br />

organisations who can help. Once printed, the new leaflet will be available in all patient<br />

areas across the two main hospital sites.<br />

The leaflet is available for download on the <strong>Trust</strong>’s website.<br />

6. The Year Ahead - Future Plans<br />

Development/Goal<br />

Date Due<br />

Implementation of a complaints annual workplan <strong>2012</strong>-2013 Summer <strong>2012</strong><br />

Distribution of a new complaints leaflet Summer <strong>2012</strong><br />

Production of easy-read complaints leaflet Summer <strong>2012</strong><br />

Develop complaints induction material Summer <strong>2012</strong><br />

Moving core complaints team onto one site Summer <strong>2012</strong><br />

Service review of processes <strong>and</strong> procedures Autumn 2013<br />

Gary Etheridge<br />

Deputy Director of Nursing<br />

Victoria Wallen<br />

Interim Head of Complaints & PALS<br />

12


TITLE:<br />

EXECUTIVE SUMMARY<br />

BOARD/GROUP/COMMITTEE:<br />

Single Operating Model – Self certification template<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

Delivering the NHS Foundation <strong>Trust</strong> Pipeline: Single<br />

Operating Model (SOM) sets out the requirement for<br />

□ PEQ……….…...……. □ STRATEGY……….….…….<br />

<strong>Trust</strong>s to complete a self-assessment.<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

The SOM requires NHS <strong>Trust</strong>s to regularly self-certify<br />

governance <strong>and</strong> financial risk ratings on a monthly basis.<br />

They are also required to submit a template of quality <strong>and</strong><br />

contractual information <strong>and</strong> provide an accurate selfassessment<br />

against a series of <strong>Board</strong> statements drawn<br />

from the Monitor Compliance Framework.<br />

□ CLINICAL GOVERNANCE …………..………….....……<br />

□ CHARITABLE FUNDS ………………………………...…<br />

TRUST BOARD – Oct <strong>2012</strong><br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

All declarations <strong>and</strong> self-certification should have been<br />

robustly discussed <strong>and</strong> approved by the <strong>Trust</strong> <strong>Board</strong> with<br />

the discussion minuted. Where an issue of non-compliance<br />

is identified the <strong>Trust</strong> should submit the relevant <strong>Board</strong><br />

approved action plan to rectify the issue. In line with the<br />

principle of avoiding duplication this would normally be the<br />

same level of detail that has been presented to the <strong>Board</strong><br />

to provide them with assurance that an issue can be<br />

rectified.<br />

2. DECISION REQUIRED: CATEGORY:<br />

The <strong>Trust</strong> <strong>Board</strong> is asked to discuss <strong>and</strong> approve the<br />

contents of the <strong>Trust</strong> Self-Assessment<br />

NATIONAL TARGET<br />

□ CQC REGISTRATION<br />

□ CNST<br />

□ HEALTH & SAFETY<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Not applicable.<br />

4. DELIVERABLES<br />

□ ASSURANCE FRAMEWORK<br />

□ CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …NHS Operating Framework<br />

AUTHOR: Claire Burns, Head of Planning, Commissioning<br />

<strong>and</strong> Information<br />

PRESENTER: Neill Moloney, Director of Delivery<br />

DATE: Oct <strong>2012</strong><br />

Meeting the Delivering the NHS Foundation <strong>Trust</strong> Pipeline: Single Operating Model (SOM) requirement for <strong>Trust</strong>s to<br />

complete a self-assessment<br />

5. KEY PERFORMANCE INDICATORS<br />

Please see attached self-assessment which includes indicators<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


SELF-CERTIFICATION RETURNS<br />

Organisation Name:<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Monitoring Period:<br />

September 12<br />

NHS <strong>Trust</strong> Over-sight self certification template


TFA Progress<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Sep‐12<br />

Select the Performance from the drop‐down list<br />

TFA Milestone (All including those delivered)<br />

Milestone<br />

Date<br />

Performance<br />

Comments where milestones are not delivered or where a risk to<br />

delivery has been identified<br />

Mar<br />

1 AA - TFA governance agreed by <strong>Trust</strong> / Cluster / SHA Aug-12 On track to deliver<br />

2 AA - <strong>Trust</strong> Transformation Programme Plan developed Sep-12<br />

3 AA - Transformation plan approved by <strong>Board</strong> Oct-12<br />

High risk to delivery<br />

within timescale<br />

High risk to delivery<br />

within timescale<br />

4 AA - All <strong>Trust</strong> <strong>Board</strong> <strong>and</strong> Executive Director positions filled Oct-12 On track to deliver<br />

complete<br />

plan developed to go to Joint Transformation board in October <strong>and</strong><br />

board in <strong>November</strong><br />

Transformation plan to be developed by Dec 12 following approval of the<br />

LTFM<br />

Chairman <strong>and</strong> Director of Nursing commenced post. Chief Information<br />

Office appointed , due to commence in Nov 12<br />

Fully On track<br />

achieved to deliver<br />

in time<br />

ll h High k risk d l h l<br />

to<br />

delivery<br />

Not fully<br />

achieved<br />

5 AA - OD plan agreed with deliverables/milestones Dec-12 On track to deliver<br />

OD plans were submitted to gain funding ‐ awaiting feedback from DoH<br />

6 AA - Quality Governance self assessment agreed by <strong>Trust</strong> <strong>Board</strong> Jan-13 On track to deliver<br />

7 AA - BGAF self assessment agreed by <strong>Trust</strong> <strong>Board</strong> Jan-13 On track to deliver<br />

Recruited Director of Governance who is taking the lead on this<br />

requirement<br />

Recruited Director of Governance who is taking the lead on this<br />

requirement<br />

8 AA - Formal review of Transformation Programme Jan-13 On track to deliver `12/13 review in Oct 12 , 13/14 plan being developed<br />

9 AA - Workforce strategy/education/training plan approved May-13 On track to deliver New Head of HR recruited <strong>and</strong> taking the lead on this development<br />

10 AA - A&E target achieved at KGH Aug-12 On track to deliver KGH meeting 95% target since June 12<br />

11 AA - A&E target achieved at Queen’s Oct-12<br />

High risk to delivery<br />

within timescale<br />

To meet this st<strong>and</strong>ard the following actions are being put in place<br />

Implement redesigned medical rotas – pilot on 7 day a week consultant<br />

cover commencing in <strong>November</strong><br />

Bed Management review ensuring defined roles <strong>and</strong> responsibilities that<br />

support <strong>and</strong> focus on flow from ED to Assessment <strong>and</strong> then with focus<br />

on the delivery of bed availability from the inpatient areas to deliver<br />

seamless use of the bed capacity to meet dem<strong>and</strong> <strong>and</strong> ensure timely<br />

patient flow.<br />

Ward reviews to commence<br />

7 day working across the <strong>Trust</strong> including support services<br />

Reducing Length of Stay by working with partner organisations <strong>and</strong><br />

families to reduce length of stay<br />

Improved communication with partner organisation to expedite<br />

discharges <strong>and</strong> forward planning to meet dem<strong>and</strong>


12 AA - Quality Improvement Strategy approved by <strong>Trust</strong> <strong>Board</strong> Jan-13 On track to deliver<br />

13 AA - March <strong>2012</strong> CQC compliance actions addressed Dec-12 On track to deliver<br />

<strong>Trust</strong> wide areas agreed in July 12. Each of the 11 Directorates to come<br />

up with up to 3 Directorate Quality indicators to be reported regularly in<br />

their performance meetings alongside progress with the <strong>Trust</strong> wide<br />

areas. These will be confirmed <strong>and</strong> discussed when each Directorate<br />

presents plans to the Quality <strong>and</strong> Safety Committee (sub committee of<br />

the <strong>Board</strong> chaired by Non‐ execs).<br />

the stratgic actions have now been incorporporated as business as usual.<br />

Mock CQC inspections are being undertaken ahead of the CQC<br />

inspections.<br />

14 AA - 12/13 monthly CIP plan re-profiled Sep-12 On track to deliver completed in August <strong>2012</strong><br />

15 AA - Plan to deliver £23m Recurrent CIP by Mar 13 agreed by <strong>Trust</strong><br />

<strong>Board</strong><br />

Oct-12<br />

High risk to delivery<br />

within timescale<br />

full year effects of current plan £17.7M<br />

16<br />

AA - Plan to deliver additional in year non recurrent CIP to deliver 12/13<br />

control total agreed by <strong>Trust</strong> <strong>Board</strong><br />

Oct-12<br />

High risk to delivery<br />

within timescale<br />

Plans in place for 17m , to go to Joint Transformation board in October<br />

<strong>and</strong> board in <strong>November</strong><br />

17 AA - <strong>2012</strong>/13 £23.2m CIP target delivered Oct-12<br />

18 AA - <strong>2012</strong>/13 Plan deficit no greater than £39.2m Apr-13<br />

High risk to delivery<br />

within timescale<br />

High risk to delivery<br />

within timescale<br />

Current forecast to deliver £17.7M CIPs. In additon to this the detail is<br />

included in the <strong>Trust</strong> FIMS return<br />

as of month 6 FOT is £46.8M<br />

19 AA - 5 year <strong>Trust</strong> productivity programme developed Sep-12 On track to deliver<br />

baseline LTFM with 5 yr productivity programme complete with report to<br />

<strong>Trust</strong> <strong>Board</strong><br />

20<br />

AA - LTFM base case assumptions <strong>and</strong> options to bridge gap agreed by<br />

commissioners<br />

Oct-12<br />

On track to deliver<br />

baseline LTFM complete <strong>and</strong> activity assumptions agreed with<br />

commissioners<br />

21<br />

AA - SHA review 5 year <strong>Trust</strong> productivity programme <strong>and</strong> LTFM<br />

baseline <strong>and</strong> options to bridge gap<br />

Oct-12<br />

On track to deliver<br />

amendments being made to final report following trust board <strong>and</strong> on<br />

track to deliver against timeframe<br />

22 AA - Clinical & Financial Viability Plan approved by <strong>Trust</strong> <strong>Board</strong> Dec-12 On track to deliver baseline LTFM complete. Awaiting completion of out of hospital LTFM<br />

23 AA - OBC (inc commissioner support) approved by <strong>Trust</strong> <strong>Board</strong> Date for OBC to be confirmed<br />

24 AA - SHA approval of OBC at CIC Date for OBC to be confirmed<br />

25 AA - FBC approved by <strong>Trust</strong> <strong>Board</strong> Date for FBC to be confirmed<br />

26 AA - SHA approval of FBC Date for FBC to be confirmed<br />

27 AA - BHR transition plan for closure KGH maternity (intrapartum care) Oct-12 On track to deliver approved at the October <strong>Trust</strong> <strong>Board</strong> MeetingMeeting<br />

28 AA - BHR system readiness assurance gateway Dec-12 On track to deliver this is a commissioner led process on track to deliver<br />

29 AA - BHR birth numbers < 8000 per annum (@660 pcm) Feb-13 On track to deliver<br />

arrangements now agreed with commissioners on how birth numbers<br />

will be reduced <strong>and</strong> escaltion policy in place for varriation in activity


30 AA - KGH maternity closed Mar-13 On track to deliver progress being monitored by Maternity Strategy <strong>Board</strong><br />

31<br />

32


TFA Progress<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Sep‐12<br />

Select the Performance from the drop‐down list<br />

TFA Milestone (All including those delivered)<br />

Milestone<br />

Date<br />

Performance<br />

Comments where milestones are not delivered or where a risk to<br />

delivery has been identified<br />

1<br />

TFA - Agreement reached on BHRUT assuming reasonability for<br />

integrated elderly pathway with transfer of staffing <strong>and</strong> assets during<br />

2011/12 (RED)<br />

Jun-11<br />

Not fully achieved<br />

No agreement reached with commissioners on the transfer of these<br />

services. Out of Hospital review currently being undertaken <strong>and</strong> due to<br />

report by December<br />

2<br />

TFA - BHRUT achieving 95th percentile st<strong>and</strong>ard for all A&E departmentsthen<br />

sustained to year end. (RED)<br />

Jun-11<br />

Not fully achieved<br />

A&E target not sustained<br />

3<br />

TFA - BHRUT achieving all Cancer targets- then sustained to year end<br />

(GREEN)<br />

Jun-11<br />

Fully achieved in time<br />

In 2011/12 this milestone was achieved although performance has<br />

deteriorated in the first quarter of <strong>2012</strong>/13<br />

4<br />

TFA - Agreement of volumes <strong>and</strong> value of transfer of elective work from<br />

Whipps Cross <strong>and</strong> tertiary providers during 2011/12 <strong>and</strong> <strong>2012</strong>/13 (RED)<br />

Jun-11<br />

Not fully achieved<br />

No agreement on the transfer of these services has been agreed.<br />

5<br />

TFA - Financial return at month 2 on target against plan YTD <strong>and</strong> yearend<br />

projection in control (RED)<br />

Jun-11<br />

Not fully achieved<br />

Financial commitments in 2011/12 not achieved.<br />

6 TFA - SHA financial challenges <strong>and</strong> productivity opportunities<br />

assessment (RED)<br />

Jun-11 Fully achieved in time complete<br />

7 TFA - Q1 review of finance, CIPs <strong>and</strong> quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Jun-11 Fully achieved in time complete<br />

8<br />

TFA - <strong>Board</strong> to <strong>Board</strong> (20 Sept) on financial challenge <strong>and</strong> productivity<br />

opportunity<br />

Sep-11 Fully achieved in time complete<br />

9<br />

TFA - Financial return at month 5 on target to meet £28.8m (including<br />

IFRS) control total(RED)<br />

Sep-11 Not fully achieved Financial commitments in 2011/12 not achieved<br />

10 TFA - <strong>Board</strong> to <strong>Board</strong> 18 October 2011 Oct-11 Fully achieved in time complete


11 TFA - Q3 review of finance, quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs) (RED)<br />

Oct-11<br />

Not fully achieved<br />

12<br />

TFA - Financial return at month 7 on target to meet £35.6m (including<br />

IFRS) control total(RED)<br />

Oct-11 Not fully achieved Financial commitments in 2011/12 not achieved<br />

13<br />

TFA - Establishment of Clinical Productivity Programme - year 1 of full<br />

delivery <strong>2012</strong>/13<br />

Nov-11<br />

Fully achieved but late<br />

Business Plans were constructed such that first draft plans were available<br />

in January <strong>2012</strong>.<br />

14 TFA - Application to CQC for removal of conditions (RED) Nov-11 Fully achieved but late Final removal of conditions achieved in Q1 of <strong>2012</strong>/13<br />

15<br />

TFA - Financial return at month 8 on target to meet £28.8m (including<br />

IFRS) control total (RED)<br />

Nov-11 Not fully achieved Financial commitments in 2011/12 not achieved.<br />

16 TFA - Q3 review of finance, quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs) (RED)<br />

Jan-12<br />

Not fully achieved<br />

17 TFA - £41.0m deficit control total for 2011/12 projected to be met (RED) Feb-12 Not fully achieved Financial commitments in 2011/12 not achieved.<br />

18 TFA - No CQC conditions (RED) Mar-12 Fully achieved but late Final removal of conditions achieved in Q1 of <strong>2012</strong>/13<br />

19<br />

TFA - Q4 review of finance, quality & performance (including<br />

achievement <strong>and</strong> trajectory of CIPs) (RED)<br />

Apr-12<br />

Not fully achieved<br />

20 TFA - Submit IBP & LTFM (RED) Jun-12 Not fully achieved<br />

Baseline LTFM completed in June <strong>2012</strong> which is being updated using 4<br />

options for clinical productivity <strong>and</strong> reconfiguration by October <strong>2012</strong><br />

21 TFA - Q1 review of finance, CIPs <strong>and</strong> quality <strong>and</strong> performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Jul-12 Fully achieved in time complete<br />

22 TFA - Undertake public consultation (RED) Jul-12 Not fully achieved Revised tracjectory to be agreed.<br />

23 TFA - Safety & Quality Assurance Gateway Review Aug-12<br />

Will not be delivered on<br />

time<br />

Revised trajectory to be agreed<br />

24<br />

TFA - Q2 review of finance. CIPs <strong>and</strong> Quality & performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Oct-12<br />

On track to deliver


25 TFA - Final IBP /; LTFM Dec-12<br />

High risk to delivery<br />

within timescale<br />

Revised trajectory for IBP to be agreed<br />

26<br />

TFA - Q3 review of finance, CIPs <strong>and</strong> Quality & Performance (including<br />

achievement <strong>and</strong> trajectory of CIPs)<br />

Jan-13<br />

High risk to delivery<br />

within timescale<br />

27 TFA - <strong>Board</strong> to <strong>Board</strong> Meeting Jan-13<br />

28 TFA - <strong>Trust</strong> <strong>Board</strong> formal approval of FT Application Feb-13<br />

29 TFA - SHA <strong>Board</strong> Approval of FT Application Mar-13<br />

30 TFA - Submission of FT Application to DH Apr-13<br />

Will not be delivered on<br />

time<br />

Will not be delivered on<br />

time<br />

Will not be delivered on<br />

time<br />

Will not be delivered on<br />

time<br />

Revised trajectory to be agreed<br />

Revised trajectory to be agreed<br />

Revised trajectory to be agreed<br />

31<br />

32


NHS <strong>Trust</strong> Governance Declarations : <strong>2012</strong>/13 In-Year Reporting<br />

Name of Organisation: BHR University Hospitals NHS <strong>Trust</strong> Period: August <strong>2012</strong><br />

Organisational risk rating<br />

Each organisation is required to calculate their risk score <strong>and</strong> RAG rate their current performance, in addition to providing comment with regard to any contractual issues<br />

<strong>and</strong> compliance with CQC essential st<strong>and</strong>ards:<br />

Key Area for rating / comment by Provider<br />

Governance Risk Rating (RAG as per SOM guidance)<br />

Financial Risk Rating (Assign number as per SOM guidance)<br />

Contractual Position (RAG as per SOM guidance)<br />

Score / RAG rating*<br />

R<br />

R<br />

g<br />

* Please type in R, A or G<br />

Governance Declarations<br />

NHS <strong>Trust</strong>s must ensure that plans in place are sufficient to ensure compliance in relation to all national targets <strong>and</strong> including ongoing compliance with the Code of<br />

Practice for the Prevention <strong>and</strong> Control of Healthcare Associated Infections, CQC Essential st<strong>and</strong>ards <strong>and</strong> declare any contractual issues.<br />

Supporting detail is required where compliance cannot be confirmed.<br />

Please complete sign one of the two declarations below. If you sign declaration 2, provide supporting detail using the form below. Signature may be either h<strong>and</strong> written<br />

or electronic, you are required to print your name.<br />

Governance declaration 1<br />

The <strong>Board</strong> is satisfied that plans in place are sufficient to ensure continuing compliance with all existing targets (after the application of thresholds), <strong>and</strong> with all known<br />

targets going forward. The board is satisfied that plans in place are sufficient to ensure ongoing compliance with the Code of Practice for the Prevention <strong>and</strong> Control of<br />

Healthcare Associated Infections (including the Hygiene Code) <strong>and</strong> CQC Essential st<strong>and</strong>ards. The board also confirms that there are no material contractual disputes.<br />

Signed by:<br />

Print Name:<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Signed by:<br />

Print Name:<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Governance declaration 2<br />

For one or some of the following declarations Governance, Finance, Service Provision, Quality <strong>and</strong> Safety, CQC essential st<strong>and</strong>ards or the Code of Practice for the<br />

Prevention <strong>and</strong> Control of Healthcare Associated Infections the <strong>Board</strong> cannot make Declaration 1 <strong>and</strong> has provided relevant details below.<br />

The board is suggesting that at the current time there is insufficient assurance available to ensure continuing compliance with all existing targets (after the application<br />

of thresholds) <strong>and</strong>/or that it may have material contractual disputes.<br />

Signed by : Print Name :<br />

Sir Peter Dixon<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Chairman<br />

Signed by : Print Name :<br />

Averil Dongworth<br />

on behalf of the <strong>Trust</strong> <strong>Board</strong><br />

Acting in capacity as:<br />

Chief Executive<br />

If Declaration 2 has been signed:<br />

Please identify which targets have led to the <strong>Board</strong> being unable to sign declaration 1. For each area such as Governance, Finance, Contractual, CQC Essential<br />

St<strong>and</strong>ards, where the board is declaring insufficient assurance please state the reason for being unable to sign the declaration, <strong>and</strong> explain briefly what steps are being<br />

taken to resolve the issue. Please provide an appropriate level of detail.<br />

Target/St<strong>and</strong>ard:<br />

The Issue :<br />

Goverance<br />

A&E performance, MRSA & Cdiff performance, CQC warning notices non compliance<br />

MRSA & Cdiff:<br />

New Director of Infection Prevention <strong>and</strong> Control is now in post. There is a change of focus to Infection prevention<br />

<strong>and</strong> the current action plan is being reviewed to identify the high impact actions, one of which is ANTT. ANTT has<br />

been introduced across the <strong>Trust</strong> <strong>and</strong> to date 60% of Matrons <strong>and</strong> 72% of senior sisters have achieved Train the<br />

Trainer competencies. These staff will now roll out the training across the wards. New h<strong>and</strong> washing campaigns <strong>and</strong><br />

training programmes have been introduced. Training for doctors has commenced for FY1/2s Consultants <strong>and</strong> is<br />

being planned for staff grades.<br />

Action :<br />

CQC:<br />

<strong>Trust</strong>-wide action plan in place that captures all outst<strong>and</strong>ing CQC requirements that has been comprehensively<br />

shared with the SHA <strong>and</strong> local Commissioners, is being implemented with <strong>Trust</strong> <strong>Board</strong> <strong>and</strong> is subjected to external<br />

monitoring.<br />

A&E target<br />

Implement redesigned medical rotas – pilot on 7 day a week consultant cover commencing in <strong>November</strong><br />

Bed Management review ensuring defined roles <strong>and</strong> responsibilities that support <strong>and</strong> focus on flow from ED to<br />

Assessment <strong>and</strong> then with focus on the delivery of bed availability from the inpatient areas to deliver seamless use of th<br />

Ward reviews to commence<br />

7 day working across the <strong>Trust</strong> including support services<br />

Reducing Length of Stay by working with partner organisations <strong>and</strong> families to reduce length of stay<br />

Improved communication with partner organisation to expedite discharges <strong>and</strong> forward planning to meet dem<strong>and</strong><br />

Target/St<strong>and</strong>ard:<br />

The Issue :<br />

Action :<br />

Finance<br />

Financial risk rating of 1<br />

In-year savings programme developed with support from external consultancy. Programme Management Office established<br />

to support delivery of cost improvement plans. Long term financial model developed along with 5 year productivity <strong>and</strong><br />

efficiency programme for review at October <strong>2012</strong> <strong>Trust</strong> <strong>Board</strong>


Effectiveness<br />

GOVERNANCE RISK RATINGS<br />

BHR University Hospitals NHS<br />

<strong>Trust</strong><br />

See 'Notes' for further detail of each of the below indicators<br />

Area Ref Indicator Sub Sections<br />

Threshold<br />

Referral to treatment information 50%<br />

1a<br />

Data completeness: Community services<br />

comprising:<br />

Referral information 50%<br />

Treatment activity information 50%<br />

Weighting<br />

Historic Data<br />

Qtr to Dec- Qtr to<br />

11 Mar-12<br />

1.0 N/a<br />

Insert YES (target met in month), NO (not met in month) or N/A (as<br />

appropriate)<br />

See separate rule for A&E<br />

Qtr to<br />

Jun-12<br />

N/a N/a N/a<br />

Current Data<br />

Jul 12 Aug-12 Sep-12<br />

Patient identifier information 50% N/a N/a N/a N/a N/a N/a Yes<br />

Data completeness, community services:<br />

1b<br />

(may be introduced later)<br />

Patients dying at home / care<br />

50% N/a N/a N/a N/a N/a N/a Yes<br />

home<br />

1c Data completeness: identifiers MHMDS 97% 0.5 N/a N/a N/a N/a N/a N/a Yes<br />

N/a<br />

N/a<br />

Qtr to<br />

Sep-12<br />

Yes<br />

Comments where target<br />

not achieved<br />

1c<br />

2a<br />

Data completeness: outcomes for patients<br />

on CPA<br />

From point of referral to treatment in<br />

aggregate (RTT) – admitted<br />

50% 0.5 N/a N/a N/a N/a N/a N/a Yes<br />

Maximum time of 18 weeks 90% 1.0 N/a N/a Yes Yes Yes yes Yes<br />

Patient Experience<br />

2b<br />

2c<br />

2d<br />

3a<br />

From point of referral to treatment in<br />

aggregate (RTT) – non-admitted<br />

From point of referral to treatment in<br />

aggregate (RTT) – patients on an<br />

incomplete pathway<br />

Certification against compliance with<br />

requirements regarding access to<br />

healthcare for people with a learning<br />

disability<br />

All cancers: 31-day wait for second or<br />

subsequent treatment, comprising :<br />

Maximum time of 18 weeks 95% 1.0 Yes Yes Yes Yes yes yes Yes<br />

Maximum time of 18 weeks 92% 1.0 Yes Yes Yes Yes yes yes Yes<br />

Surgery 94%<br />

Anti cancer drug treatments 98%<br />

Radiotherapy 94%<br />

From urgent GP referral for<br />

suspected cancer<br />

85%<br />

3b All cancers: 62-day wait for first treatment: 1.0 yes<br />

From NHS Cancer Screening<br />

90%<br />

Service referral<br />

N/A 0.5 no no no no no no No<br />

1.0 yes<br />

yes yes yes yes yes<br />

yes<br />

no<br />

Yes<br />

No yes yes No<br />

the <strong>Trust</strong> is meeting meeting 5 of the 6<br />

requirements . The area not yet fully<br />

compliant 'audit of practice' against policy.<br />

Business Units will review casenote for<br />

patients with LD treated in the service during<br />

October to meet this requirement<br />

This measure was not met in July. The<br />

underachievement was due to complex<br />

pathways, endoscopy capacity <strong>and</strong> lack of<br />

escalation across the pathways. The annual<br />

trajectory was approved by the <strong>Trust</strong><br />

Executive Committee (TEC) with action plans<br />

being provided by each specialty. In addition<br />

the NHS Intensive Support Team provided<br />

the Service with advice. Weekly specialtylevel<br />

patient target list (PTL) meetings with<br />

each Service Manager have been<br />

introduced; a more robust escalation process<br />

for delays in radiological <strong>and</strong> pathology<br />

reporting has been implemented together<br />

with a review of endoscopy capacity. The<br />

Service is also recruiting additional MDT coordinators<br />

a senior MDT coordinator <strong>and</strong> a<br />

float MDT coordinator to provide cover for<br />

leave. The target has been achieved since<br />

August <strong>2012</strong>.


3c<br />

3d<br />

All Cancers: 31-day wait from diagnosis to<br />

first treatment<br />

Cancer: 2 week wait from referral to date<br />

first seen, comprising:<br />

all urgent referrals 93%<br />

for symptomatic breast patients<br />

(cancer not initially suspected)<br />

93%<br />

96% 0.5 yes yes yes yes yes yes Yes<br />

0.5 yes yes yes yes yes yes Yes<br />

Quality<br />

3e<br />

3f<br />

3g<br />

3h<br />

A&E: From arrival to<br />

admission/transfer/discharge<br />

Care Programme Approach (CPA) patients,<br />

comprising:<br />

Minimising mental health delayed transfers<br />

of care<br />

Admissions to inpatients services had<br />

access to Crisis Resolution/Home<br />

Treatment teams<br />

Maximum waiting time of four<br />

hours<br />

Receiving follow-up contact within<br />

7 days of discharge<br />

Having formal review<br />

within 12 months<br />

95% 1.0 No No No No no no No<br />

95%<br />

1.0 N/a N/a N/a N/a n/a n/a Yes<br />

95%<br />

≤7.5% 1.0 yes yes Yes Yes yes yes Yes<br />

95% 1.0 N/a N/a N/a n/a n/a n/a Yes<br />

Implement redesigned medical rotas – pilot<br />

on 7 day a week consultant cover<br />

commencing in <strong>November</strong><br />

Bed Management review ensuring defined<br />

roles <strong>and</strong> responsibilities that support <strong>and</strong><br />

focus on flow from ED to Assessment <strong>and</strong><br />

then with focus on the delivery of bed<br />

availability from the inpatient areas to deliver<br />

seamless use of the bed capacity to meet<br />

dem<strong>and</strong> <strong>and</strong> ensure timely patient flow.<br />

Ward reviews to commence<br />

7 day working across the <strong>Trust</strong> including<br />

support services<br />

Reducing Length of Stay by working with<br />

partner organisations <strong>and</strong> families to reduce<br />

length of stay<br />

Improved communication with partner<br />

organisation to expedite discharges <strong>and</strong><br />

forward planning to meet dem<strong>and</strong><br />

3i<br />

Meeting commitment to serve new<br />

psychosis cases by early intervention<br />

teams<br />

95% 0.5 N/a N/a N/a N/a n/a n/a Yes<br />

3j<br />

Category A call – emergency response<br />

within 8 minutes<br />

75% 1.0 N/a N/a N/a N/a n/a n/a Yes<br />

3k<br />

Category A call – ambulance vehicle<br />

arrives within 19 minutes<br />

95% 1.0 N/a N/a N/a N/a n/a n/a Yes<br />

There were 7 cases of infection reported<br />

during September, none of the patients<br />

acquiring the infection was as the result of<br />

cross contamination.<br />

4a<br />

Clostridium Difficile<br />

Enter<br />

Are you below the ceiling for your<br />

contractual<br />

monthly trajectory<br />

ceiling<br />

1.0 yes yes no no no no No<br />

Exception reporting occurred in all 7 cases<br />

against the st<strong>and</strong>ardised 17 criteria. 6 wards<br />

scored 100%, one ward (heather) scored<br />

less than 100% <strong>and</strong> has been required to<br />

produce an action plan to address the issues<br />

highlighted by the infection control exception<br />

report. No primary cause was identified for<br />

this case. The issues identified were practice<br />

related. The Infection Control Committee<br />

monitors the wards progress against their<br />

action plans


Safety<br />

4b<br />

MRSA<br />

Enter<br />

Are you below the ceiling for your<br />

contractual<br />

monthly trajectory<br />

ceiling<br />

1.0 yes yes no no No No No<br />

2 cases Q1 , 2 cases in September. 6 YTD<br />

against ceiling 7 per year New Director of<br />

Infection Prevention <strong>and</strong> Control is now in<br />

post.There is a change of focus to Infection<br />

prevention <strong>and</strong> the current action plan is<br />

being reviewed to identify the high impact<br />

actions, one of which is ANTT. ANTT has<br />

been introduced across the <strong>Trust</strong> <strong>and</strong> to date<br />

60% of Matrons <strong>and</strong> 72% of senior sisters<br />

have achieved Train the Trainer<br />

competencies. These staff will now roll out<br />

the training across the wards. New h<strong>and</strong><br />

washing campaigns <strong>and</strong> training<br />

programmes introduced. Training for doctors<br />

has commenced for FY1/2s Consultants <strong>and</strong><br />

is being planned for staff grades.<br />

A<br />

CQC Registration<br />

Non-Compliance with CQC Essential<br />

St<strong>and</strong>ards resulting in a Major Impact on<br />

Patients<br />

0 2.0 yes yes Yes No No No No<br />

B<br />

Non-Compliance with CQC Essential<br />

St<strong>and</strong>ards resulting in Enforcement Action<br />

0 4.0 yes yes Yes Yes Yes Yes<br />

<strong>Trust</strong>-wide action plan in place that captures<br />

all outst<strong>and</strong>ing CQC requirements that has<br />

been comprehensively shared with the SHA<br />

<strong>and</strong> local Commissioners, is being<br />

implemented with <strong>Trust</strong> <strong>Board</strong> <strong>and</strong> is<br />

subjected to external monitoring.<br />

C<br />

NHS Litigation Authority – Failure to<br />

maintain, or certify a minimum published<br />

CNST level of 1.0 or have in place<br />

appropriate alternative arrangements<br />

0 2.0 no no No No No No No<br />

RAG RATING :<br />

GREEN = Score of 1 or under<br />

TOTAL 5.5 5.5 8.5 8.5 7.5 3.5 8.5<br />

AMBER/GREEN = Score between 1 <strong>and</strong> 1.9<br />

AMBER / RED = Score between 2 <strong>and</strong> 3.9<br />

RED = Score of 4 or above<br />

Overriding Rules - Nature <strong>and</strong> Duration of Override at SHA's Discretion<br />

Greater than six cases in the year to date, <strong>and</strong> either:<br />

i) Meeting the MRSA Objective<br />

Breaches the cumulative year-to-date trajectory for three<br />

successive quarters<br />

no no no No No no No<br />

Breaches its full year objective<br />

Greater than 12 cases in the year to date, <strong>and</strong> either:<br />

Breaches the cumulative year-to-date trajectory for three<br />

ii) Meeting the C-Diff Objective<br />

successive quarters<br />

Breaches its full year objective<br />

no no no no No No No<br />

Reports important or signficant outbreaks of C.difficile, as<br />

defined by the Health Protection Agency.<br />

Breaches:<br />

The admitted patients 18 weeks waiting time measure for a<br />

third successive quarter


iii) RTT Waiting Times The non-admitted patients 18 weeks waiting time measure<br />

for a third successive quarter<br />

The incomplete pathway 18 weeks waiting time measure for<br />

a third successive quarter<br />

no<br />

no<br />

no no No<br />

No<br />

No<br />

Fails to meet the A&E target twice in any two quarters over<br />

iv) A&E Clinical Quality Indicator a 12-month period <strong>and</strong> fails the indicator in a quarter during yes yes yes yes Yes Yes Yes<br />

the subsequent nine-month period or the full year.<br />

v) Cancer Wait Times<br />

Breaches either:<br />

the 31-day cancer waiting time target for a third successive<br />

quarter<br />

the 62-day cancer waiting time target for a third successive<br />

quarter<br />

no no no no No<br />

No<br />

No<br />

vi)<br />

Ambulance Response Times<br />

Breaches either:<br />

the category A 8-minute response time target for a third<br />

successive quarter<br />

the category A 19-minute response time target for a third<br />

successive quarter<br />

N/a<br />

n/a n/a n/a N/a N/a<br />

Yes<br />

vii)<br />

Community Services data completeness<br />

Fails to maintain the threshold for data completeness for:<br />

referral to treatment information for a third successive<br />

quarter;<br />

service referral information for a third successive quarter,<br />

or;<br />

treatment activity information for a third successive quarter<br />

n/a<br />

n/a<br />

n/a n/a N/a<br />

N/a<br />

Yes<br />

viii) Any Indicator weighted 1.0 Breaches the indicator for three successive quarters.<br />

yes yes yes yes Yes<br />

Number of Overrides Triggered 2.0 2.0 2.0 2.0 1.0 1.0 4.0<br />

A&E target


FINANCIAL RISK RATING<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Insert the Score (1-5) Achieved for each<br />

Criteria Per Month<br />

Risk Ratings<br />

Reported<br />

Position<br />

Normalised<br />

Position*<br />

Criteria Indicator Weight 5 4 3 2 1<br />

Year to<br />

Date<br />

Forecast<br />

Outturn<br />

Year to<br />

Date<br />

Forecast<br />

Outturn<br />

Underlying<br />

performance<br />

EBITDA margin % 25% 11 9 5 1


FINANCIAL RISK TRIGGERS<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Insert "Yes" / "No" Assessment for the Month<br />

Historic Data<br />

Current Data<br />

Criteria<br />

Qtr to<br />

Dec-11<br />

Qtr to<br />

Mar-12<br />

Qtr to<br />

Jun-12<br />

Jul 12 Aug-12 Sep-12<br />

Qtr to<br />

Sep-12<br />

Comments where risks are triggered<br />

1<br />

Unplanned decrease in EBITDA margin in two<br />

consecutive quarters<br />

yes yes yes no No Yes Yes<br />

11/12 figures influenced by position against Plan where<br />

agreed Control total with SHA adjusted £10m. Ytd at Sep<br />

<strong>2012</strong>/13 EBITDA -2.2% against plan of -1.6%<br />

2<br />

Quarterly self-certification by trust that the financial risk<br />

rating (FRR) may be less than 3 in the next 12 months<br />

yes yes yes yes Yes Yes Yes<br />

Driven by deficit position both planned <strong>and</strong> actual<br />

3<br />

Working capital facility (WCF) agreement includes default<br />

clause<br />

4<br />

Debtors > 90 days past due account for more than 5% of<br />

total debtor balances<br />

yes yes yes yes Yes Yes Yes<br />

Taken from AR ledger, after application of bad debt provision.<br />

Debtors > 90 days account for 9% of total debt. Overseas<br />

patients forms a particular risk. Some debt written off in<br />

September<br />

5<br />

Creditors > 90 days past due account for more than 5% of<br />

total creditor balances<br />

yes yes yes yes Yes Yes Yes<br />

Taken from AP ledger, creditors over 90 days form 14% of<br />

total creditors. Heavily influenced by cash-flow consequences<br />

of running a deficit, plus planning for October's PFI payment.<br />

6<br />

7<br />

8<br />

Two or more changes in Finance Director in a twelve<br />

month period<br />

Interim Finance Director in place over more than one<br />

quarter end<br />

Quarter end cash balance


CONTRACTUAL DATA<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

Insert "Yes" / "No" Assessment for the Month<br />

Historic Data<br />

Current Data<br />

Criteria #REF! #REF! #REF! #REF! #REF! #REF! #REF! Comments where reds are triggered<br />

Are the prior year contracts* closed? yes yes yes yes yes yes Yes<br />

Are all current year contracts* agreed <strong>and</strong><br />

signed?<br />

Are both the NHS <strong>Trust</strong> <strong>and</strong> commissioner<br />

fulfilling the terms of the contract?<br />

yes yes yes yes yes yes Yes<br />

yes yes no no no no No<br />

CDIFF Targets, A&E admissions, Activity<br />

reductions <strong>and</strong> Readmissions reinvestment<br />

are currently all under review<br />

on a weekly basis to ensure acheivement<br />

by the end of the Financial year.<br />

Are there any disputes over the terms of the<br />

contract?<br />

Might the dispute require SHA intervention or<br />

arbitration?<br />

no no no no no no No<br />

no no no no No no No<br />

no<br />

Are the parties already in arbitration? no no no no no no No<br />

no<br />

Have any performance notices been issued? yes yes no no no no No<br />

Sexual health notice was issued in 2011/12<br />

<strong>and</strong> has now been resolved <strong>and</strong> removed.<br />

Have any penalties been applied? no no no no no no No


QUALITY<br />

#REF!<br />

Insert Performance in Month<br />

Criteria<br />

Unit Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12<br />

Septemb<br />

er 12<br />

Comments on Performance in Month<br />

1 SHMI - latest data Ratio 95.6<br />

2<br />

Venous Thromboembolism (VTE)<br />

Screening<br />

% 92 92 90 90 91 91 94 94 93 94 94 95<br />

To improve performance to ensure delivery of this<br />

st<strong>and</strong>ard the following actions have been taken<br />

A review of the pathway for patients who go straight to a<br />

procedure without attending a pre‐admission clinic to<br />

ensure that these patients are swabbed prior to admission.<br />

This pathway will be implemented from October<br />

3a Elective MRSA Screening % no data 71 61 67 81 78 78 78 74 78 79 84<br />

A review of data capture to ensure that all swabs are<br />

matched correctly to admissions – this will be completed in<br />

September<br />

Training of Admissions Team Leader on data accuracy,<br />

which will improve data quality when patients are added to<br />

waiting list <strong>and</strong> thereby improve coverage of data for MRSA<br />

elective screening; this will be completed in September<br />

To improve performance to ensure delivery of this<br />

st<strong>and</strong>ard the following actions have been taken<br />

3b Non Elective MRSA Screening % no data 76 72 71 70 69 69 74 83 77 75 79<br />

• A change of process in emergency day unit (EMDU) to<br />

screen patients who currently do not qualify for screening<br />

has been implemented in September<br />

• Using the ward board rounds to check if patents have<br />

been screened. The Ward Sponsors will work with the<br />

wards to ensure that screening takes place.<br />

• Staff to be reminded to write legibly on test requests to<br />

ensure that the Lab is able to identify which patient the<br />

swabs have come from. This error will be addressed by the<br />

roll out of order communications for Pathology in<br />

December <strong>2012</strong>,<br />

• Review of the data to ensure patients who do not require<br />

screening are excluded from the data this will be<br />

completed in September


4<br />

Single Sex Accommodation<br />

Breaches<br />

Number 39 34 14 17 21 30 30 21 10 12 19 13<br />

These occurred within the High Dependency Unit (9),<br />

Intensive Therapy Unit (3), <strong>and</strong> Coronary Care Unit (1) at<br />

Queen’s Hospital. All of the breaches occurred due to<br />

delays in the transfer out of patients who had been<br />

‘stepped down’ to general care. This was due to constraints<br />

on the availability of suitable beds for ‘step down’ due to<br />

patient flow delays across the organisation. A root cause<br />

analysis on all patients who breach will commence on the<br />

1st October <strong>2012</strong>.The Deputy Director of Nursing during<br />

September r<strong>and</strong>omly spoke to a number of patients who<br />

breached during September <strong>and</strong> they confirmed that the<br />

reason for the breach was explained to them <strong>and</strong> that their<br />

privacy <strong>and</strong> dignity was maintained during this period of<br />

their care.<br />

5<br />

Open Serious Incidents Requiring<br />

Investigation (SIRI)<br />

Number 320 318 274 274 274 270 216 105 91 68 46 35<br />

6 "Never Events" in month Number 0 1 0 0 0 0 0 0 0 0 0 0<br />

7 CQC Conditions or Warning Notices Number 3 3 3 3 2 2 2 2 2 2 2 2<br />

8<br />

Open Central Alert System (CAS)<br />

Alerts<br />

Number 0 0 0 0 0 0 0 0 0 0 0 0<br />

<strong>Trust</strong>‐wide action plan in place that captures all<br />

outst<strong>and</strong>ing CQC requirements that has been<br />

comprehensively shared with the SHA <strong>and</strong> local<br />

Commissioners, is being implemented with <strong>Trust</strong> <strong>Board</strong> <strong>and</strong><br />

is subjected to external monitoring.<br />

9<br />

10<br />

RED rated areas on your maternity<br />

dashboard?<br />

Falls resulting in severe injury or<br />

death<br />

Number 16 13 10 6 7 5 8 10 9 7 5<br />

Number 4 1 1 1 3 3 3 2 8 2 3 0<br />

11 Grade 3 or 4 pressure ulcers Number 12 5 8 11 6 5 5 4 6 5 2 1<br />

one grade 3 pressure ulcer occurred in Sept 12. The trust is<br />

now focussing on reducing the number of grade 2 PU by<br />

50%<br />

12<br />

100% compliance with WHO<br />

surgical checklist<br />

Y/N n y y n y y<br />

13 Formal complaints received Number 85 111 78 121 120 128 101 98 85 100 85 67<br />

14<br />

Agency as a % of Employee Benefit<br />

Expenditure<br />

% 5.3 6.5 4.7 5.3 4.8 4.65<br />

15 Sickness absence rate % 5.46 5.13 6 5.15 5.81 4.41 4.29 4.51 4 4.59 4.68 4.88<br />

16<br />

Consultants which, at their last<br />

appraisal, had fully completed their<br />

previous years PDP<br />

% this data is not collected


<strong>Board</strong> Statements<br />

BHR University Hospitals NHS <strong>Trust</strong><br />

September 12<br />

For each statement, the <strong>Board</strong> is asked to confirm the following:<br />

For CLINICAL QUALITY, that: Response Comments<br />

The <strong>Board</strong> is satisfied that, to the best of its knowledge <strong>and</strong> using its own processes <strong>and</strong> having had regard to the<br />

SHA's Provider Management Regime (supported by Care Quality Commission information, its own information on<br />

1 serious incidents, patterns of complaints, <strong>and</strong> including any further metrics it chooses to adopt), the trust has, <strong>and</strong> will Yes<br />

keep in place, effective arrangements for the purpose of monitoring <strong>and</strong> continually improving the quality of healthcare<br />

provided to its patients.<br />

2<br />

The board is satisfied that plans in place are sufficient to ensure ongoing compliance with the Care Quality<br />

Commission’s registration requirements.<br />

Yes<br />

3<br />

The board is satisfied that processes <strong>and</strong> procedures are in place to ensure all medical practitioners providing care on<br />

behalf of the trust have met the relevant registration <strong>and</strong> revalidation requirements.<br />

Yes<br />

For FINANCE, that: Response Comments<br />

4 The board anticipates that the trust will continue to maintain a financial risk rating of at least 3 over the next 12 months. No<br />

The board is satisfied that the trust shall at all times remain a going concern, as defined by relevant accounting<br />

5 Yes<br />

st<strong>and</strong>ards in force from time to time.<br />

For GOVERNANCE, that: Response Comments<br />

6 The board will ensure that the trust remains at all times compliant with has regard to the NHS Constitution.<br />

Yes<br />

All current key risks have been identified (raised either internally or by external audit <strong>and</strong> assessment bodies) <strong>and</strong><br />

7 Yes<br />

addressed – or there are appropriate action plans in place to address the issues – in a timely manner.<br />

8<br />

The board has considered all likely future risks <strong>and</strong> has reviewed appropriate evidence regarding the level of severity,<br />

likelihood of it occurring <strong>and</strong> the plans for mitigation of these risks.<br />

Yes<br />

The necessary planning, performance management <strong>and</strong> corporate <strong>and</strong> clinical risk management processes <strong>and</strong><br />

9 mitigation plans are in place to deliver the annual operating plan, including that all audit committee recommendations Yes<br />

accepted by the board are implemented satisfactorily.<br />

An Annual Governance Statement is in place, <strong>and</strong> the trust is compliant with the risk management <strong>and</strong> assurance<br />

10 framework requirements that support the Statement pursuant to the most up to date guidance from HM Treasury<br />

Yes<br />

(www.hm-treasury.gov.uk).<br />

The board is satisfied that plans in place are sufficient to ensure ongoing compliance with all existing targets (after the<br />

11 application of thresholds) as set out in the relevant GRR; <strong>and</strong> a commitment to comply with all known targets going No<br />

forwards.<br />

12<br />

The trust has achieved a minimum of Level 2 performance against the requirements of the Information Governance<br />

Toolkit.<br />

No<br />

Details are included in previous on the GRR commentary<br />

Last year 10/45 requirements at level 1<br />

Action plans agreed to ensure level 2 reached for all<br />

st<strong>and</strong>ards<br />

Majority of actions will be complete by Dec 12 although<br />

evidence will not be available for a small number until<br />

Feb 13<br />

The board will ensure that the trust will at all times operate effectively. This includes maintaining its register of interests,<br />

13 ensuring that there are no material conflicts of interest in the board of directors; <strong>and</strong> that all board positions are filled, or Yes<br />

plans are in place to fill any vacancies.<br />

The board is satisfied that all executive <strong>and</strong> non-executive directors have the appropriate qualifications, experience <strong>and</strong><br />

14 skills to discharge their functions effectively, including setting strategy, monitoring <strong>and</strong> managing performance <strong>and</strong> risks, Yes<br />

<strong>and</strong> ensuring management capacity <strong>and</strong> capability.<br />

15<br />

The board is satisfied that: the management team has the capacity, capability <strong>and</strong> experience necessary to deliver the<br />

annual operating plan; <strong>and</strong> the management structure in place is adequate to deliver the annual operating plan.<br />

Yes<br />

Signed on behalf of the <strong>Trust</strong>: Print name Date<br />

CEO Averil Dongworth 18/09/<strong>2012</strong><br />

Chair Sir Peter Dixon 18/09/<strong>2012</strong>


TITLE:<br />

EXECUTIVE SUMMARY<br />

BOARD/GROUP/COMMITTEE:<br />

Workforce Key Performance Indicators<br />

<strong>Trust</strong> <strong>Board</strong> & TEC<br />

1. KEY ISSUES: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

• For the month of September <strong>2012</strong> the overall<br />

number of FTE's in post across the <strong>Trust</strong><br />

decreased by 2.52 FTE's on the August position<br />

but has increased overall by 67.18 FTE's across<br />

the 12 month period.<br />

• The number of starters in month was 53.78<br />

FTE's compared to 47.92 FTE's in the previous<br />

month, September saw an increase in the<br />

number of leavers with 71.42 fte leavers<br />

compared to 57.75 fte's in August. Following a<br />

period of focussed recruitment activity, a total of<br />

582.93 FTE's have started in the <strong>Trust</strong> since<br />

October 11 whilst 556.14 fte's have left.<br />

• Starters & leavers data analysis over the same<br />

period differs from the staff in post growth for the<br />

same 3 reasons as in previous reports.<br />

1. If new starters commence employment or leave<br />

after the payroll cut off date (midmonth) they will not<br />

be entered or removed onto/off ESR until month end<br />

– therefore they will not appear on the staff in post<br />

report generated from ESR until the following month.<br />

2. Staff who increase or decrease their hours will<br />

affect the reported FTE’s in post but not the starters<br />

<strong>and</strong> leavers<br />

3. Timliness of managers completing <strong>and</strong> submitting<br />

the appropriate forms to HR - for entering onto ESR.<br />

• Overall <strong>Trust</strong> Bank & Agency spend decreased<br />

by £32,847 in month. The bank <strong>and</strong> agency<br />

spend continues to account for 11.9% of the pay<br />

bill despite a 2.68% decrease over the 12 month<br />

period. Bank & Agency spend is provided by the<br />

Finance department <strong>and</strong> relates to paid invoices<br />

in month. The YTD figure reported on the<br />

dashboard relates to the rolling 12 month period<br />

spend ( Oct 11 to Sept 12) rather than the fiscal<br />

year measurement which may be reported<br />

elsewhere.<br />

• Overall <strong>Trust</strong> bookings of Bank & Agency<br />

decreased on the August position with a<br />

reduction of 31.65 FTE. The number of agency<br />

bookings decreased by 16.96 FTE's in month -<br />

bank bookings decreased by 14.70 FTE's in the<br />

same period.<br />

1. Midwifery bank <strong>and</strong> agency FTE bookings<br />

decreased in September by 0.14 FTE's on<br />

the August position<br />

2. Registered nursing temporary staff bookings<br />

increased in September by 0.59 FTE's on<br />

the August position.<br />

• For the month of September, <strong>Trust</strong> annualised DATE:<br />

√ TEC October<br />

□ FINANCE ……………<br />

□ EPB ………..…….<br />

□ AUDIT ………..….<br />

□ CLINICAL GOVERNANCE …………..…...……<br />

□ CHARITABLE FUNDS ………………………...…<br />

√ TRUST BOARD <strong>November</strong> <strong>2012</strong><br />

□ REMUNERATION ………………………….…...<br />

□ OTHER ………………………. (please specify)<br />

CATEGORY:<br />

□ NATIONAL TARGET<br />

□ CNST<br />

□ STANDARDS FOR BETTER HEALTH<br />

□ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

□ TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE …………………..<br />

……………………………………………………..<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER:<br />

Author – Linda Baker – Head of workforce<br />

Planning<br />

Presenter – Dorothy Hosein – Director of<br />

Transformation<br />

1


turnover increased by 0.34% to 11.57% -<br />

despite the increase this remains 0.43% below<br />

the current average of other large Acute <strong>Trust</strong>s.<br />

• The reported sickness absence rate for the<br />

month of September has decreased slightly by<br />

0.13% on the August position, reducing from<br />

4.68% to 4.55% across the month. The sickness<br />

absence rate has decreased by 0.25% when<br />

compared to the same period last year.<br />

• The pan London benchmarking exercise against<br />

other acute Large London <strong>Trust</strong>s has been<br />

repeated which shows that the combined<br />

average sickness absence rate for this group is<br />

3.59% - as such the graph has been revised to<br />

reflect this. Based upon this revised information<br />

BHRUT's benchmarked position shows us as<br />

currently sitting 0.94% above the 3.59% average<br />

of all other large acute London <strong>Trust</strong>s. The<br />

<strong>Trust</strong>'s target remains at 3.6%<br />

• Part of the increase in reported sickness<br />

absence rates is related to improve recording<br />

through the roll out of electronic systems such as<br />

e-rostering. This has minimised the effort in<br />

recording <strong>and</strong> reporting of all types of staff<br />

absence, including sickness through<br />

managers/supervisors especially in the clinical<br />

areas no longer having to complete <strong>and</strong> submit<br />

weekly absence returns.<br />

• It is acknowledged that key to achieving a<br />

significant reduction in rates is: reviewing &<br />

updating our existing sickness absence policy,<br />

sickness absence management training <strong>and</strong><br />

working with proactively managers to underst<strong>and</strong><br />

the support they require to manage sickness<br />

absence.<br />

• These actions have been initiated <strong>and</strong> additional<br />

schemes such as staff MOT days continue in<br />

order to encourage staff to proactively manage<br />

their own health & wellbeing at work.<br />

• Occupational Health have implemented monthly<br />

case meetings with Directorates to discuss the<br />

management <strong>and</strong> progress of individual cases<br />

• The estimated costs associated with sickness<br />

absence have increased this month. It is<br />

estimated that the cost to the <strong>Trust</strong> for<br />

September was £878,995. This figure has risen<br />

by an estimated £259,997 on the same period<br />

last year despite the sickness rate reducing by<br />

0.25%. The rise in the estimated costs of<br />

sickness absence is attributed to the b<strong>and</strong>ing<br />

<strong>and</strong> roles of those staff taking sick absence<br />

compared to the same period last year, the<br />

higher the b<strong>and</strong> or more senior the role the<br />

higher the associated cost.<br />

• When the number of FTE's lost due to sickness<br />

absence is analysed by reason for absence, the<br />

highest loss remains 'Unknown causes - not<br />

specified' with 39.40 fte lost.<br />

• To counteract this as previously presented to the<br />

<strong>Trust</strong> <strong>Board</strong>, the <strong>Trust</strong> as part of their contract<br />

review <strong>and</strong> renewal process with McKesson<br />

have requested that this reason be removed<br />

from the reporting options. Therefore 'unknown<br />

2


causes/ Not specified' will be removed from the<br />

option list from <strong>November</strong> providing greater<br />

clarity on the reasons for absence allowing for a<br />

review of potential proactive measures to be<br />

taken in reducing sickness absence.<br />

• Compliance to Statutory & M<strong>and</strong>atory training<br />

programmes has been included within the KPI<br />

report for the first time. Currently this information<br />

will continue to be reported to the <strong>Board</strong> on a<br />

quarterly basis, however, a new system, WIRED<br />

which has been successful within other NHS<br />

Organisations for reporting m<strong>and</strong>atory training is<br />

in the process of being commissioned to provide<br />

clear, real time information in regards to<br />

Statutory & M<strong>and</strong>atory training.<br />

2. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

3. ALTERNATIVES CONSIDERED/REASONS FOR REJECTION:<br />

N/A<br />

4. DELIVERABLES:<br />

Continuous measurement <strong>and</strong> monitoring of workforce performance against NHS <strong>and</strong> local agreed<br />

targets<br />

5. EVIDENCE :<br />

ESR data<br />

IView Data<br />

NHSIE data<br />

6. RECOMMENDATION/ACTION REQUIRED:<br />

No action for information only<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE ___________________________<br />

(if applicable)<br />

3


TRUST - WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Sep-11 Oct-11 Nov-11 Dec-11 Jan-12 Feb-12 Mar-12 Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 YTD<br />

Staff In Post 5263.48 5313.23 5363.19 5353.99 5355.45 5350.71 5366.64 5366.82 5397.95 5397.08 5392.02 5382.93 5380.41 5368.37<br />

Starters *¹ 70.57 78.23 55.37 31.24 44.46 38.74 58.25 50.44 50.53 29.00 44.97 47.92 53.78 582.93<br />

Leavers *¹ 49.75 38.32 40.87 42.38 39.15 41.19 52.31 46.83 32.93 34.59 58.39 57.75 71.42 556.14<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 10.69% 10.60% 10.70% 10.78% 10.82% 11.0% 10.9% 10.9% 10.9% 10.8% 10.9% 11.2% 11.57%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

4.5% 4.80 5.46 5.13 6.00 5.15 5.81 4.41 4.29 4.51 4.00 4.59 4.68 4.55<br />

<strong>Trust</strong> Sickness<br />

Absence Rolling 12<br />

Month Period<br />

<strong>Trust</strong> Estimated Cost<br />

of Sickness Absence<br />

(Month)<br />

3.6% 4.49 4.63 4.31 4.77 4.76 4.87 4.92 4.99 5.09 5.00 4.96 4.90 4.88<br />

£618,998 £760,710 £707,395 £903,771 £756,866 £764,730 £594,960 £582,757 £645,566 £511,345 £750,024 £824,139 £878,995 £8,681,258<br />

Appraisals 80.0% 76.03% 76.42% 72.25% 73.74% 77.80% 79.3% 74.3% 77.9% 78.49% 76.40% 72.69% 68.49% 67.96%<br />

Resus 80.0% 69.04% 68.22% 68.26% 72.15% 75.69% 77.8% 78.6% 76.3% 77.86% 77.89% 77.50% 75.09% 75.09%<br />

Paybill Budget £21,393,649 £21,806,873 £22,000,988 £21,907,263 £22,422,582 £22,276,976 £25,028,069 £23,895,905 £23,701,154 £23,492,904 £23,179,203 £25,711,256 £24,350,165 £279,773,338<br />

Paybill £24,012,335 £24,085,519 £24,357,038 £24,267,150 £24,857,841 £24,430,745 £24,518,224 £24,282,126 £24,950,935 £24,441,456 £24,764,208 £24,607,757 £24,508,722 £294,071,722<br />

Bank/Agency Spend £3,259,189 £3,179,473 £3,176,222 £3,079,296 £3,527,427 £3,053,265 £3,584,109 £3,155,363 £3,326,525 £2,988,710 £3,011,923 £2,929,439 £2,896,592 £37,908,344<br />

% Paybill Budget spent<br />

on bank & Agency staff<br />

15.23% 14.58% 14.44% 14.06% 15.73% 13.71% 14.32% 13.20% 14.04% 12.72% 12.99% 11.39% 11.90% 13.55%<br />

Overtime Spend (£) £116,637 £67,772 £65,940 £58,911 £69,768 £70,658 £62,666 £53,941 £61,881 £57,877 £54,076 £56,638 £49,581 £729,709<br />

IHB FTE Bookings 646.05 663.25 661.31 600.15 667.76 672.17 714.77 587.37 586.98 592.32 578.73 565.82 534.17 7424.80<br />

IHB FTE Booked as a<br />

% of Substantive SIP<br />

12.27% 12.48% 12.33% 11.21% 12.47% 12.56% 13.32% 10.94% 10.87% 10.97% 10.73% 10.51% 9.93% 11.53%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

Financial value in month of February <strong>2012</strong> for Bank/Agency spend has been adjusted by a £353,356 reduction relating to prior period accruals. This has come about from: an improved system between IHB <strong>and</strong> Finance creating a more accurate base<br />

resulting in an downward adjustment of £182,354 for agency; a further reduction to the agency accrual due to writing off of old year agency accruals from the system of £51,186 as part of an aged analysis; <strong>and</strong> as a reduction for ageing to the Bank<br />

Accrual of £119,816.<br />

1


Staff In Post<br />

Starters & Leavers<br />

FTE's<br />

5500.00<br />

5400.00<br />

5300.00<br />

5200.00<br />

5100.00<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

Month<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

FTE's<br />

90.00<br />

80.00<br />

70.00<br />

60.00<br />

50.00<br />

40.00<br />

30.00<br />

20.00<br />

10.00<br />

0.00<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Month<br />

Mar-12<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Staff In Post<br />

Starters *¹ Leavers *¹<br />

Staff in Post ( SIP )<br />

For the month of September <strong>2012</strong> the overall number of FTE's in post across the <strong>Trust</strong> decreased by 2.52 FTE's on the August position but has increased overall by 67.18 FTE's<br />

across the 12 month period.<br />

Starters & leavers<br />

The number of starters in month was 53.78 FTE's compared to 47.92 FTE's in the previous month, September saw an increase in the number of leavers with 71.42 fte leavers<br />

compared to 57.75 fte's in August. Following a period of focussed recruitment activity , a total of 582.93 FTE's have started in the <strong>Trust</strong> since October 11 whilst 556.14 fte's have left<br />

Supported by the HR Advisors, Divisions have been tasked to actively promote Exit interviews so that 'reasons for leaving' can be truly understood.<br />

Starters & leavers data analysis over the same period differs from the staff in post growth for the same 3 reasons as in previous reports.<br />

1. If new starters commence employment or leave after the payroll cut off date (mid month) they will not be entered or removed onto/off ESR until month end – therefore they will not<br />

appear on the staff in post report generated from ESR until the following month. Starters <strong>and</strong> leavers numbers are refreshed each month to capture any late input to ESR.<br />

2. Staff who increase or decrease their hours will affect the reported FTE’s in post but not the starters <strong>and</strong> leavers<br />

3.Timliness of managers completing <strong>and</strong> submitting the appropriate forms to HR - for entering onto ESR.<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Temporary staff Use <strong>and</strong> Spend<br />

4500000<br />

Bank/Agency Spend ( Provided by Finance)<br />

800<br />

IHB Bookings - FTE<br />

3750000<br />

700<br />

Spend (£'s)<br />

3000000<br />

2250000<br />

1500000<br />

750000<br />

FTE<br />

600<br />

500<br />

400<br />

300<br />

200<br />

100<br />

Agency<br />

Bank<br />

0<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Bank/Agency Spend<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

Month<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

0<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Date<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Bank & Agency Spend<br />

Overall <strong>Trust</strong> Bank & Agency spend decreased by £32,847 in month. The bank <strong>and</strong> agency spend continues to account for 11.9% of the pay bill despite a 2.68% decrease over the 12<br />

month period. Data relating to Bank & Agency spend is provided by the Finance department <strong>and</strong> relates to paid invoices in month. The YTD figure reported on the dashboard relates to<br />

the rolling 12 month period spend ( Oct 11 to Sept 12) rather than the fiscal year measurement which may be reported elsewhere.<br />

Bank & Agency Usage<br />

Overall <strong>Trust</strong> bookings of Bank & Agency decreased on the August position with a reduction of 31.65 FTE. The number of agency bookings decreased by 16.96 FTE's in month - bank<br />

bookings decreased by 14.70 FTE's in the same period.<br />

Midwifery bank <strong>and</strong> agency FTE bookings decreased in September by 0.14 FTE's on the August position.<br />

Registered Nursing temporary staff bookings increased in September by 0.59 FTE's on the August position.<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


TURNOVER<br />

Actual Versus Target Annualised Turnover<br />

14.0<br />

Turnover %<br />

12.0<br />

10.0<br />

Turnover<br />

For the month of September, <strong>Trust</strong> annualised turnover increased by 0.34% to<br />

11.57% - despite the increase this remains 0.43% below the current average of<br />

other large Acute <strong>Trust</strong>s.<br />

8.0<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Actual Turnover<br />

SICKNESS ABSENCE<br />

Percentage (%)<br />

6.50<br />

6.00<br />

5.50<br />

5.00<br />

4.50<br />

4.00<br />

3.50<br />

3.00<br />

2.50<br />

2.00<br />

1.50<br />

1.00<br />

0.50<br />

0.00<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Month<br />

Target Turnover<br />

Real - Time Sickness Absence<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

Month<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Sickness Absence<br />

Reported sickness absence rates for the month of September has decreased<br />

slightly by 0.13% on the August position, reducing from 4.68% to 4.55% across<br />

the month. The sickness absence rate has decreased by 0.25% when<br />

compared to the same period last year. The pan London benchmarking<br />

exercise against other acute Large London <strong>Trust</strong>s has been repeated which<br />

shows that the combined average sickness absence rate for this group is<br />

3.59% - as such the graph has been revised to reflect this. Based upon this<br />

revised information BHRUT's benchmarked position shows us as currently<br />

sitting 0.94% above the 3.59% average of all other large acute London <strong>Trust</strong>s.<br />

The <strong>Trust</strong>'s target remains at 3.6%<br />

Driving down our sickness absence rates is a key focus for the trust for 12/13<br />

Part of the increase in reported sickness absence rates is related to improve<br />

recording through the introduction of electronic systems such as e-rostering.<br />

This has minimised the effort in recording <strong>and</strong> reporting of all types of staff<br />

absence, including sickness through managers/supervisors especially in the<br />

clinical areas no longer having to complete <strong>and</strong> submit weekly absence returns.<br />

It is acknowledged that key to achieving a significant reduction in rates is:<br />

reviewing & updating our existing sickness absence policy, sickness absence<br />

management training <strong>and</strong> working with proactively managers to underst<strong>and</strong> the<br />

support they require to manage sickness absence. These actions have been<br />

initiated <strong>and</strong> additional schemes such as staff MOT days continue in order to<br />

encourage staff to proactively manage their own health & wellbeing at work.<br />

BHRUT Target Other Large Acute London<br />

Occupational Health have implemented monthly case meetings with<br />

Directorates to discuss the management <strong>and</strong> progress of individual cases<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


<strong>Trust</strong> Estimated Cost of Sickness Absence (Month)<br />

£1,000,000<br />

Estimated Cost (£'s)<br />

£900,000<br />

£800,000<br />

£700,000<br />

£600,000<br />

£500,000<br />

£400,000<br />

£300,000<br />

£200,000<br />

Estimated costs of sickness absence<br />

The estimated costs associated with sickness absence has increased this<br />

month. It is estimated that the cost to the <strong>Trust</strong> for September was £878,995.<br />

This figure has risen by an estimated £259,997 on the same period last year<br />

despite the sickness rate reducing by 0.25%. The rise in the estimated costs of<br />

sickness absence is attributed to the b<strong>and</strong>ing <strong>and</strong> roles of those staff taking sick<br />

absence compared to the same period last year, the higher the b<strong>and</strong> or more<br />

senior the role the higher the associated cost.<br />

£100,000<br />

£0<br />

Sep-11<br />

Oct-11<br />

Nov-11<br />

Dec-11<br />

Jan-12<br />

Feb-12<br />

Mar-12<br />

Apr-12<br />

May-12<br />

Jun-12<br />

Jul-12<br />

Aug-12<br />

Sep-12<br />

Month<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


FTE Lost due to Sickness Absence by Absence Reason<br />

S10 Anxiety/stress/depression/other psychiatric illnesses<br />

S11 Back Problems<br />

Absence Reason<br />

S12 Other musculoskeletal problems<br />

S13 Cold, Cough, Flu - Influenza<br />

S14 Asthma<br />

S15 Chest & respiratory problems<br />

S16 Headache / migraine<br />

S17 Benign <strong>and</strong> malignant tumours, cancers<br />

S19 Heart, cardiac & circulatory problems<br />

S20 Burns, poisoning, frostbite, hypothermia<br />

S21 Ear, nose, throat (ENT)<br />

S22 Dental <strong>and</strong> oral problems<br />

S23 Eye problems<br />

S24 Endocrine / gl<strong>and</strong>ular problems<br />

S25 Gastrointestinal problems<br />

S26 Genitourinary & gynaecological disorders<br />

S27 Infectious diseases<br />

S28 Injury, fracture<br />

S29 Nervous system disorders<br />

S30 Pregnancy related disorders<br />

S31 Skin disorders<br />

S98 Other known causes - not elsewhere classified<br />

S99 Unknown causes / Not specified<br />

0 5 10 15 20 25 30 35 40 45<br />

FTE Lost<br />

Reasons for Sickness Absence v FTE's<br />

lost<br />

When the number of FTE's lost due to<br />

sickness absence is analysed by reason for<br />

absence, the highest loss remains 'Unknown<br />

causes - not specified' with 39.40 fte lost. HR<br />

acknowledge this creates concern as it<br />

means that staff are not providing their<br />

absence reason or it isn't being recorded by<br />

their manager / supervisor. • To counteract<br />

this as previously presented to the <strong>Trust</strong><br />

<strong>Board</strong>, the <strong>Trust</strong> as part of their contract<br />

review <strong>and</strong> renewal process with McKesson<br />

have requested that this reason be removed<br />

from the reporting options. Therefore<br />

'unknown •causes/ Not specified' will be<br />

removed from the option list from <strong>November</strong><br />

providing greater clarity on the reasons for<br />

absence allowing for a review of potential<br />

proactive measures to be taken in reducing<br />

sickness absence.<br />

In order to further improve the accuracy of<br />

sickness absence reporting <strong>and</strong> recording, HR<br />

have incorporated 'effective recording<br />

processes' in their ' Essential Skills for<br />

Managers ' training programme. The effects<br />

of this training on the actual reported data may<br />

take time to show a demonstrable change.<br />

Directorates must not only ensure that<br />

managers record absence correctly within the<br />

weekly absence returns but also that returns<br />

are submitted in a timely way.<br />

STATUTORY & MANDATORY TRAINING COMPLIANCE<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


The table below provides a quarterly <strong>Trust</strong>-wide perspective of compliance to identified statutory & m<strong>and</strong>atory training programmes for monitoring purposes . This data is run <strong>and</strong><br />

analysed by the workforce information department on a quarterly basis via ESR for the Education <strong>Board</strong>, with the education department providing the commentary to the data (located<br />

on the following page). At the current time due to the method of recording <strong>and</strong> inputting attendance to training data onto ESR analysis by the workforce information team takes 3 days<br />

per course, as such this data can only be provided quarterly. However, a national solution called WIRED will revolutionise recording <strong>and</strong> reporting allowing the <strong>Trust</strong> to increase its<br />

frequency <strong>and</strong> complexity of reporting in the medium term <strong>and</strong> participate in an employee 'passport' scheme where compliance to training requirements moves with the employee as<br />

they change jobs . A Business case is currently being developed with funding identified, for presentation to TEC, in the meanwhile the workforce information <strong>and</strong> education departments<br />

will continue to report to the <strong>Board</strong> quarterly.<br />

Statutory <strong>and</strong> M<strong>and</strong>atatory Training Monitoring as at 30th September <strong>2012</strong><br />

Reporting Period - Compliance Rate<br />

Course Name Frequency 31-Dec-10 28-Feb-11 30-Jun-11 30-Sep-11 31-Dec-11 31-Mar-12 30-Jun-12 30-Sep-12<br />

Conflict Resolution 3 yearly 11.61%<br />

Equality, Diversity & Human Rights 3 yearly 55.92%<br />

Fire Training Annual 52.46% 39.49% 36.33% 28.63% 33.57% 21.63% 35.10% 45.46%<br />

Health & Safety Annual 41.31%<br />

Infection Control Annual 41.61%<br />

Information Governance Annual 37.42% 36.22% 36.92% 37.98% 17.43% 21.45% 21.35% 28.23%<br />

Manual H<strong>and</strong>ling (Loads) 2 yearly 12.77% 18.76% 20.37% 22.77% 33.00% 39.54% 33.53% 38.28%<br />

Manual H<strong>and</strong>ling (People - Refresher) 2 yearly 55.97% 63.50% 68.83% 69.22% 85.12% 73.84% 76.19% 71.16%<br />

Manual H<strong>and</strong>ling (People + Loads) Once 14.23% 46.60% 41.62% 40.90% 40.55% 40.77% 65.95% 63.80%<br />

Resuscitation Yearly 93.32% 89.72% 78.42% 69.04% 72.15% 78.61% 77.89% 75.09%<br />

Safeguarding Adults 3 Yearly 65.84%<br />

Safeguarding Children Level 1 3 yearly 67.86% 62.61% 70.50% 56.61% 67.79% 69.72% 71.15% 71.12%<br />

Safeguarding Children Level 2 3 yearly 32.37% 26.87% 37.50% 10.76% 53.25% 58.29% 30.08% 42.93%<br />

Safeguarding Children Level 3 3 Yearly 54.98% 54.49% 50.97% 34.78% 67.68% 80.82% 72.14% 71.29%<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


The data on the previous page has been presented by training subject, to reflect the Skills for Health National Training Framework. This sets minimum training st<strong>and</strong>ards <strong>and</strong><br />

frequency <strong>and</strong> promotes consistency <strong>and</strong> avoids duplication between organisations. Therefore Conflict Resolution, Equality, Diversity <strong>and</strong> Human Rights are now included.<br />

This format also reflects previous discussion <strong>and</strong> agreement to not report by programme but to report by subject.<br />

Detailed reports for Resuscitation, RN, HCA <strong>and</strong> ODP M<strong>and</strong>atory are still provided.<br />

Subject Matter Experts (SME) are aware of their responsibilities to drive up compliance in their area, this is dependent on them being provided with robust data<br />

Fire <strong>and</strong> Health <strong>and</strong> Safety have now been separated into specific Subject Matter to reflect the national requirements.<br />

Infection Control figures now include the Risk Management St<strong>and</strong>ard (RMS) requirements for H<strong>and</strong> Hygiene training which is now included on <strong>Trust</strong> Induction <strong>and</strong> on<br />

M<strong>and</strong>atory programmes.<br />

Conflict Resolution training has not been regarded as a m<strong>and</strong>atory priority. However in view of the CQC findings this will need to be mapped into the ongoing work on cultural<br />

change which will improve compliance. to complete this successfully there will need to be a resource review.<br />

Did Not Attend (DNA) data is shown on the next page to reflect requirements of internal audit, <strong>and</strong> this is followed up by the SME.<br />

The data demonstrates that release <strong>and</strong> uptake remains the biggest challenge as the amount of places offered for most subjects exceeds the amount required. Low compliance<br />

rates for Information Governance are reflective of the change of frequency from 3yearly to annual. Safeguarding children level 2 uptake saw a drop as nursing staff are now<br />

required to do this <strong>and</strong> not level 1 as was previously the case.<br />

In April <strong>2012</strong> the <strong>Trust</strong> launched new M<strong>and</strong>atory programmes specifically designed to improve compliance for other clinical staff groups <strong>and</strong> for admin <strong>and</strong> clerical staff.<br />

It is anticipated that should the <strong>Board</strong> endorse the proposal to implement the WIRED system, compliance will rise across subjects as data will be timely, transparent, accurate<br />

<strong>and</strong> align to the Training Needs Analysis <strong>and</strong> available to all Managers.<br />

CONFLICT RESOLUTION<br />

HEALTH & SAFETY<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 447 470 472<br />

Number of Staff<br />

Requiring Training 1408<br />

Actual Number Trained 131 135 147 Actual Number Trained 915<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Places Offered 184 163 196 Places Offered 2051<br />

DNAs 31 30 28 DNAs 173<br />

EQUALITY, DIVERSITY & HUMAN RIGHTS<br />

INFECTION CONTROL<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 469<br />

Number of Staff<br />

Requiring Training 1408<br />

Actual Number Trained 517 Actual Number Trained 908<br />

Places Offered 1316 Places Offered 2051<br />

DNAs 89 DNAs 173<br />

FIRE<br />

INFORMATION GOVERNANCE<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 1408<br />

Number of Staff<br />

Requiring Training 1400 1408 1408<br />

Actual Number Trained 728 Actual Number Trained 286 307 713<br />

Places Offered 728 Places Offered 1550 1912 <strong>2012</strong><br />

DNAs 0 DNAs 25 53 52<br />

MANUAL HANDLING - LOADS<br />

MANUAL HANDLING - PEOPLE & LOADS 1 DAY<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 200 293 317<br />

Number of Staff<br />

Requiring Training 163 92 83<br />

Actual Number Trained 160 182 96 Actual Number Trained 49 67 52<br />

Places Offered 664 852 647 Places Offered 127 185 156<br />

DNAs 44 62 13 DNAs 6 1 6<br />

MANUAL HANDLING - PEOPLE REFRESHER SAFEGUARDING LEVEL 1<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 480 319 327<br />

Number of Staff<br />

Requiring Training 364 214 211<br />

Actual Number Trained 216 381 355 Actual Number Trained 283 393 186<br />

Places Offered 772 775 704 Places Offered 1059 815 950<br />

DNAs 31 8 77 DNAs 38 26 34<br />

RESUS SAFEGUARDING LEVEL 2<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Requiring Training 996 1000 995<br />

Number of Staff<br />

Requiring Training 53 208 207<br />

Actual Number Trained 613 574 895 Actual Number Trained 0 333 366<br />

Places Offered 1661 1791 1711 Places Offered 240 318 923<br />

DNAs 154 186 166 DNAs 11 38 156<br />

SAFEGUARDING ADULTS SAFEGUARDING LEVEL 3<br />

<strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4 <strong>2012</strong> Q1 <strong>2012</strong> Q2 <strong>2012</strong> Q3 <strong>2012</strong> Q4<br />

Number of Staff<br />

Number of Staff<br />

Requiring Training 467 469 472<br />

Requiring Training 51 52 51<br />

Actual Number Trained 277 517 831 Actual Number Trained 26 20 19<br />

Places Offered 956 1394 2031 Places Offered 189 318 328<br />

DNAs 31 77 164 DNAs 27 15 28<br />

DIRECTORATE WORKFORCE KPI REPORTS<br />

DIAGNOSTICS & SPECIAL MEDICINE DIRECTORATE -<br />

WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

Staff In Post 1094.28 1104.66 1104.97 1104.66 1101.17 1102.35 1102.02<br />

Starters *¹ 9.43 12.66 6.00 10.91 8.43 11.15 58.58<br />

Leavers *¹ 6.12 4.46 12.20 12.00 7.70 10.77 53.25<br />

Turnover (Annualised) *¹ 12.0% 9.1% 8.6% 9.1% 9.1% 9.4% 9.6%<br />

<strong>Trust</strong> Sickness Absence %<br />

for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

Directorate Sickness<br />

Absence Rolling 12 Month<br />

Period<br />

Directorate Estimated Cost<br />

of Sickness Absence<br />

(Month) *²<br />

3.6% 5.11% 5.03% 4.50% 5.36% 5.64% 5.43%<br />

3.6% 5.11% 5.07% 4.88% 5.00% 5.13% 5.18%<br />

£151,450 £162,189 £116,008 £151,225 £164,939 £194,557 £940,368<br />

Appraisals Compliance 80.0% 71.95% 71.96% 69.55% 61.65% 57.28% 61.49%<br />

Resus Compliance 80.0% 77.57% 77.13% 77.83% 78.15% 78.77% 75.09%<br />

Paybill Budget<br />

£4,719,045 £4,655,044 £4,745,751 £4,659,061 £4,669,833 £4,582,046 £28,030,779<br />

Paybill £4,763,991 £4,859,576 £4,799,919 £4,957,346 £4,879,298 £4,778,114 £29,038,245<br />

Bank/Agency Spend £496,296 £517,013 £461,899 £569,332 £562,077 £477,070 £3,083,687<br />

% Paybill Budget spent on<br />

bank & Agency staff<br />

10.52% 11.11% 9.73% 12.22% 12.04% 10.41% 11.00%<br />

Overtime Spend (£) £15,913 £22,366 £21,338 £29,976 £21,885 £16,800 £128,278<br />

IHB FTE Bookings 77.34 75.64 73.15 85.37 83.02 72.12 466.64<br />

IHB FTE Booked as a % of<br />

Substantive SIP<br />

7.07% 6.85% 6.62% 7.73% 7.54% 6.54% 7.06%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

EMERGENCY, GEN. MEDICINE & NEUROSCIENCES DIRECTORATE -<br />

WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Staff In Post 1497.50 1488.89 1537.40 1532.03 1480.44 1481.43 1502.95<br />

Starters *¹ 24.47 16.73 8.40 15.40 20.43 12.80 98.23<br />

Leavers *¹ 17.71 5.00 10.99 19.20 23.27 20.97 97.14<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 12.3% 12.4% 12.6% 12.7% 13.6% 14.2%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

3.6% 3.71% 3.88% 3.46% 3.58% 3.85% 3.75%<br />

Directorate Sickness<br />

Absence Rolling 12<br />

Month Period<br />

3.6% 3.71% 3.80% 3.68% 3.66% 3.70% 3.71%<br />

Directorate Estimated<br />

Cost of Sickness<br />

Absence (Month) *²<br />

Appraisals<br />

Compliance<br />

£128,632 £143,589 £119,511 £169,367 £202,747 £214,494 £978,340<br />

80.0% 74.07% 75.21% 75.82% 73.91% 68.83% 66.33%<br />

Resus Compliance 80.0% 76.26% 78.64% 79.23% 77.88% 72.52% 73.68%<br />

Paybill Budget<br />

£6,897,802 £6,887,836 £6,900,253 £6,626,925 £7,353,490 £6,655,213 £41,321,519<br />

Paybill £6,945,598 £7,283,477 £7,305,661 £7,090,481 £6,856,072 £6,752,570 £42,233,860<br />

Bank/Agency Spend £1,351,514 £1,514,580 £1,455,228 £1,412,147 £1,171,550 £1,063,376 £7,968,395<br />

% Paybill Budget<br />

spent on bank &<br />

Agency staff<br />

19.59% 21.99% 21.09% 21.31% 15.93% 15.98% 19.28%<br />

Overtime Spend (£) £4,331 £6,229 £6,057 £3,546 £6,139 £5,823 £32,125<br />

IHB FTE Bookings 247.95 261.02 256.04 247.01 224.43 210.39 1446.84<br />

IHB FTE Booked as a<br />

% of Substantive SIP<br />

16.56% 17.53% 16.65% 16.12% 15.16% 14.20% 16.04%<br />

SURGICAL DIRECTORATE - WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

Staff In Post 1122.50 1151.10 1094.11 1094.93 1100.01 1099.09 1110.29<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Starters *¹ 7.00 3.60 5.00 7.43 6.21 7.00 36.24<br />

Leavers *¹ 10.67 7.43 6.20 7.00 7.31 10.61 49.22<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 8.5% 8.9% 8.7% 8.9% 9.3% 10.0%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

3.6% 3.44% 3.90% 3.65% 4.45% 3.58% 3.98%<br />

Directorate Sickness<br />

Absence Rolling 12<br />

Month Period<br />

3.6% 3.44% 3.67% 3.66% 3.86% 3.80% 3.83%<br />

Directorate Estimated<br />

Cost of Sickness<br />

Absence (Month) *²<br />

£99,908 £120,250 £109,709 £178,309 £151,067 £171,684 £830,927<br />

Appraisals Compliance 80.0% 85.65% 86.14% 83.32% 82.55% 79.02% 77.86%<br />

Resus Compliance 80.0% 76.42% 78.59% 78.65% 77.18% 74.18% 73.87%<br />

Paybill Budget<br />

£5,182,485 £5,288,767 £5,177,341 £5,149,402 £5,857,824 £5,332,322 £31,988,141<br />

Paybill £5,501,762 £5,495,357 £5,380,580 £5,434,785 £5,471,086 £5,497,975 £32,781,545<br />

Bank/Agency Spend £753,584 £655,882 £629,230 £647,069 £659,381 £711,319 £4,056,465<br />

% Paybill Budget spent<br />

on bank & Agency staff<br />

14.54% 12.40% 12.15% 12.57% 11.26% 13.34% 12.68%<br />

Overtime Spend (£) £25,315 £22,791 £20,505 £11,955 £19,845 £17,212 £117,623<br />

IHB FTE Bookings 137.79 112.35 121.92 111.77 116.02 116.41 716.26<br />

IHB FTE Booked as a %<br />

of Substantive SIP<br />

12.28% 9.76% 11.14% 10.21% 10.55% 10.59% 10.75%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

WOMEN, CHILDREN & SUPPORT SERVICES DIRECTORATE -<br />

WORKFORCE KEY PERFORMANCE INDICATORS - SEPTEMBER <strong>2012</strong><br />

Indicator Target Apr-12 May-12 Jun-12 Jul-12 Aug-12 Sep-12 Oct-12 Nov-12 Dec-12 Jan-13 Feb-13 Mar-13 Apr-13 YTD<br />

Staff In Post 1181.94 1180.51 1181.31 1181.78 1171.20 1163.20 1176.66<br />

Starters *¹ 3.40 10.80 7.60 5.01 7.00 6.83 40.64<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


Leavers *¹ 13.33 12.60 5.20 12.59 16.87 12.54 73.13<br />

Turnover (Annualised)<br />

*¹<br />

12.0% 11.4% 11.7% 11.4% 10.9% 11.7% 12.0%<br />

<strong>Trust</strong> Sickness<br />

Absence % for month<br />

3.6% 4.29% 4.51% 4.00% 4.59% 4.68% 4.55%<br />

Directorate Sickness<br />

Absence For Month<br />

3.6% 5.24% 5.57% 4.83% 5.04% 5.41% 5.02%<br />

Directorate Sickness<br />

Absence Rolling 12<br />

Month Period<br />

3.6% 5.24% 5.41% 5.21% 5.17% 5.22% 5.19%<br />

Directorate Estimated<br />

Cost of Sickness<br />

Absence (Month) *²<br />

£140,926 £149,545 £125,186 £183,603 £206,326 £193,995 £999,581<br />

Appraisals Compliance 80.0% 85.03% 86.20% 82.43% 77.28% 75.18% 72.89%<br />

Resus Compliance 80.0% 76.40% 77.79% 76.66% 78.35% 79.04% 78.43%<br />

Paybill Budget<br />

£4,559,907 £4,562,188 £4,567,601 £4,542,598 £4,537,970 £4,600,939 £27,371,203<br />

Paybill £4,627,315 £4,640,770 £4,569,944 £4,597,102 £4,585,629 £4,576,345 £27,597,106<br />

Bank/Agency Spend £444,148 £422,884 £420,487 £385,261 £401,752 £423,014 £2,497,546<br />

% Paybill Budget spent<br />

on bank & Agency staff<br />

9.74% 9.27% 9.21% 8.48% 8.85% 9.19% 9.12%<br />

Overtime Spend (£) £2,542 £3,422 £3,818 £2,275 £2,864 £2,266 £17,187<br />

IHB FTE Bookings 103.68 108.89 110.33 98.74 101.42 100.52 623.58<br />

IHB FTE Booked as a %<br />

of Substantive SIP<br />

8.77% 9.22% 9.34% 8.36% 8.66% 8.64% 8.83%<br />

*¹ Starters, Leavers & Turnover figures excludes junior doctors on rotation<br />

<strong>Trust</strong> Overall Scorecard - September <strong>2012</strong> - Workforce Information Department


EXECUTIVE SUMMARY<br />

TITLE:<br />

COST IMPROVEMENT UPDATE<br />

BOARD/GROUP/COMMITTEE:<br />

TRUST BOARD<br />

1. PURPOSE: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong> DATE:<br />

TO UPDATE THE TRUST BOARD ON PROGRESS AND<br />

CURRENT STATUS OF THE COST IMPROVEMENT<br />

PROGRAMME – MONTH 6 (SEPT <strong>2012</strong>)<br />

□ TEC ……………..….. □ STRATEGY……….….…….<br />

□ FINANCE ……..……… □ AUDIT ………….……..….<br />

□ QUALITY & SAFETY …………..………….....……<br />

□ WORKFORCE<br />

□ CHARITABLE FUNDS ………………………………...…<br />

X TRUST BOARD ……………………………….………….<br />

□ REMUNERATION ………………………………….…...<br />

□ OTHER …………………………..……. (please specify)<br />

2. DECISION REQUIRED: CATEGORY:<br />

TO NOTE PROGRESS, RISKS AND MITIGATIONS<br />

□ NATIONAL TARGET □ CNST<br />

□ CQC REGISTRATION □ HEALTH & SAFETY<br />

□ ASSURANCE FRAMEWORK<br />

X CQUIN/TARGET FROM COMMISSIONERS<br />

□ CORPORATE OBJECTIVE ……………………………....<br />

□ OTHER …………………….. (please specify)<br />

3. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

AUTHOR/PRESENTER: Dorothy Hosein<br />

DATE: 29/10/<strong>2012</strong><br />

The CIP position shows year to date delivery of £4.3m against a period target of £6.5m. This is a shortfall of £2.2m.<br />

The forecast delivery is £17.7m of which £8.4m is considered to be at high risk, this is however <strong>and</strong> improvement on the<br />

£6.2m of high risk schemes reported at Month 5 (August <strong>2012</strong>)<br />

4. DELIVERABLES<br />

5. KEY PERFORMANCE INDICATORS<br />

Cost Improvement Tracker<br />

AGREED AT ______________________ MEETING<br />

OR<br />

REFERRED TO: __________________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE (if applicable) ___________________________


Cost Improvement Programme Update September <strong>2012</strong><br />

Summary<br />

The CIP position shows year to date delivery of £4.3m against a target for the period of<br />

£6.5m, a shortfall of £2.2m. The forecast delivery is £17.7m of which £4.8m is<br />

considered to be at high risk as compared to £6.2m of schemes identified in Month 6;<br />

CIP mitigation plans to achieve the £17.7m forecast are now as follows:<br />

Blue Green Amber Red Total<br />

£000 £000 £000 £000 £000<br />

Draft Forecast Outturn Workstream 7,090 2,270 2,190 2,998 14,548<br />

Add/(Deduct):<br />

Repatriation JAK 2 tests ‐ Path; Non recurrent Diagnostics 10 10<br />

Further opportunities identified post ‐ M6 Diagnostics 66 66<br />

Medicines Management ‐ various Medicines Management ‐121 182 166 227<br />

Lucentis ‐ pass back 65% of income to commissioners Medicines Management ‐152 ‐152<br />

VAT on Utilities ‐ b/f start by 1 month to December Estates 30 30<br />

Rates assessment Estates 100 100<br />

Emergency Care Non‐pay 24 100 124<br />

Outpatients ‐ 140k deducted in Tracker; replaced by Outpatients 36 300 16 352<br />

Outpatients ‐ FURTHER POSTS Outpatients 37 37<br />

Theatres ‐ ITU skill mix Theatres 62 62<br />

AHP's Workforce ‐ AHP ‐26 100 74<br />

Neurosciences Workforce ‐ Medical 16 94 20 130<br />

Nursing ‐ Bed & Site team Workforce ‐nursing 8 8<br />

Annual Leave accrual Corporate 750 750<br />

Medicines Management Medicines Management 400 400<br />

Stroke Consultant release 5 PA's Workforce ‐ Medical 20 20<br />

Medical locums ‐ VAT Corporate 600 600<br />

Other ‐ Salary sacrifice (Car parking), Pharmacy VAT Corporate 66 ‐49 297 314<br />

Final M6 Forecast Outturn 7,090 2,365 3,453 4,792 17,700<br />

Key areas to focus to maximise run rate <strong>and</strong> in year delivery <strong>and</strong> turn red schemes<br />

green:<br />

• Continue to implement mechanisms for monitoring, <strong>and</strong> challenging budget<br />

holders against agreed plans<br />

• Provide strong project management <strong>and</strong> delivery support to Directorates <strong>and</strong><br />

Work streams<br />

• Validate Bank <strong>and</strong> Agency reductions as real cost containment, supporting the<br />

achievements of the control total<br />

• Ensure rapid escalation of risks <strong>and</strong> issues relating to CIP delivery.<br />

• Embed recently developed Executive SRO roles<br />

1


Month 6 CIP Performance<br />

Workstream progress<br />

Admin& Clerical: Approximately 30% of the A&C workforce spend relates to bank <strong>and</strong><br />

agency. There has been an improvement of £<br />

Medical Efficiency: The Job planning process has commenced with CDs arranging<br />

formal meetings with Consultants <strong>and</strong> Managers. Completion of 1st level sign off<br />

<strong>November</strong> <strong>2012</strong> with final JPA sign off December <strong>2012</strong>. Directorates agreeing bank <strong>and</strong><br />

agency spend in line with budgets. Benchmarking with pan-London Bank rates being<br />

undertaken.<br />

Allied Health Professionals: There is a cost pressure of circa £300k relating to length<br />

of Stay. On-call payment analysis is underway. Further investigation of opportunities for<br />

CIPs in pharmacy production.<br />

Workforce Reduction: In terms of established vacancies throughout the <strong>Trust</strong>, a<br />

reduction of 30 vacancies has attracted savings. A further 14 vacancies identified <strong>and</strong><br />

associated savings are anticipated by December <strong>2012</strong>. The Head of Workforce<br />

Transformation has established a project plan for further potential vacancies where<br />

savings are anticipated at the end of this financial year. Agreement was reached at the<br />

Transformation <strong>Board</strong> to take forward a 3 year pay protection policy to the Joint Staff<br />

Committee for ratification. PAUL<br />

Beds & Length of Stay – Bed Reduction: A further saving of equivalent costs for 30<br />

beds in year is required to achieve the CIP. Plans are currently being worked up with<br />

options to provide ‘winter’ contingency beds.<br />

2


Diagnostics – Introduction of ‘Hot’ Reporting of CT & MRI Scans: To support the<br />

A&E four hour target <strong>and</strong> to ensure maximum efficient use of <strong>Trust</strong> ward beds ‘hot’<br />

reporting on a five day week with a view to extend to seven day week has commenced.<br />

Continued progress is being monitored. Additional schemes are under review.<br />

Diagnostics - Interventional Radiology (non clinical): To date a review of current<br />

activity is being undertaken by Radiology <strong>and</strong> will be completed in three main phases;<br />

1. A review of recorded <strong>and</strong> reported activity with cross referencing to income,<br />

audit data <strong>and</strong> PAS/RIS information<br />

2. A cross referencing of this analysis with the current Contractual (Device)<br />

exclusions<br />

3. A cross referencing with Procurement colleagues to assess cost saving<br />

opportunities.<br />

This work is in progress. Data from the <strong>Trust</strong> Information department has now been<br />

received <strong>and</strong> analysis has commenced.<br />

Outpatients - Reduction in DNA <strong>and</strong> Cancellations: Key metrics have been<br />

developed <strong>and</strong> are being monitored <strong>and</strong> action taken as required with the General<br />

Managers. All specialties have developed action plans to reduce the need for additional<br />

activity <strong>and</strong> capacity, <strong>and</strong> ensure that efficient use of resources is optimised.<br />

Outpatients – e.Choose <strong>and</strong> Book <strong>and</strong> administration: Efficiency <strong>and</strong> Clinical<br />

governance assurance has now been achieved with E Choose & Book now compliant<br />

(71%). Turnaround times for referral validation have reduced further. The review of PAS<br />

clinic letter volumes reducing from 7000 to 900.<br />

Outpatients – Dem<strong>and</strong> & Capacity: Action plan for the delivery of a reduction in New to<br />

Follow Up attendances is now at the implementation stage. All specialities have<br />

developed action plans to reduce the need for additional activity <strong>and</strong> capacity.<br />

Outpatients – Printing & Postage Services (non-clinical): Work is about to<br />

commence on the outsourcing of printing <strong>and</strong> postage services <strong>and</strong> resultant potential<br />

savings. Implementation is likely to commence in Q4.<br />

Theatres – Theatre Utilisation: Theatre utilisation has been reviewed to encompass<br />

start times <strong>and</strong> rescheduling of theatre lists. Workstream programmes have been ratified.<br />

Audits are underway which have <strong>and</strong> will inform the work programme for the next month.<br />

Theatre – Consumables (non-clinical): Procurement analysis on key consumables<br />

have been completed outcomes to be implemented.<br />

Facilities & Estates: Work is on going to identify new opportunities.<br />

Medicine Management – Drugs: Full uptake of homecare services has taken place.<br />

PbR exclusion drug reimbursement <strong>and</strong> the reduction in FP10 issues still to be<br />

addressed.<br />

3


Governance<br />

The Cost Improvement Programme Governance Framework has now been ratified by<br />

The Transformation <strong>Board</strong> (October <strong>2012</strong>). A specific change to the framework is the<br />

inclusion of the Executive Workstream Sponsor who will provide executive level<br />

oversight, support <strong>and</strong> direction to the individual CIP workstream, ensuring an<br />

appropriate escalation route for risks <strong>and</strong> non delivery of schemes.<br />

Weekly Workstream Accountability meetings are held to ensure the ongoing delivery <strong>and</strong><br />

progress of existing directorate schemes. Identified Executive SROs are identified below.<br />

Quality Assurance<br />

A Clinical Quality assurance panel has been set up <strong>and</strong> has reviewed the process <strong>and</strong><br />

documentation to assess <strong>and</strong> monitor the risks associated with each work stream within<br />

the Cost Improvement Programme. The group is chaired by Dr Maureen Dalziel the Non<br />

Executive Director <strong>and</strong> supported by a number of executive <strong>and</strong> clinical staff.<br />

The framework includes impact assessments on clinical outcomes, safety <strong>and</strong> patient<br />

experience in addition to parameters measured by the Quality <strong>and</strong> Safety board. The<br />

Quality Assurance panel meets monthly <strong>and</strong> will provide assurance to both the<br />

Transformation <strong>and</strong> Quality <strong>and</strong> Safety <strong>Board</strong>s. Focused work using this framework is<br />

now taking place to carry out quality impact assessments on any schemes previously<br />

assessed as high or moderate risk.<br />

4


CIP Project Governance – Approval Flowchart<br />

New CIP scheme generated<br />

Work stream steering group<br />

Operational/ directorate<br />

Agree work stream<br />

Complete a Quality Impact Assessment<br />

Directorates add to their risk register<br />

Director/ divisional<br />

review meetings<br />

All schemes‐<br />

Complete a Risk Assessment<br />

CD review of risk assessment<br />

Does the risk assessment contain any<br />

Moderate (M) or High (H) risks after mitigation?<br />

CIP delivery ( as per tracker)<br />

Clinical risk assessment<br />

Blue Green Amber Red<br />

1 2 3 4<br />

Low 1 1 2 3 4<br />

Medium 2 2 4 6 8<br />

High 3 3 6 9 12<br />

PMO add to CIP risk register<br />

Service<br />

Transformation<br />

Office<br />

Complete a Project M<strong>and</strong>ate<br />

for schemes over £50,000<br />

Transformation<br />

<strong>Board</strong><br />

(Monthly)<br />

Ongoing monitoring of operational <strong>and</strong> clinical indictors via directorates dash boards<br />

Patient satisfaction, Length of stay<br />

HCAI’s, Hospital readmission rates, Staff satisfaction<br />

Clinical Quality Assurance<br />

Panel (Monthly)<br />

Quality <strong>and</strong> Safety<br />

<strong>Board</strong> (Bi‐monthly)<br />

Version 3- JM 19/10/12<br />

Status to be tracked in both CIP <strong>and</strong> departmental risk register <strong>and</strong> the Q&S board<br />

5


1<br />

REPORT TO:<br />

REPORT FROM:<br />

<strong>Trust</strong> <strong>Board</strong><br />

Chief Executive<br />

DATE: 11 October <strong>2012</strong><br />

SUBJECT:<br />

FOR:<br />

CHAIRMAN & CHIEF EXECUTIVE’S REPORT<br />

Information<br />

______________________________________________________________<br />

1. INTRODUCTION<br />

This report contains a summary of:<br />

• Actions taken under emergency powers<br />

• Executive decisions<br />

• National Issues/News<br />

• Local Issues/News<br />

2. RECOMMENDATION<br />

The <strong>Board</strong> is asked to note this report.<br />

3. ACTIONS TAKEN UNDER EMERGENCY POWERS<br />

No actions have been taken by the Chairman, or Chief Executive acting under<br />

emergency powers.<br />

4. EXECUTIVE DECISIONS<br />

The <strong>Trust</strong> Executive Committee has been meeting on a monthly basis <strong>and</strong> have<br />

reviewed <strong>and</strong> inputted into several reports prior to their submission to the <strong>Trust</strong><br />

<strong>Board</strong>, such as the <strong>Board</strong> Assurance Framework, Information Governance<br />

Strategy <strong>2012</strong>/13, Complaints Annual Report 2011/12 <strong>and</strong> the Single Operating<br />

Model. .<br />

1.<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


2<br />

NATIONAL ISSUES/NEWS:<br />

New health ministerial team:<br />

Jeremy Hunt has been appointed Secretary of State for Health following the<br />

Government’s reshuffle. He is MP for South West Surrey <strong>and</strong> was previously<br />

Secretary of State for Culture, Olympics, Media <strong>and</strong> Sport. His team consists of<br />

three new health ministers, joining Lord Howe who remains as Health Minister in<br />

the Lords. They are Norman Lamb, Minister of State, Dr Daniel Poulter,<br />

Parliamentary Under Secretary of State <strong>and</strong> Anna Soubry, also Parliamentary<br />

Under Secretary of State.<br />

For further information, go to: http://www.dh.gov.uk/health/aboutus/people/ministers<br />

Fund will boost digital innovation:<br />

The Department has announced that local NHS organisations could now be<br />

awarded funding to develop new digital services that improve patient care <strong>and</strong><br />

can be used to share information more easily across the NHS. Funded projects<br />

are expected to lead to a successful deployment <strong>and</strong> use, in an NHS<br />

environment, of solutions based on the NHS Interoperability Toolkit.<br />

For further information, go to:<br />

http://www.connectingforhealth.nhs.uk/systems<strong>and</strong>services/interop<br />

Join the conversation on how to strengthen the NHS Constitution:<br />

The NHS Future Forum, which is advising the Government on how the NHS<br />

Constitution might be strengthened, is talking about what the NHS Constitution<br />

means to them <strong>and</strong> is keen to hear your views. On a newly-launched blog,<br />

members of the NHS Future Forum will explain what the NHS Constitution<br />

means to them <strong>and</strong> discuss ways of strengthening it.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/constitutionblog<br />

Cancer drugs fund – National Cancer Action Team bulletin:<br />

The National Cancer Action Team has published a bulletin providing an update<br />

on drugs that were funded through the cancer drugs fund (CDF) in 2011/12,<br />

highlighting the current systems <strong>and</strong> processes in place <strong>and</strong> focusing on the work<br />

that is underway for the second <strong>and</strong> third year of the fund’s operation.<br />

Link:<br />

http://ncat.nhs.uk/sites/default/files/uploaded/CDF%20National%20Bulletin%20S<br />

ummer%20<strong>2012</strong>.pdf<br />

The Foundation <strong>Trust</strong> Non-Executive role - meeting the challenges:<br />

On 15 <strong>November</strong> <strong>2012</strong>, Monitor, in partnership with the King’s Fund, is holding a<br />

one-day conference in London to support FT Non-Executive Directors. It will<br />

provide a forum for learning, discussion <strong>and</strong> debate on how Non-Executives can<br />

best meet specific challenges facing Foundation <strong>Trust</strong>s <strong>and</strong> those of the<br />

changing health l<strong>and</strong>scape, including regulation.<br />

Link: http://www.kingsfund.org.uk/events/ft_nonexecutive_rol.html#tab_2<br />

Preventing suicide in Engl<strong>and</strong> – a cross-government outcomes strategy:<br />

A new suicide prevention strategy has been launched, with the objectives of<br />

reducing the suicide rate <strong>and</strong> providing better support for those bereaved, or<br />

affected by suicide. Much of the work to prevent suicides is carried out locally<br />

<strong>and</strong> the strategy outlines evidence-based approaches to inform this work. NHS<br />

<strong>and</strong> Local Authority Chief Executives will consider the strategy in preparing joint<br />

strategic needs assessments <strong>and</strong> joint health <strong>and</strong> wellbeing strategies.<br />

For further information, go to: www.dh.gov.uk/health/<strong>2012</strong>/09/suicide-prevention<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


3<br />

Preparations for winter planning <strong>and</strong> reporting:<br />

A letter from David Flory, Deputy NHS Chief Executive <strong>and</strong> Shaun Gallagher,<br />

Acting Director General, Social Care, Local Government <strong>and</strong> Care Partnerships,<br />

sets out preparations for winter planning <strong>and</strong> reporting, which will run from 6<br />

<strong>November</strong> <strong>2012</strong> to the end of February 2013. SHA Cluster Chief Executives<br />

have been asked to ensure preparations are in place <strong>and</strong> encourage local NHS<br />

organisations to review local winter plans <strong>and</strong> observe the timetable for daily<br />

SITREP reporting.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/winterreporting-<strong>2012</strong>-13<br />

Commissioning specialised services nationally – new proposals:<br />

The Clinical Advisory Group for prescribed services (CAG) has made<br />

recommendations about which specialised services for people with rare<br />

conditions should be commissioned in Engl<strong>and</strong>. The services listed on its latest<br />

report will be commissioned by the NHS Commissioning <strong>Board</strong> from April 2013,<br />

rather than by Clinical Commissioning Groups. The list will be agreed by<br />

Ministers <strong>and</strong> the Commissioning <strong>Board</strong> in the Autumn.<br />

For further information, go to: http://www.dg.gov.uk/health/<strong>2012</strong>/09/cagreport<br />

New National Equalities Lead for NHS:<br />

The NHS Commissioning <strong>Board</strong> Authority has appointed Paula Vasco-Knight as<br />

National Equality Lead. Reporting to Jim Easton, National Director<br />

Transformation, Paula will lead the equalities work at the <strong>Board</strong>, whilst continuing<br />

her full time role as CEO at the South Devon Healthcare NHS Foundation <strong>Trust</strong><br />

<strong>and</strong> Senior Responsible Officer for the equality delivery system.<br />

Link: http://www.commissioningboard.nhs.uk/<strong>2012</strong>/09/07/national-equalities-leadappointed-to-the-nhs-commissioning-board<br />

Safeguarding children <strong>and</strong> adults in the future NHS – interim advice:<br />

The NHS Commissioning <strong>Board</strong> Authority has published interim advice on<br />

arrangements to secure children’s <strong>and</strong> adult safeguarding, which provides<br />

additional information, in particular to emerging Clinical Commissioning Groups.<br />

A covering letter from Jane Cummings, Chief Nursing Officer, <strong>and</strong> Shaun<br />

Gallagher, Acting Director General, Social Care, Local Government <strong>and</strong> Care<br />

Partnerships, reminds PCTs <strong>and</strong> SHAs of the vital importance of maintaining<br />

appropriate arrangements, as the health system goes through transition.<br />

Link: http://www.commissioningboard.nhs.uk/<strong>2012</strong>/09/12/safeguarding<br />

Publication of organisation patient safety incident data:<br />

The NHS Commissioning <strong>Board</strong> Authority has released the latest organisation<br />

patient safety incident data. High levels of incident reporting provide an<br />

indication of an increased safety culture within the organisation.<br />

Link: http://www.nrls.npsa.nhs.uk/patient-safety-data/organisation-patient-safetyincident-reports<br />

Doctors urged to encourage staff immunisation against flu:<br />

In an open letter to Doctors, Professor Dame Sally Davies, the Chief Medical<br />

Officer <strong>and</strong> Dr Mark Porter, Chair of Council at the British Medical Association,<br />

have stressed the vital role that Doctors can play in ensuring that as many<br />

frontline staff are vaccinated against flu as possible. The letter also includes<br />

supporting evidence on the importance of the influenza vaccine. NHS<br />

organisations are urged to use this letter locally to encourage Doctors to have<br />

their flu jabs.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/get-flu-jab<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


4<br />

Nurses <strong>and</strong> midwives have vital role in flu vaccination:<br />

In an open letter to nurses <strong>and</strong> midwives, Professor Viv Bennett, Director of<br />

Nursing, Department of Health, <strong>and</strong> the Government’s principal advisor on public<br />

health nursing, has stressed the vital role that nurses <strong>and</strong> midwives play in<br />

making sure frontline staff are vaccinated against flu <strong>and</strong> patients are protected.<br />

This drive is supported by the Royal College of Nursing (RCN) <strong>and</strong> the Royal<br />

College of Midwives (RCM).<br />

Frontline healthcare workers are more likely to be exposed to the influenza virus,<br />

particularly during winter months, when some of the people in their care will be<br />

infected. It has been estimated that up to 1 in 4 healthcare workers may catch<br />

flu during a mild influenza season, a much higher incidence than expected in the<br />

general population.<br />

For further information, go to:<br />

http://www.nhsemployers,org/HealthyWorkplaces/SeasonalFluCampaign/Latestnews/pages/DepatmentOfHealthIssueLetterToNursesAndMidwivesFluVaccinatio<br />

n.aspx<br />

Hospital patients need high quality food <strong>and</strong> drink:<br />

Principles outlining what patients should expect from hospital food were<br />

announced recently by Health Secretary, Jeremy Hunt. These include the<br />

provision of high quality <strong>and</strong> healthy hospital food <strong>and</strong> drink, <strong>and</strong> patients being<br />

given a choice from a varied menu. A particular focus will be on the most<br />

vulnerable, such as older people, which is a top priority for the Secretary of State.<br />

These principles will be a feature of new patient-led assessments covering areas<br />

such as hospital food, cleanliness, privacy <strong>and</strong> dignity.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/hospital-food<br />

Equality duty to make reasonable adjustments:<br />

Although the duty to make reasonable adjustments for disabled service users is<br />

not new, the Department of Health wants to make sure all service providers are<br />

aware of their responsibilities. Where a provider does not comply with the duty<br />

to make reasonable adjustments in the provision of services of a public nature, it<br />

will be committing an act of unlawful discrimination. Further guidance is<br />

available in chapter 7 of the Equality <strong>and</strong> Human Rights Commission’s Statutory<br />

Code of Practice for Services, Public Functions <strong>and</strong> Associations.<br />

Link: http://www.equalityhumanrights.com/uploaded_files/EqualityAct/services<br />

code.pdf<br />

NHS Leadership Recognition Awards <strong>2012</strong> finalists:<br />

The NHS Leadership Academy’s short-listed finalists for these awards represent<br />

outst<strong>and</strong>ing leadership across nine categories <strong>and</strong> exemplify the quality,<br />

dedication <strong>and</strong> innovation of staff working in the system today. The winners will<br />

be announced at the awards ceremony at Barts Great Hall on 10 December<br />

<strong>2012</strong>.<br />

Link: http://www.nhsleadershipawards.nhs.uk/about-the-awards/awards-<br />

<strong>2012</strong>.aspx<br />

Managing nursing performance <strong>and</strong> supporting nurses in difficulty:<br />

With an opening presentation from Professor Juliet Beal, Director of Nursing<br />

Quality, Improvement <strong>and</strong> Care at the NHS Commissioning <strong>Board</strong> Authority, this<br />

Conference in London on 6 December <strong>2012</strong> is for all nurse managers <strong>and</strong><br />

leaders. It offers practical guidance for managing nursing performance <strong>and</strong><br />

supporting nurses in difficulty to ensure safe, high quality patient care.<br />

Link: http://www.healthcareconferencesuk.co.uk/managing-poor-performancesupporting-nurses<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


5<br />

Preparing the Payment by Results package for <strong>2012</strong>/13:<br />

A letter from David Flory updates the NHS on work to prepare the payment by<br />

results (PbR) package for <strong>2012</strong>/13 <strong>and</strong> outlines a provisional timetable for the<br />

rest of the process. NHS Chief Executives will discuss planning for the road test<br />

of the PbR package with relevant colleagues <strong>and</strong> subsequent implementation<br />

from 1 April 2013.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/09/pbr-<strong>2012</strong>-14<br />

Views sought on vision for nursing:<br />

A proposed new vision for nursing, midwifery <strong>and</strong> care given sets out the values<br />

of compassionate care <strong>and</strong> asks how they can be developed further across<br />

health <strong>and</strong> social care. Over recent months, Viv Bennett, Director of Nursing,<br />

Department of Health <strong>and</strong> Jane Cummings, Chief Nursing Officer for Engl<strong>and</strong>,<br />

have been talking to care givers across the Country to start to develop what the<br />

new vision looks like <strong>and</strong> what values unite the profession. They now want to<br />

hear your views on the ideas contained in the draft vision.<br />

For more information, go to: www.dh.gov.uk/health/<strong>2012</strong>/09/views-vision-nursing<br />

Equality, diversity <strong>and</strong> inclusion in the NHS <strong>Board</strong> recruitment process:<br />

Two guides have been developed to build equality, diversity <strong>and</strong> inclusion into<br />

the NHS <strong>Board</strong> recruitment process for both Executives <strong>and</strong> Non-Executives.<br />

These practical resources help ensure selection panels <strong>and</strong> appointed board<br />

members demonstrate confidence, commitment <strong>and</strong> competency in these areas<br />

<strong>and</strong> are able to apply these to core board level business.<br />

Link: www.leadershipacademy.nhs.uk/board-recruitment-guides<br />

NICE Fellowships:<br />

Chief Executives <strong>and</strong> other senior professionals can now apply for Fellowships<br />

provided by NICE. These are unique opportunities to engage in the Institute’s<br />

work more strategically, participate in high level discussions <strong>and</strong> support NICE in<br />

the implementation of its guidance. Appointments start in April 2013 <strong>and</strong> run for<br />

three years.<br />

Link: www.nice.org.uk/fellows<strong>and</strong>scholars<br />

Healthwatch Engl<strong>and</strong> launched:<br />

Healthwatch Engl<strong>and</strong>, the new independent consumer champion for health <strong>and</strong><br />

social care in Engl<strong>and</strong>, has been launched. A key milestone in achieving the<br />

Government’s vision set out in the White paper ‘Equity <strong>and</strong> Excellence:<br />

Liberating the NHS’, Healthwatch Engl<strong>and</strong>’s role is to give a national voice to the<br />

key issues affecting people who use health <strong>and</strong> care services.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/healthwatchengl<strong>and</strong>-launched<br />

NHS friends <strong>and</strong> family test – National implementation guidance:<br />

This guidance is now available <strong>and</strong> aims to support those who will be<br />

implementing this work, initially providers of NHS funded acute services for<br />

inpatients, <strong>and</strong> patients discharged from A&E, from April 2013.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/guidance-nhs-fft<br />

Information flows <strong>and</strong> personal information in the new commissioning<br />

l<strong>and</strong>scape:<br />

Robust information governance enables us to safeguard the privacy <strong>and</strong><br />

confidentiality of personal confidential information. In the new commissioning<br />

environment, information governance remains vitally important. Liability for<br />

information governance rests with the legal entity responsible for the processing<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


6<br />

of data, even where this is contracted out, <strong>and</strong> organisations need to ensure they<br />

comply with their legal obligations.<br />

Link: http://www.nigb.nhs.uk/igplgflows<br />

Consensus statement supporting the Liverpool Care Pathway:<br />

Over 200 organisations have signed a consensus statement in support of the<br />

Liverpool Care Pathway for the dying patient, including professional bodies, third<br />

sector organisations, disease specific charities <strong>and</strong> organisations representing<br />

care homes, hospices, social services <strong>and</strong> palliative care specialists.<br />

Link: http://www.endoflifecareforadults.nhs.uk/tools/core-tools/liverpool-carepathway<br />

Radiotherapy treatment to be rolled out across the NHS:<br />

Almost 8,000 more cancer patients a year could benefit from the roll-out of an<br />

advanced radiotherapy technique with fewer side effects, thanks to a £15m<br />

investment announced by the Department of Health. The Cancer Radiotherapy<br />

Innovation Fund will exp<strong>and</strong> NHS capacity to deliver life-saving advanced<br />

radiotherapy techniques by April 2013. The money will be used to speed up the<br />

use of Intensity Modulated Radiotherapy (IMRT) building on the success of the<br />

Cancer Drugs Fund, which has already benefited over 21,000 patients. The<br />

£15m Radiotherapy Innovation Fund will cover the remainder of <strong>2012</strong>/13.<br />

For further information, go to: http://mediacentre.dh.gov.uk/<strong>2012</strong>/10/08/eightthous<strong>and</strong>-patients-to-benefit-from-advanced-cancer-treatment<br />

The Quarter shows continued strong NHS Performance:<br />

David Flory’s quarterly report for Quarter 1 (April to June) <strong>2012</strong>/13, published<br />

recently, provides a summary of the NHS financial position <strong>and</strong> performance<br />

against National priorities set out in the NHS Operating Framework <strong>2012</strong>/13. It<br />

shows the NHS has continued to perform strongly against key performance<br />

measures in the first quarter of this important year for the NHS. The NHS also<br />

continues to make progress with system transformation <strong>and</strong> the financial savings<br />

required to deliver the quality, innovation, productivity <strong>and</strong> prevention (QIPP) <strong>and</strong><br />

reform challenge.<br />

For further information, go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/quarter-1-<br />

<strong>2012</strong>-13<br />

Medical revalidation of doctors to start in December:<br />

Medical revalidation, the process by which all doctors who are licensed with<br />

the General Medical Council (GMC) regularly demonstrate they are up-todate<br />

<strong>and</strong> fit to practice, will start in December <strong>2012</strong>.<br />

The new system will help doctors maintain the st<strong>and</strong>ard expected of them by<br />

making sure they keep pace with the latest techniques, technologies <strong>and</strong><br />

research. Revalidation will also require a doctor to tackle any concerns about<br />

skills such as communication <strong>and</strong> maintaining trust with patients.<br />

A joint letter from Sir David Nicholson <strong>and</strong> Sir Bruce Keogh provides more<br />

detail.<br />

To read the letter go to: http://www.dh.gov.uk/health/<strong>2012</strong>/10/medicalrevalidation-uk/<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


7<br />

People with dementia to receive more support:<br />

The Department of Health is providing dedicated funding to create care<br />

environments for people with dementia that help reduce anxiety <strong>and</strong> distress,<br />

<strong>and</strong> make them feel safer.<br />

Up to £50 million will be available to NHS trusts <strong>and</strong> local authorities, working<br />

in partnership with care providers, to help tailor hospitals <strong>and</strong> care homes to<br />

the needs of people with dementia. The care providers involved will need to<br />

sign up to the Dementia Care <strong>and</strong> Support Compact, which commits them to<br />

providing first-rate care <strong>and</strong> support for people with dementia <strong>and</strong> their<br />

families.<br />

For further information go to :<br />

http://www.dh.gov.uk/health/<strong>2012</strong>/10/dementiaenvironments<br />

National Self Care week 12-18 <strong>November</strong> <strong>2012</strong>:<br />

(Gateway reference number: 18251)<br />

This campaign to be launched by Health Minister Norman Lamb, raises<br />

awareness of the support available to help people, especially those with longterm<br />

conditions, to grow older healthily. This year's theme, which builds on<br />

the European Healthy Ageing Initiative, focuses on supporting people to take<br />

control of their own health <strong>and</strong> wellbeing, <strong>and</strong> play a more active role in<br />

decisions about their care.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/self-care-week-<strong>2012</strong>/<br />

Pricing of NHS services:<br />

(Gateway reference number: 18128)<br />

From April 2014, Monitor <strong>and</strong> the NHS Commissioning <strong>Board</strong> will take over<br />

responsibility for pricing NHS services from the Department of Health. They<br />

will do this through the national tariff. The consultation seeks views on which<br />

providers can formally object to Monitor’s way of calculating prices, <strong>and</strong> what<br />

level of objection from commissioners <strong>and</strong>/or providers would require Monitor<br />

to reconsider how it calculates prices.<br />

Link: http://health<strong>and</strong>care.dh.gov.uk/pricing-consultation/<br />

Latest wave of NHS staff survey launched:<br />

(Gateway reference number: 18280)<br />

The Department of Health has commissioned GFK NOP, an independent<br />

research agency, to conduct a survey among NHS staff of their awareness of<br />

a range of important issues, including major NHS policy initiatives <strong>and</strong><br />

attitudes towards them. Fieldwork will begin on 2 <strong>November</strong> <strong>2012</strong> <strong>and</strong> will<br />

run through December <strong>and</strong> possibly into early January 2013. The survey will<br />

be conducted across all SHA clusters, to make sure staff views are<br />

represented across the country. The link below takes you to the results of last<br />

year's NHS staff attitudes survey.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/06/public-perception/<br />

Finance transition planning arrangements:<br />

(Gateway reference number: 18269)<br />

The Department of Health, in collaboration with PCT <strong>and</strong> SHA finance<br />

colleagues, has developed a draft document covering the main year-end<br />

finance transition areas that SHAs <strong>and</strong> PCTs will need to plan for in <strong>2012</strong>/13.<br />

The final document will be issued by the end of <strong>November</strong> <strong>2012</strong>.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/finance-transition/<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


8<br />

H<strong>and</strong>over <strong>and</strong> closedown: planning for a secure transition:<br />

(Gateway reference number: 18231 <strong>and</strong> 18228)<br />

The Department of Health Integrated Programme Office is working with<br />

transition leads in SHAs to support <strong>and</strong> assure h<strong>and</strong>over <strong>and</strong> closedown<br />

activity. Guidance is being produced by experts in the field, <strong>and</strong> policy <strong>and</strong><br />

business leads, to make sure best practice is followed <strong>and</strong> there is a<br />

consistent approach across all organisations. The first set of guidance is now<br />

available, covering 'transfer documentation' <strong>and</strong> 'intellectual property rights'.<br />

Link: http://www.dh.gov.uk/health/<strong>2012</strong>/10/h<strong>and</strong>over-guidance-transition/<br />

LOCAL NEWS:<br />

Executive Director Appointments:<br />

Recent Executive Director appointments include Flo Panel-Coates, Director of<br />

Nursing, Dr Mike Gill, Medical Director, Steve Huddleston, Chief Information<br />

Officer <strong>and</strong> Dr Ian Hosein, Director of Infection Prevention <strong>and</strong> Control.<br />

Staff Engagement Sessions:<br />

A recent initiative has commenced with staff being invited to attend face to<br />

face briefings from the Chief Executive <strong>and</strong> the Senior Team on<br />

developments around the <strong>Trust</strong>. This is an opportunity for staff to put their<br />

questions <strong>and</strong> suggestions forward <strong>and</strong> to get involved in the <strong>Trust</strong>’s plans for<br />

the future.<br />

HSJ Award Nomination:<br />

The Chief Executive, Director of Estates <strong>and</strong> several other representatives<br />

from the <strong>Trust</strong> recently attended an award ceremony sponsored by the Health<br />

Service Journal, where BHRUT had been nominated in the Category of<br />

Efficiency in Clinical Support Services. Although the <strong>Trust</strong> was not successful<br />

in winning the Award, the Directorate should be congratulated for reaching<br />

the shortlist <strong>and</strong> being nominated for this prestigious Award.<br />

World Health Organisation H<strong>and</strong> Hygiene Compliance Education<br />

Programme:<br />

Through the Infection Control Committee, BHRUT has agreed to a fantastic<br />

opportunity to become only the third NHS <strong>Trust</strong> in the UK to participate in the<br />

World Health Organisation H<strong>and</strong> Hygiene Compliance Education Programme.<br />

Representatives who have been trained by the World Health Organisation will<br />

undertake this Programme.<br />

This is a one year Programme, which will involve four wards at Queen’s <strong>and</strong><br />

three wards at King George Hospital (a cross section of specialties have been<br />

selected). Preliminary Audits will be carried out on the seven wards <strong>and</strong><br />

customised Education Programme Tools will be designed for the specific<br />

needs of each ward. Mid-year Audits will also be undertaken to provide an<br />

interim measure of the effectiveness of the Programme. It will cover all<br />

groups of staff <strong>and</strong> a concise KPI Dashboard will be designed, in order to<br />

track <strong>and</strong> monitor progress.<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


9<br />

Clinical Patient Management <strong>and</strong> H<strong>and</strong>over System (eH<strong>and</strong>over):<br />

The e-H<strong>and</strong>over system developed by Dr Aklak Choudhury, Respiratory<br />

Consultant <strong>and</strong> Mr John White, Consultant Orthopaedic Surgeon/Clinical IT<br />

Director is an award winning business critical SharePoint Hospital solution<br />

that improves patient safety <strong>and</strong> staff productivity. It has been running in the<br />

<strong>Trust</strong> for the past two years <strong>and</strong> is used by many disciplines, including<br />

Doctors, Nurses, Managers <strong>and</strong> Performance Teams.<br />

Dr Choudhury <strong>and</strong> Mr White have been invited by Microsoft to be the first<br />

case study produced as part of the business critical SharePoint Programme<br />

<strong>and</strong> will attend a Microsoft Conference in Las Vegas in <strong>November</strong>.<br />

The eH<strong>and</strong>over solution is the first to identify <strong>and</strong> successfully manage the<br />

shift gap issue, which results in significant communication failure <strong>and</strong> patient<br />

risk during nights <strong>and</strong> weekends. It provides the user with the functionality to<br />

complete their h<strong>and</strong>over tasks safely, efficiently <strong>and</strong> without duplication <strong>and</strong><br />

has the backing of the London Deanery <strong>and</strong> NHS Innovations. It won the<br />

EHI 2011 Award for “Best use of IT to promote patient safety” <strong>and</strong> the<br />

Microsoft Partner of the Year for Health Award. It has also been adopted by<br />

three other organisations <strong>and</strong> they are working with one of the Medical<br />

Education Teams to potentially set the processes as a ‘st<strong>and</strong>ard’ for all health<br />

organisations in the UK.<br />

Chairman & Chief Executive’s Report – <strong>November</strong> <strong>2012</strong>


QUALITY & SAFETY COMMITTEE<br />

PART II - OPEN<br />

Minutes of the meeting held on Tuesday 14 th August <strong>2012</strong> at 15.45 hrs in <strong>Board</strong> Rooms 1&2,<br />

<strong>Trust</strong> Headquarters, Queen’s Hospital, Romford.<br />

Present:<br />

Prof. Anthony Warrens, Non Executive Director (AW) (Chair)<br />

Caroline Wright, Non Executive Director (CW)<br />

Maureen Dalziel, Non Executive Director (MD)<br />

George Wood, Chairman (GW)<br />

Averil Dongworth, Chief Executive (AD)<br />

Mike Gill, Medical Director (MG)<br />

Magda Smith, Associate Medical Director MS)<br />

Stephen Burgess, Director of Clinical Strategy (SB)<br />

Pam Strange, Clinical Governance Director (PS)<br />

Alison Crombie, Director of Education (AC)<br />

John Alcolado, Director of Medical Education (JA)<br />

Gary Etheridge, Deputy Director of Nursing (GE)<br />

Portia Omo-Bare, Chief Pharmacist (POB)<br />

Andrew Deaner, Clinical Director – Acute Medicine (ADe)<br />

Dele Olorunshola, Clinical Director – Women’s Services (DO)<br />

Derek Hicks, Clinical Director – Emergency Care (DH)<br />

Gabriel Sayer, Clinical Director – Specialist Surgery (GSa)<br />

Dip Mukherjee, Clinical Director – Surgery (DM)<br />

Geraldine Soosay, Clinical Director – Pathology (GS)<br />

Jane Stevens, Clinical Director – Specialist Medicine (JS)<br />

Zoltan Narg, Clinical Director – Radiology (ZN)<br />

Imogen Shillito, Director of Communications (IS)<br />

Cris Robinson, Committee Coordinator (Minutes) (CR)<br />

Rachel Brady, NHS North East London <strong>and</strong> City (RB)<br />

Elaine Clark, Chair of Improving Patient Experience Group (EC)<br />

In Attendance: Lucy Etheridge, Medical Education<br />

Dr Rull, Emergency Care<br />

Dr Umo-Etuk, Clinical Lead, Anaesthetics deputising for Remi Odejinmi<br />

Dr Andole, Clinical Lead, Neurosciences deputising for Jonathan Pollock<br />

1


102/<strong>2012</strong> Apologies<br />

Apologies were received from:<br />

Ambalika Das, Clinical Director – Children’s Services (ADa)<br />

Remi Odejinmi, Clinical Director – Anaesthetics (RO)<br />

Jonathan Pollock, Clinical Director – Neurosciences (JP)<br />

Cathy Geddes, Chief Operating Officer (CG)<br />

Vanessa Lodge, Deputy Director of Quality & Clinical Governance, NHS<br />

North East London & City<br />

103/<strong>2012</strong> Minutes of the Meeting held on the 12 th June <strong>2012</strong><br />

The minutes from the previous meeting were agreed to be a true record.<br />

104/<strong>2012</strong> Matters Arising<br />

Action Log<br />

18/<strong>2012</strong> - SB advised there had been further discussions with Health UK about<br />

the ISTC that has resulted in the <strong>Trust</strong> agreeing to support cardiac arrests in<br />

the centre. However, the <strong>Trust</strong> declined to provide advice to ISTC clinicians,<br />

although a pathway for referring the patient to A&E was agreed.<br />

36/<strong>2012</strong> – Information Governance Committee reports would in future be<br />

independent items <strong>and</strong> not part of the Feeder Committee update.<br />

42/<strong>2012</strong> – The infection control items were included as agenda items.<br />

45/<strong>2012</strong> – DO advised that the range used for Emergency LSCS performed<br />

within graded times was 30 for grade 1, <strong>and</strong> 60 for grade 2. The national<br />

figure for grade 2 was 75, but the <strong>Trust</strong> had agreed an internal ‘stretch’ target.<br />

45/<strong>2012</strong> – DO <strong>and</strong> IS agreed to jointly review the potential for a positive journal<br />

article on the <strong>Trust</strong>’s experience of meeting NHSL performance indicators for<br />

Emergency LSCS.<br />

54/<strong>2012</strong> – The item on patient stories to be deferred to the October meeting.<br />

70/<strong>2012</strong> – The update from each CD on NICE compliance was deferred to the<br />

October meeting.<br />

70/<strong>2012</strong> – The Deanery/GMC visit was included an agenda item.<br />

72/<strong>2012</strong> – POB reported that the missing methadone had been found, so the<br />

issue was due to a lag in reporting <strong>and</strong> it was not therefore an SI.<br />

74/<strong>2012</strong> – The Dr Foster reports had been re-circulated to members.<br />

74/<strong>2012</strong> – PS advised the <strong>Trust</strong> was in the process of introducing CHKS<br />

mortality data <strong>and</strong> had discontinued the contract with Dr Foster. Further<br />

information would be made available to the next meeting <strong>and</strong> once the<br />

changeover is complete the presentation will be scheduled into the<br />

Committee’s agenda.<br />

MS explained in relation to the update required on weekend mortality data<br />

relating to elective weekend deaths that she had been reviewing the notes of<br />

these patients <strong>and</strong> had identified that some were miscoded; some were<br />

attributable to the way cancer was coded. Of the notes reviewed only 8 relate<br />

to true elective surgical deaths, which she needed to discuss further with<br />

neurosurgery to fully underst<strong>and</strong>. There were 3 actions following the review<br />

i.e. 1) work with the coders to review the miscoding of emergency admissions<br />

as planned deaths, 2) further investigate how cancer day unit cases are coded<br />

<strong>and</strong> 3) review with neuro that the deaths were not inappropriately coded.<br />

IS confirmed that appropriate publicity would be given to ensure mortality data<br />

was transparent.<br />

Action<br />

DO / IS<br />

GE<br />

CDs<br />

PS<br />

2


77/<strong>2012</strong> – GE confirmed invitations to the MenCap Charter launch had been<br />

completed.<br />

78/<strong>2012</strong> – GE confirmed the letter to the Safeguarding team was completed.<br />

79/<strong>2012</strong> – GE confirmed the letter to the Chaplains was completed<br />

81/<strong>2012</strong> – SB confirmed the issue from the PALS Annual Report had been<br />

escalated to the <strong>Trust</strong> <strong>Board</strong>. However, 50% of the total PALS contacts<br />

continue to be in relation to cancellation of Outpatient appointments <strong>and</strong> the<br />

often extensive delays in rebooking some patients. SB felt this was an<br />

ongoing problem that was generating high levels of complaints, but was also a<br />

significant cause of concern for clinicians as patient’s individual risks factors<br />

needed closer scrutiny. It was agreed this item should be referred to the<br />

Directorate Manager for Outpatients for urgent resolution <strong>and</strong> feedback.<br />

GE confirmed that the letter to the PALS team was completed.<br />

Rolling Programme<br />

Members were advised that following discussions aimed at ensuring the<br />

Committee focused on clinical governance outputs, over the next few meetings<br />

the Directorates would be required to provide updates on their progress with<br />

embedding clinical governance. This would by necessity mean some items on<br />

the rolling programme were deferred. It was agreed that MG, SB <strong>and</strong> PS<br />

would revise the rolling programme <strong>and</strong> advise Directorates when they would<br />

be required to make their reports. It was also proposed that the presentations<br />

should focus on the 3 top corporate <strong>and</strong> 3 local priorities.<br />

105/<strong>2012</strong> Quality Dashboard<br />

STRATEGY<br />

PS explained the new dashboard was still being developed <strong>and</strong> future<br />

iterations would include more detail e.g. corporate indicators. The expectation<br />

is that CDs will add to the overall dashboard’s effectiveness by providing<br />

exception reports in future.<br />

AW said the dashboard was moving in the right direction. He asked that the<br />

RAG rating be shown in words as well as in colour.<br />

106/<strong>2012</strong> Items for Escalation from Feeder Committees<br />

This report was presented for information.<br />

107/<strong>2012</strong> Deanery / GMC Visit Report <strong>and</strong> Action Plan<br />

JA reported on the annual Deanery visit in May that required the <strong>Trust</strong> to take<br />

immediate remedial actions in relation to OPD cover, gynae continuity of care,<br />

gynae outpatients, consultant attendance out of hours, triage of patients <strong>and</strong><br />

FY2 responsibilities on HDU. JA explained that all m<strong>and</strong>atory actions had<br />

been completed but further work was needed to address consultant reticence<br />

to attend the <strong>Trust</strong> when they are called at home.<br />

The GMC Survey of trainees identified there was good core training, but<br />

GPVTS in emergency <strong>and</strong> obs. <strong>and</strong> gynae. was poor; paediatrics was<br />

satisfactory. The issues identified are not within the gift of the Education<br />

Department to resolve as they are trustwide issues not specifically educational<br />

ones.<br />

JA also advised there were ongoing patient safety concerns relating to<br />

supervision of junior doctors, the pressure in very busy areas such as obs. <strong>and</strong><br />

gynae. <strong>and</strong> emergency medicine <strong>and</strong> the poor quality of locums.<br />

Action<br />

AK<br />

MG / SB<br />

/ PS<br />

3


Action<br />

Members were advised that acute services <strong>and</strong> maternity should expect<br />

similar visits soon. JA summarised the ongoing challenges to be:<br />

• The need for a clinical governance bulletin<br />

• Hospital at Night<br />

• Bleep free time for junior doctors that would also assist in getting the<br />

11am discharge target met.<br />

• Phlebotomy cover at KGH<br />

• Daily Consultant Ward Rounds<br />

• Study Leave<br />

• Obs. <strong>and</strong> gynae. Middle grade numbers<br />

Most importantly JA felt the issue of clinical supervision of junior doctors must<br />

be focused on.<br />

AD also highlighted the Deanery’s requirement for obs. <strong>and</strong> gynae. junior<br />

doctors to be withdrawn from King George Hospital <strong>and</strong> repatriated to Queen’s<br />

within 72 hours of the MLU opening. MG said he would clarify expectations<br />

around this at his meeting with Andy Mitchell next week.<br />

AW felt that the Clinical Directors needed to tackle the issue of clinical<br />

supervision. JA confirmed that the <strong>Trust</strong>’s Medical & Education Policy for<br />

Supervision was updated in February this year <strong>and</strong> key performance indicators<br />

are in place. It was agreed that JA would write to the Clinical Directors<br />

requesting that each area should have a written policy that clearly states the<br />

level of clinical supervision expected; it should also clarify the <strong>Trust</strong>’s<br />

expectation that a Consultant will always attend to support a trainee if<br />

specifically requested to do so by the trainee.<br />

CW suggested that copies of the presentation would have been useful as<br />

would a broader executive summary that included the salient points. Both CW<br />

<strong>and</strong> AD were concerned that the action plans were not in the <strong>Trust</strong>’s format.<br />

JA explained the action plan was originally generated by the Deanery.<br />

However, GW felt there were too many action plans <strong>and</strong> there should be more<br />

consolidation; the action plans should be developed <strong>and</strong> owned by the <strong>Trust</strong><br />

with segments presented to the various audiences that request it.<br />

There was discussion around potential financial costs resulting from these<br />

visits/surveys that the <strong>Trust</strong> <strong>Board</strong> will be considering, but they will need to be<br />

added to the deficit.<br />

MG concluded the discussion by stating that other <strong>Trust</strong>s do provide better<br />

supervision of their juniors <strong>and</strong> that this leads to safer care. There will be<br />

some challenges but the emergency pathway will be an area to prioritise.<br />

PATIENT SAFETY<br />

108/<strong>2012</strong> Care Quality Commission Update<br />

PS explained that the report was for information but did highlight the action<br />

plan was being updated <strong>and</strong> there was a big drive to sign off as much as<br />

possible.<br />

AW was pleased to note the last Condition had been lifted.<br />

MG<br />

JA<br />

4


109/<strong>2012</strong> Infection Control Annual Report<br />

MS reported that the Infection Control Annual Report includes, at Appendix 3,<br />

the Infection Control Annual Plan that has been reviewed by the Infection<br />

Control Committee. The Plan shows there has been a significant rise in the<br />

first 4 months in both MRSA <strong>and</strong> C.difficile. The Infection Control Committee<br />

is solely focusing on these issues <strong>and</strong> incidence of MSSA. More positively,<br />

urinary catheter infections are decreasing this year. MS felt there needs to be<br />

a different approach with staff to ensuring that the basic principles of patient<br />

care are implemented.<br />

There have also been significant changes in the Infection Control Team with<br />

the Matron retiring recently <strong>and</strong> the Infection Control Doctor due to retire<br />

imminently. There are plans for a new Matron <strong>and</strong> Director of Infection<br />

Prevention <strong>and</strong> Control (DIPC) to be appointed. It was also important that<br />

aseptic touch technique is focused on.<br />

AW questioned whether there was enough support; MS felt that generally<br />

there was, although more Directorate representation at the Infection Control<br />

Committee was needed. She also felt colleagues had a role in being more<br />

challenging with issues such as h<strong>and</strong> hygiene <strong>and</strong> bare below the elbow. An<br />

invitation to Sodexo was being extended to improve environmental control<br />

scrutiny via the Infection Control Committee.<br />

DM commented that in general surgery Matrons <strong>and</strong> Nurses are empowered<br />

to challenge clinicians; this had resulted from a previous poor h<strong>and</strong> hygiene<br />

audit. He felt that there had been a view some time ago that infection control<br />

was a ‘nursing’ issue; this attitude is changing.<br />

MS advised that once the Infection Control Committee had completed its<br />

revision of the Annual Plan, it would be brought back to the Committee by the<br />

new DIPC.<br />

PATIENT OUTCOMES<br />

111/<strong>2012</strong> Surgical Site Infection Surveillance Update<br />

It was noted that a preliminary report had been reviewed by the Infection<br />

Control Committee relating to infections on fractured neck of femur patients. It<br />

was agreed this would be discussed with the CD <strong>and</strong> a decision taken on<br />

when <strong>and</strong> where this data should be presented.<br />

112/<strong>2012</strong> Implementing Patient Stories<br />

PATIENT EXPERIENCE<br />

This item to be deferred to the October meeting.<br />

113/<strong>2012</strong> Energise for Excellence<br />

This report was submitted for information <strong>and</strong> was duly noted. MD was<br />

concerned that dirty utensils in ward areas was affecting patient care. MS<br />

confirmed this was a cultural issue that was being monitored through the<br />

Infection Control Committee.<br />

114/<strong>2012</strong> Complaints Policy<br />

GE explained that the Complaints Policy required approval. It had been<br />

completely revised to take account of the 2009 Regulations <strong>and</strong> current best<br />

evidence. It has received wide circulation <strong>and</strong> comment. Members were<br />

asked to provide any comments to GE within 1 week of this meeting, subject to<br />

which the policy was duly approved.<br />

Action<br />

GSa /<br />

MS<br />

All<br />

5


Action<br />

115/<strong>2012</strong> Any Other Business<br />

The Complaints Annual Report for 2011/12 was tabled. The report was based<br />

on the requirements within the NHS Complaints (Engl<strong>and</strong>) Regulations 2009<br />

providing a summary of complaints received by the <strong>Trust</strong> in relation to its own<br />

services. Since the Annual Report was required for the September <strong>Trust</strong><br />

<strong>Board</strong> meeting, members were asked to pass any comments to GE within 2<br />

weeks from the date of this meeting.<br />

116/<strong>2012</strong> Summary of Issues for Escalation to <strong>Trust</strong> <strong>Board</strong><br />

• Continuing risks to patient care from high levels of cancelled outpatient<br />

appointments <strong>and</strong> delays with rebooking patients.<br />

117/<strong>2012</strong> Date of Next Meeting<br />

The next scheduled meeting will be held in <strong>Board</strong> Rooms 1&2 at 14.00 hours<br />

on the 16 th October <strong>2012</strong><br />

The dates for 2013 will be circulated.<br />

All<br />

MG<br />

CR<br />

6


ACTION LOG – PART I<br />

104/<strong>2012</strong> MATTERS ARISING<br />

45/<strong>2012</strong> - Joint review of potential for a positive journal article on the <strong>Trust</strong>’s<br />

experience of meeting NHSL performance indicators for emergency LSCS.<br />

Responsibility<br />

IS / DO<br />

70/<strong>2012</strong> – NICE compliance updates from CDs to be agenda item in October. CDs<br />

74/<strong>2012</strong> – Mortality update to the next meeting PS<br />

81/<strong>2012</strong> – Continuing risks to patient care from high levels of cancelled outpatient<br />

appointments <strong>and</strong> delays with rebooking patients to be escalated to the Directorate<br />

General Manager for Outpatients for early resolution <strong>and</strong> feedback.<br />

104/<strong>2012</strong> – Schedule of Directorate presentations on progress with embedding<br />

clinical governance to be developed, circulated <strong>and</strong> included in Rolling<br />

Programme.<br />

107/<strong>2012</strong> DEANERY / GMC VISIT REPORT AND ACTION PLAN<br />

Clarification to be sought concerning repatriation of junior doctors from KGH to<br />

Queen’s within 72 hours of MLU opening.<br />

It was agreed that JA would write to the Clinical Directors requesting that each<br />

area should have a written policy that clearly states the level of clinical supervision<br />

expected<br />

111/<strong>2012</strong> SURGICAL SITE INFECTION SURVEILLANCE<br />

Fractured neck of femur infections to be reviewed.<br />

112/<strong>2012</strong> IMPLEMENTING PATIENT STORIES<br />

This item to be included in the October meeting agenda.<br />

114/<strong>2012</strong> COMPLAINTS POLICY<br />

Any comments on the policy to be submitted to Gary Etheridge within 1 week<br />

115/<strong>2012</strong> ANY OTHER BUSINESS<br />

Any comments on the Complaints Annual Report to be submitted to Gary<br />

Etheridge within 2 weeks.<br />

116/<strong>2012</strong> ISSUES FOR ESCALATION TO TRUST BOARD<br />

The continuing risks to patient care from high levels of cancelled outpatient<br />

appointments <strong>and</strong> delays with rebooking patients to be escalated.<br />

117/<strong>2012</strong> DATE OF NEXT MEETING<br />

Dates for 2013 to be circulated to members<br />

AK<br />

MG / SB / PS<br />

MG<br />

JA<br />

GS / MS<br />

GE<br />

All<br />

All<br />

CR<br />

CR<br />

7


EXECUTIVE SUMMARY<br />

TITLE:<br />

Finance Report – Month Six (September)<br />

<strong>2012</strong>/13<br />

BOARD/GROUP/COMMITTEE:<br />

<strong>Trust</strong> <strong>Board</strong><br />

1. KEY ISSUES: REVIEWED BY (BOARD/COMMITTEE) <strong>and</strong><br />

DATE:<br />

• In the six month period to the end of September the<br />

trust recorded a year to date deficit of £26.0m<br />

(adjusted for impairments & IFRS reversals), which is<br />

£2.0m worse than plan for the period. This adverse<br />

variance is primarily explained by a £2.2m shortfall<br />

against the CIP target to date.<br />

• The in-month deficit of (£3.5m) was in line with plan.<br />

This represents an improvement on the average monthly<br />

run rate deficit to Month 5 of £4.5m <strong>and</strong> the deficit in<br />

Month 5 of £5.5m.<br />

• The income position to date is £2.1m ahead of plan.<br />

Some payment for over-performance with ONEL has<br />

now been agreed <strong>and</strong> £2.7m of this additional income is<br />

reflected in the year to date income position. Underperformance<br />

on non-ONEL SLAs (primarily Essex) has<br />

reduced income during the period by £0.4m.<br />

• The projected income position at the year-end is for<br />

an over-performance of £19.6m on the ONEL contract,<br />

less £0.9m under-performance for non-ONEL. This<br />

represents a significant risk as the commissioners have<br />

not yet agreed to fund £5.0m of these treatments.<br />

• Aside from the CIP shortfall, the expenditure position<br />

shows a £1.7m overspending year to date. This<br />

overspending is largely associated with the activity overperformance.<br />

An appropriate proportion of the income<br />

over-performance is being devolved to business units, to<br />

mitigate the marginal cost of over-performance.<br />

• The CIP position shows year to date delivery of £4.3m<br />

against a target for the period of £6.5m, a shortfall of<br />

£2.2m. The forecast delivery is £17.7m of which<br />

£4.8m is considered to be at high risk, which is an<br />

improvement on the £6.2m of high risk schemes<br />

reported last month. The <strong>Trust</strong> aims to have plans in<br />

place by the end of the month to deliver all of the £17.7m<br />

forecast.<br />

• This compares to a CIP target of £23.1m for the year.<br />

The PMO/E&Y are leading further work to mitigate the<br />

risks, maximise the savings opportunities <strong>and</strong> is aiming<br />

to deliver at least £20m CIPs.<br />

□ S&SIB ………………□ EPB…...…………..<br />

□ FINANCE ……………□ AUDIT ….……..….<br />

□ CLINICAL GOVERNANCE …………..…......<br />

□ CHARITABLE FUNDS ……………………….<br />

TRUST BOARD ………………………………<br />

□ REMUNERATION ……………………………<br />

□ OTHER ………………………(please specify)<br />

CATEGORY:<br />

□ NATIONAL TARGET □ CNST<br />

□ STANDARDS FOR BETTER HEALTH<br />

□ ASSURANCE FRAMEWORK<br />

□ TARGET FROM COMMISSIONERS<br />

CORPORATE OBJECTIVE To achieve financial<br />

security for the <strong>Trust</strong>, with reduced costs, improved<br />

productivity <strong>and</strong> collecting income due<br />

□ OTHER …………………….. (please specify)<br />

AUTHOR/PRESENTER:<br />

Alan Davies, Deputy Director of Finance / David<br />

Gilburt, Director of Finance<br />

DATE:<br />

• The <strong>Trust</strong> has significant risks to both income <strong>and</strong><br />

CIP delivery. With this level of risk our ability to<br />

deliver the £39.7m year-end control total must be in<br />

doubt.<br />

• We need Commissioners to fund the projected activity<br />

<strong>and</strong> the <strong>Trust</strong> has to deliver the CIP savings.<br />

• Discussions continue with the commissions <strong>and</strong> a<br />

detailed review of the forecast outturn will be<br />

completed <strong>and</strong> reported to the <strong>November</strong> Finance<br />

Committee<br />

2. FINANCIAL IMPLICATIONS/IMPACT ON CURRENT FORECAST:<br />

Set out under key issues<br />

3. ALTERNATIVES CONSIDERED/REASONS FOR REJECTION:<br />

1


N/A<br />

4. DELIVERABLES:<br />

N/A<br />

5. EVIDENCE :<br />

N/A<br />

6. RECOMMENDATION/ACTION REQUIRED:<br />

The <strong>Trust</strong> <strong>Board</strong> is request to approve the report <strong>and</strong> note the actions to mitigate risk in achieving<br />

the control total deficit of £39.7m<br />

AGREED AT ______________________<br />

MEETING, OR<br />

REFERRED TO: ______________________<br />

DATE: ____________________________<br />

DATE: ____________________________<br />

REVIEW DATE _________________________<br />

(if applicable)<br />

2


1. EXECUTIVE SUMMARY<br />

Monthly I&E Run rate<br />

m<br />

£<br />

43.0<br />

41.0<br />

39.0<br />

37.0<br />

35.0<br />

33.0<br />

31.0<br />

29.0<br />

Month 6 ‐ Monthly Run Rate Trend<br />

1 2 3 4 5 6 7 8 9 10 11 12<br />

Incom e Exp net of Blue/Green/Amber CIP Expenditure Further red CIPs required to m eet forecast<br />

<strong>Trust</strong> I&E Summary (+ve variances = favourable, -ve = adverse)<br />

<strong>2012</strong>/13 In Month (£'000) <strong>2012</strong>/13 Year to date (£'000)<br />

<strong>2012</strong>/13 <strong>2012</strong>/13 Foreast (£'000)<br />

2011/12<br />

2011/12 YTD Annual<br />

Actual £'000 Var £'000 Var % Actual £'000 Var £'000 Var % Actual £'000 Budget £'000 Actual £'000 Var £'000 Var % Actual<br />

(35,508) 1,296 3.79% Income (209,703) 2,138 1.03% (198,584) (413,055) (420,630) 7,575 -1.83% (419,121)<br />

Expenditure<br />

24,509 (159) -0.65% - Pay 147,555 (571) -0.39% 144,367 292,971 297,334 (4,363) -1.49% 291,010<br />

11,068 (207) -1.90% - Non-pay 67,348 (527) -0.79% 66,700 132,269 133,954 (1,685) -1.27% 138,248<br />

(656) -100.00% - QIPP/Cost Reduction (2,782) (13,710) (8,446) (5,264) 38.40%<br />

(78) -100.00% - Contract adjmt. & reserves (189) (122) 3,088 (3,210) 2635.09%<br />

68 198 74.33% EBITDA 5,200 (1,931) -59.07% 12,482 (1,646) 5,300 (6,946) 10,137<br />

ITDA<br />

1,171 37 3.08% - Depreciation 7,104 143 1.97% 7,003 14,494 14,162 332 2.29% 14,033<br />

355 0.00% - Capital Dividends 2,132 0.00% 1,943 4,263 4,263 0.00% 3,613<br />

1,823 21 1.11% - Net Interest 11,904 22 0.19% 11,488 23,822 23,756 66 0.28% 23,011<br />

3,417 255 6.95% Net position 26,339 (1,766) -7.18% 32,917 40,933 47,481 (6,548) -16.00% 50,794<br />

Impairments (2,005) (5,318) (2,005) (2,005) (1,133)<br />

3,417 255 6.95% Net position 24,334 (1,766) -7.82% 27,599 38,928 45,476 (6,548) -16.82% 49,661<br />

In Month <strong>and</strong> YTD Performance<br />

Income<br />

• Income of £35.5m in Month Six was £1.3m over the plan <strong>and</strong> is £2.1m ahead of<br />

plan YTD. The ONEL contract is £4.8m ahead of contract YTD, less transitional<br />

funding not agreed of £2.1m, with a forecast over-performance of £13.0m, less<br />

£4.3m transitional funding. Over-performance has continued to increase,<br />

particularly for non-elective activity, which is only funded at 30% marginal tariff<br />

above 2011/12 baseline, against which the commissioners are applying a 65%<br />

marginal tariff (i.e. net 20% tariff). The forecast expenditure position now<br />

includes £1.8m of non-elective costs not covered by the marginal tariff.<br />

Pay expenditure<br />

• Pay is £159k overspent in the Month, mainly related to Medical staffing £129k<br />

(Radiology £71k <strong>and</strong> Specialist Surgery £93k) <strong>and</strong> £78k (Acute Medicine<br />

£128k).<br />

• The YTD position is £571k overspent, mainly related to Medical staff £508k<br />

(Radiology £497k) <strong>and</strong> Nursing staff £595k (mainly Acute Medicine £640k <strong>and</strong><br />

Midwifery £243k, partly offset by under spending in Corporate Nursing<br />

budgets), both partly offset by under spending on Management/Admin staff of<br />

£679k.<br />

Non-pay expenditure<br />

• Non-pay is £207k overspent in the Month, mainly related to Pathology £109k<br />

<strong>and</strong> Pharmacy £136k<br />

• YTD the overspending is £527k, mainly related to Pathology £355k <strong>and</strong><br />

Specialist Medicine (£224k – Oncology <strong>and</strong> Pharmacy)<br />

EBITDA<br />

• Earnings before Interest, Tax, Depreciation <strong>and</strong> amortisation (EBITDA) were<br />

£0.1m negative in the Month <strong>and</strong> £5.2m negative YTD. The improved in month<br />

position was primarily driven by income. The YTD EBITDA of £5.2m negative is<br />

£1.9m adverse against plan YTD but has improved by £7.3m compared with<br />

the same period last year. The forecast is £5.3m negative, £4.8m better than<br />

last year’s outturn..<br />

Net deficit<br />

• The net deficit is £25.7m to date, which is £1.8m worse than plan. The forecast<br />

deficit is £46.8m, primarily related to:<br />

o £4.3m transitional income support not agreed by commissioners<br />

o £1.0m increased income over-performance not agreed by<br />

commissioners<br />

o £1.8m unfunded cost of Non-elective activity<br />

• The forecast assumes full delivery of £4.8m red-rated CIPs (in addition to the<br />

£12.9m CIP rated as blue/green/amber, making a total of £17.7m)<br />

Add back - Impairment 2,005 2,005 2,005 1,133<br />

121 (221) IFRS reversed (380) (221) (1,202) (759) (443) (882)<br />

3,538 34 Net against control 25,960 (1,987) 39,731 46,722 (6,991) 49,912<br />

3


CIP<br />

CIP<br />

• Overall CIP delivery in month <strong>and</strong> YTD is £1.4m <strong>and</strong> £4.3m respectively. The forecast outturn is £12.9m for blue/green/amber rated schemes, with a further £4.8m of red-rated schemes,<br />

which are in the process of being validated, with the aim of confirming the full £17.7m before the end of October.<br />

Financial risk rating (per Monitor criteria) KPIs<br />

Criteria Indicator Weight 5 4 3 2 1<br />

Underlying<br />

performance<br />

Achievement of<br />

plan<br />

Financial<br />

efficiency<br />

Risk Ratings<br />

Reported<br />

Position<br />

Year to<br />

Date<br />

Forecas<br />

t<br />

Outturn<br />

Normalised<br />

Position*<br />

Year to<br />

Date<br />

Forecast<br />

Outturn<br />

EBITDA margin % 25% 11 9 5 1


<strong>Trust</strong> I&E summary by Division/Directorate:<br />

<strong>2012</strong>/13 In Month <strong>2012</strong>/13 In Month <strong>2012</strong>/13 Year to date (£'000) 2011/12 <strong>2012</strong>/13 <strong>2012</strong>/13 Foreast (£'000)<br />

Actual £'000 Var £'000 Var %<br />

Adj Actual<br />

WTE<br />

Variance<br />

WTE Actual £'000 Var £'000 Var %<br />

Adj Average<br />

Actual WTE<br />

Average<br />

Actual £'000<br />

YTD Actual<br />

£'000<br />

Annual<br />

Budget £'000 Actual £'000 Var £'000<br />

(32,691) 888 2.79% Central Income (193,737) 1,924 1.00% (32,119) (182,812) (381,659) (388,538) 6,879<br />

Surgical Services Division<br />

3,692 (109) -3.04% 662.14 -0.81 Anaesthetics 22,296 (672) -3.11% 613.40 3,507 19,928 42,137 44,268 (2,130)<br />

1,370 (140) -11.38% 224.94 -0.93 Specialist Surgery 8,271 (242) -3.01% 250.26 1,340 7,900 15,600 16,271 (671)<br />

1,475 (73) -5.19% 327.24 -5.18 Surgery 8,678 (203) -2.40% 384.78 1,624 9,614 16,625 17,178 (553)<br />

6,538 (322) -5.17% 1,214.32 -6.92 Total 39,245 (1,117) -2.93% 1,248.44 6,472 37,443 74,363 77,717 (3,354)<br />

Emergency Care, Gen Med & Neurosciences<br />

3,774 (245) -6.95% 957.31 -63.82 Medicine 22,747 (909) -4.16% 1,033.10 3,829 22,837 42,811 44,476 (1,666)<br />

2,371 47 1.95% 523.96 13.12 Emergency Care 15,012 (191) -1.29% 583.37 2,573 14,499 28,732 29,933 (1,201)<br />

1,096 32 2.83% 237.60 -3.74 Neurosciences 6,916 11 0.16% 230.86 1,136 6,927 13,536 13,703 (166)<br />

7,240 (166) -2.35% 1,718.87 -54.44 Total 44,675 (1,089) -2.50% 1,847.33 7,538 44,262 85,079 88,112 (3,032)<br />

Women's, Children & Support Services<br />

1,148 28 2.34% 269.75 -17.84 Children 6,922 117 1.66% 263.71 1,188 7,162 14,093 13,958 135<br />

882 1 0.08% 377.20 -7.52 Support Services 5,380 (119) -2.27% 382.87 887 5,319 10,212 10,685 (473)<br />

2,937 (26) -0.89% 634.61 35.36 Women 17,960 (401) -2.28% 678.97 3,124 18,846 34,907 35,659 (752)<br />

4,967 2 0.05% 1,281.56 10.00 Total 30,262 (403) -1.35% 1,325.55 5,200 31,327 59,212 60,302 (1,090)<br />

Diagnostics & Specialist Medicine<br />

1,884 (158) -9.13% 279.47 7.71 Pathology 11,125 (631) -6.01% 284.06 1,777 10,854 20,519 22,003 (1,484)<br />

1,730 (158) -10.08% 313.05 -21.16 Radiology 10,357 (629) -6.47% 287.38 1,543 9,081 18,869 20,445 (1,576)<br />

3,226 105 3.15% 575.57 7.30 Specialist Medicine 20,354 (349) -1.74% 605.48 3,441 20,440 38,961 40,058 (1,097)<br />

6,840 (211) -3.18% 1,168.09 -6.15 Total 41,836 (1,609) -4.00% 1,176.92 6,762 40,375 78,349 82,506 (4,157)<br />

7,082 504 6.65% 840.00 34.75 Corporate 43,441 1,107 2.49% 728.52 6,777 41,169 87,962 87,437 524<br />

(23) 695 103.46% 6,222.84 -22.76 - Sub-total 5,721 (1,187) -26.18% 6,326.76 630 11,763 3,307 7,536 (4,229)<br />

91 (57) -167.77%<br />

Central adjustment including<br />

provisions & red CIP (520) 725 353.73% 134 764 410 (7,113) 7,523<br />

(440) Contract QIPP adjmt. & reserves (1,465) (5,353) 4,888 (10,241)<br />

1,171 37 3.08% Depreciation 7,104 143 1.97% 1,169 6,958 14,494 14,162 332<br />

2,178 20 0.90% PDC & Net Interest 14,034 18 0.13% 2,209 13,431 28,075 28,008 67<br />

3,417 255 6.95% Total 26,339 (1,766) -7.18% 6,326.76 4,142 32,917 40,933 47,481 (6,548)<br />

Impairments (2,005) (5,318) (2,005) (2,005)<br />

3,417 255 6.95% Net position 24,334 (1,766) -7.82% 6,326.76 4,142 27,599 38,928 45,476 (6,548)<br />

• Central income over-performance primarily driven by over-performance on out-patients (£3.9m), less shortfall of £2.2m transitional funding to be agreed.<br />

• Surgical Services YTD overspending primarily driven by £0.4m CIP shortfall, Medical staffing £0.5m <strong>and</strong> Theatres non-pay £0.2m.<br />

• Emergency/Medicine/Neuro YTD overspending primarily related to CIP shortfall £0.3m <strong>and</strong> Nursing in Acute Medicine £0.6m<br />

• Women/Children/Support YTD, primarily in Women, related to Midwifery £0.2m <strong>and</strong> HIV drugs £0.2m, although run rate has improved in M5.<br />

• Diagnostics & Specialist Medicine primarily related to Pathology consumables £0.4m, pay of £0.8m (mainly Radiology medical staff £0.6m) <strong>and</strong> CIP shortfall £0.5m<br />

• Corporate under-spending primarily from non-recurrent charitable funds contribution £0.4m <strong>and</strong> Estates £0.5m<br />

5


2. CLINICAL INCOME<br />

Key points:<br />

• In line with guidance from the SHA, the <strong>Trust</strong> <strong>and</strong> Commissioners’<br />

have agreed a monthly profile plan based on Commissioners’ QIPP<br />

schemes; as such the Budget has been re-profiled to reflect this<br />

change.<br />

• Income for Month 6 has been forecast using first cut activity for the<br />

Month. Activity for A&E, OP <strong>and</strong> IP were all taken at day 31. This<br />

has ensured that activity is more accurate <strong>and</strong> gives greater<br />

assurance around Income for the current month.<br />

• There was an under- performance of £1.8m in the month, with a year<br />

to date over-performance of £4m, on an ‘activity times price’ basis.<br />

Final Month 5 actual income came in at £30.9m, £1.2m more than<br />

was accrued, <strong>and</strong> as such, the YTD position reflects the actual activity<br />

for Months 1 – 5 <strong>and</strong> the current month forecast.<br />

Business Unit<br />

Performance<br />

In Month Year to date Forecast<br />

Actual Var Actual Var Actual Var<br />

(7,223) 919 Acute Medicine (44,732) 3,240 (89,557) 7,894<br />

(1,950) 223 Anaethetics (11,101) (47) (22,180) (197)<br />

(1,781) (127) Children (11,430) (736) (22,709) (1,347)<br />

(2,318) 192 Emergency Care (14,437) (219) (28,853) 331<br />

(2,257) (56) Neurosciences (13,991) (461) (28,034) (817)<br />

(784) 42 Pathology (4,912) 25 (9,945) 27<br />

(1,062) 61 Radiology (6,191) 493 (12,484) 1,088<br />

(2,734) 538<br />

Specialist<br />

Medicine (16,017) 1,825 (32,324) 3,758<br />

(3,546) 457<br />

Specialist<br />

Surgery (21,402) 1,248 (43,127) 2,569<br />

(3,484) 222 Surgery (21,756) 293 (43,835) 965<br />

(4,393) 494 Women (26,601) 1,107 (53,424) 2,693<br />

547 (1,129) Corp (1,168) (2,695) (2,042) (10,108)<br />

(30,984) 1,837 Total (193,737) 4,074 (388,514) 6,855<br />

• The forecast reflects an £8.7m FOT over- performance on the ONEL<br />

contract, with an FOT under-performance of £1.8m on other ‘non-<br />

ONEL’ contracts. The over-performance for the ONEL contract is now<br />

being renegotiated as the likely outturn has increased by c.£2m due<br />

to increased activity. The £8.7m is net of £4.3m shortfall on<br />

transitional funding (i.e. £13m gross over-performance)<br />

• The <strong>Trust</strong> is currently negotiating for additional income with ONEL for<br />

Best Practice Tariff, Breast Screening <strong>and</strong> Commissioners’ failure to<br />

move births to other providers. Discussions with the cluster are still<br />

on-going.<br />

• On the East of Engl<strong>and</strong> Contract, there has been a reduction in the<br />

Non Elective Activity partially offset by an increase in the use of<br />

Devices; the net effect is an FOT under performance of £1.5m.<br />

• A&E activity has grown by 7% year on year, but this is primarily due to<br />

the full-year effect of the Queen’s UCC, which was taken on by<br />

BHRUT in August <strong>2012</strong>.<br />

• There is a growth of 4% in Day cases year on year as a result of the<br />

achievement of the 18 weeks targets, coupled with the <strong>Trust</strong><br />

undertaking work that went to the ISTC last year.<br />

• Non Elective admissions activity has declined by 3% year on year.<br />

6


Income by POD<br />

In Month Year to date Forecast<br />

Actual Var Actual Var Actual Var<br />

(1,708) 199 A<strong>and</strong>E (10,595) (9) (21,173) 628<br />

(64) (3) Ambulatory Care (451) 6 (912) 10<br />

(216) 50 Breast Screening (1,026) (77) (2,077) (165)<br />

(217) 0 Challenge <strong>Trust</strong> <strong>Board</strong> (1,300) 0 (2,600) 0<br />

(378) 0 CQUIN (2,268) 0 (4,536) 0<br />

(2,419) 295 Critical Care (13,598) 191 (26,971) 117<br />

(2,617) 234 Daycases (16,480) 749 (33,366) 1,380<br />

(945) (11) Devices & Drugs (5,876) 545 (11,880) 1,249<br />

(1,292) 170 Direct Access (7,859) 448 (15,913) 865<br />

(1,798) 36 Elective (11,690) 147 (23,667) 198<br />

(355) 0 HIV Contract (2,132) 0 (4,264) 0<br />

(33) (12) ISTC Contract (211) (59) (412) (128)<br />

(10,931) 767 Non Elective (67,412) 707 (134,441) 3,984<br />

(2,720) 494 OP First Attendances (16,353) 1,557 (33,109) 3,103<br />

(2,875) 528 OP Follow Ups (17,555) 1,989 (35,543) 3,967<br />

(513) 118 OP Procedures (3,040) 428 (6,154) 844<br />

(480) (993) Other (6,972) (1,867) (14,041) (3,637)<br />

Patient Transport<br />

(308) 27 Services (1,762) 78 (3,523) 157<br />

(342) 53 Radiotherapy (2,060) 158 (4,109) 249<br />

496 0 Readmissions 2,976 0 5,953 0<br />

(519) 97 Regular Day Attenders (2,911) 135 (5,806) 173<br />

(92) (147) Road Traffic Accidents (1,168) (264) (2,000) (864)<br />

0 0 Transitional Funding 0 0 0 (4,300)<br />

(659) (65) XBD (3,993) (790) (7,969) (976)<br />

(30,984) 1,837 Total (193,737) 4,074 (388,514) 6,855<br />

Note: Other includes the 65% marginal rate adjustment in respect of ONEL performance (£7.1m)<br />

Activity<br />

POD Group 2011-12 <strong>2012</strong>-13 Var % Change<br />

A<strong>and</strong>E 95,652 110,117 14,465 7%<br />

Ambulatory Care 1,458 1,527 69 2%<br />

Breast Screening 10,482 10,360 (122) -1%<br />

Critical Care 13,383 13,857 474 2%<br />

Daycases 20,254 22,110 1,856 4%<br />

Direct Access 2,447,662 2,401,471 (46,191) -1%<br />

Elective 3,827 3,848 21 0%<br />

Non Elective 39,972 37,897 (2,075) -3%<br />

OP First Attendan 85,277 89,951 4,674 3%<br />

OP Follow Ups 201,644 200,710 (934) 0%<br />

OP Procedures 16,201 18,147 1,946 6%<br />

Other 41,071 43,931 2,860 3%<br />

Radiotherapy 8,931 10,806 1,875 9%<br />

Regular Day Atten 6,912 7,221 309 2%<br />

XBD 20,319 15,084 (5,235) -15%<br />

Total 3,013,045 2,987,037 (26,008)<br />

7


Cluster Performance<br />

In Month Year to date Forecast<br />

Actual Var Actual Var Actual Var<br />

(25,605) 2,011 Outer North East London (161,828) 4,832 (324,928) 8,700<br />

(559) 82 Inner North East London (2,881) 9 (5,776) 5<br />

(1,016) 67 London Specialist Commissioning (5,891) 199 (11,610) 227<br />

East Of Engl<strong>and</strong> Specialist<br />

(3,027) (134) Commissioning (18,288) (787) (36,843) (1,516)<br />

(427) (63) Non Contract Activity (2,297) 127 (4,596) 397<br />

(95) 32 North Central London (383) 3 (768) 5<br />

(255) (158) <strong>Trust</strong> (2,169) (308) (3,992) (963)<br />

(30,984) 1,837 (193,737) 4,074 (388,514) 6,855<br />

8


Devolved income<br />

Annual<br />

Budget<br />

Forecast<br />

Variance<br />

Forecast<br />

Income overperformance<br />

against plan<br />

Income<br />

attibuted to<br />

Directorate<br />

Net variance<br />

after income<br />

attribution<br />

9<br />

Difference<br />

between<br />

forecast<br />

income overperformance<br />

<strong>and</strong> income<br />

attributed<br />

Comment<br />

Surgical Services<br />

Anaesthetics 44,614 (2,476) (197) 479 (1,997) 676<br />

Includes allocation from Surgical Business Units for<br />

over/(under) performance<br />

Specialist Surgery 16,166 (566) 2,569 439 (127) (2,130) Over‐performance primarily related to Out‐patient<br />

Surgery 16,977 (351) 965 29 (322) (936) QiPP non‐delivery<br />

Surgical Services Total 77,757 (3,393) 3,337 948 (2,445) (2,389)<br />

Emergency Care, Gen Med & Neurosciences<br />

Emergency Care 30,208 (1,476) 331 (162) (1,638) (493)<br />

Neurosciences 13,724 (188) (817) (62) (250) 755 Adjustment for Drugs/devices & NEL activity<br />

Medicine 44,561 (1,751) 7,894 1,438 (313)<br />

Most of over‐performance associated with nondelivery<br />

of QiPP as opposed to increase in activity<br />

(6,456) from 2011/12<br />

Emergency Care, Gen Med & Neuroscie 88,493 (3,415) 7,408 1,214 (2,201) (6,194)<br />

Women's, Children & Support Services<br />

Most of under‐performance associated with reclassification<br />

of PAU activity from NEL to Outpatients,<br />

Children 13,858 236 (1,347) 134 370 1,481<br />

not reflected in contract<br />

Support Services 10,779 (567) 172 (395) 172<br />

Most of over‐performance associated with lower<br />

Women 35,567 (660) 2,963 (170) (830) (3,133) reductions in births than planned<br />

Women's, Children & Support Services 60,204 (991) 1,616 136 (855) (1,480)<br />

Diagnostics & Specialist Medicine<br />

Pathology 21,974 (1,455) 27 179 (1,276) 152<br />

Radiology 19,509 (640) 1,088 832 192 (256) Includes allocation from other Business Units for<br />

Specialist Medicine 41,488 (2,527) 3,758 1,259 (1,268) (2,499) support services<br />

Diagnostics & Specialist Medicine Tota 82,971 (4,622) 4,873 2,270 (2,352) (2,603)<br />

Total of above 309,425 (12,421) 17,234 4,569 (7,852)<br />

Most of difference associated with non‐delivery of<br />

(12,665) circa £10m QiPP reductions in contract<br />

• The table above, gives a summary of the forecast outturn position for each business unit, <strong>and</strong> then builds in an appropriate share of over-performance income, as mitigation against the<br />

increased marginal cost of the over-performance for each area.<br />

• Business Unit budgets are funded to 2011/12 outturn levels (as forecast at Month 8), so the principle applied is as follows:<br />

o Take the increase (or decrease) in activity from the 2011/12 outturn (as at Month 8 forecast) to the <strong>2012</strong>/13 forecast outturn (as at Month 6)<br />

o Apply 65% of the full tariff, as a proxy for marginal costs (this is also the level that commissioners are paying for over-performance <strong>and</strong> is commensurate with the average level<br />

of direct & indirect costs, as calculated through SLR)<br />

o Apply 50% of the 65% to Business Units in respect of direct costs, with the other 15% apportioned to clinical support services (e.g. Pathology, Radiology)<br />

o Of the 50%, a proportion is then allocated to Operating Theatres, in respect of the surgical specialties.<br />

o<br />

• It is proposed to allocate budgets through the ledger on this basis for Month 7 <strong>and</strong> to review the allocation again at Q3 (Month 9) <strong>and</strong> Month 12.


3. COST IMPROVEMENT PROGRAMME<br />

Commentary<br />

Forecast outturn<br />

The Month 6 forecast is £17.7m - at the same level as at Month 5. A new “Blue” rating is used to denote schemes that have been fully implemented, e.g. a post has been removed.<br />

£1.5m has moved in the RAG profile from Red to Blue, Green <strong>and</strong> Amber which are forecast at £12.9m.<br />

This includes:<br />

Reversal of Annual Leave Provision 750<br />

Outpatients schemes 330<br />

Emergency Care 120<br />

Neurosciences 110<br />

Rates Assessment 100<br />

Other 90<br />

Total new BAG schemes £1,500k<br />

CIP mitigation schemes (Red rated currently) include:<br />

Short Term Controls 2,350<br />

VAT on Medical Locum spend 600<br />

Medicines Management 560<br />

VAT on Pharmacy 250<br />

Length of Stay 200<br />

Workforce – AHP’s 200<br />

Salary sacrifice 50<br />

Other 580<br />

Total CIP mitigation £4,790k<br />

YTD position<br />

The <strong>Trust</strong> has achieved savings of £4.3m against a target of £6.5m, a shortfall of £2.2m (34%). This is mainly due to the Unidentified CIP gap of £1.4m. In addition there are<br />

material adverse variances in Diagnostics - £200k - <strong>and</strong> Nursing - £400k - relating to workforce <strong>and</strong> temporary pay reduction schemes.<br />

10


4. BALANCE SHEET<br />

Balance Sheet Current Previous Last<br />

(£m) Period Period Yr End<br />

Aug-12 Jul-12 Mar-11<br />

Non-current assets £390.4 £390.3 £389.1<br />

Current assets<br />

Inventories £5.8 £5.8 £7.0<br />

Trade <strong>and</strong> other receivables £35.1 £40.2 £29.5<br />

Cash <strong>and</strong> cash equivalents £1.4 £5.4 £2.8<br />

£42.4 £51.4 £39.3<br />

Current liabilities<br />

Trade <strong>and</strong> other payables (£67.2) (£69.1) (£48.2)<br />

PFI \ Borrow ings (£6.3) (£6.3) (£5.5)<br />

Provisions (£1.9) (£2.1) (£1.8)<br />

Net current assets/(liabilities) (£33.1) (£26.1) (£16.2)<br />

Non-current liabilities:<br />

PFI \ Borrow ings (£255.8) (£255.8) (£259.9)<br />

Trade <strong>and</strong> other payables (£4.9) (£4.9) (£4.9)<br />

Provisions (£4.2) (£5.6) (£5.0)<br />

Total assets employed £92.4 £98.1 £103.0<br />

Financed by taxpayers' equity:<br />

Public dividend capital £365.7 £365.7 £307.3<br />

Retained Earnings - P&L (£284.7) (£279.1) (£216.4)<br />

Retained Earnings - Donated Assets - - -<br />

Revaluation reserve £11.5 £11.5 £11.3<br />

Donated asset reserve £0.0 £0.0 £0.8<br />

Total taxpayers' equity £92.4 £98.1 £103.0<br />

Current Prior Last<br />

KPIs Period Period Yr End<br />

Aug-12 Jul-12 Mar-12<br />

Average Debtors days 16 17 21<br />

Debtors >90 days (£'000s) £1,240 £1,261 £592<br />

Debtors >180 days (£'000s) £466 £495 £1,536<br />

Debtors >365 days (£'000s) £2,089 £2,034 £2,825<br />

Total Bad Debt Provision (£'000s) £2,412 £2,413 £1,926<br />

>365 days provided (£'000s) £1,822 £1,782 £1,293<br />

Average creditor days 50 53 58<br />

Current ratio 53% 62% 71%<br />

Better payment practice code performance:<br />

- Non-NHS<br />

- Volume - paid on time 1,569 1,781 2,773<br />

- Volume - % paid on time 52.35% 52.41% 27.96%<br />

- Value - paid on time (£'000s) £5,874 £20,475.00 £5,150<br />

- Value - % paid on time 68.33% 78.85% 35.85%<br />

- NHS<br />

- Volume - paid on time 39 185 316<br />

- Volume - % paid on time 33.91% 58.36% 34.39%<br />

- Value - paid on time (£'000s) £169 £904 £1,630<br />

- Value - % paid on time 10.82% 26.25% 30.52%<br />

Key points:<br />

• Overall balance sheet position shows a reduction of £5.7m,<br />

related to the in month I&E deficit The cash position shows a<br />

reduction of £4.0m, compared with July.<br />

Key points:<br />

• Average creditor days reduced from 53 in June to 50 in August whilst<br />

average debtor days reduced from 17 to 16. Value of Non-NHS invoices<br />

paid on time reduced from £20.4m to £5.9m in August this was due to PFI<br />

unitary payment in July of £13.3m.<br />

13


5. CAPITAL AND CASHFLOW<br />

Summary Cashflow - Year to date<br />

£000's<br />

Operating Deficit (9,601)<br />

Interest Paid (12,266)<br />

PDC Dividend Paid 0<br />

Interest received 204<br />

Impairments (1,728)<br />

Transfers -<br />

Net I&E deficit (cash impact) (23,390)<br />

Depreciation <strong>and</strong> Amortisation 5,933<br />

Movements in w orking balances:<br />

Decrease in Inventories (5)<br />

Increase in Trade <strong>and</strong> Other Receivables 2,126<br />

Increase in Trade <strong>and</strong> Other Payables 23,159<br />

Decrease in Provisions (1,622)<br />

- sub-total 6,201<br />

Capital expenditure (6,646)<br />

Revenue Rental Income 546<br />

Net cashflow before financing 101<br />

Capital Element of Finance Leases <strong>and</strong> PFI (3,002)<br />

Loans repaid -<br />

Public Dividend Capital Received -<br />

Net Increase/(Decrease) in Cash <strong>and</strong><br />

Cash Equivalents<br />

(2,901)<br />

Opening cash balance 4,343<br />

Closing cash balance 1,442<br />

Capital Programme Summary Aug-12<br />

Total<br />

Approved<br />

Total<br />

Proposed<br />

Total<br />

Funding<br />

YTD<br />

Expenditure<br />

<strong>2012</strong>-13 <strong>2012</strong>-13 <strong>2012</strong>-13<br />

Internally Funded Assets<br />

Medical Equipment 1,926 1,848 3,774 1,609<br />

IT - Hardware 1,429 299 1,728 737<br />

IT - Software 482 0 482 88<br />

Other Plant & Machinery 500 0 500 0<br />

Estates 3,372 382 3,754 962<br />

sub-Total 7,709 2,529 10,238 3,395<br />

Externally Funded Assets<br />

Pathology 4,342 900 5,242 525<br />

SAN 967 0 967 711<br />

MLU 2,396 0 2,396 217<br />

Access Funded Assets 117 0 117 49<br />

sub-Total 7,822 900 8,722 1,503<br />

<strong>Trust</strong> Variation Enquiries 3,380 0 3,380 225<br />

Total <strong>Trust</strong> - Funded 18,911 3,429 22,340 5,123<br />

Subject to External Approval & Funding<br />

Cardiac Cath Lab 0 1,700 1,700 0<br />

CT Scanners 0 2,000 2,000 0<br />

A&E Reconfiguration 0 3,000 3,000 0<br />

Digital Mammography 0 1,548 1,548 0<br />

PAS Replacement 0 10,000 10,000 0<br />

sub-Total 0 18,248 18,248 0<br />

Total Capital Plan to Date 18,911 21,677 40,588 5,123<br />

Total <strong>Trust</strong> Submitted Plan 40,011<br />

Balance to Submitted Plan (577)<br />

Assets to be Considered via Charitable Funds<br />

Da Vinci Robot 0 2,400 2,400<br />

Cashflow - Key points:<br />

• The net cash position decreased from £5.4 to £1.4<br />

in August.<br />

Capital - Key points:<br />

• Against the total <strong>Trust</strong> Capital Plan of £40.9m, £18.3m of externally<br />

funded schemes have yet to be fully approved (including PAS). Of<br />

the remaining £22.6m, £19.2m of projects have been approved, with<br />

a further £3.4m awaiting business case approval.<br />

• Against this position, year to date capital expenditure is £5.1m, an increase<br />

of £1.3m compared with July.<br />

• The <strong>Trust</strong> has frozen all non-essential capital schemes, pending mitigation<br />

of risk in achieving the £40m revenue control total<br />

14


6. Business Unit Summaries<br />

Attached are the summary financial reports for each of the Clinical Business Units. These show:<br />

1. A graphical dashboard summary of the key financial indicators<br />

2. Key financial variances with mitigating actions, including leads <strong>and</strong> timescales<br />

3. CIP report for the Business Unit<br />

4. Income <strong>and</strong> Expenditure statement for each Business Unit. This shows each Business Unit’s share of the Central Income position <strong>and</strong> their local Income <strong>and</strong><br />

Expenditure position, giving an overall Net Deficit (+) / Surplus (‐) position. All Income is shown as a credit (‐) <strong>and</strong> all variances are expressed as Adverse (‐) or<br />

Favourable (+). It should be noted is not a true SLR report, as none of the central income has been apportioned out to the services that are supporting it (e.g.<br />

Diagnostics, Therapies), rather it represents where the income is coded to. They do show, however, the movement in the relationship between coded<br />

income <strong>and</strong> expenditure between current year to date <strong>and</strong> prior year average for expenditure <strong>and</strong> actual reported income.<br />

5. Forecast outturn, with a reconciliation to the previous month’s forecast.<br />

15

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!